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ABSTRACT 
The intergenic region (IG) transcriptional activity of Mycoplasma hyopneumoniae strain 
232 was studied via two-color microarrays and quantitative real-time polymerase chain 
reactions (RT-qPCR). Two types of microarrays were constructed, one consisting of PCR 
products and the other of synthesized oligonucleotides. The PCR-array consisted of 994 PCR 
products (probes) which covers 98% (683/698) of the total open reading frames (ORFs) of 
strain 232, five structural ribosomal RNA probes, and 159 IG probes for 112 of 215 IG 
regions greater than 124 bp. The oligonucleotide-array consisted of 528 oligonucleotide 
probes ranging in size between 50 and 60 bp, and was designed for IG regions for which 
PCR products were not constructed or the length of the region (50-124 bp). Transcriptional 
signals were identified in 93.6% (321/343) of the IG regions larger than 49 bp. From these IG 
regions with transcriptional activity, five large (>500 bp) IG regions and the region upstream 
of dnaK were chosen for further analysis by RT-qPCR. A novel method to compare the 
relative quantity estimates of several different targets was developed for the RT-qPCR 
assays, and various methods were investigated to obtain error estimates of the fold change 
and relative quantity by applying top-down or bottom-up statistical approaches for two 
different experimental designs. The results from these assays indicate that no single 
transcriptional start site can account for transcriptional activity within IG regions. 
Transcription can end abruptly at the end of an ORF, but this does not seem to occur at high 
frequency. Rather, transcription continues past the end of the ORF, with RNA polymerase 
gradually releasing the template. Transcription can also be initiated within IG regions in the 
absence of accepted promoter-like sequences. Also, when conducting small scale RT-qPCR 
studies, the error in estimation of amplification efficiency should not be ignored in 
determining statistically significant differences. An assay design which uses serial dilutions 
of each individual sample to determine the amplification efficiency of a target sequence is 
favored over an assay design which uses the Stock I methodology to evaluate target sequence 
amplification efficiencies. In summary, methods to analyze the transcriptional activity of M. 
hyopneumoniae have been developed and the results have shown that IG regions are 
transcriptionally active and under some regulatory control. 
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CHAPTER 1. GENERAL INTRODUCTION 
 
Introduction 
The subject of this study is RNA transcription in the microorganism Mycoplasma 
hyopneumoniae. This highly contagious and chronic disease causing bacteria is associated 
with respiratory disease and reduced productivity in swine (2). Pathogenesis is known to 
occur through the adherence of the organism to the cilia of the respiratory epithelia in the 
swine lung, however little else is known about the pathogenic mechanisms (1). Mycoplasmas 
are thought to control gene expression through simple mechanisms because they exist only 
within hosts. Thus, the switching mechanisms needed to regulate transcription during 
significant environmental shifts do not seem to be required for these host-adapted organisms. 
However, several studies have demonstrated differential gene expression in M. 
hyopneumoniae, but the mechanisms involved are largely unknown. Since mycoplasmas 
contain only a single sigma factor and few regulator-type proteins, it is likely that other 
mechanisms control gene regulation, possibly involving intergenic (IG) regions. This 
research increases our knowledge of the RNA transcriptional profile of the IG regions 
through use of microarrays and relative quantitative real-time reverse transcription PCR (RT-
qPCR) technologies. In addition to applying these experimental techniques, sound statistical 
methods for analyzing data from these assays were developed. 
 
Dissertation Organization 
This dissertation begins with a literature review of M. hyopneumoniae and genomic 
transcription in bacteria and specifically what is known about M. hyopneumoniae 
transcription. The background of the experimental technologies and the statistical methods 
applied are also reviewed in Chapter 2. Chapter 3 describes the studies conducted for the 
detection of IG transcription in M. hyopneumoniae. Chapter 4 presents the research on 
experimental design comparison for small-scale RT-qPCR assays. Chapter 5 contains a 
general discussion of the dissertation with a look towards future research. The bibliography, 
acknowledgments, and appendices which include six studies related to M. hyopneumoniae 
transcription complete this document. 
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Summary with Goals and Hypothesis 
The overall goal of this research is to determine if the intergenic regions of M. 
hyopneumoniae are being transcribed into RNA. Additionally, we hope to gain insights into 
the possible mechanisms for transcription control. Experimental design and sound statistical 
analysis are also major objectives of the research. 
 
References 
1. Minion, F. C. 2002. Molecular pathogenesis of animal mycoplasma respiratory 
pathogens. Front. Biosci. 7:1410-1422. 
2. Ross, R. F. 1992. Mycoplasmal disease, p. 537-551. In A. D. Leman, B. E. Straw, W. 
L. Mengeling, S. D'Allaire, and D. J. Taylor (ed.), Diseases of Swine. Iowa State 
University Press, Ames. 
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CHAPTER 2. LITERATURE REVIEW 
 
Mycoplasmas 
 
The first use of the term mycoplasma was by A. B. Frank in 1889 and then later by J. 
Erickson in 1896 to refer to a cytological concept. The first use of the term for taxonomic 
purposes was by J. Nowak in 1929 in the description of a bovine pleuropneumonia microbe 
(71). Throughout this dissertation the later taxonomic use of the term mycoplasma will be 
used and will refer to the genus of the organism that is the focus of this research. 
Mycoplasmas are members of the class Mollicutes, a group of cell wall-less bacteria that 
infect a wide variety of plants and animals (including humans). The class Mollicutes consists 
of low G + C-content eubacteria that are phylogenetically related to the Gram positive 
eubacteria bacilli, clostridia, enterococci, lactobacilli, staphylococci, and streptococci (6, 35, 
87, 90, 91, 124, 165).  The first mycoplasma identified, Mycoplasma mycoides formally 
known as Asterococcus mycoides (109), was cultured in 1898 by Edmund Nocard and Emile 
Roux and described as the microbe of pleuropneumonia (59, 101, 102). Since then, 119 
species in the genus Mycoplasma have been identified and an additional 109 species in 14 
other genera compose the class Mollicutes (45). Though related taxonomically, members of 
the Mollicutes differ significantly in their habitats, their growth requirements, and their 
overall structure (99, 111).  
Mycoplasmas are considered to be the smallest cells that are able to propagate in a cell-
free medium (142), and all mycoplasmas have small genomes with a limited number of genes 
resulting in a lack of biosynthetic pathways (63, 111). They are believed to have evolved 
from more complex organisms through degenerative evolution with the concomitant loss of 
genetic material (39, 99). It has been proposed that their interactions with a host are less 
complex due to their minimal genome with limited coding capacity (85). The lack of 
biosynthetic pathways implies that they obtain amino acids, purines, pyrimidines, and 
membrane components from their growth environment. For the members of the family 
Mycoplasmataceae, the animal pathogens, this occurs primarily at the host mucosal surface 
where damage to host cells occurs through different mechanisms (117). 
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Mycoplasma hyopneumoniae 
Background 
The subject of this study, Mycoplasma hyopneumoniae, is associated with respiratory 
disease in swine resulting in reduced productivity. It is the causative agent of porcine 
enzootic pneumonia, and when co-infections occur with a secondary (bacterial or viral) 
infection, the respiratory disease is more severe and has been designated as porcine 
respiratory disease complex (126). Even though the virulence of M. hyopneumoniae appears 
to be low, substantial economic losses occur as a consequence of reduced average daily gain 
and efficiency of feed utilization, prophylactic and therapeutic costs, and mortality (110, 
126). Control measures such as vaccines are beneficial in limiting the disease, but do not 
prevent the establishment of M. hyopneumoniae infections in the lung. Thus, infections are 
endemic in almost every herd worldwide (90). 
Mycoplasma hyopneumoniae is one of the smallest free living organisms known and has 
a round or oval cell morphology that ranges in size from 400 to 1200 nm (149). It was first 
cultured in 1965 (88), and the genome of strain 232 was sequenced in 2004 (91). In 2005, 
two additional strains, one pathogenic (strain 7448) and one non-pathogenic (strain J) were 
sequenced (154). The genomes of these 3 strains are all less than 1 Mbp (strain 232: 892,758 
bp; strain 7448: 920,079 bp; strain J: 897,405 bp) and have a low G + C content (strain 232: 
28.6%; strain 7448: 28%; strain J: 28%). The number of predicted coding sequences is also 
low (strain 232: 698; strain 7448: 681; strain J: 679) and their average CDS length are similar 
(strain 232: 1164; strain 7448: 1190; strain J: 1178) (91, 154). 
Transcription is essential to the basic process of gene expression, but surprisingly, little 
information has been obtained experimentally for defining the transcription process in 
mycoplasmas (96). Due to the difficulty in growing cultures in vitro and the lack of genetic 
tools, advancements in the knowledge of gene expression in mycoplasmas are rudimentary 
with few studies that actually address the mechanisms involved (9, 22, 53, 80, 161, 162). 
Studies of M. hyopneumoniae has been particularly limited by fastidious growth 
requirements, poor growth on agar media, and the difficulty of establishing infections with 
lab grown organisms in swine (90).  
Pathogenesis 
In general, mycoplasmas are infective to a single host species and cause diseases that are 
generally chronic where the infectious agents typically have mechanisms to circumvent the 
immune response of the host (6). They are obligate parasites which obtain many essential 
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molecules from their host (14). Often these chronic infections enhance the virulence of other 
infectious agents resulting in synergistic pathogenesis. Mycoplasma hyopneumoniae is 
typical in that it infects only swine, but the mechanisms for host specificity are unknown (6). 
It causes enzootic pneumonia disease which is chronic and self limiting in swine and is a 
primary component in Porcine Respiratory Disease Complex. It colonizes the epithelia of the 
respiratory track by attaching exclusively to the cilia. This results in ciliostasis and death of 
the epithelia cells of the lung (85, 90). 
Virulence factors of M. hyopneumoniae are poorly understood. For example, there is no 
evidence for many genetic diversity mechanisms found in other mycoplasma species such as 
1) intragenic recombination to form chimeric genes, 2) phase switching due to poly(A) tracts 
in promoter regions, structural gene sequences or DNA inversions, or 3) small sequence 
changes and/or recombination events (86). Infections tend to induce a slow and ineffective 
immune response with immunopathologic changes such as decreased phagocytic activity in 
alveolar phagocytes, decreased responsiveness in lymphocytes to nonspecific mitogens, and 
production of proinflammatory cytokines (90). Due to the difficulty in studying cultures of 
M. hyopneumoniae, most early studies focused on descriptive studies of infective tissue and 
in vitro interactions of various cell types (90). The mechanisms of adherence and ciliostasis 
are the most studied.  
 
Promoter Structure in Bacteria 
Transcription 
Transcription is the process of RNA synthesis where RNA polymerase (RNAP) uses 
DNA as a template to synthesize a complementary single strand of RNA (62, 167). The RNA 
complement to DNA is similar to the DNA complementary strand synthesized during 
replication with two major exceptions: 1) RNA nucleotides contain ribose instead of 
deoxyribose, and 2) RNAP replaces thymine bases with uracil. The process of transcription is 
generally thought of as the first step in gene expression where DNA is made into messenger 
RNA (mRNA) which is then translated into a protein. In addition to mRNA there are several 
other RNA molecules synthesized by transcription such as ribosomal RNA (rRNA), transfer 
RNA (tRNA), and ribozymes or other catalytic RNAs (5, 8, 62, 153, 167). 
The process of transcription may be divided into three major steps: initiation, elongation, 
and termination (153). For initiation to occur, RNAP must first be reversibly bound by a 
sigma factor to form a holoenzyme which then is able to recognize specific promoter regions 
in the DNA (62). The promoter regions in Gram negative bacteria are the -35 region and the -
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10 (Pribnow box) region and the corresponding promoters in Gram positive bacteria are -26 
and -11 region (167). The minus sign indicates the number of bases upstream of where 
transcription of the DNA starts. The holoenzyme binds via the sigma factor to the double 
stranded DNA at the promoter region to form what is referred to as the closed complex. 
Approximately ten to twelve basepairs of DNA are then unwound near the transcription 
initiation site (+1) to form the open complex which allows RNA transcription to begin. For 
transcription to continue, the sigma factor must disassociate from the holoenzyme where it 
may then be bound by another RNAP molecule. If the sigma factor is not cleared, then only a 
truncated RNA transcript is synthesized, and the holoenzyme disassociates from the DNA. 
Thus the disassociation of the sigma factor from the RNAP molecule is the start of the 
elongation step. Elongation of the mRNA is carried out by the RNAP molecule moving along 
the DNA template in the 3′ to 5′ direction synthesizing RNA in 5′ to 3′ direction (62, 167). 
Elongation continues until termination occurs generally by either of two mechanisms: rho-
independent and rho-dependent termination (158). In rho-independent termination, a 
terminator sequence is synthesized in the nascent RNA molecule and a tertiary structure 
forms that signals the RNAP to stop synthesizing RNA. Terminator sequences are usually 
palindromic and form a stem-loop hairpin structure that results in RNAP disassociating from 
the DNA. In rho-dependent termination, a protein called the rho factor binds the nascent 
RNA at a specific site and moves along the RNA towards the RNAP molecule. The RNAP 
molecule will pause upstream of the terminator region due the formation of a stem-loop 
hairpin structure. The rho factor will catch up to the RNAP and cause it to disassociate from 
the DNA thereby terminating transcription (5, 8, 62, 153, 158, 167). 
Synthesized RNAs are the products of structures called Transcriptional Units (TU). An 
organism's DNA contains many TUs which are composed of a regulatory region upstream of 
a gene (up to 400 bp), a transcriptional start site, one or more open reading frames (ORF), 
and a transcriptional termination site. The regulatory region is a cis element that regulates 
transcription. There are several trans factors that affect transcription, but the most important 
is RNAP and various sigma factors as described above. However, there are other trans 
elements such as anti-sigma factors and transcription factors (TFs) that can modulate 
holoenzyme binding. Some TFs promote binding while others inhibit binding. Most 
inhibition is the result of a TF binding the DNA at the -35 and/or -10 promote sites thereby 
preventing the binding of the holoenzyme, whereas TFs that promote transcription usually 
bind upstream of the promoter regions and help recruit the holoenzyme to the promoter sites. 
The DNA regions to which TFs bind are called transcription factor-binding sites (TFBS) (5, 
8, 153). If more than one ORF is transcribed into one mRNA molecule, the mRNA strand is 
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called polycistronic otherwise it is monocistronic. Some ORFs are transcribed from multiple 
promoters, yielding several overlapping TUs in the organism's genome (8, 139, 153).  
Transcriptional regulation of TUs is important for precise gene expression for forming 
the molecular machinery needed for growth and development. In 1959, the first evidence of 
transcriptional regulation was observed in the lac operon of Escherichia coli (106). Since that 
initial observation, many molecules and modes of action have been identified that modulate 
gene expression. Transcriptional regulation mainly occurs at the initial binding of RNAP to 
DNA (e.g., TF), the creation of the transcriptional bubble (isomerization), and the initial 
elongation process of the mRNA (153). Sigma factors are essential small proteins that 
regulate gene expression at the initiation step of transcription. In E. coli, there are two main 
families of sigma factors: σ54 and σ70. Members of the σ70 family are generally involved with 
control of gene expression under normal growth conditions with the one exception of a 
subgroup that is involved with an environmental stress response and is referred to as 
extracytoplasmic factors. Members of the σ54 family are associated with the limited nitrogen 
stress response. The associated promoter consensus sequences for these two families are 
considerably different and are the basis for the differentially binding of the RNAP molecule. 
Most sigma factors have associated anti-sigma factors that bind to the factor and prevent 
them from binding with RNAP. Transport systems also modulate sigma factor activity by 
sequestering them until environmental conditions induce their release (62, 167).  
Transcription factors are another large group of proteins that regulate gene expression by 
acting like regulatory switches during the initial binding of RNAP to DNA. Most TFs are 
single proteins with two functional domains, but one exception is two-component systems 
which form a functional complex, usually in the membrane. Transcription factors may be 
classified into several families based on their two functional domains: the signal sensor 
domain and the response domain (8, 153). The signal sensor domain operates via ligand 
binding or through protein-protein interactions. Once the signal sensor is activated, it induces 
the response domain to interact with the TFBS thereby modulating transcription. This 
modulation may be either an activation or inhibition of transcription. The TF usually binds 
the TFBS upstream of the promoter region during activation and helps to recruit the RNAP 
molecule, whereas during inhibition, the TF will often bind the TFBS near the promoter 
region preventing sigma factors from finding the promoter. Several different TF may bind 
multiple TFBSs with varying degrees of affinity. This degeneracy of TF-TFBS binding leads 
to a variable, stochastic type of transcriptional regulation. If the TFBS has weak affinity for a 
TF, high concentrations of TFs are needed to induce function; whereas if the TFBS has a 
strong affinity for a TF, low concentrations of TFs will induce function. In general, local TFs 
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tend to have strong affinity to TFBS and will function at lower concentrations since they are 
more specific and targeted, whereas global TFs tend to have weak affinity to TFBS and will 
function only at higher concentrations since they are less specific. Some TFs also have dual 
activity where they activate transcription of one gene while inhibiting another at the same 
time (5, 8).  
Presently it is not possibly to reliable predict DNA binding activity of TFs from protein 
structure, thus experimental techniques are needed to confirm predictions. In general though, 
it has been observed that the number of TFs increases in squared proportion to the total genes 
in the genome which suggests that larger genomes have greater regulatory complexity. 
However, recent evidence suggests that genome size is independent of mean number of 
TFBSs per regulatory region (8). Another difficulty in predicting TF binding activity is that 
TFs can differ significantly between phyla, families, and even the genetic targets of a given 
regulon between closely related species (5). In fact, often orthologous TFs regulate different 
sets of genes in related bacteria species (107). 
Transcription factors and sigma factors are the most prominent features in bacterial gene 
regulation due to their impact on the RNAP molecule, but other elements such as 
riboswitches, small non-coding RNAs (sRNA), RNA-binding proteins, protein-protein 
interactions, promoter escape regulation, DNA supercoiling and methylation, and mRNA 
degradation also modulate gene expression in important ways (89, 139, 148, 153). 
Riboswitches and other sRNAs are sometimes referred to as microRNAs and will be 
described in more detail in the section on microRNAs below. Gene expression regulation 
through the modulation of mRNA translation commonly occurs via RNA-binding proteins 
and protein-protein interactions whereby ribosome activity is disrupted during mRNA 
translation. The two-component system is another common example of protein-protein 
regulation where membrane-bound histidine kinase senses an environmental cue and in 
response catalyzes the transfer of a phosphate group to a response regulator to activate it 
(89). The ability for RNAP to continue past the promoter region and enter into active 
transcription is regulated by its affinity to the promoter region, the exit of the sigma factor 
from the RNAP molecule, and by the binding of other RNAP molecules to adjacent promoter 
sites. In the later case, the RNAP molecule needs an open path to progress along the DNA in 
order to transcribe mRNA, but it may be blocked by another RNAP molecule. If RNAP is 
blocked, the molecule may pause and then fall off before completely transcribing the mRNA 
strand (8, 62, 107).  
The architecture of the DNA plays a significant role in gene expression. In order for the 
holoenzyme to recognize a promoter sequence, access to the DNA is necessary. Supercoiling, 
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bending, and packing of DNA are all modulated by DNA chaperones and accessory proteins. 
Bending proteins, such as IHF, HU, and Fis, and DNA bridging proteins (H-NS) affect the 
packing of the DNA (8). Also the location and orientation of the TFBS in relation to the 
regulate gene is important. In general, the TFBS is on the same side of the DNA helix as the 
promoter in order for a bound TF to have an effect on the RNAP molecule. Thus, a highly 
active TF may have no influence if the TFBS is on the opposite side of the helix or is in the 
wrong orientation for the TF to be active (107). Epigenetic factors such as DNA methylation 
and cellular components of the mother cell further affect gene transcription (8).  
The lifespan of synthesized mRNA also plays an important role in gene expression since 
a single mRNA strand may be translated several times by numerous ribosomes, often in a 
continuous fashion. Thus, the degradation of mRNA by RNase E and RNase III is an 
important process to limit the amount synthesized protein. These ribonucleases degrade 
double stranded RNA, thus sRNAs may facilitate the formation of RNA duplexes for their 
endonuclease activity (139, 160). 
MicroRNAs (sRNAs, ncRNAs) 
Small non-coding regulatory RNAs vary in size from 50 to 500 nt with the majority of 
them 100 to 200 nt in size. They are small in comparison to a typical mRNA strand which is 
about 1000 nt (4, 52, 155, 160). They are generally found in the intergenic regions and 
several have been identified as the ‘missing link’ in various regulons (4, 155). A uniform 
nomenclature for sRNAs has not been resolved as of yet. In bacteria, the term small RNAs 
predominates, whereas in eukaryotes, the term non-coding RNA or microRNA predominates. 
Furthermore, the discovery and naming of several sRNAs in E. coli occurred in parallel at 
different laboratories resulting in multiple names (145, 155). The term sRNA will be used 
throughout this section and any example sRNA named will use the name from the source 
literature.  
Across many bacterial species, hundreds of candidate regulatory sRNA genes have been 
predicted and several have been experimentally confirmed through the use of various 
technologies such as multilayered computational searches, deep sequencing, RNA labeling 
and staining, functional genetic screens, shotgun cloning (RNomics), co-purification with 
proteins, and full genome tiled microarrays (155, 160). Diverse cellular functions such as 
RNA processing, DNA maintenance and stability, mRNA stability and translation, and 
protein stability and secretion have been observed to be regulated by sRNAs (52, 159, 160). 
These functions are modulated through various mechanisms such as conformation changes in 
target RNA, protein and RNA binding, and DNA interactions. A division of sRNAs into 
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broad classes based on mechanism action is: riboswitches, RNA binding, protein binding, 
and CRISPR (clustered regularly interspaced short palindromic repeats). Riboswitches are cis 
elements that are part of the transcribed mRNA that undergoes conformational changes in 
response to small molecules, such as nutrients, and thereby affect the transcription or 
translation of the mRNA. The sRNAs that bind other RNAs act as trans elements that 
modulate the target RNA stability and translation in response to environmental effects. The 
sRNAs that bind proteins are also trans acting elements that generally inhibit protein activity. 
However some protein-binding sRNAs have intrinsic activity or contribute essential 
functionality to the protein. The CRISPR elements contain homologous regions to 
bacteriophage and plasmid sequences that interfere in bacteriophage infection and plasmid 
conjugation through an unknown mechanism that probably involves this homology (159, 
160). Each of these four regulatory mechanism-based classes of sRNAs is described in more 
detail below. 
Riboswitches are metabolite sensors that are generally found on the 5′-UTR of the 
mRNA they regulate. Thus, they are both cis encoded and cis acting (160). Riboswitches are 
most often composed of two functional domains: an aptamer region that binds a ligand and 
an expression platform that regulates gene expression. Ligands binding these riboswitch 
regions regulate gene expression via RNA structures that alter transcription or translation. 
For example, in response to changing environmental conditions such as a reduction in 
nutrients, a buildup of uncharged tRNAs, heat shock, and presence of ligands, the aptamer 
region senses the signal via binding the signal, and in response to that binding, the expression 
platform changes conformation. This conformational change of the expression platform 
results in a regulatory activity such as ribosome binding in order to stall translation. Most 
riboswitches act as repressors in the presence of the ligand, but a few activators have been 
characterized. Riboswitches in Gram positive bacteria generally attenuate transcription, 
whereas in Gram-negative bacteria, translation is generally attenuated (160). Thus, 
riboswitches have several modes of action, and in fact, some mRNA strands have tandem 
riboswitches and others have riboswitches that act as ribozymes to catalyze self cleavage. 
Riboswitches with multiple aptamers bound with ligands confer a more substantial change in 
the tertiary structure of the expression platform thereby increasing their regulatory activity 
(160). 
The sRNAs that bind other RNAs are the most extensively studied class of sRNAs. They 
may be divided into two broad categories: those that have potential for extensive base pairing 
and those that have limited potential for base pairing. The first category is made up of cis-
encoded transcripts that act in a trans fashion. These constitutively expressed sRNA are up to 
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75 nt in length and are transcribed from the opposite strand of the mRNA that they regulate 
and thus have potential for extensive base pairing with the target mRNA. The most studied 
sRNAs of this type are the antisense sRNAs on plasmids. The function(s) of these sRNAs are 
not well understood, but it has been noted that they are constitutively expressed, and some 
promote the degradation and/or repress the translation of mRNAs that encode proteins that 
are toxic at high concentrations. They have also been implicated in the regulation of the 
expression of operons (121, 145, 159, 160). 
The other category of RNA binding sRNAs is trans-encoded. This is the most commonly 
known type of sRNA and generally acts by modulating translation and stability of mRNAs 
via imperfect base pairing. The main mode of action is the repression of gene expression by 
preventing ribosome binding and then the subsequent degradation of the RNA-RNA duplex, 
thereby enhancing the repression in an irreversible mode of regulation. The activation of 
gene expression has also been noted through an anti-antisense mechanism where an anti-
antisense sRNA binds an antisense sRNA that targets an mRNA for repression. The 
chromosomal location of the sRNA and its target mRNA are not correlated and typically the 
sRNA will have multiple mRNA targets (160). The binding region is generally small (10-25 
nt) and is believed to require the chaperone protein Hfq to mediate duplex formation in this 
small complementary region that may be discontiguous and an imperfect match to the target 
RNA. The binding of Hfq to the duplex also appears to enhance the degradation activity of 
RNase E. However, only half of the sequenced bacterial genomes have Hfq homologs. Thus, 
the requirement for Hfq for RNA-RNA duplex formation may not be universal, especially for 
regions with longer stretches of complementary base pairing. These sRNAs appear to be 
under environmental control and may act in a similar fashion as TF with multiple TFBS, but 
at the post-transcriptional level (121, 145, 155, 159, 160).  
The sRNAs that act through protein binding are less well studied. These are trans acting 
regulatory sRNAs that are generally discrete transcripts with their own promoter and 
termination site. They act via binding proteins and may either enhance or repress activity of 
the protein. Some protein binding sRNAs have been identified to contribute to the function of 
the protein (e.g., 4.5S and tmRNA) or have intrinsic activity such as the ribozyme RNase P. 
While other protein binding sRNAs, repress their targets by mimicking the structures of other 
nucleic acids (155, 160).  
The CRISPR element is a sRNA that is believed to provide a defense against 
bacteriophage infection and plasmid conjugation. It has been found in ~40% of the 
sequenced bacteria genomes and ~90% of the sequenced Archaea genomes (160). The 
CRISPR sequence consists of ~550 nt leader sequence followed by a series of palindromic 
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repeat sequences with spacers in-between. The repeat sequences are conserved across 
species, but the spacer regions are diverse even among strains of the same species. 
Furthermore, the spacer region sequences are homologous to bacteriophage and plasmid 
sequence. This homology in the sRNA is believed to be used to target the invading DNA, but 
the mode of action for defense is not known (160). 
Approximately 140 sRNAs have been identified to date in bacteria with the potential of 
hundreds more to be discovered (4, 121). The functions of some are unknown, and the three 
dimensional structure has yet to be solved for any of them (160). Additionally, the 
relationship between the target mRNA and sRNA is not mutually exclusive. That is, several 
different sRNAs may regulate a given mRNA target, and a given sRNA may target several 
different mRNA strands. Redundant homologous and repetitive sRNAs may act additively by 
responding to different environment cues to induce a complex response, and they may 
compensate for the loss of any one of them. There are also some sRNAs with dual activity in 
that they code for proteins in addition to their regulatory functions. These dual acting sRNAs 
are generally RNA-binding trans-encoded genes that may bind target mRNA as well as code 
for protein. It is also suspected that riboswitches that catalyze autocleavage or are a result of 
transcription attenuation may result in diffusible sRNSs that have addition functions (155, 
160). 
The advantages of sRNA as regulators are quite varied. Since they are shorter than 
mRNAs that need to be translated into proteins, they are much less energy costly and faster 
for the cell to produce in response to environmental cues. For example, the cis-acting 
riboswitches are extremely fast and sensitive due to being coupled with the mRNA they 
regulate. Also, the response property for sRNAs appears to be threshold based versus linear 
response. Thus, they do not induce cellular changes in response to small or transient 
environmental signals but instead produce a strong and reliable repression of gene expression 
when the signals are strong or persistent (160). Therefore sRNAs have key roles in important 
regulatory cascades such as stress response and expression of virulence factors. They act on 
top of and in addition to other transcriptional regulators and protein stability mechanisms, 
thereby providing a rapid response to changing environmental conditions (52). 
 
Transcriptional Control in Mycoplasmas 
 
Gene expression regulation is not well understood in mycoplasmas. They lack several 
regulatory mechanisms of other bacteria such as multiple sigma factors, well-defined 
transcriptional start sites and terminators, and two-component systems (9, 22, 29, 35, 41, 49, 
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55, 64, 80, 83, 150, 151, 157, 171). An analysis of mycoplasmal genomes have shown that 
they contain a complete gene set for replication, transcription, and translation processes but 
lack annotated genes for post-translational modification (142). Recent studies using 
microarrays to study global transcriptional changes clearly show that M. hyopneumoniae can 
regulate its genes in response to environmental changes (84-86, 105, 130). These studies give 
a snapshot of transcription across the genome in the annotated genes, but they lack the ability 
to discover basic features of transcription such as start and stop sequences and mechanisms 
of regulation. The effects of transcriptional changes in mycoplasmas is suspected to be 
greater due to their smaller volume (~ 0.1 μm3) than E. coli (~ 3 μm3) with smaller numbers 
of gene products resulting in higher effective concentrations (86). A summary of what is 
known about mycoplasmal transcription and gene regulation is discussed below.  
Mycoplasma genetic tools 
One reason for limited knowledge on gene regulation in mycoplasmas is the lack of 
genetic tools available to study them and the difficulties of applying the ones that do exist. 
Genetic tools that are well developed in model organisms such as E. coli and Bacillus subtilis 
have not been successfully adapted to mycoplasmas. For example, the use of the UGA codon 
for tryptophan in place of a stop codon has been a major obstacle in the expression of 
mycoplasma proteins in heterologous hosts (35). Another obstacle in some mycoplasmas is 
the insufficient efficiency of homologous recombination. The use of homologous 
recombination to construct targeted gene knockout mutants has been hampered by what is 
thought to be insufficient expression of the initial recombination genes and the resolution of 
Holliday junctions in mycoplasmas especially in Mycoplasma pneumoniae. However, there 
has been some success with mycoplasmas such as Mycoplasma genitalium, Mycoplasma 
gallisepticum, and Mycoplasma pulmonis (57).  
Due to the difficulties with constructing gene deletions via homologous recombination, 
transposon mutagenesis is the only method left to construct specific gene mutations. The 
Gram-positive transposons Tn916 and Tn4001 and their various derivatives have been used 
in several mycoplasmal species such as Mycoplasma agalactiae, Mycoplasma athritidis, 
Mycoplasma bovis, M. gallisepticum, M. genitalium, Mycoplasma hominis, Mycoplasma 
hyorhinis, M. mycoides, M. pneumoniae, and M. pulmonis (20, 23, 33, 34, 60, 70, 119, 122, 
164). Due to the random nature of transposon integration, it is necessary to screen large 
transposon mutant libraries. This difficulty is mitigated somewhat by haystack mutagenesis 
which is a recent technical method developed to screen large number of mutants in an 
efficient fashion (57). An additional problem to the random nature of transposon integration 
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is that transposons may change the genetic context at the site of integration resulting in 
undesirable side effects. Plasmids can avoid these side effects but mycoplasmas are not 
generally known to have naturally occurring plasmids (35, 98), although a cryptic plasmid 
that only encodes genes for replication has been identified in M. mycoides subsp. mycoides 
(12) and other plasmids have been identified in Mycoplasma capricolum subsp. capricolum 
and Mycoplasma cottewii (98). Artificial plasmids have been constructed but after several 
passages these plasmids tend to integrate into the host cell chromosome at the oriC site via 
homologous recombination (15). It is projected, though, that with the availability of 
sequenced genomes, stably replicating oriC plasmids will soon be constructed to overcome 
this difficulty.  
These plasmid and transposon genetic tools have been used in a few studies aimed at 
identifying and defining promoters in mycoplasmas. The lacZ gene and fluorescent proteins 
on plasmids or part of transposable elements have been developed and used with some 
success in mycoplasmas. The lacZ reporter system has been developed for the following 
mycoplasmas: M. genitalium, M. gallisepticum, M. pulmonis, M. arthritidis, M. capricolum, 
and M. pneumoniae (34, 56, 65, 77, 80). The green fluorescent protein (GFP) has been 
developed using standard cloning vectors and then transferred to targeted mycoplasma 
species via a transposon delivery system (29). The study of promoter activity in vivo is 
difficult due to the lack of a plasmid transformation system in mycoplasmas (83), but the 
tools are now available to overcome many of the obstacles for genetic analysis and need only 
to be adapted to specific mycoplasma species.  
Mycoplasma transcription 
The RNAP molecule of mycoplasmas resembles RNAP in other bacteria in that it 
contains rpoA (alpha subunit), rpoB (beta subunit), and rpoC (beta prime subunit) genes, but 
it lacks the rpoZ (omega subunit) gene of E. coli (83). A single sigma factor homologous to 
the σ70 of Gram negative and σA of Gram positive bacteria completes the holoenzyme. 
However, homologues to the stress response gene rpoE (delta subunit or σE) have been 
identified in four Mollicutes genomes (M. pneumoniae, M. genitalium, M. gallisepticum, and 
Ureaplasma urealyticum) (83). There is a dearth of sigma factors in comparison to organisms 
like E. coli with at least six sigma factors and B. subtilis with eighteen sigma factors. This 
suggests that mycoplasmas either don’t need to respond to changing external conditions or 
the RNAP molecule doesn’t need alternative sigma factors for selectivity (83). The -10 and -
35 promoter sequences common in Gram negative bacteria are present in mycoplasmas (35, 
51, 83), but the -35 region often has weak consensus and is suspected to not be necessary for 
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transcriptional initiation (9, 29, 51, 55, 57, 154, 157). The weak -35 region and AT richness 
of the intergenic regions leads to poor promoter prediction (83). In addition, it is important to 
note that a definitive description of promoter sequences in mycoplasmas, particularly M. 
hyopneumoniae, has not been obtained.  
Transcriptional termination is also not well understood. The Rho protein has not been 
found in any sequenced mycoplasmal genome (9, 28, 80, 83, 118, 158) which suggests that 
rho-independent termination is the likely mechanism of transcriptional termination. 
However, free energy calculations of regions downstream of stop codons of known genes do 
not indicate that hairpin loops are likely to form (158). Although the Rho protein gene has 
not been found in mycoplasma genomes, rho-dependent cofactors NusA, NusB, and NusG 
and elongation factor greA (factor G) have been identified in several Mollicute genomes and 
are believed to be involved in transcription termination (25, 83). The lack of well-defined 
mechanisms for transcription termination has lead many researchers to suggest that a 
majority of the genes are transcribed due to run-on transcripts from upstream genes (83).  
Most gene regulation in mycoplasmas is believed to occur at the transcriptional level due 
to the low number of putative regulatory proteins such as CcpA (58) and the fact that the 
protein synthesizing machinery of bacteria are often directly associated with the DNA as it is 
being transcribed (83). Only five proteins in M. hyopneumoniae and eight proteins in 
Mycoplasma synoviae have been identified to contain DNA-binding motifs (83). 
Mycoplasma mycoides has some regulatory proteins such as fur (ferric uptake regulator), 
fruR (transcriptional repressor of the fructose operon), and sucrose PTS 
(phosphoenolpyruvate-dependent phosphotransferase system) repressor (83, 120). The few 
regulators identified in M. pneumoniae are the proteins HrcA (heat shock transcription 
factor), HPrK/P (phosphoenolpyruvate kinase/phosphorylase) of the PTS (sugar 
phosphotransferase system), and PrpC (protein phosphatase) (55, 120). These three potential 
transcription regulators make up less than 0.5% of all the M. pneumoniae genes, whereas 
Pseudomonas aeruginosa, an environmental bacteria, devotes about 10% of their genes for 
regulating gene expression (133). Additionally, homologs of the chaperone protein Hfq has 
not found via BLAST searches in any mycoplasma genome (146, 152).  
The HrcA protein is a negative regulator of the heat shock response (95, 123, 134). All 
twelve completely sequenced mycoplasmal genomes contain the hrcA gene, but only the 
single sigma factor could be identified. A potential CIRCE element (an inverted repeat) 
upstream of dnaK was identified in the M. hyopneumoniae genome and was shown to 
interact with the HrcA protein (22). However, no evidence of other heat shock repressors 
CtsR and HspR were found in any the mycoplasmal genomes (22, 97, 140). The authors 
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predict all mycoplasmas that contain hrcA use the HrcA-CIRCE negative regulatory 
mechanism and propose that they have evolved this mechanism as a single repressor system 
due the absence of other heat shock repressors such as CtsR and HspR. A single repressor 
system is perhaps the most simple and economical means for a heat shock response in the 
reduced genome of mycoplasmas (22). 
A proteomic study of ackA (acetone kinase) and ldh (lactate dehydrogenase) genes in M. 
pneumoniae demonstrated that they are regulated in a carbon source-dependent manner (55). 
In the presence of glycerol, the ackA gene is repressed and the ldh gene is induced, whereas 
the response is reversed in the presence of glucose, where the ldh gene is repressed and the 
ackA gene is induced. Sequence analysis and mapping promoters via primer extension 
analysis and lacZ reporter fusions found that the ackA and ldh genes lack a SD sequence, but 
they both contain a putative -10 consensus sequence. Furthermore, promoter recognition and 
transcription initiation was not greatly influenced by the sequence at the -35 region. Another 
caveat is that it is difficult to define the M. pneumoniae SD consensus sequence since only 
about twenty genes in the genome contain a SD sequence in their leader mRNA that is 
complementary to the 3′ end of the 16S rRNA. The authors conclude that regulation of 
expression must be by some other mechanism than differential promoter activity since the 
activity of these promoter regions is constitutive for both genes (55, 58). They go on to 
suggest that translation regulation by regulatory RNAs and mRNA processing may be 
important in the regulation of expression of these genes due to a lack of regulatory proteins 
and few transcriptional signals (55).  
In another study on glycerol metabolism genes, the carbon source had no influence on the 
expression levels of glpF, glpK, and glpD (58). Glucose, fructose, and glycerol are the only 
carbon sources used by M. pneumoniae, but these three glycerol metabolism genes were 
constitutively expressed under growth conditions with any one of these carbon sources. That 
is, there is no catabolite repression of gene expression. An attempt to construct knockout 
mutants via haystack mutagenesis resulted in only a glpD knockout mutant. The low 
probability of not constructing a nonessential knockout gene mutant suggests that glpF and 
glpK are essential genes. The authors propose that essentiality and constitutive expression of 
these two glycerol metabolism genes suggests that they have additional functions (58). 
The hmw gene cluster in M. pneumoniae has been analyzed in detail for transcriptional 
behavior. This gene cluster consists of ten ORFs, three of which are known to be essential to 
cytadherence (p30, hmw3, and hmw1), six of unknown function, and the last ORF is the 
putative ribosomal protein S4 (rpsD) (30, 157). This locus is flanked by putative 
transcriptional terminators suggesting it is a single transcriptional unit, but four probable 
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transcriptional start sites containing sequences that have homology to the Pribnow-Schaller 
box are at -10 regions within this locus. As with many mycoplasma transcription units, 
corresponding -35 regions were not identified. Two of the putative transcriptional start sites 
mapped by primer extension and S1 nuclease studies are at the beginning of the gene cluster 
while the other two are internal to the locus. This evidence suggests that overlapping 
transcripts may result from the genes in this locus. A Rho-factor independent terminator 
downstream of hmw3 was identified (30), but this internal terminator may act as an 
attenuator since it precedes the hmw1 gene and has weak free energy value in comparison to 
the second putative terminator located at the end of the gene cluster (157). Mycoplasmas lack 
obvious transcriptional regulators; however the evidence of multiple promoter-like structures 
and overlapping transcriptional units suggests a complex transcriptional organization and 
regulation. Furthermore, the presence of rspD in this probable co-transcribed RNA suggests 
that coordinate function is not always inferable in these transcriptional units (157). 
A sRNA was discovered in both M. pneumoniae and M. genitalium within the pdh 
(pyruvate dehydrogenase) gene cluster. In M. pneumonia, a 205-210 nt RNA fragment is 
encoded from a 319 bp intergenic region between pdhB and pdhC, and in M. genitalium, a 
homologous 170-180 nt RNA fragment is encoded from the 253 bp intergenic region 
between pdhB and pdhC. A putative promoter was found in the -10 region of the M. 
pneumoniae intergenic region between pdhB and pdhC, and similar to other genes, no 
consensus sequence was found in the -35 region. The RNA fragment has a predicted 
secondary structure which suggests it may be a regulatory RNA that binds other RNAs or 
proteins. The sRNA may have some intrinsic activity or this fragment may also encode a 
protein, but the authors could not assign one of these functions and did not rule out that it 
may have multiple functions (51). 
Another gene cluster analyzed for its transcription behavior is the gene cluster containing 
the ftsZ gene in M. genitalium and M. pneumoniae (9). The most conserved bacterial cell 
division gene is ftsZ which codes for a tubulin homolog that is involved in mechanical 
invagination of a dividing cell (2, 81, 103) and is often in the dcw (division and cell wall) 
gene cluster of many bacteria. Since M. genitalium and M. pneumoniae lack a cell wall, their 
cluster consists of only four genes (M. hyopneumoniae only has three) in comparison to 
sixteen genes in E. coli and seventeen genes in B. subtilis dcw gene clusters (2, 9). In 
addition to the four genes of the dcw cluster in M. genitalium and M. pneumoniae, there are 
two amino acid permease genes that are adjacent and downstream of the dcw cluster, but 
these two genes are not preceded by a hairpin terminator sequence (9). There is a hairpin 
terminator after the second permease gene in M. pneumoniae, but not in M. genitalium. 
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Termination of M. genitalium does occur after the second permease gene but does so by an 
unknown mechanism at two closely spaced points. One promoter preceding the permease 
genes was found in M. genitalium, but not in M. pneumoniae. An analysis of the mRNA 
levels of this locus showed a decreasing gradient of mRNA from the first gene to the last and 
across gene junctures that differed by no more than five-fold in concentration (9, 83). 
Surprising to the authors, the analysis also detected transcripts of non-coding regions (10 fold 
higher than the detection level), albeit at much lower levels (20-100 fold lower than coding 
regions) (9). Thus, experimental and analytical evidence suggests that these six genes with 
disparate functions are co-transcribed from this locus. The regulation of transcriptional 
initiation is uncertain, but there is evidence of a strong -10 region in M. pneumoniae and as 
with other mycoplasmal genes, a weak or non-existent -35 region. Both mycoplasmas 
terminate transcription discretely downstream of the second permease gene, but this 
termination was not 100% efficient due to the existence of some longer transcripts, albeit at 
low levels. This lack of definitive transcriptional terminators suggests that functionally 
unrelated genes are often co-transcribed due to “run-on” transcription from upstream 
promoters since no Rho factor has been identified and only rare weak hairpins are present to 
terminate transcription (9, 83). 
A recent study defined the complete metabolic map of M. pneumoniae (171). As with 
other mycoplasmal studies, TFs that regulating metabolic gene factors such as CRP are 
lacking as well as major sigma factors and other regulators. However, a few regulator factors 
were identified, some of which had been previous noted. For example, four TFs (spxA, gntR, 
fur, and hrcA), the general sigma 70 factor (sigA), two putative sigma factors (sigD and 
ylxM), and a putative DNA-binding protein (whiA) was identified by sequence analysis. The 
authors found that even with this reduced number of regulatory genes, environmental stresses 
and metabolic insults could induce changes in gene transcriptional levels. However, 
repression of ribosomal protein operons and rRNA synthesis was not observed. The ability to 
respond in similar manner to that of more complex bacteria with more known regulatory 
mechanisms suggests that other unknown mechanisms may exist. 
Varying RNA transcriptional levels is a mechanism many bacteria use to adapt to 
changing environmental conditions and to maintain virulence. Mechanisms to achieve this 
variation such as DNA rearrangements, recombination, phase variation, and alternative 
transcripts are evident in mycoplasmas (1, 35, 53, 83, 86, 141). Variation in surface antigen 
expression is believed to occur through DNA recombination between surface antigen genes 
and repetitive elements throughout the genome (35). Homologous recombination occurs in 
mycoplasmas and may be common since the recA gene has been found in several 
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mycoplasma species. Thus, it is likely that the RecA-dependent pathways drive this 
recombination, but RecA-independent pathways may also be present (35).  
Phase variation is a high frequency reversible on-off mechanism of gene expression 
resulting in changes in surface antigens such as lipoproteins. One mechanism for surface 
antigen variation via phase variation is DNA inversion systems. The vsa locus is an example 
of a complex site-specific DNA inversion system that regulates phase-variable surface 
antigens in M. pulmonis. Only one of the eleven vsa genes is expressed at any time due to the 
5′-end containing a ribosome binding site, an ATG start codon, and the characteristic 
lipoprotein signal peptide sequence. The replacement of the 3′ end of the expressed vsa gene 
via a DNA site-specific inversion with one of the silent vsa genes is facilitated by a 34-bp vrs 
box (35, 135). Another phase variation gene system is the seven gene vlp (variable surface 
lipoproteins) system in M. hyorhinis that displays high frequency phase variation correlating 
with the number of adenine residues in the promoter region (26). It is proposed that the 
length of the poly(A) tract may directly induce phase variation by influencing the binding of 
RNAP to the vlp promoter and/or the activity of an enhancer or repressor trans-acting factor 
(26, 35).  
Phase variation has also been observed in methyltransferase genes associated with 
restriction modification (R-M) systems in M. pulmonis involving a transferred phase-variable 
type I R-M system with a DNA inversion mediated switching mechanism controlling the 
expression of the genes hsdM and hsdR (host specificity determinant) (141). The hsd locus in 
M. pulmonis undergoes inversion and results in changes in DNA methylation that may 
regulate some gene expression (35, 137). Methyltransferase (mod) and a restriction 
endonuclease (res) make up the type II R-M system and are co-transcribed to form a two-
subunit enzyme. Multiple mod genes have been identified in M. hyopneumoniae and M. 
pulmonis (141). The non-pathogenic M. hyopneumoniae J strain mod gene does not have the 
associated res gene suggesting that in pathogenic strains, a mechanism for modulating the res 
and other genes may exist to enhance virulence. Differential methylation of the genome by 
the phase-variable type III R-M system has also been proposed as another gene regulation 
mechanism. It has been proposed that randomizing the expression of virulence factors via a 
global phase-variable methyltransferase may enhance virulence. For instance, the type III 
methyltransferase ORF without an associated endonuclease exists in several mycoplasmas 
which suggest that the mod gene may have functions other than R-M systems such as gene 
regulation. Interestingly , the phase-variable R-M system has been found in several Gram 
negative pathogens, but in no Gram positive pathogens, only the mycoplasmas (141). 
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Alternative transcripts appear to be common in mycoplasmas due to variation in start and 
stop sites of transcription (28, 40, 48, 53). Güell et. al. (53) showed that most operons had a 
canonical or slightly altered sigma-70 promoter regions and RNA hairpin termination sites. 
Through the use of tiling arrays, transcriptome sequencing, and spotted microarrays, they 
elucidated alternative transcription in M. pneumonia (53). Of the 341 identified operons, 
almost half of the 139 polycistronic operons displayed a stair-like decay in expression which 
indicates that partial operon transcription commonly occurs where the RNAP molecule stops 
transcription before reaching the operon termination site. Furthermore, alternative transcripts 
were found under various conditions as evidenced by the 447 smaller transcriptional units 
that were subsets of the identified operons (53). This is similar to other bacteria where 
operons are partially transcribed under various conditions (48). It was also observed that 
various growth conditions modulated the expression or repression of individual genes within 
an operon as well as the beginning or end of the operon. Interestingly, genes that were split 
into sub-operons tended to be from different functional groups. Thus it appears that genome 
reduction has resulted in longer operons that have retained the ability of internal transcription 
initiation and termination under various conditions (53). The presence of alternative 
transcripts suggests that many factors may be involved in gene expression regulation. 
 The presence of antisense non-coding RNA (ncRNA) transcripts is thought to be a 
common mechanism to regulate gene expression in mycoplasmas (40, 48, 53, 80). Antisense 
transcripts have been shown to cause truncated transcription of target mRNA, facilitate 
mRNA degradation, and to induce or repress translation in various organisms (156). The 
study by Güell et al (53) identified 117 new transcripts in M. pneumoniae that were mostly 
ncRNAs. The authors suggest that antisense transcripts which are produced by 13% of the 
genes provide regulatory roles probably via dsRNA. Evidence of reduced levels of the 
antisense target transcripts supports this hypothesis (53). In a study of M. genitalium, 
approximately 1/3 of the insertions of a promoterless lacZ reporter gene analyzed were 
oriented in the opposite direction of the coding frame (80). This suggests that antisense 
transcripts are being synthesized and may be involved in the control of gene expression.  
Heterogeneity of gene expression within operons, alternative transcripts, and antisense 
RNA suggest that transcriptional regulation is more complex and more closely resembles that 
of eukaryotes than first thought. The complex transcriptome of these genome-reduced 
bacterium cannot be explained by the few predicted regulators. A single sigma factor and 
evidence such as only eight predicted transcription factors in M. pneumoniae (53) suggests 
more regulatory mechanisms are yet to be discovered. 
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Quantitative Real-Time Reverse Transcriptase PCR 
Polymerase Chain Reactions (PCR) 
The PCR procedure is a simple method for making billions of high fidelity copies of a 
specific DNA sequence. Kary Mullis received the Nobel Prize in Chemistry in 1993 for the 
idea which he states came to him as he drove late one night in northern California in 1983 
(94). The first published description of the PCR technique was in a 1985 article which 
described an application of DNA amplification for detecting sickle cell anemia (129). This 
first application was laborious due to the use of the thermolabile E. coli DNA polymerase 
which had to be added at every cycle of the reaction. The procedure was greatly enhanced 
with the adaptation of the thermostable Thermus aquaticus (Taq) DNA polymerase (128). 
Since then the PCR procedure has been modified extensively to be applied to a vast array of 
genetic research applications and is a common tool in almost every lab that conducts research 
involving nucleic acids.  
The PCR procedure requires few reagents, a thermocycler, and involves three basic steps 
per cycle of the reaction: 1) denaturation, 2) annealing, and 3) extension. Each cycle of the 
reaction doubles the amount of target DNA and after n cycles, there are 2n copies of the 
target DNA. Thus after thirty cycles, there are over a billion copies of the original target 
DNA sequence. The reagents needed for a reaction include template DNA, two primers 
usually about 20 bases in length that are complementary to the 3′ ends of the sense and anti-
sense target DNA strands, Taq polymerase, dNTP’s, cations such as Mg2+, buffers, and other 
various components that may be added to enhance specific reactions. The first step in the 
reaction usually starts with an initialization step of heating the mixture of the reagents to 
about 95°C for 5 minutes in reaction volumes that typically range between 10 to 200 μl. The 
reaction cycle then starts with a 1 minute denaturation step at this same temperature in which 
the double stranded DNA separates into single strands. The next step, annealing, lowers the 
temperature to about 55°C for 30 seconds to allow the primers to anneal to the single 
stranded DNA. The reaction is then heated to about 70°C for 30 seconds to facilitate the 
synthesis of DNA by the polymerase enzyme from the 3′ end of the primers thereby creating 
a copy of the target DNA. A second cycle begins with the denaturation step and the newly 
minted DNA copy is now available as template for copying. Note however, that these new 
strands of template DNA are truncated at the 5′ ends at the location where the primers 
annealed in the first reaction. Thus after a few cycles, the majority of the DNA strands in the 
reaction are only the segment of DNA whose ends are defined by the two primer pairs. After 
about 30 cycles, a final extension step of about 10 minutes is usually done to ensure that all 
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remaining single stranded DNA is fully extended and then the reaction may be cooled to 4°C 
for short time storage.  
The PCR assay is an essential tool for research laboratories and has become the gold 
standard in molecular diagnostics for detecting nucleic acids from a vast array of origins 
(82). The procedure was originally applied mostly for qualitative analysis of DNA, but the 
technique was soon adapted to quantify nucleic acids via a technique referred to as 
quantitative real-time PCR (qPCR) where DNA concentration is detected as the PCR 
progresses (43). Many aspects, such as the simplicity, speed, sensitivity, specificity, 
reliability, reproducibility, avoidance of radioactivity, reduced risk of carry-over 
contamination from biological samples, minimal concentration of template, and no post-PCR 
handling, have resulted in qPCR becoming the hallmark assay to quantify nucleic acids (17, 
82, 108, 115). The use of the reverse transcriptase (RT) enzyme has extended the qPCR assay 
to the quantification of RNA via the amplification of cDNA synthesized by reverse 
transcription. This assay is referred to as reverse transcription quantitative real-time PCR 
(RT-qPCR) and will be described in more detail in the following section.  
RT-qPCR 
Background 
The transcriptome, in comparison to the genome, is context dependent in that mRNA 
levels are highly dependent on the physiology, pathology, and/or development state of the 
organism (19). Therefore, the functional status of cell can be characterized by the gene 
expression pattern it presents (93). This ability to modulate mRNA transcription levels is 
crucial for the organisms survival and enables researchers to understand the basic biology of 
systems such as cell development processes, responses to therapeutic drug treatment of 
disease, tumorigenesis, and the diagnosis and quantification of viral disease (115). This 
ability to quantify the amount of mRNA in a sample enables the determination of the extent 
of transcription of a specific DNA sequence and the potential amount of functional protein 
present (43). One caveat of the assay is that the information obtained is only a snapshot of the 
transcriptional levels at a given point in time. Thus, an assessment of the biological 
significance needs to take into account information regarding the levels and activity of 
regulatory RNAs and protein. The amount of functional protein roughly correlates with the 
amount of mRNA transcribed from DNA. However, there is evidence of the non-
concordance of mRNA and protein levels (17, 43). 
Reverse transcription of RNA followed by qPCR is a highly sensitive technique for 
quantifying the small changes in RNA transcription levels of the transcriptome (19, 43, 79, 
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108, 136). Many methods of RNA detection exist (e.g., Northern blotting, in situ 
hybridization, RNase protection assay, qualitative RT-PCR, competitive RT-PCR, serial 
analysis of gene expression (SAGE), microarray analysis, and cDNA chip arrays), but RT-
qPCR has become the favored assay for obtaining RNA transcription profiles (115, 136). 
Nanotechnology-based methods that detect transcripts directly without amplification may 
soon be available, but for now RT-qPCR is the assay of choice (19, 75). The RT-qPCR assay 
can be divided into two broad applications, research applications where the focus is on low 
throughput of a wide range of targets on many different sample types and diagnostic 
applications where the focus is on high throughput of a limited number of targets and sample 
types on large number of samples (17). Fundamental biological research in a variety of 
organisms (e.g., microbes, plant, and animals), biotechnology, and forensic science are some 
of the scientific fields that employ RT-qPCR to detect and quantify specific RNA sequences 
in a variety of applications such as the validation of microarray gene expression assay results, 
measurements of (transgenic) DNA copy number, pathogen detection and quantification, 
mutation analysis, cancer cell quantification, and drug therapy studies (32, 43, 66, 170). An 
example of how RT-qPCR differs from other assays that measure RNA levels is that 
microarray analysis aims to study large-scale expression patterns whereas RT-qPCR provides 
the sensitivity to validate findings for specific genes (19). 
 
Aspects of the RT-qPCR Assay 
The RT-qPCR assay basically consists of converting a small, specific strand of RNA into 
cDNA via reverse transcriptase and then amplifying this cDNA strand in a qPCR assay (43, 
147). An assay where the original isolated RNA is used directly in the qPCR master mix 
without transformation is referred to as One-Step RT-qPCR. A Two-Step RT-qPCR assay is 
where cDNA is prepared from the RNA and then the cDNA is added to the qPCR master mix 
(43). It has been proposed that assay variation in a Two-Step RT-qPCR assay will always be 
lower than a One-Step RT-qPCR assay due to the single RT reaction that occurs in the Two-
Step assay from which multiple targets can be analyzed (108). However, the One-Step assay 
requires less handling of the sample. In either the One- or Two-Step assay, the cDNA 
generated is the template for the qPCR assay where it is amplified in a PCR reaction via a 
DNA-dependent DNA polymerase such as Taq. At each cycle (i.e., in real-time) of the PCR 
reaction, fluorophores are used to detect the amount of DNA in the sample. The exponential 
increase in amplified target sequence corresponds linearly (on a logarithmic scale) to the 
increase in fluorescent signal and is directly proportional to the initial amount of target 
sequence in the sample (43, 66, 170). Thus, the higher the number of RNA copies in a 
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sample, the lower the number of PCR cycles needed to produce detectable fluorescent signal 
(32, 66, 75). 
A perfect PCR reaction (i.e., 100% efficiency) would result in a doubling of the PCR 
products with each cycle (66, 170). However, the PCR amplification efficiency is rarely 
perfect or even constant throughout all PCR cycles (54, 66). A plot of the cycle number 
versus the fluorescence, referred to as an amplification curve, is sigmoidal in shape. This 
curve can be divided in to three phases: Phase I is the lag phase in which the amplification 
can not be discerned over background fluorescence and is used to assess the baseline 
fluorescence noise in the system, Phase II is the exponential phase in which the amplification 
quantities at each cycle appears to approximately double, and Phase III is the plateau phase in 
which exponential amplification decreases until finally a plateau is reached due to what is 
believed the result of either one or more reagents limiting the reaction or an inhibition by the 
PCR products themselves. Even though the efficiency in Phase I can not be measured due to 
background noise, the reaction may be suboptimal due to low concentration of template DNA 
in the sample. In Phase II, the efficiency of the PCR reaction is maximal, fairly stable, and 
can be estimated. The quantity of PCR product in the exponential phase is assumed to be 
proportional to the initial amount of target DNA (66). This proportional relationship can be 
described by the PCR kinetics equation (NC = N0 x E C ) which is the amount of product after 
C cycles (NC) is equal to the product of the starting concentration (N0) and the reaction 
efficiency raised to power of the number of cycles (E C ) (116).  
The RT-qPCR assay is described as a “closed” or homogenous system since manipulation 
of the post-amplified amplicon is not necessary. Benefits of a homogenous system are the 
reduced turnaround time of assay results, minimization of carry-over contamination, and 
ability to assess the assay performance (82). Other major advantages of this technique are the 
wide dynamic range under which RT-qPCR is assayable and the high degree of sensitivity 
(19, 82, 136). A dynamic range on the order of 7-8 magnitudes coupled with the ability of 
some assays to detect the presence of as few as 5-10 molecules has resulted in the use of RT-
qPCR over other methods of detecting and measuring RNA (16, 54, 136). However it should 
be noted that the precision of the assay is typically proportional to the concentration of the 
target (17). 
The two types of florescent chemistries for RT-qPCR are nonspecific and specific 
detection (19). Intercalating dyes such as DNA binding fluorophores (e.g., SYBR Green I) 
are used for nonspecific detection via the binding of any dsDNA and fluorescence occurs 
upon excitation by suitable wavelength of light. In contrast, target-specific fluorescent probes 
such as 5′ nuclease oligoprobes, adjacent linear oligoprobes, hairpin oligoprobes, and self 
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fluorescing amplicons are designed and synthesized for specific detection (19, 82, 170). The 
two main advantages of nonspecific detection are 1) the ability of the fluorophore to be 
incorporated into existing protocols with specific primers and experimental conditions, and 
2) the avoidance of significant costs of time and materials to develop probes for specific 
detection methods. The disadvantages of nonspecific detection are 1) the indiscriminate 
binding of any dsDNA such as primer-dimers and non-target dsDNA, 2) the use of melt 
curves are obligatory to confirm that only target PCR products were amplified, and 3) the 
possibility of multiple fluorophores binding a single target and thereby generating a signal 
strength that is dependent on target size in addition to copy number (17, 19, 78, 82). In 
comparison, the main advantages of specific detection are 1) that only amplified targets 
produce a signal and not any nonspecific amplification or extraneous dsDNA, and 2) the 
potential for multiplex assays via the construction of different probes with different reporter 
dyes. Disadvantages of specific detection are 1) the inability to detect artifacts that interfere 
with amplification efficiency and 2) the cost to develop specific probes for every target (19). 
Target specific primers are probably the most sensitive option for quantification, but the 
DNA binding fluorophore SYBR Green I that binds the minor groove of dsDNA is one of the 
simplest techniques for detection of newly synthesized PCR products and has provided 
reliable and reproducible results (17, 82, 108). 
Results of a RT-qPCR assay may be assessed via absolute or relative quantification (32, 
79, 82, 108). Absolute quantification estimates the number of amplicons per some unit (82). 
This method relies on internal or external calibration curves to determine initial template 
copy number and is only needed when absolute copy number is desired and/or relevant (79, 
108, 170). Competitive co-amplification of an internal control of known concentration with 
equal amplification efficiency of the target sequence is an example of a means for absolute 
quantification (82). The greatest disadvantage of absolute quantification is the time costs to 
generate a stable and reliable standard such as recombinant DNA or RNA for precise 
quantification methods (108). Another difficulty with absolute quantification is that the 
amplification efficiency may vary between purified targets and a target in the samples 
complex mixture of nucleic acids (32, 44).  
In contrast to absolute quantification, relative quantification estimates the amount of the 
target sequence in the sample in relation to the level of a reference target in a related 
matrix/sample (79, 108, 170). This method often relies on normalizing the target gene with 
an endogenous standard reference gene, thereby enabling the ability to normalize the 
reactions with respect to the RNA integrity, extraction yields, the RT reaction, qPCR 
amplification efficiencies, and sample loading variations (17, 47, 79, 108). The advantages of 
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relative quantification are 1) the target and reference sequence are exposed to similar sample 
isolation and amplification environments, and 2) the endogenous reference gene may be used 
as an internal control to assess the quantity and integrity of cDNA in the specific reaction 
(32). However, the selection of a reference sequence that is stable across all samples may be 
difficult (17, 32, 43). “Housekeeping” genes may be used as a reference gene for relative 
quantification since they are present in all nucleated cell types and are necessary for cell 
survival, but they need to be validated under the experimental conditions being investigated 
as being appropriate for normalization (108). An example of an application of the relative 
quantification method is an assay where the PCR signal of the target transcript for one 
treatment group is related to that of another treatment group (often an untreated control) (79). 
In addition to determining the expression profile of a target gene under experimental 
conditions, the relative abundance of the target gene in relation to other genes of interest may 
also be determined via the use of a reference gene (32). In general, relative quantification is a 
simpler and sufficient method to assess an assay, but absolute quantification may be more 
informative due to the ability to interpret results across different assay platforms (82). Thus, 
the relevance of relative quantification of the target gene needs to be assessed in the context 
of the question under investigation (17). 
One of the first steps in a relative quantification RT-qPCR assay is the identification of 
an appropriate reference gene for the individual experimental setting (17, 115). It has been 
suggested that having more than one reference gene ensures more reliable results, especially 
for in vivo tissue biopsies (19, 42, 115). Endogenous reference genes are the most widely 
used for normalization as an internal standard in relative quantification, but are highly 
controversial due to evidence that not all reference genes are stably expressed in all samples 
(42, 47, 78, 93). Candidate reference genes therefore must be validated for the experimental 
conditions under study; otherwise the results may be unreliable and lead to misinterpretations 
(42, 47, 93, 115). An ideal reference gene should not be regulated or influenced by the 
experimental conditions being studied. This stably expressed reference gene would then 
enable the normalization of the assay results for differences due to non-treatment effects such 
as different amounts of starting material, varying quality of starting material, and variations 
due to RNA preparation and cDNA synthesis since the reference gene and target sequence 
are exposed to same sample preparation environment (115). The identification of suitable 
reference genes is a time consuming and expensive process but must be done to ensure valid 
results, otherwise the target gene expressions may be over or under-estimated due to the use 
of inappropriate reference genes (42). The difficulty in selecting a reference gene is 
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evidenced by the large number of publications concerning the validation of internal reference 
genes (47).  
Several potential endogenous reference gene controls have been suggested which include 
β-actin, glyceraldehyde-3-phosphate dehydrogenase, TATA-Box binding protein, RNA 
polymerase II, hypoxanthine-guanine phosphoribosyltransferase, peptidyl prolyl isomerase 
A, glucose 6-phosphate dehydrogenase, β2-microglobulin, a-tubulin, porphobilinogen 
deaminase, ribosomal protein L13, and rRNA (42, 78, 79, 115). However, many of these 
have been shown to be unsuitable in several experimental cases (17, 115). One study that 
evaluated several of these reference genes across different tissues types and treatment 
conditions concluded that RNA polymerase II was stable and thus a good candidate for a 
reliable reference gene for multiple experimental conditions (115). The difficulty of 
identifying a stable endogenous reference gene has led to investigating the use of exogenous 
controls which are characterized RNA or DNA that is added to each sample at a known 
concentration to function as internal positive controls for distinguishing true target negatives 
or to assess the efficiency of the reaction of sample extraction (47, 78). However, this method 
introduces some of the disadvantages of absolute quantification, namely the need for precise 
quantification methods. 
Protocols for the performance and interpretation of RT-qPCR experiments vary widely. 
Hence, RT-qPCR assay data that is presented in the literature may be difficult to interpret. 
There are many aspects of the assay such as template quality, operator variability, the RT 
step conditions, subjectivity of data analysis, and the reporting of results that may contribute 
to the misinterpretation of the results (17-19, 54, 136). Critical components of the assay that 
are required in order to generate meaningful results include standardization of protocols 
implemented within the study, consistency of reagents, assay design, template preparation, 
and analysis methods (19). These key factors of the assay and others such as sample 
acquisition and handling, RNA quality and integrity, details of the reverse transcription 
reaction, efficiency of the PCR reactions, and data analysis parameters should be reported 
(17). Common assay procedures that may introduce factors that lead to erroneous results and 
thus must be optimized include nuclease treatments, reverse transcription reactions, sample 
dilutions to kinetically proper levels, choice of primers and probes, construction of master 
mixes, pipetting technique, and the PCR reaction cycle times and temperatures. Additionally, 
enzymatic inhibition by a myriad of substances is of concern (18, 43).  
The first potential source of experimental variability in any RT-qPCR assay is the 
acquisition of the sample where the mRNA profiles may be perturbed by the collection and 
processing methods (17, 75). The reproducibility and biological relevance is dependent upon 
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the template quality obtain in the initial process of sample acquisition and purification (18, 
19, 43, 54, 93). Degradation of RNA and the presence of inhibitors are of utmost concern 
(19, 43, 54). This is particularly evident in the case of relative quantification where 
differential RNA degradation may occur not only between samples, but between the targets 
and reference genes (47). Ensuring the quality and quantity of the RNA sample are essential 
steps in any RT-qPCR protocol. The standardization of the RNA quantification protocol is 
necessary since quantification of a sample by different methods, such as spectrophometry, 
microfluidic analysis, capillary gel electrophoresis, or fluorescent dye detection, produce 
variable results (17).  
The method used for reverse transcription is another source of substantial variation in the 
RT-qPCR assay (18). The RNaseH activity of the native RT enzyme can cleave the RNA 
before polymerization initiation thereby leading to reduced amounts of cDNA synthesis. 
Thus, commercial reverse transcriptases lacking RNaseH activity (e.g., Superscript II) have 
the highest relative cDNA synthesis and best assay reproducibility (136). The efficiency of 
reverse transcription is also a limiting factor in the power of any RT-qPCR assay (19). The 
nucleic acid target structure such as stem loops has a substantial impact on the efficiency of 
reverse transcription as well as the qPCR reaction efficiency (18). Another critical factor in 
reverse transcription is template abundance since lower amounts of template has been 
associated with more variable amounts of amplified product (19).  In general, small inter-
assay variation and high reproducibility is associated with high reverse transcription 
efficiency (136). Therefore, the choice of RT enzyme is important, since an enzyme with low 
efficiency cannot truly be compensated by additional PCR cycles in the assay, especially for 
low abundant transcripts (136).  
Sample related reaction inhibition is one of the most often ignored and potentially most 
problematic aspects of the RT-qPCR assay (43, 44). The accuracy and precision of the assay 
can be severely impacted by inhibition of the key enzymatic steps via a myriad of substances. 
The source of the inhibition is often unknown, but may be introduced via the type of sample 
under study, the method of RNA isolation, and the sample preparation for the assay. Phenolic 
compounds from the extraction process and plastic-ware, cellular debris, and the 
concentration of DNA or RNA in the sample are all potential sources of inhibition. Other 
inhibitory contaminants that have been identified include hemoglobin, heme, porphyrin, 
heparin, glycogen, polysaccharides, proteins, cell constituents, Ca2+, immunoglobulin G, 
dextran sulfate, humic and tannic acids, bile salts, urea, polyphenolics, and DNA or RNA 
binding proteins (43, 44, 54). Inhibitory agents may generate inaccurate quantitative results 
and at worst produce false negatives (54). Since no method of sample extraction and 
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purification is entirely able to remove all potential  inhibitory substances, testing for 
inhibition is necessary for every sample (43, 44).  
Additionally, inhibition of the qPCR step by the RT enzyme has been previously shown 
to mostly occur when small amounts of RNA are transcribed or when a rarely expressed 
transcript is transcribed (147). Several methods have been developed to reduce the impact of 
RT on qPCR which include heating to deactivate RT before qPCR, the addition of the T4 
gene 32 protein, the addition of non-homologous RNA as a carrier, the addition of foreign 
DNA, the exclusion of DDT from the RT reaction, an ethanol precipitation of the RT 
reaction products, and a phenol extraction followed by alcohol precipitation of RT reaction 
products. Suslov and Steindler recommend that the RT enzyme should be removed from the 
sample before conducting qPCR (147), but this additional step in the protocol introduces 
another potential source for error in the assay. A simpler solution is obtained by noting that 
the ratio of RT/Taq polymerase has an influence on the amount of inhibition. By decreasing 
the ratio via diluting the RT reaction will also decrease the amount of inhibition by the RT 
enzyme (147) as well as any inhibition by the myriad of other potentially inhibiting 
compounds that may be in the sample (43, 44). 
The efficiency of the qPCR reaction is another critical aspect of the RT-qPCR assay and 
is most affected by the type of amplicon and to some extent by the sample assayed, but in 
general the target concentration does not affect the efficiency of the reaction. Methods that 
ignore PCR reaction efficiency may have sensitive and reproducible results but do not 
accurately quantify nucleic acid amounts (66). Primers may also impact the assay through the 
formation of primer-dimers which will lower the efficiency of the reaction (17, 66). In 
addition to the target structure effects on reaction efficiency (18), the context of the target can 
affect the efficiency of amplification. In a study in which amplicons and amplicon-containing 
plasmids were assessed in the non-inhibitory dilution ranges by qPCR, the amplification 
efficiencies of the target were stable and significantly higher in the plasmid context (44). 
Livak and Schmittgen claim qPCR efficiency near 100% are obtainable for amplicons of less 
than 150 bases and PCR reactions where the primers and Mg2+ concentrations have been 
optimized (79). However, target amplification of less than 100% appear to be stable in most 
cases (43). One hypothesis for less than 100% efficiencies is that samples with template that 
contain partial targets will display linear amplification in addition to exponential 
amplification which would then result in lowering the amplification efficiency estimate (66). 
Interestingly, stable amplification efficiencies greater than 100% have also been observed 
(personal communication, Jack M. Gallup). One hypothesis for greater than 100% efficiency 
is that inhibition is occurring in the more concentrated samples and that the more dilute 
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samples are displaying less reaction inhibition (43). Alternatively, PCR amplification 
efficiencies are often overestimated from the slope of a calibration curve, thus it is not 
uncommon to have amplification efficiencies exceeding 100% (136, 147). Therefore, the 
validation that amplification efficiencies of the target and endogenous control are stable is 
necessary before application of any analysis method (43, 78).  
In summary, there are several considerations when designing RT-qPCR assays. The 
design choice (relative or absolute quantification), the concentrations of primers/probes, the 
choice of master mix reagents, the RNA isolation (quality and quantity), cDNA synthesis 
(One- or Two-step), the use of endogenous reference genes or exogenous controls, the 
reaction efficiencies (RT and qPCR), valid dynamic dilutions (avoidance of inhibitory 
dilution range), and the handling, processing, and storage of samples are some of the several 
factors that need careful consideration. Furthermore, there are several elements of the assay 
that need to be standardized to ensure sample inter-comparability. The RNA/DNA isolation, 
purification, and storage methods, the DNase/RNase treatments, the formulation of the 
reverse transcription reaction, sample dilutions to same ng/μl concentrations beyond the 
expected inhibitory range of RT and/or PCR reaction, and the design of primers and probes 
for the same reaction conditions (43). Finally, a no template control is essential in any 
experimental setup and should never be compromised (19). Yet given all these difficulties, 
the assay is still widely accepted as the best method for quantifying gene expression (75). 
 
RT-qPCR Data Analysis 
Data analysis for RT-qPCR needs careful consideration, but none of the current RT-
qPCR assay software packages is capable of adequate analysis without user intervention. 
Thus, the choice of which data analysis method to use is a real problem with RT-qPCR 
assays and further research on analysis methods is needed (54, 75, 93, 170). This section will 
discuss analysis methods for relative quantification. In the most common assay analysis 
method, the amplification efficiency and changes in threshold fluorescence values (Cq) of a 
target and reference sequence are the only model parameters needed (108). The Cq value is 
defined as the fractional qPCR cycle at which the sample fluorescence is appreciably above 
the background fluorescence (108, 115, 127, 170). Absolute quantification analysis methods 
will not be covered in detail. 
There are two main approaches to estimating amplification efficiency, the individual 
reaction method and the standard curve method (66). The individual reaction method 
involves fitting a sigmoid or exponential function to the amplification curve (e.g., nonlinear 
curve fitting) or by fitting a linear regression to the exponential phase (Phase II) of the 
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amplification curve (66, 127). However, single sample efficiency estimation is highly 
variable due to the strong effect of the baseline estimation method used. Baseline is defined 
as the level of fluorescence in lag phase (Phase I) of the amplification curve before specific 
amplification can be detected (127). An assessment of the methods of sigmoid and 
exponential curve fitting showed that they generally had poor resolution and accuracy (66). 
Thus currently, there is not a widely accepted method for determining PCR efficiency from a 
single reaction (54). However, it has been reported that the mean of several individual PCR 
efficiencies estimates has less bias than efficiencies derived from the standard curve method 
described below (127). 
The standard curve method involves serially diluting a sample, performing the qPCR 
assay, and fitting a simple linear regression to the Cq versus log of the dilutions (66, 116). 
The Cq value is inversely related to the logarithm of the initial amount of template in the 
reaction (108, 115, 127, 170). Thus, the lower the Cq value, the more of the target sequence 
there is in the sample. The cycle at which the fluorescent signal is significantly greater than 
the background signal is generally defined as approximately 10 standard deviations above the 
background signal and corresponds to approximately 1010 copies of the target sequence (43). 
Thus with a 100% efficient qPCR reaction, a single copy number target would theoretical 
cross this threshold at 33.22 cycles, but due to stochastic nature of the PCR reaction, a single 
copy is expected to cross the threshold level at 34.37 ± 1.15 cycles (43). The influence of the 
stochastic process is greatest at low copy numbers, but improves rapidly with an increase in 
copy number and reliable signals can be detected from samples with as few as 10 copies (43).  
The Cq value is the dependent variable for serial dilution analyses since its value is 
directly influenced by the treatment, sample concentration, and sample effects (170). The 
mathematical model for the standard curve method may be written as Cq = mx + b, where x 
has most often been defined as log10 of the dilution factor and the parameters m and b are the 
slope and intercept of the fitted linear regression (108). In other formulations of this equation, 
x has been defined as the log2 of the dilution factor (170). Either formulation is valid and will 
generate identical estimates of PCR efficiencies (E) when using the corresponding efficiency 
formula; however the log2 formulation may be more user-friendly since a slope of -1 
corresponds to 100% efficiency, whereas in the log10 formulation the slope for 100% 
efficiency is approximately -3.3219. The efficiency equation is E = 10-1/m for the log10 
transformation (108); and E = 2-1/m for the log2 transformation. The reaction efficiency 
percentage is obtained by subtracting 1 from the efficiency and multiplying by 100% (i.e., 
reaction efficiency percentage = (E – 1)*100%). The efficiency estimate could then be used 
in the PCR kinetics equation (NCq = N0 x E Cq) (116) to estimate initial number of target 
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copies (N0) after Cq cycles if the number of copies (NCq) at threshold fluorescence in the 
reaction were known. The estimation of NCq is the basis of absolute quantification but will 
not be covered in detail. 
The two commonly used serial dilution mathematical models for relative quantification 
analysis are the Delta-Delta Ct (ΔΔCt ) model and the efficiency calibrated model (170). 
Both of these analysis methods are for experimental designs where control and treated 
samples are interrogated for expression levels of a target and reference gene in a serially 
diluted assay (79, 108, 170). These methods estimate the ratio of the control and unknown 
sample (e.g., treatment) expression levels using the reference gene to normalize for non-
treatment effects. One of the first methods for data analysis developed was the ΔΔCt method 
which is simple to apply; however, this method assumes that amplification efficiencies are 
100% or at least identical for all amplicons (54, 66, 78, 79, 108, 116, 170). Studies have 
shown that the ΔΔCt method does not accurately estimate relative amounts of DNA for 
different amplicons and significantly underestimates the actual DNA quantities (66). Large 
quantitative errors may result from even small difference in amplification efficiencies (54). 
For example, if the PCR efficiencies were 78% and 82% (i.e., only a 4% difference), the 
resultant fold change calculation would have a 4-fold error (54, 116). Thus, the ΔΔCt method 
is very sensitive to variation in PCR efficiencies and hence does not have a broad application 
to the majority of RT-qPCR assays where the reaction efficiencies differ significantly from 
100% (116).  
The efficiency calibrated model is a generalization of the ΔΔCt model (108, 170). This 
model does not assume all targets are amplified at 100% efficiency, but does assume that the 
amplification efficiency is the same for all samples for a given target (170). The relative 
quantification of a target transcript in relation to a reference gene transcript using the 
efficiency calibrated method is done via a ratio calculation based on PCR efficiencies (E) and 
deviations of Cq values (ΔCq) of a control and unknown sample (108). The mathematical 
model of the relative expression ratio is ( ) ( ) ( ) ( )sample - control  refsample - control  target reftarget CqCq EER ∆∆=  (108). 
Theoretically, if there are not any non-treatment differences between the samples (e.g., 
sample loading differences, differential RNA degradation, etc.) and the reference gene is 
unaffected by the treatment, then the denominator of R will reduce to 1 since all the reference 
gene Cq values would be identical. The distribution of R is non-symmetric since targets 
where the control samples have a higher expression than the treated samples can take on any 
value greater than 1; whereas when the control samples have lower expression levels than the 
treated samples, the R values are restricted to values less than 1 but greater than 0. A 
logarithmic transformation of R is a way to obtain a more Gaussian distribution in order to 
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apply Gaussian distribution theory for statistical analysis (47). Thus, log2(R) is a common 
statistic that is reported to express the log base 2 fold change in gene expression between the 
control and unknown sample of the target gene. The efficiency calibrated method has been 
found to produce reliable and reproducible results for studies with Cq values ranging from 15 
to 30 and is the generally accepted method to analyze RT-qPCR results which use standard 
curves to estimate amplification efficiencies (66). 
 
Microarray 
Background 
General Technology and Two-color DNA Microarrays 
The concept of a microarray is basically the localization of reactions to “microspots” 
distributed on an inert solid surface. It was first developed for immunodiagnostics in the 
1980’s (36, 37) and then extended to nucleic acid experiments in the 1990’s (132). Currently, 
microarrays are commonly used for assessing patterns of gene expression within an organism 
or for comparing mRNA expression levels between identical cell types under different 
growth conditions. Other examples include the comparison of mRNA expression levels 
between cells that exhibit different phenotypes or are in different developmental stages (61). 
The interest in microarrays is mainly due the assay’s ability to produce large scale 
quantification and comparison of gene expressions in a relatively inexpensive assay (169).  
There are several types of DNA microarrays for assessing RNA expression levels that 
may be categorized by the source of the DNA that is affixed to the slide. For all of these 
types of microarrays, the spots are arrayed in rectangular grids on a solid surface and are 
referred to as probes. The first DNA microarrays consisted of spotted cDNA sequences 
synthesized via reverse transcription of mRNA. The construction of cDNA probes is an 
expensive and time consuming process but was necessary due to the lack of genome 
sequences. With the increase of sequenced genomes, cDNA probes were replaced by spotted 
DNA probes generated from purified PCR products. Advances in DNA synthesis techniques 
have led to spotted oligonucleotides arrays which bypass the PCR product generation and 
purification steps (72, 131). In addition to spotted DNA arrays, in situ synthesized 
oligonucleotides arrays are another type of DNA microarray. These arrays are constructed by 
synthesizing the oligonucleotides probes directly on the substrate in a process such as 
photolithography (104, 131).  
Several different assays employ these DNA microarrays platforms where fluorescently 
labeled targets are hybridized to the DNA probes. The two most common assays are the one-
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color and two-color arrays. In one-color arrays, targets are labeled with a single dye and 
RNA expression levels are determined relative to other targets on the same slide. In two-
color arrays, targets from two treatments are labeled with two different dyes and are 
competitively hybridized to the probes on the array. Relative RNA levels between the 
treatments are then determined for each probe (131). Only two-color microarray experiments 
will be discussed throughout the rest of this dissertation.  
Two-color DNA microarray experiments consist of several slides with DNA probes 
arranged with known location and identity on slides in a rectangular grid. Targets are 
generated from RNA samples from various treatments via the generation of cDNA labeled 
with one of two fluorescent dyes (‘red’ or ‘green’). Two treatments with differently labeled 
targets are assigned to a slide and an equal mixture of labeled cDNA is washed over the slide. 
Targets from the two treatments will co-hybridize to the complementary DNA probes under 
stringent conditions, and any unhybridized target strands are washed away. The amount of 
target hybridized to a probe is assayed via a confocal laser scanner that measures the 
fluorescence intensity when the labeled targets are excited by a laser. The ‘red’ and ‘green’ 
signal from each probe indicates the amount of RNA hybridized for each treatment. This 
enables a measurement of the relative RNA expression levels of the targets for all the probes 
simultaneously (7, 69, 74, 76, 132, 169).  
The identification of a small subset of genes that are differentially expressed among the 
treatments is the goal of many microarray experiments (74). There are many aspects to 
consider in achieving this goal such as experimental design, data acquisition, data 
normalization, analysis, and false discovery rate (FDR) that will be discussed below. Due to 
the multifaceted process of a microarray experiment and analysis, results should be verified 
with an independent method such as RT-qPCR, in situ hybridization, northern blots, or 
western blots (138, 169).  
 
Microarray Experimental Issues and Designs 
Experimental design is essential for obtaining reliable data to analyze and interpret 
experiments in a meaningful way (72). The main goals of experimental design are to ensure 
the economical use of resources, to avoid obvious biases, and to answer the primary question 
of interest (169). Three fundamental statistical design principles for microarray experiments 
are randomization, replication, and blocking, and these will be described in more detail 
below (67). Balance is often another fundamental principle of a good design. A properly 
balanced design ensures the effects of interest are not confounded with other the sources of 
variation (69). Other considerations when choosing a design are the simplicity and 
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extendibility of the design and the usefulness of any sub-designs (67). Generally, a suitable 
analysis will be suggested by a well designed experiment (24). Furthermore, it needs to be 
stated that the information content from an experiment can not be increased by an analysis 
once the data has already been collected (67). Thus, the designing of an experiment is a 
crucial step in the process of conducting scientific research. 
In designing microarray experiments, the multiple sources of variation are identified to 
ensure that any ancillary effects are not confounded with the effects of interest (24, 69, 72). 
There are three hierarchical levels to consider when assessing these. The first level is the 
experimental units to which treatments are randomly applied, and this is where biological 
replication is determined. The second level is the RNA samples obtained from the 
experimental units, and this where technical replication may occur if more than one RNA 
sample is taken from an experimental unit or if multiple labeled cDNA target pools are 
constructed from a single RNA sample. The third level is the arrangement and replication of 
probes on the microarray. These three levels partition the sources of variation into biological 
variation at the first level, technical variation at the second level, and measurement variation 
at the third level (7, 24, 67, 169). The identification of independent experimental units at the 
first level is crucial for legitimate statistical analysis since unrecognized dependencies will 
result in statistics with bias and inflated significance levels (24, 50, 67). These independent 
biological replicates are replicates in the classical statistical sense and when randomly 
sampled from a population will enable the ability to make inferences about the population 
(24, 67). Also, the precision of estimates and degrees of freedom for error estimation are 
obtained through biological replication (69). Multiple probes and multiple hybridizations of 
an experimental unit are referred to as technical replicates since they may be used to address 
the measurement error of the assay (67, 76). Technical replicates reduce the uncertainty of 
particular RNA expression patterns in a study and are useful in cases where these expression 
patterns are of interest individually such as in a diagnostic assay (67).  
The overall objective when designing a microarray experiment is to have a design which 
is powerful, simple to analyze, and easily interpretable given the question of interest and 
material constraints. Material constraints (e.g., the number of slides and the amount of 
available sample) and other constraints (e.g., the costs associated with reagents and time) 
need to be considered when designing an experiment (50, 169). An optimal experimental 
design estimates the effects of interest with maximal precision given the resources available 
and other practical constraints (50). The number and variability of the experimental units, the 
number of repeated observations per unit, and the measurement error all affect the precision 
of estimates based on the collected data. If the cost of sampling individuals is negligible 
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relative to the cost of taking a measurement, it is advantageous to sample many individuals 
instead of conducting repeated measurements on the same individuals due to the increased 
precision for estimating population parameters when using more individuals (24, 67). 
Therefore, it is always better to increase biological replication over technical replication. The 
importance of biological replication can not be overstated for its role in generating adequate 
power and validity of statistical tests. Excessive technical replication and little biological 
replication is an all too common mistake in microarray experiments (24).  
Technical replication provides enhanced precision and provides a means to test for within 
treatment differences (24, 125). But, true replication can not be replaced by technical 
replication which is always less effective in determining statistical significance of the 
parameters of interest and the extent of inference that may be drawn from the experiment (50, 
67, 76). Concerning the replication of probes on the array, a practical design criterion is that 
the probes should be dispersed over the microarray slide to minimize correlations; they are 
treated as repeated observations in the analysis. Replicated probes increase precision, 
introduce a means for quality control, and add a level of robustness to the assay (24). Thus, 
arrays should be printed with multiple, well spaced probes to avoid bias and to discern 
variability across the slide (169). 
Pooling of samples is a method sometimes used to reduce biological variation in the 
samples, but it does not reduce technical or measurement variation (24, 50). Pooling is valid 
when insufficient quantities of RNA for an assay are obtained from individual samples. 
However, if the pooling of samples results in significant decreases in the number of 
experimental units, than the pooling is not appropriate since this will reduce the ability to 
measure and assess this variability which is needed for inference (67). For example, in the 
extreme case, pooling all the samples from a given treatment would result in the elimination 
of independent replication and hence would eliminate the possibility to estimate the between 
pool variance which is needed when testing if the difference between treatment pools is 
statistically significant (24).  
The validity of statistical results is rooted in the randomization of treatments to randomly 
selected biological units (24). Microarray experiments are multistage assays where multiple 
levels of randomization may be applied, some of which are essential and others of which 
reduce hidden biases (24, 67). The treatment phase is the most important level to apply 
randomization in order to ensure independent observations. The measurement phase is also 
an important level to randomize as much as is feasible since microarray assays are prone to 
technical artifacts that may bias results. An example of a technical artifact is that the order in 
 37  
which slides were printed may have a systematic effect, and thus slides should be randomly 
used during an experiment to counter this systematic bias (67). 
A unique aspect of the two-color microarray is the ability to conduct direct comparisons 
of two samples on a single slide (24). However, this aspect also dictates that the assay is a 
block design with blocks of size two since for each probe on a slide only two values (‘red’ 
and ‘green’ fluorescence) are obtained (7, 67). Thus, designs for experiments with more than 
two treatments are by necessity incomplete block designs (69, 72, 74). Note that each block 
consists of two factors with two or more levels. The first factor is a dye effect which is 
usually two levels and takes into account the varying dye florescence and labeling efficiency. 
The second factor is a treatment effect which is the factor of interest (72). Having two factors 
with blocks of size two implies that on the level of a single array, the dye and treatment 
effect are confounded (72). Therefore, a major design question and a determinant of design 
efficiency is the choice of how to pair samples for co-hybridization to slides in order to 
disentangle the confounding of the dye and treatment factors. This decision of how to pair 
slides is also tied to another essential design question which is the amount and type of 
replication needed to address the question under study (50, 61, 125, 138, 169).  
Three basic designs types that are commonly employed in microarray experiments are the 
reference sample, loop, and dye-swap designs. In a reference sample design, all the samples 
of interest are co-hybridized with another sample which is often not of interest to the 
researcher. It was one of the first designs used due to its ease of analysis and interpretability. 
However, the reference sample design lacks power and most of the information obtained is 
on the extraneous reference sample since it is co-hybridized with all the other samples of 
interest (24, 50, 67, 69). The lack of power in reference sample design has led to the 
development of more sophisticated designs such as the loop and dye-swap designs (67). A 
loop design is one in which treatment groups alternate in a chain of co-hybridizations. Loop 
designs provide good average precision, but have the some limitations. Loop designs may be 
inefficient for large loops, the loss of a single array greatly reduces the efficiency of the 
design, and the appropriate analysis of relative expression is not always obvious (24, 67). For 
example, large loop designs may result in comparisons between samples separated by several 
chains of co-hybridizations. This design structure results in low precision between these 
separated samples. However, this may be acceptable for an analysis such as time course 
experiments where comparisons between samples that differ by many time points are not of 
primary interest (168). A dye-swap design is one in which each pair of samples is hybridized 
twice with alternate dyes (67). Two technical replicates are assigned two different dye labels 
in order to conduct dye-swap hybridizations. Dye-swap experiments are a simple and 
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effective design for direct comparisons. A replicated dye-swap experiment uses independent 
samples for each dye-swap pair and will thereby account for both technical and biological 
variation (24). Other benefits of the dye-swap design are that it has the same precision as the 
loop design, is more robust and less complicated to implement, and offers an opportunity for 
nonparametric analyses (67). 
A convenient method of displaying a microarray experimental design is through a 
graphical representation by depicting samples as nodes and slides as directed edges with the 
tail of an edge corresponding to one label and the head as the other label (67, 69, 169). These 
graphical representations enable a quick visual assessment of the precision of the relative 
expression estimate between any two samples since the precision is inversely related to 
number of edges that separate nodes in the design (i.e., the greater the number of edges that 
separate two samples, the more variable the relative expression estimate will be). For 
example, consider an experiment with two microarray slides. A direct comparison between 
two samples could be done with a dye-swap design or an indirect comparison of these two 
samples may be done via a reference sample design. In the direct comparison, the log ratio 
relative expression variance is σ2/2, whereas in the indirect comparison, the variance is 2σ2. 
This difference between direct and indirect comparisons results in variance estimates that 
differ by a factor of 4 (24, 169). Thus, it can be seen from this simple example that direct 
comparisons of the contrasts of interest are generally the most efficient designs and that the 
design goal is to develop short paths for contrasts of secondary interest (24). 
The quality of the microarray data also relies heavily on the choice of the experimental 
design (72). Several different criteria have been proposed to compare competing designs 
such as maximizing the precision of contrasts of interest, increasing efficiency and 
robustness, and reducing bias. A key premise in comparing experimental designs is that 
comparisons of interest are defined a priori so that designs may be judged as to which one 
provides the maximal information for the contrasts of interest. Thus, identification of the 
parameters of interest is necessary for design formulation (50). The selection of an efficient 
design from a set of candidate designs is to select the design that minimizes the variance of 
treatment effect estimators of interest while ensuring their estimability (72). Estimability of 
the effects of interest is an issue due to the confounding of the dye and treatment effects on a 
single array (74). A-optimality and D-optimality are examples of methods to assess the 
precision of parameter estimates. An A-optimal design is one in which the average variance 
is less than or equal than the average variance of any other design within some specified class 
of designs. A D-optimal design is one which minimizes the volume of the confidence 
ellipsoid for a vector of treatments within some specified class of designs. In the case of an 
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experiment with only two treatments, A-optimal and D-optimal designs are identical, but in 
general these criteria are not identical for experiments with more than two treatments (7). 
Another proposed criterion for comparing designs that considers the precision of the 
contrasts of interest is the concept of admissibility. Admissible designs are designs in which 
the diagonal elements of (XTX)-1, where X is the incidence matrix of the design, is minimal 
for at least one of the diagonal elements in comparison to any other design. Glonek and 
Soloman propose that only admissible designs should be considered and that these then could 
be judged by a criterion such as D-optimality. Note that in general, if a design is optimal for a 
particular question, it is probably not optimal for another question (50). A general guideline 
for a good design in terms of the precision is one in which the comparisons of interest are 
close to one another in a directed graph (67). 
There are many factors that contribute to the observed variation in a microarray assay 
(50). For example, the efficiency of fluorescent dye incorporation and of target hybridization 
is known to vary between different pools of cDNA (69). Dye-swap replicates are a means to 
reduce systematic bias due to dye differences. Although dye-swap designs are not necessary 
or sufficient to eliminate dye bias, they are highly recommended if replicated hybridizations 
are performed to avoid bias that may affect estimates of treatment differences and their 
variance estimates (7, 24, 50, 67, 169). Another way to account for dye bias is through the 
use of row-column designs where schematically the rows may represent the different dyes 
and the columns slides (7). In general, it is recommended to balance dyes and samples to 
further minimize bias (24, 50, 69). 
 Another design criterion is the robustness of a design which may be defined as a measure 
of the amount experimental material that may be lost while maintaining estimability of 
treatment differences (7). Often the search for the optimal design results in a complex design 
that may not be robust against missing data and hence may not be the best choice (72). 
Missing data in microarray experiments are a common difficulty and are due to various 
reasons such as image resolution, image corruption, dust or scratches on the array platform, 
etc. (74). Thus, robustness of the microarray experimental design is important for the 
retention of design efficiency when missing data occur due to failed or poorly constructed 
arrays. For example, the loop design is not robust since a loss of one array will break the 
chain of the loop, but the reference sample design is robust since a lost array only affects that 
one sample (67). Technical replicates can account for missing values thereby increasing the 
robustness of the assay, and they are also good for quality control (76). Therefore, another 
strategy in experimental design may be to limit the design choice to those designs in which 
parameters remain estimable when any single slide is removed from the design (50). 
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Experimental design of microarray experiments is not a trivial endeavor. Careful 
consideration of the sources of variation, potential confounding, and operational limitations 
and pitfalls is needed. Ensuring sufficient biological replication to obtain enough power to 
estimate relative RNA expression patterns is a key factor in designing the assay and is often 
not fully appreciated by the researcher conducting the researcher. The number of biological 
replicates needed for an experiment is hard to determine, but three replicates has been 
indicate as being sufficient (169). Others have recommended that no fewer than 5 degrees of 
freedom are needed for statistical tests, but microarray analyses often have fewer (24). Not 
enough consideration of the experimental design is far too often an occurrence and results in 
the lack of a powerful analysis and at worst a failed experiment. 
 
Data Acquisition, Multiple Scan Methodology, and Normalization 
Data for each probe on a slide are obtained by scanning hybridized arrays with a confocal 
laser scanner which is able to differentiate the fluorescent signal from the two dyes. The most 
common dyes used for labeling are Cy5 and Cy3 which produce signal at 663 nm (red) and 
543 nm (green), respectively, when excited by a laser. The Cy5 channel is scanned first since 
it is more susceptible to photodegradation, and then the Cy3 channel is scanned (61). Most 
protocols recommend scanning each channel with settings that minimize spot saturation. 
However, this protocol has the potential to not detect differential expression due solely to 
signal intensity. That is, low-signal targets may not be detected in order to prevent saturation 
of high-signal targets (125, 138). A method to increase the dynamic range of expression 
measurement is to scan each slide for both channels three times with varying laser power and 
photomultiplier tube gain settings (84). This method was used for all the microarray 
experiments presented in this dissertation. A description of the image processing procedure 
for multiple scans is described below. 
There are three steps involved in processing a scanned image. First the probes are 
identified and differentiated from any spurious signals, second the background signal is  
estimated, and third the background corrected signal intensity is calculated (61). These three 
steps are applied to each scan setting separately. The identification of probes is referred to as 
spotfinding and is facilitated by software. The grid pattern of the printing greatly assists this 
process, but user input is needed to visual assess and correct probe identification due to 
spurious “spots” caused by various hybridization artifacts and contaminants. The mean signal 
intensity is obtained for each channel/spot and may be calculated by various algorithms 
provided by the software. A discussion of signal intensity algorithms is beyond the scope of 
this dissertation, but the interested reader is referred to the software manual for SoftWorRx 
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Tracker (Applied Precision, Inc., Issaguah, WA.) for more details. The estimation of 
background signal is done locally since the hybridization process often results in an uneven 
background signal across the slide. The median signal for each channel in the local area 
around each spot is obtained, and there are also several algorithms for estimating background 
signal provided by the software. Finally, the background corrected signal is calculated for 
each scan separately as the mean signal intensity minus the median background signal for 
each spot. This results in three processed images for each slide and dye channel, one for each 
of the three scanning settings for both dye channels. 
A method to combine these three scans into a single value has been developed by Dr. 
Dan Nettleton of Iowa State University (ISU). A brief synopsis of the method follows. A 
transformation of the background corrected signal for each scan is done by converting any 
negative values to 0 and then adding 1 to all the values. These values are then log 
transformed to produce a more Gaussian distribution of signal intensity. The three scans are 
then “compressed” into a single value for each spot by first median centering the three scans 
to 0 and then for each spot computing the median of the three median centered values. The 
functions (“log.0” and “compress”) written in the R statistical software package (114) 
perform this process and may be found in the Appendix. 
After image processing and combining the multiple scans, data normalization is the final 
data processing step conducted before statistical analysis of the microarray experiment. Data 
normalization is a process that prepares the data so that it meets the assumption of comparing 
two RNA samples in a block design with a block size of 2 (67). In order that meaningful 
comparisons may be made, the normalization process aims to minimize systematic variation 
in microarray experiments for factors (other than those under study) that affect the expression 
level measurement (13, 113, 168). Normalization is needed due to various reasons such as 
unequal starting quantities of RNA, variations in labeling and detection efficiency (dye 
effects), variation in array production processes (slide to slide variation), differences due to 
data acquisition process such as the scanning of the slide, and other systematic biases in 
measured intensities (13, 61, 113, 168).  
Several methods for normalization have been developed where the primary underlying 
assumption is that for a subset of probes, the measured log expression ratio averaged over 
this set should be equal to 0 (i.e., equal levels of expression) (61). Global, intensity-
dependent, within-print tip group, scale, and composite normalizations are some examples of 
the various normalization methods that have been developed (168). An example of a global 
normalization method is total intensity normalization which is a process that assumes that the 
total amount of labeled target in the sample is approximately equal, and thus, the signal 
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summed over all probes should be the same for each sample. There are several variations of 
this global methodology such as centering on the signal intensity mean or median within or 
across arrays or using just a subset of the entire array for normalization. Other global 
methods for normalization include linear regression analysis, log centering, rank invariant 
methods, and Chen’s ratio statistic, but none of these methods account for any systematic 
intensity dependent bias that may be present in the data (113). Hence, global normalizations 
methods are inadequate when the systematic variation depends on the intensity of the signal 
and/or location within the array. However, local regression methods are able to account for 
intensity and spatial dependency as a result of systematic variation (168). A method that 
accounts for intensity-dependent effects is a locally weighted linear regression (lowess) (27) 
normalization (113, 168). Lowess normalization applies the lowess scatter plot smoother to 
the MA plot of each slide. A MA plot is a scatter plot constructed from functions of the red 
(R) and green (G) signal intensities. The intensity log-ratio (M = log2(R/G)) is plotted on the 
y-axis and the mean log intensity ( RGA 2log= ) is plotted on x-axis (31, 168). Lowess 
normalization will not affect the small percentage of differential expressed genes in most 
microarray experiments which appear as outliers on a MA plot, and it also corrects for spatial 
bias. One caveat of using lowess normalization with all of the genes is that the process may 
not be adequate for experiments where there are significant divergences between the 
biological samples under study. However, this is in contrast to the more common assumption 
that most genes are not differentially expressed (168). An implementation of a lowess 
smoother is available in the “stats” package of the R statistical software package (114). Two 
R functions (“msn” and “normalize”), written by Dr. Nettleton of ISU, apply the lowess 
function to microarray data and may be found in the Appendix. Additionally, Bioconductor, 
an open source software project based on the R programming language, provides software 
tools to conduct these analyses as well as a host of other software tools for microarray data 
analysis (46).  
 
Microarray Data Analysis 
Once the data have been acquired and normalized, a statistical analysis may be done. The 
identification of a set of differentially expressed genes is one of the main objectives of many 
cDNA microarray experiments. The first microarray analyses focused on the fold change of 
expression; however, rules to identify differentially expressed genes based solely on fold 
change will miss biologically important genes that have small fold changes that can be 
estimated precisely (i.e., expression levels with small variance) and conversely, will declare 
other genes as differentially expressed even though they are highly variable and thus have 
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low statistical significance (166). Methods for differential expression identification which 
account for the variability of the expression estimate will be discussed below. In additional to 
identification of differential expression, a researcher may want to conduct cluster analysis of 
gene expression patterns in order to provide insight on the function of unknown genes that 
cluster with genes of known function (68, 69). This section, however, will only focus on the 
former objective of identification of differentially expressed genes. 
An often used strategy that may be applied to data from a microarray experiment and 
accounts for the precision of the expression measurement is to analyze the differential gene 
expression data from microarray assays via a generalized linear model. These models need to 
consider the hierarchical structure of microarray data and the sources of systematic and 
random variation in order to avoid biased results (76). The four basic experimental factors 
that the variation needs to be accounted for are treatment (T), target (gene, G), dye (D), and 
array (slide, S). Also, an assumption in model fitting is that a transformation, such as the log, 
exists such that the effects become additive (69). Historically, analysis of variance techniques 
for the entire data set were applied via a fixed linear model for the logged signal intensities 
with these four main effects (T, G, D, and S) and interactions between some of these effects 
such as treatment by target (TG). The interaction TG is then the contrast of interest to 
identify differentially expressed genes. The problem of this global method is that it wrongly 
assumes a common variance across all of the genes. When fitting an overall model, this 
underlying heterogeneity of variance has the potential to lose sensitivity for some of the 
genes and to overestimate the significance for other genes since there is only one error term 
across all the genes. The alternative is to conduct an ANOVA on each gene separately which 
produces the same contrast estimate, but a different error estimate for each gene (31). Thus, 
the widely accepted method is to conduct an analysis of each probe separately. 
Linear modeling is a flexible approach for analyzing data from a wide class of designs. 
This modeling approach allows researchers to include any effects they deem appropriate for 
the design. Note however, that not just any effect may be added. For example, a design with 
some dye-swap hybridization on experimental units is needed in order to include a dye effect 
in a model (166). Recall that data normalization is aimed to eliminate global dye bias, but 
gene specific dye bias is still present. Hence, it is recommended that the dye factor remains in 
the model if possible. The dye effect accounts for any interaction effects between the target 
and dye (72, 74). The assumption of normality has been questioned for linear models and 
various resampling procedures have been suggested to circumvent this assumption, but the 
experience of Wolfinger, et al. is that the assumption of normality on the log scale is 
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reasonable. Though it is strongly recommended that the assumption of normality be checked 
using graphical and statistical methods (166). 
A mixed linear model that fits the logarithms of the normalized fluorescence values for 
each target separately is another example of a flexible method to account for variability. By 
fitting individual mixed models to each target, a separate estimate of variability for each 
target is available for inference. Mixed models consist of random effects which are assumed 
to have Gaussian distribution with mean 0 and a respective variance component. The method 
of restricted maximum likelihood (REML) is commonly used to estimate these variance 
components (166). For example, consider an experiment with two treatments (treated and 
control) which fits the model yijk = μ + τi + δj + αk  + εijk  where yijk is the logarithm of the 
normalized fluorescence values of a given probe for treatment i, dye j, and slide k. The 
parameter μ is a baseline parameter, τi is a fixed treatment effect for treatment i, δj is a fixed 
dye effect for dye j, αk is a random slide effect for slide k, and εijk is random error for 
treatment i, dye j, and slide k of a given probe. The contrast of interest, treated minus control 
(τT – τC), is estimated from this fitted model, and an estimate of the error variance is also 
obtained. A test of the null hypothesis of no treatment effect may then be done to obtain a p-
value in order to assess the statistical significance of the estimated difference. 
Another approach to modeling the data is to fit the difference in the logarithms of the 
normalized fluorescence values for each target separately (72). This is identical to fitting the 
logarithm of the ratio of normalized values. Explicitly, the equivalence is log(yi1k) - log(yi2k) 
= log(yi1k/yi2k)  (referring to the notation in the example above). This difference model, when 
applied to the mixed model above, results in a fixed linear model since the slide effect is 
removed by computing the difference for each slide. The difference for each slide is 
computed in the same direction for dye (e.g., green minus red). The resultant model may be 
written as z = (δ1 - δ2) + x(τT – τC) + ε* where z is the difference in logarithms of the 
normalized fluorescence values (log(yi1k) - log(yi2k)), x is either ± 1 to denote the direction 
which the treatment subtraction was done, and ε* is the random error associated with the 
difference. The intercept for this model is the difference in dye effects (δ1 - δ2) and the 
parameter of interest is the difference in treatment effects (τT – τC). A test of the null 
hypothesis of no treatment effect may then be done to obtain a p-value in order to assess the 
statistical significance of the estimated difference. 
Due to the large number of probes on an array, the identification of targets with 
differential expression is a situation of extreme multiple hypothesis testing. Defining an 
appropriate Type I error rate and constructing a powerful multiple testing procedure with 
respect to this error rate while accounting for the joint distribution of the test statistic is a 
 45  
difficult challenge in array analysis. Multiple testing procedures are designed to compute 
adjusted p-values which control the family-wise Type I error rate (FWER) while accounting 
for dependence structures between the gene expression levels. The FWER is the probability 
of at least one Type I error in the family of hypothesis tests (i.e., the probability of one or 
more false discoveries) (31). Methods to control the stated error rate may be described as 
providing strong or weak control. Methods that provide strong control of the FWER are 
procedures that control the error rate for any realization of number of true null hypotheses in 
a family of hypothesis test. Methods that provide weak control of the FWER are procedures 
that guarantee control of the error rate only when all the null hypotheses are true. Examples 
of multiple testing procedures that provide strong control of the FWER are the Bonferroni 
procedure, the Holm procedure, and the Sidak procedure. However, these procedures do not 
account for any dependency structures in the test statistics which are highly likely to be 
present in microarray experiments due to the co-regulation of genes. The Bonferroni and 
Holm procedures provide strong control of the FWER for any dependence structure but will 
be too conservative if there is any dependency, and the Sidak procedure requires that the tests 
be independent (31, 38). To account for test statistic dependencies, other methods such as the 
Westfall and Young procedure and the step-down maxT adjusted p-value have been 
developed (31). But with any of these procedures that provide strong control of FWER, the 
power of the procedure is generally low. For the purposes of many microarray experiments, 
strong control of FWER may be too stringent a criterion. Strong control of the FWER is 
important for experiments where a Type I error for any one of the multiple tests is a serious 
error in relation to the overall conclusion of experiment (10). This is not the case in the 
identification of differentially expressed genes. A few false positives in a list of declared 
differentially expressed targets may be tolerated in order to capture more true positives in 
many microarray experiments. 
An alternative concept to controlling the FWER is to control the false discovery rate 
(FDR) which was originally proposed by Benjamini and Hochberg (10, 31). The FDR 
procedure is a method to control the expected proportion of Type I errors among the rejected 
hypothesis. Table 2.1 below (adapted from Benjamini and Hochberg Table 1 in (10)) 
tabulates the possible outcomes for m null hypothesis tests is useful for describing the 
concept of FDR. Within the table are four unobservable random variables defined as: U is the 
number true negatives, T is the number of false negatives (Type 2 errors), V is the number of 
false positives (Type 1 errors), and S is the number of true positives. The observable random 
variable R is the number of rejected null hypotheses. In the column on the right side of the 
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table is the observable constant m (the number of hypotheses tested) and the unobservable 
constant m0 (the number of true null hypotheses). 
 
Table 2.1 Possible outcomes for m hypothesis tests 
 
 Declared Declared  
 non-significant significant  
True null 
hypotheses U V m0 
False null 
hypotheses T S m - m0 
Total hypotheses 
tested R - m R m 
Using the notation in the table above, the FDR can be formerly defined as E(Q) where Q = 
V/R if R > 0 and Q = 0 otherwise. 
 
Procedures for estimating FDR use the p-values computed from a test statistic such as a t-
statistic. These procedures start with an ordered list of p-values (denoted as p(1),  p(2), …, p(m)) 
from the m hypothesis tests and then define a cutoff value c = p(k) for the largest k which 
satisfies either ( ) α≤kmp k  or ( ) α≤kmp k 0ˆ  for some significance level α . Benjamini and 
Hochberg presented the criterion as ( ) mkp k α≤  which strongly controls FDR at level α 
when the hypothesis tests are independent (10). The other criterion for estimating the FDR 
requires 0mˆ , an estimate of m0 (i.e., the number of true null hypotheses), in order to compute 
the cutoff value c. The estimation of 0mˆ  has been an active area of research and numerous 
methods such as Lowest Slope (11), mixture modeling of a Uniform and Beta distribution (3, 
112), λ Threshold (143, 144), Density Estimation (73), and histogram based estimation (92, 
100) have been developed. Once 0mˆ  is estimated, the cutoff value may be computed. An 
alternative to defining a specific cutoff value c, is to compute the q-value which is an FDR 
analogue to the p-value. For an individual hypothesis test among a family of hypothesis tests, 
the q-value is defined as minimum FDR for that test and all other tests with smaller p-values. 
Some of the studies in the Appendix use the R function “bh.fdr.R” written by Dr. Nettleton to 
implement the FDR methods of Benjamini and Hochberg (10) and to compute q-values. 
Other studies in the Appendix use the R functions written by Dr. Nettleton “mosig.R” and 
“q.value.R” to implement the FDR methods of Mosig et al. (92) and to compute q-values 
according to the methods of Storey and Tibshirani (144). 
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Top-Down and Bottom-Up Methods of Analysis 
 
An analysis of a complex system requires careful consideration on how the data is 
generated and the information the researcher wants to obtain from the experiment. The 
fundamental question the analyst faces is how to model the system to obtain estimates of 
quantities of interest and then how to estimate the precision of these estimated quantities. 
There are two fundamental approaches to the modeling which may be termed as top-down 
and bottom-up methods of analysis. These methods were applied and compared within a 
specific RT-qPCR experimental setting in Chapter 4 of this dissertation. A description of the 
principles of these methods is presented below. 
Often researchers approach a complex problem by constructing sensible summaries of 
some quantities from a function(s) of the observations obtained via an experiment. The 
researcher will then analyze the composite quantities generated from this function as if they 
are the observed random variables and perform a statistical analysis of them. This approach 
to modeling a system is termed the top-down method since the analysis is done on top of 
calculated composite quantities. In the top-down method, the observed quantities for each 
experimental unit are combined via a function of interest to produce a single “observed” 
quantity for each experimental unit. These composite quantities are treated as independent 
observed random variables and an estimate of variance can be obtained through standard 
procedures of calculating the standard error of the mean. One of the aims (in addition to the 
simplification of the system) in constructing composite quantities is to reduce any random 
variation that is not of interest to the researcher. However, this methodology may 
inadvertently lose information about the system under study when a function of the observed 
values is constructed. 
In contrast, the statistician would often prefer to model the data at the level from which 
the data is generated. By modeling at the level of data generation, the variation observed in 
the system may be partitioned to various components in the model. Quantities of interest and 
their precision may then be estimated from a function of the parameter estimates and 
estimated variances of the selected model. This approach to modeling a system is termed the 
bottom-up method since the analysis is done on the lowest level of data generation. In the 
bottom-up method, the observed measurements are themselves the random variables and an 
estimation of their variance is done directly. The Delta Method (21) may then be applied to 
obtain a variance estimate of a function of the estimated parameters where the function of the 
parameters is the quantity of experimental interest. The difficulty of this approach is that the 
model needs to be sufficiently specified to account for the variation in the system in order to 
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generate accurate estimates of the parameters and their precision to be used in the estimation 
of the quantity of interest.  
Often it is possible to model the quantity of interest from either the top-down or bottom-
up method. For simple systems and functions of interest, the results are often identical or 
nearly so. But in a complex system, the results often vary widely between the two methods 
and the appropriate approach is not always obvious. The question then is which approach 
should be used. An assessment of both methods may be done to consider the merits and 
deficiencies of each method. A question to consider for the top-down method is; does the 
function of the observed random variables ignore an important source of variation in the 
system? And for the bottom-up method; is the model selected to estimate the parameters and 
their distribution adequately specified for the system?  
An example of how these two methods may be implemented is described below for a 
replicated dye-swap two-color microarray experiment with only two treatments. Focusing on 
an analysis of a single probe and ignoring any extraneous sources of variation, the observed 
data from the experiment could be described as a two way factorial design where each factor 
has two levels. Estimating the difference in relative RNA expression between the treated (T) 
and control (C) is the common question of interest to the researcher for this type of 
experiment. The dye effect, green (G) or red (R) is generally not of interest to the researcher 
and thus is a nuisance factor. A simple model for the observed data in the two way table is y 
= μ + si + δd + τt + ε where y is the observed fluorescence signal, μ is the overall mean, si is 
the slide effect for slide i, δ is the dye effect for dye d (G or R), τt is the treatment effect for 
treatment t (T or C), and ε is random error. One possible top-down approach to address the 
question of interest is to calculate the difference of the G minus R signal for each slide and 
construct a design matrix with ± 1 to denote the direction which the treatment subtraction 
was done. The model would then reduce to Δy = Δδ + xΔτ + ε* where Δy is the difference (G 
- R) of the observed fluorescence signal from each slide, Δδ = (δG - δR) is an overall mean 
which represents the difference in signal due only dye effects, x is ± 1 to denote the treatment 
direction, Δτ  = (τT – τC) the difference due treatment which is the quantity of interest, and ε* 
is random error for this difference model. A t-test of Δτ ≠ 0 may then be done to determine if 
there is a significant difference in relative RNA expression.  
A bottom-up approach to this example would be to fit the model y = μ + si + δd + τt + ε to 
the observed data from the experiment and estimate all the parameters. The quantity of 
interest could then be estimated as contrast of (τT – τC) and tested as being different from 
zero. The result from this formulation of the model would be nearly identical for both 
methods. But if the model doesn’t adequately explain the system and there is an interaction 
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between the dye and treatment effects, then another model should be considered. A model 
with the interaction term would be y = μ + si + δd + τt + (δτ)dt + ε΄. The bottom-up method is 
easily extended to this model and a test for the interaction term not equal to zero may be 
done. However, the top-down method can not be easily extended to this model. The 
difference model would result to be Δy = Δδ + xΔτ + z1[(δτ)GT – (δτ)RC]+ z2[(δτ)GC – (δτRC)] + 
ε΄* where z1 and z2 are 0 or 1 respectfully depending on hybridization direction of slide. This 
model has estimability problems since the design matrix is not of full rank. Thus, the bottom-
up method is a more appropriate method for this example when an interaction between dye 
and treatment is significant.  
 
Delta Method 
 
Many experiments generate observations of random variables which are not of interest in 
themselves, but functions of these random variables are of interest to the researcher. For 
example, a forester interested in the volume (v) of a log can easily observe the area of the 
cross section at the base (b) and top (t) of a log and the length (l) of a log. An estimate of the 
volume of the log is v = ((b + t)/2) * l (163) which is a function of the observed random 
variables. The distribution of the observed random variables is sometimes known or 
assumed, but often functions of these random variables are too complex for an analytical 
computation of the distribution of the function. A linear approximation of the function by a 
first-order Taylor series is the basis of a method to approximate the distribution of a complex 
function. This approach to approximate the distribution of a function of random variables is 
referred to as the Delta Method (21). 
The first-order Taylor series is a linear approximation of a function which uses the Taylor 
polynomial only up to the first derivative terms. Define T = (T1,…,Tk) as a vector of random 
variables with θ = (θ1,…, θk) a vector of means of the random variables. Suppose we want an 
approximate variance for some differentiable function g(T). The first-order Taylor series 
expansion of g about θ is 
( ) ( ) ( ) ( ) Remainder 
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ii
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and lower case t is used to denote an arbitrary values of the random variable T. The 
remainder may be ignored for the approximation which is 
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where the last equality is derived by expanding the square and applying the definition of 
variance and covariance. This approximation of the mean and variance of g(T) is then used in 
the Delta Method. 
The Delta Method is a generalization of the Central Limit Theorem. Casella and Berger 
(21) present the Delta Method as Theorem 5.5.24 for the univariate case where n refers to 
Gaussian distribution.  
 
“Let Yn be sequence of random variables that satisfies ( ) ( )2,0 n σθ →−nYn  in 
distribution. For a given function g and a specific value θ, suppose that ( )θig ′  exists 
and is not 0. Then ( ) ( )( ) ( )[ ]( )2 2,0 n θσθ ggYgn n ′→−   in distribution.” 
 
The extension to multivariate case is straightforward since the Taylor series expansion 
presented above is for the multivariate case. Casella and Berger (21) present the Delta 
Method as Theorem 5.5.28 for the multivariate case. 
 
“Let X1,…,Xn be a random sample with E(Xij) = μi and Cov(Xik, Xik) = σij. For a given 
function g with continuous first-order derivatives and specific value of μ = (μ1,…, μp)  
for which ( ) ( )∑∑ >∂
∂
∂
∂
= 02
ji
ij
gg
µ
µ
µ
µστ  , then  
( ) ( )[ ] ( )211 ,0n ,...,  ,..., τµµ →− ps gXXgn   in distribution.” 
 
The forester’s estimation of volume of a log presented above is an example of a case 
where the multivariate Delta Method may be applied. This function consists of three random 
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variables (b, t, and l). The partial derivatives with the respect to each of these variables is 
non-zero and are 2lbv =∂∂ , 2ltv =∂∂ , and ( ) 2tblv +=∂∂ . The approximation of the 
variance of the estimate of v is obtained through the following matrix computation using the 
partial derivatives evaluated at the parameter estimates and the variance-covariance matrix of 
the parameters. 
 
( )
( ) ( ) ( )
( ) ( ) ( )
( ) ( ) ( )
















+












 +≈
2
2
2
  
Var,Cov,Cov
,CovVar,Cov
,Cov,CovVar
 
222
Var
tb
l
l
lltlb
ltttb
lbtbb
tbllv
 
 
An application of the Delta Method is presented in Chapter 4 of this dissertation. A 
comparison of the top-down versus bottom-up variance estimates of the estimated relative 
RNA quantities and estimated log base 2 fold change in gene expression in RT-qPCR assay 
is presented for two different experimental designs. Each experimental design has a different 
implementation of the Delta Method to the bottom-up method of variance estimation due to 
different sources of observed measurements.  
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Mycoplasmas are thought to control gene expression through simple mechanisms. The 
switching mechanisms needed to regulate transcription during significant environmental 
shifts do not seem to be required for these host-adapted organisms. Mycoplasma 
hyopneumoniae, a swine respiratory pathogen, undergoes differential gene expression, but as 
for all mycoplasmas, the mechanisms involved are still unknown. Since mycoplasmas 
contain only a single sigma factor and few regulator-type proteins, it is likely that other 
mechanisms control gene regulation, possibly involving intergenic (IG) regions. To study 
this further, we investigated whether IG regions are transcribed in M. hyopneumoniae, and 
measured transcription levels across five specific regions. Microarrays were constructed with 
probes covering 343 IG regions of the M. hyopneumoniae genome, and RNA isolated from 
laboratory-grown cells was used to interrogate the arrays. Transcriptional signals were 
identified in 321 (93.6 %) of the IG regions. Five large (>500 bp) IG regions were chosen for 
further analysis by qRT-PCR by designing primer sets whose products reside in flanking 
ORFs, bridge flanking ORFs and the IG region, or reside solely within the IG region. The 
results indicate that no single transcriptional start site can account for transcriptional activity 
within IG regions. Transcription can end abruptly at the end of an ORF, but this does not 
seem to occur at high frequency. Rather, transcription continues past the end of the ORF, 
with RNA polymerase gradually releasing the template. Transcription can also be initiated 
within IG regions in the absence of accepted promoter-like sequences.  
 
Introduction 
Mycoplasmas are members of the class Mollicutes, cell-wall-less bacteria that infect a 
wide variety of plants and animals (including humans). Though related taxonomically, 
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members of the Mollicutes differ significantly in their habitats, their growth requirements and 
their overall structure. They are believed to have evolved from more complex organisms 
through degenerative mechanisms with the concomitant loss of genetic material (26); all 
mycoplasmas have small genomes with a limited number of genes, resulting in a lack of 
biosynthetic pathways (13, 29). Thus, they must obtain amino acids, purines, pyrimidines and 
membrane components from their growth environment. For the members of the family 
Mycoplasmataceae, the animal pathogens, this occurs primarily at the host mucosal surface, 
where damage to host cells occurs through different mechanisms (30).  
Mycoplasmas are found in association with hosts and not in a variety of external 
environments like many other pathogenic bacteria. Thus, the question arises as to whether 
mycoplasmas need to regulate genes if their environments are restricted to host mucosal 
surfaces, and if they do, then by what mechanisms. It has been suggested that with the loss of 
biosynthetic pathways, the remaining genes that are responsible for the basic processes of the 
cell, i.e., DNA replication, transcription and translation, are thought to be constitutively 
expressed, and in constant environments, the organism supposedly has little need for 
sophisticated genetic control mechanisms (25). Our knowledge of gene expression in 
mycoplasmas is rudimentary, with few studies that actually address the mechanisms involved 
(2, 5, 12, 18, 40, 41). Transcription is essential to the basic process of gene expression, but 
surprisingly, little information has been obtained experimentally defining the transcription 
process in mycoplasmas (25). The heat-shock response has been studied in a limited number 
of mycoplasma species (19, 24, 40), and it is clear that a transcriptional activator, HrcA, is 
involved in regulating transcription of two heat-shock genes (5). In addition, transcriptional 
start sites have been mapped for a limited number of genes (14, 36, 37, 41), and promoter-
probe vectors have been used in several different species (15-18). These studies show that the 
-10 box of the Pribnow sequence is relatively conserved, but not the -35 sequence. This lack 
of progress has been partly due to the few genetic tools available for use with mycoplasmas 
and with some species, e.g., Mycoplasma hyopneumoniae, the total lack of such tools. The 
limited genome capacity suggests simple regulatory mechanisms, and experimental evidence 
indicates that mycoplasmas have few regulatory systems for several reasons: 1) only a single 
sigma factor has been identified in any of the complete mycoplasma genome sequences, 2) 
transcriptional activators have rarely been identified (5), and 3) the genes for a few repressor-
like proteins have been identified in genome sequence studies (7, 10, 23). The global 
assessment of transcription has been reported using arrays (19-21, 27, 34, 40), but these tools 
are limited because they only assess transcriptional changes in annotated gene sequences and 
do not address mechanisms of transcription control.  
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The subject of this study, M. hyopneumoniae, is associated with respiratory disease and 
reduced productivity in swine (32). It is the causative agent of porcine enzootic pneumonia, 
and when co-infections occur with a secondary (bacterial or viral) infection, the respiratory 
disease is more severe and has been designated as porcine respiratory disease complex (32). 
Even though the virulence of M. hyopneumoniae appears to be low, substantial economic 
losses occur as a consequence of reduced average daily weight gain and efficiency of feed 
utilization, prophylactic and therapeutic costs, and mortality (28, 32). The virulence factors 
of M. hyopneumoniae are largely unknown, and to better understand the mechanisms 
involved, we are studying transcription in M. hyopneumoniae both in vitro and in vivo (1, 19-
21, 27, 34). Recent studies using microarrays to study global transcriptional changes clearly 
show that M. hyopneumoniae can regulate its genes in response to environmental changes 
(19-21, 27, 34). These studies give a snapshot of transcription across the genome in the 
annotated genes, but they cannot reveal basic features of transcription, i.e., start and stop 
sequences and mechanisms of regulation.  
Many mycoplasma genes lack defined, typical or canonical transcriptional stop 
sequences; rho- dependent termination does not seem to operate in mycoplasmas (31) and 
rho-independent sequences cannot often be found. To better understand transcription 
termination in mycoplasmas and as a first step in defining potential regulatory RNAs that 
may serve a role in gene regulation (11, 35, 39), we sought to determine if intergenic (IG) 
regions were transcribed in M. hyopneumoniae. The genome of M. hyopneumoniae consists 
of 698 protein-coding ORFs and 35 rRNA genes, and due to overlapping and juxtaposed 
ORFs there are 573 IG regions (23). To complicate the study, the overall G + C content of 
the genome is 28.6 mol% with ORFs having 29.6 mol% and IG regions 18.7 mol% G + C 
content. Surprisingly, the results of this study indicate that transcripts specific to virtually all 
of the 343 IG regions longer than 50 bases can be identified in M. hyopneumoniae RNA 
preparations. In a more defined quantitative analysis of five IG regions, it was clearly shown 
that internal initiation of transcription in IG regions occurs and probably does so at high 
frequency, suggesting that these RNAs may play an important role in the physiology of the 
mycoplasma, such as acting as regulatory RNAs. To our knowledge this is the first study to 
assess transcription across IG regions of the M. hyopneumoniae genome. A recent report by 
Güell et al. (12) also demonstrated IG transcription in Mycoplasma pneumoniae, suggesting 
that transcripts arising from IG regions are common in mycoplasmas.  
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Methods 
Mycoplasma strains and culture conditions. Pathogenic M. hyopneumoniae strain 232, 
a derivative of strain 11, was used in this study (22). Cultures were passed fewer than 15 
times in vitro in Friis medium (8). For the microarray and IG transcriptional studies, three 
250 ml flasks containing 125 ml cultures were grown at 37 ºC to early exponential phase, as 
determined by medium colour change and optical density. Cells were pelleted by 
centrifugation at 24 000 g, 500 μl of RNAlater (Ambion) was added, and pellets were stored 
at -70 ºC until the total RNA was isolated.  
For the heat shock study, six cultures of 5.6 ml were grown to exponential phase as 
described previously (19). Three cultures were randomly chosen and then shifted to 42 ºC for 
2 h while the other three cultures were maintained at 37 ºC for these 2 h. Cells were then 
pelleted and stored as described above until total RNA isolation. 
RNA Isolation. RNA was isolated from frozen cell pellets using Ambion’s RiboPure kit 
according to the manufacturer’s protocol. Each sample was treated with 4 U of DNase at 37 
°C for 30 min followed by purification using a Millipore Ultracell YM-30 Microcon 
Centrifugal Filter unit. Quantification and purity checks of each sample were done using a 
Nanodrop ND-1000 spectrophotometer. RNA samples were confirmed to be DNA free via 
PCR and gel electrophoresis.  
Microarrays. Two types of microarrays were constructed, one consisting of PCR 
products and the other of synthesized oligonucleotides. Intergenic regions were defined as 
non-coding DNA sequences between annotated genes in the M. hyopneumoniae genome 
sequence (23). Only IG regions larger than 49 bp were considered for analysis, and those 
greater than 124 bp were considered for PCR-based probes. Oligonucleotides were used for 
the smaller IG regions and for sequences that failed in PCRs to complete the coverage 
(defined as >50 % of the IG region). PCR primers were designed for products of 125-450 bp 
using the Primer3 online software program (33). PCRs were performed in 96-well plate 
format in a MJ Research Dyad thermocycler in 100 μl reactions using the following 
conditions: 1X MgCl2-free PCR buffer (Invitrogen); 3.5 mM MgCl2; 0.2 mM each of dATP, 
dTTP, dGTP and dCTP; 200 pmol of each primer; 2 units Taq polymerase (Invitrogen); and 
100 ng M. hyopneumoniae strain 232 chromosomal DNA obtained via phenol-chloroform 
extraction and ethanol precipitation. Thermocycler conditions started with a denaturation at 
95 ºC for 5 min followed by 30 cycles of denaturation at 94 ºC for 1 min, annealing at 56 ºC 
for 1 min, and elongation at 68 ºC for 30 s and ending with a final elongation at 68 ºC for 10 
min. Products were confirmed by 1.2 % agarose gel electrophoresis and purified via Mo 
Bio’s UltraClean PCR Clean-Up kit according to the manufacture’s protocol. Purified PCR 
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products were quantified by visual inspection, dried via vacuum centrifugation, and 
resuspended to approximately 200 ng μl-1 in Corning spotting buffer. Products suspended in 
spotting buffer were electrophoresed in 1.2 % agarose gels to confirm purity and 
concentration of each product and its size. The PCR product microarrays were spotted to 
Corning UltraGAPS glass substrates in triplicate by the University of Iowa DNA facility. 
Oligonucleotides were designed for some IG regions based on the inability to produce 
PCR products or the length of the region (49-124 bp). The strand chosen to be synthesized 
for the IG region probes was in the same orientation as the closest adjacent ORF. 
Oligonucleotides were synthesized by IDT and ranged in size between 50 and 60 bp. 
Oligonucleotides were resuspended to 100 pmol μl-1 in nuclease-free water, and then 9 μl 
were vacuum dried and diluted to 30 μM in IDT Epoxide spotting buffer. These 
oligonucleotides were spotted to Corning Epoxide substrates in triplicate.   
Microarray experimental design. To test for transcripts in IG regions, cDNA was 
generated from M. hyopneumoniae RNA using either random hexamers or a set of 129 
hexamer oligonucleotide primers designed for M. hyopneumoniae mRNA (19). A single total 
RNA sample was split into eight 5 μg samples, and cDNA synthesis was conducted on four 
of these samples using random hexamers (IDT); for the other four samples, cDNA was 
generated using primers designed for M. hyopneumoniae as described by Madsen et al. (19). 
In each set of four, two samples were fluorescently labelled with Cy3 and the other two were 
labelled with Cy5 using an indirect labelling protocol (19). After labelling and cleanup, all 
eight samples were quantified on a Nanodrop ND-1000 spectrophotometer. For each array on 
the slide, 1 μg of labelled cDNA from each type of primer generation (Cy3 or Cy5, random 
or specific primer set) was combined and hybridized to a PCR-featured array and an 
oligonucleotides-featured array. This resulted in two arrays of PCR probes hybridized with 
dye swaps and two arrays of oligonucleotide probes with dye swaps. A second RNA sample 
was split into four 5 μg samples of total RNA, and the hybridization process was repeated for 
the oligonucleotide probe array. The hybridization and wash protocols have been described 
for PCR (19) and oligonucleotide arrays [as per manufacturer's instructions (Corning)]. 
Microarray data acquisition and analysis. Slides were scanned using a ScanArray 
Express laser scanner as described previously (19). The SoftWorRx Tracker analysis 
software package (Applied Precision) was used to quantify the images. Probes were declared 
to detect signal if their normalized intensity in both channels on at least one array was more 
than 6 SEM greater than the mean intensity of features containing spot buffer only.  
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Microarray data accession number. The microarray descriptions and the microarray 
data can be accessed through the Gene Expression Omnibus 
(http://www.ncbi.nlm.nih.gov/geo) under accession number GSE17893. 
qRT-PCR primer design. The IG sequence and 300 bases into adjacent ORFs were 
targeted for relative quantitative real-time-PCR (qRT-PCR) analysis. Primers were designed 
using the IDT Primer Quest tool. The goal was to design six primer pairs for each region with 
unique target sequences ranging in size from 80 to 200 bp. One target sequence each was 
designed to reside completely within each flanking ORF, one each to bridge the transition 
region from ORF to IG region, and two within the IG region itself. For clarity, the IG regions 
were designated according to the upstream ORF (numbered clockwise around the genome), 
independent of transcription direction. Additional primers for the heat-shock assay were 
similarly designed for the region upstream of dnaK. This region of the genome does not 
contain a large IG region; thus primers were designed such that a target sequence was located 
in each gene (uvrC, mhp071 and dnaK); and three target sequences bridged genic/intergenic 
regions (uvrC/ig-070, mhp071/ig-071 and ig-071/dnaK). Additionally, primers for a target 
sequence within the reference gene control (mhp381) used in the analysis were designed. 
Table 3.1 describes the primers used for the qRT-PCR analysis. All of the primers were 
tested using a M. hyopneumoniae chromosomal DNA template to ensure their effectiveness 
in producing a correct product as determined by size via agarose gel analysis.  
qRT-PCR experimental design and data acquisition. A test of the sensitivity of the 
qRT-PCR assay was done using DNA from M. hyopneumoniae 232 diluted to 4 ng μl-1. The 
Express One-Step SYBR GreenER kit (Invitrogen) was used for qRT-PCR with the 
Mx3005P QPCR System (Stratagene) and MxPro 4.1 software. Reaction volumes for each 
well totalled 15 µl and contained 0.895 µl of water, 7.5 µl qPCR mix, 0.6 µl of each primer 
at 2.5 µM, 0.03 µl ROX reference dye, 5 µl of template DNA or RNA at 4 ng μl-1 and 0.375 
µl SuperScript III. The DNA template was diluted 11 times as described by the PREXCEL-Q 
software program (9). These 11 dilutions and a negative control were run in a 96-well plate 
for the six target sequences in region ig-072. The thermal cycling conditions were a (mock) 
cDNA synthesis step at 50 ºC for 30 min; RT deactivation at 95 ºC for 10 min; 40 PCR 
cycles of 95 ºC for 30 s, 56 ºC for 30 s, and 68 ºC for 30 s; and a melt-curve step of 95 ºC for 
10 min, 55 ºC for 30 s, and 95 ºC for 30 s. These thermal cycling conditions were used for all 
qRT-PCR assays throughout this study.  
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Table 3.1. Primers used for qRT-PCR analysis. 
Region 
Primer 
Set Forward Primer Sequence Reverse Primer Sequence 
Product 
size 
ig-070/071 1 RT_uvrC.L TGCTCCTTTTGCATACTGATTC RT_uvrC.R AAAATTGATGCTGCCAAACC 121 
ig-070/071 2 RT_uvrC-ig070.L TTTGGCAGCATCAATTTTT RT_uvrC-ig071.R TCACTCTAATTTATTTTAACTTCAAGG 150 
ig-070/071 3 RT_mhp071.L TCTGTTCCTAAAATAAAACAGTTGAAA RT_mhp071.R CGATAAAATCATTTGGCAAGC 142 
ig-070/071 4 RT_mhp071-ig071.L AAAAGTTGAAAGAGATATTGAAACTCA RT_mhp071-ig072.R TGCCAGAATTTATGAAAAATAGTCA 126 
ig-070/071 5 RT_ig071-dnaK.L TTTTTCATAAATTCTGGCACTTTT RT_ig071-dnaK.R CCTAAAATGATTTCTTTTGCCATT 147 
ig-070/071 6 RT_dnaK.L CCTGTCGTTCTCGAAAATCC RT_dnaK.R CCCCGACAATTTCTTCATTG 82 
ig-072* 1 RT_mhp072.F ACAGTTCGTGCCGAAGGGCTTATT RT_mhp072.R TTGGGCAGCTGCTTCAATTTGGTC 183 
ig-072* 2 RT_mhp072.ig1.F AACCGCGCAGCAAGCAAATACATC RT_mhp072.ig1.R CTAGCAGAAATTTGCAAGTGTGCGT 129 
ig-072* 3 RT_mhp072.ig2.F AAGAAATCCAGGAAGCCTACGA RT_mhp072.ig2.R AAGCCACTAGACCCACCACCAAAT 112 
ig-072* 4 RT_mhp072.ig3.F TTTGGTGGCTCACAAGAACAAA RT_mhp072.ig3.R CGCCTGAACCCTTACAGTTATCACA 157 
ig-072* 5 RT_mhp072.ig4.F GATAACTGTAAGGGTTCAGGCGCT RT_mhp072.ig4.R TGAACCCGACCAAATCCGGGAATA 116 
ig-072* 6 RT_mhp073.F TATTCCCGGATTTGGTCGGGTTCA RT_mhp073.R AAACATTCCATCCTGGATTCCGGC 166 
ig-106 1 RT_mhp106.F TGAGTTGCAAGCAATTGATTATCGC RT_mhp106.R CCATATTCCCTTAATTTAATTTCAAGTTTGC 200 
ig-106 2 RT_mhp106.ig2.F TGTCTTCAAGTTAGACTTGCTTAT RT_mhp106.ig2.R2 GGATAATTTAGGTGATTTCATGTTATT 123 
ig-106 3 RT_mhp106.ig3.F ACATGAAATCACCTAAATTATCCT RT_mhp106.ig3.R AGAAGCCACTAAATTATTCAAGA 82 
ig-106 4 RT_mhp106.ig4.F AATTGTAAATTCGCGGAGGTGAAC RT_mhp106.ig4.R CCCGCGGGTGAGAACCATTATATTT 170 
ig-106 5 RT_mhp107.F GCAGGCTAATTTGATTGGCAGA RT_mhp107.R CCGCGGGTGAGAACCATTATATTT 139 
ig-282* 1 RT_mhp282.F CCATAGTAAGAGCATAAATTGGAACCC RT_mhp282.R CCACCGGATTTAATTTCAGAACGCCC 91 
ig-282* 2 RT_mhp282.ig2.F GATGGATGTAAGTGAGTTTGGGCA RT_mhp282.ig2.R TTTCCCGACAAAGTGGCTCT 88 
ig-282* 3 RT_mhp282.ig3.F ATTAGAGCCACTTTGTCGGG RT_mhp282.ig3.R AATTAGATTCTCCAATCGATCAAA 115 
ig-282 4 RT_mhp282.ig4.F GCACGTAATTTATAGTGCTTT RT_mhp282.ig4.R GCCGTTGAGTCTAATTCAGATG 153 
ig-282 5 RT_mhp283.F ACTGCGGAGACGATAATCTGA RT_mhp283.R TCCTTGGACCTTCCTTCTGCGATT 90 
ig-682 1 RT_mhp682.F2 AGTGACTCAAAGTTAGTGAAGCA RT_mhp682.R ATAAAGTCGCTGTCTGGG 199 
ig-682* 2 RT_mhp682.ig1.F ACAATTACAATCAAAGGCGAAATGC RT_mhp682.ig1.R GTTATGGTGTCCGCACTCGAAACT 142 
ig-682* 3 RT_mhp682.ig2.F TCTCTGCTTAAAGAGCAATTGGA RT_mhp682.ig2.R GGGCTGAATTGTTGTGGGTAGT 179 
ig-682 4 RT_mhp682.ig3.F2 CAGCCCCAACCAATCAAATA RT_mhp682.ig3.R CTAATAACTGTAAGAGTCAAG 118 
ig-682* 5 RT_mhp682.ig4.F TCATTCTACCAGAAATTAGA RT_mhp682.ig4.R GGGCTATTTAGGGAATAAA 170 
ig-682* 6 RT_mhp683.F TCGTCTTGGGCTTGGGTATTGGTA RT_mhp683.R ATGATAGCTCTGATGAGCCTGAGC 136 
ig-684* 1 RT_mhp684.F AAACTTTCAAGTTCAGCGCGGG RT_mhp684.R ACAGCCATTGTCGGAGTTGCAGTA 98 
ig-684 2 RT_mhp684.ig1.F ACAATGGCTGTTGCTGTTAC RT_mhp684.ig1.R AACCAATCAAGAAATTTCAGAACA 194 
ig-684* 3 RT_mhp684.ig2.F AACAATAGTTGACAACCAAA RT_mhp684.ig2.R AATGAGGGTTAAACCAA 116 
ig-684* 4 RT_mhp684.ig3.F GGTTTAACCCTCATTATTTATTAC RT_mhp684.ig3.R TTGTGTTATAACTCGGAATTT 135 
ig-684 5 RT_mhp684.ig4.F2 CCTAGGAGGTTCATATGCGTTT RT_mhp684.ig4.R GGTTAGAAATCCCGC 104 
ig-684 6 RT_mhp685.F AAAGAGGCGGGATTTCTAACCCA RT_mhp685.R ATATCGCTTAGTTTATTGCGTACTTCC 200 
Reference 1 RT_mhp381.L2 TGACTAAATTCGGGCAATCC mhp381.R ACTGTCGAATCGGTGAGGC 172 
* indicates primers were confirmed with DNA template in qRT-PCR 
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Test plates (9) were run on five qRT-PCR regions (ig-072, ig-106, ig-282, ig-682, ig-684) 
for detection of inhibition and primer specificity of qRT-PCR. Test plates used in the 
transcriptional analysis were conducted on a mixture of equal volumes of two M. 
hyopneumoniae strain 232 RNA samples (stock I) diluted to 4 ng μl-1. A common non-
inhibitory dilution series for the five or six target sequences within an IG region was 
determined separately for each region. 
The qRT-PCR assays were conducted in a single 96-well plate on each of the two RNA 
samples in the non-inhibitory dilution range as determined in the test plates. The region ig-
072 assay consisted of six primer sets and four dilutions per primer set. Each well condition 
was run in duplicate. Assay for regions ig-106 and ig-282 consisted of five primer sets and 
eight dilutions per primer set. Duplicate wells were run for primer set 3 in region ig-106 and 
for primer set 4 in region ig-282. Assays for regions ig-682 and ig-684 consisted of six 
primer sets and eight dilutions per primer set. No duplicate wells were run in these two 
regions.  
Quantification cycle (Cq) values were obtained from the MxPro 4.1 software’s default 
amplification-based threshold method. This method specifies the threshold as the mid-point 
of the exponential amplification phase across all amplification curves on the plate. For 
duplicate samples on an assay plate (technical replicates), the Cq values were averaged for 
subsequent analysis. 
qRT-PCR relative quantity index. A simple linear model of Cq = mx + b, where Cq is 
the quantification cycle and x = log2(z), where z is the dilution factor, was fitted to the data of 
each primer set in an assay. Note that the dilution factor z (and x) is inversely related to the 
concentration of target RNA in the sample; as the sample dilution increases, the 
concentration of the target sequence RNA decreases. A standard curve is constructed by 
estimating m and b from the data of a given dilution series. Extrapolating this standard curve 
to Cq = 0, the cycle preceding PCR where a sample would be at the detection level, the 
model becomes 0 = mx + b. Solving for x results in x = –b/m. This quantity is a relative 
measure of the initial amount of target sequence RNA in the sample, but since x is inversely 
related to relative quantity; –b/m is also inversely related to relative quantity. Thus, a lower –
b/m corresponds to more target RNA in the sample. An index that would be more intuitive is 
the negative of –b/m, namely b/m. This index is directly related to relative quantity. That is, 
the higher the b/m, the more target sequence RNA there is in the sample. A derivation of this 
relative quantity may also be seen as follows:  b/m = –x = –log2(z) = log2(z-1) = log2(Q), 
where Q is the relative quantity measure of the target RNA in a sample. An example 
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calculation of the relative quantity index is available with the online version of this paper 
(Supplemental Methods: example calculation of the relative quantity index).  
qRT-PCR DNA assay analysis. A single plate and sample DNA was used in the assay. 
Separate linear models were fitted to each primer set to obtain estimates of m and b. These 
estimates were used to estimate the relative quantity index (b/m), and the Delta Method (4) 
was employed to obtain an estimate of the SE of these quantity indices. All pairwise 
comparisons of the six primer set indices were done with a Bonferroni correction for multiple 
testing. 
qRT-PCR transcript analysis. For the IG region assays with two RNA samples, the 
simple linear model above was extended to a linear model with a separate mean for each 
RNA sample: Cq = mx + bi, where bi is the intercept for RNA sample i. Thus, the model 
assumes that the two RNA samples have the same slope (m) but different intercepts. For 
primer sets that had technical replications, the linear model was fitted to the averaged Cq 
values. Separate linear models were fitted to each primer set to obtain estimates of m and bi 
for each RNA sample. The relative quantity index (b/m) was estimated from these results and 
the delta method was employed to obtain an estimate of the SE of these quantity indices. All 
pairwise comparisons of the six primer set indices were done with a Bonferroni correction for 
multiple testing. To identify stem-loop structures in the ig-072, ig-106, ig-282, ig-682 and ig-
684 IG regions, SoftBerry FindTerm software was used.  
Heat-shock experimental design and data analysis. The upstream region (ig-070/071) 
and downstream region (ig-072) of dnaK served as a positive control since previous studies 
have shown that dnaK is upregulated during heat shock (19). Six RNA samples, three control 
and three heat-shock, were used in the assays. Test plates for the RNA samples and primer 
sets for both regions on either side of dnaK were conducted on equal volumes of three heat 
shock RNA samples and three control RNA samples diluted to 4 ng μl-1 (stock I). Once the 
non-inhibitory dilution range for each region had been determined across the six target 
sequences in each region, the qRT-PCR assay was run in duplicate. Half of an assay plate 
consisted of six dilutions of stock I (individual wells for the target sequences and duplicates 
for the reference gene) in order to construct the standard curves. The other half of the assay 
plate consisted of each RNA sample combined with the six primer sets run individually and a 
seventh primer set for the reference gene (mhp381) run in duplicate. In the downstream 
region (ig-072), the three heat- shock RNA samples and three control RNA samples were 
diluted 1:3 for an in-well dilution of 1:9; and for the region upstream of dnaK (ig-070/071), 
these samples were diluted 1:5 for an in-well dilution of 1:15. These sample dilutions 
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corresponded near to the centre of the stock I dilution series as determined from the test 
plates for each region.  
The standard curves for each probe set were calculated from the stock I dilution series by 
fitting the linear model (Cq = mx + b) to obtain estimates of m and b for each primer set per 
plate. The observed Cq values for the RNA samples were then normalized (Cq') by the 
reference gene (see Supplemental Methods for an example calculation). After normalization, 
the relative quantity of a primer set was then calculated as Cq'/m. This relative quantity is a 
linear shift of the relative quantity index b/m. The derivation is easily seen by recalling that 
the linear model is Cq = mx + b, so Cq/m = (mx + b)/m = x + b/m. Thus, for each target 
sequence there are two sets of three relative indices, one set for the control samples and the 
other set for the heat-shock samples. These indices are then averaged within treatment groups 
and the SEM for each target sequence/treatment combination are calculated. Fold change was 
calculated as described by ISU equation of Gallup & Ackermann (9).  
 
Results 
Microarray design. An analysis of the IG regions of the annotated M. hyopneumoniae 
strain 232 genome (23) identified 215 IG regions of 125 bp or more and 128 IG regions of 
50-124 bp for a total of 343 IG regions (see Supplementary Fig. 3.S1). The remaining 230 IG 
regions of less than 50 bp were not analysed since previous studies have shown that regions 
this small could serve to separate ORFs in an operon from which a polycistronic mRNA is 
produced (1). A total of 158 PCR-generated probes for 112 of the 215 IG regions larger than 
125 bp were designed. Some of the larger regions had more than one probe designed to 
achieve at least 50 % coverage. An additional 517 oligonucleotides for 247 IG regions were 
designed covering 128 IG regions of 50-124 bp and 119 IG regions of 125 bp or more for 
which PCR primers could not be designed due to the high A + T content of the IG regions 
(81.3 mol%) or a failure of PCRs (after repeated primer designs) for unknown reasons. A 
total of 16 IG regions had both PCR and oligonucleotide probes constructed.  
Microarray IG region probe detection. Since mycoplasmal mRNAs lack 
polyadenylated sequences, we sought the most efficient primer set for producing cDNAs 
from RNA preparations. Our choices were a full random primer set of hexamers and a subset 
of 129 hexamer primers shown to bind to protein-encoding M. hyopneumoniae ORFs used in 
previous microarray studies, and listed in Supplementary Table S3 of Madsen et al. (19). We 
compared the two using the same RNA preparation at identical concentrations in reverse 
transcriptase reactions to generate cDNA for subsequent labelling reactions. Our hypothesis 
was that the random primers would be more efficient in producing cDNAs from IG RNAs 
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than the subset of primers selected for ORF sequences and consequently produce stronger 
signals on the IG arrays. One caveat that might confound that hypothesis is the fact that we 
would be labelling rRNAs as well. A visual inspection of both arrays following hybridization 
with the two labelled cDNA preparations showed no appreciable difference in probe 
fluorescence between the two types of primers used to generate cDNA (data not shown). 
Therefore, the data from both primer sets were used in the analysis of the array features.  
Applying the detection criterion (more than 6 SEM above the mean intensity of spot 
buffer-only probes in both channels) to the scanned arrays resulted in most of the IG regions 
declared as being transcribed. For the PCR probe array 94 out of 112 (83.9 %) IG regions 
had positive signals, and for the oligonucleotide array 239 out of 247 (96.8 %) IG regions 
had positive signals. Not all probes within an IG region had a positive signal, but for a region 
to be declared positive, at least one probe within a region was positive. Since 16 IG regions 
had both kinds of probes, of which 12 detected positive signals, this resulted in a total of 321 
(94 PCR + 239 oligonucleotide -12 double counted) out of the 343 IG regions (93.6 %) with 
positive signals across both array types. Interestingly, of the 73 IG regions with outwardly 
divergent transcription, 68 (93.2 %) had positive signals. Those IG regions with inward 
transcription from both ORFs had 98 % positive signals (52/53), and the IG regions with at 
least one inward transcript had 92.6 % (201/217) positive signals (see Supplementary Table 
3.S1). Analysis of five IG regions for stem-loop structures identified potential stem-loops in 
ig-072 at the end of mhp072 and in ig-682 at the end of mhp683 (Fig. 3.1b, e). However, 
these putative structures lacked sufficient G + C content, suggesting that transcription 
termination is ineffective in the typical rho-independent fashion (6). 
qRT-PCR DNA assay. Mycoplasma hyopneumoniae chromosomal DNA template was 
used as a negative control to assess the relative quantity index and accuracy of the qRT-PCR. 
In this assay, no significant differences between the six target sequences in region ig-072 
would be expected since the relative concentration of template should be the same across all 
areas of the IG and flanking regions. As expected, no differences were observed across all 
pairwise comparisons of six probes (15 tests of significance) at P < 0.01 (Fig. 3.1a).  
qRT-PCR IG regions assay. Thirty-five IG regions greater than 500 bases in length 
were identified in our analysis, and from these, five were selected for qRT-PCR analysis 
based on the direction of transcription of the flanking ORFs. Representative regions of the 
four possible read direction combinations were selected with the following criteria in mind: 
1) one IG region had both flanking ORFs on the forward strand (ig-072); 2) one IG region 
had both flanking ORFs on the reverse strand (ig-282); 3) one region had both flanking ORFs 
transcribed into the IG region (ig-682); and 4) two regions had both flanking ORFs  
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Fig. 3.1. qRT-PCR analysis of IG regions of M. hyopneumoniae. Shown are the relative 
quantity (b/m) estimates of each qRT-PCR plotted vertically over the corresponding product 
location in the M. hyopneumoniae genome sequence given in base pairs. The data represent 
the relative quantity index estimate ± 2 SE of the estimate. The IG designation is given at the 
top of each panel. The circles and squares depict results for the two biologically distinct 
samples. Each curve represents an independent RNA sample except for (a), where genomic 
DNA was used as a template for a positive control reaction. The letters indicate statistically 
significant differences. Points with the same letter are not statistically different (P< 0.01) for 
that independent RNA sample. The ORF designation and gene name is given for each 
flanking gene (H, hypothetical), and the arrows indicate the direction of transcription. The 
open bars indicate the location of PCR products used as probes in the microarrays. The filled 
bars indicate the qRT-PCR target sequences, and the numbers indicate the qRT-PCR primer 
sets described in Table 3.1 in that region. ND indicates that the probe was not detected in the 
assay. Ω, putative stem-loop structure as predicted by SoftBerry FindTerm software.  
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divergently transcribed away from the IG region (ig-106, ig-684). A sixth region of less than 
500 bp comprising the upstream region of dnaK was examined as a positive control; this 
region is known to undergo significant upregulation during heat-shock (19). 
The five IG regions were assayed using two biologically distinct RNA samples. The 
pattern of relative transcription was nearly identical for both RNA samples, as can be seen in 
Fig. 3.1(b-f). Statistically significant differential levels of transcription were detected in four 
out of five regions. The most common difference was a drop-off in RNA levels at 
ORF/intergenic transitions. In only one region, ig-682, did we fail to detect a signal by qRT-
PCR at one of the six target sequences. To confirm the primers and reaction conditions for 
this target sequence, for other selected primer sets (Table 3.1), and for the entire ig-072 
region, M. hyopneumoniae chromosomal DNA was used as a template in the qRT-PCR, 
which gave positive reactions for every primer set tested (data not shown). In Fig. 3.1(a) we 
show an example of the chromosomal DNA control reactions for region ig-072.  
Analysis of region ig-072 (Fig. 3.1b) shows that for both biological samples, the qRT-
PCRs that bridge the transition from ORF to IG region (primer sets 2 and 5) have 
significantly lower amounts of transcripts (P< 0.02) than the adjacent ORF regions (primer 
sets 1 and 6) although some signal was detected. There was no significant difference between 
the IG probes (primer sets 3 and 4) and the two ORF probes (primer sets 1 and 6). Following 
the decrease in transcript levels at the end of mhp072 (primer set 2), there was an increase in 
transcript levels across the IG region (primer sets 3 and 4) followed by another decrease at 
the ig-072-mhp073 junction (primer set 5). This increase was statistically significant (P< 
0.01) between primer sets 2 versus 3 and 4 for one of the two RNA samples and the decrease 
was significant for both RNA samples (primer sets 3 and 4 versus 5).  
Region ig-106 (Fig. 3.1c), which contains sequences between divergently transcribed 
(outward) genes mhp106 and mhp107, shows a different pattern of transcription. The IG 
region (primer sets 2 and 3) demonstrates a statistically indistinguishable level of 
transcription (P> 0.1) relative to mhp107 (primer set 5) for one of the two RNA samples. 
Transcription in mhp106 (primer set 1), however, is significantly higher (P< 0.01) than that 
in the IG region (primer sets 2 and 3).  
Region ig-282 (Fig. 3.1d), which has both ORFs transcribed in the same direction on the 
reverse strand relative to DNA replication, also demonstrated IG transcripts. At the end of 
mhp283 (primer set 4), transcription decreased significantly (P< 0.0001) from levels within 
mhp283 (primer set 5) and then increased within the IG region (primer sets 2 and 3, P< 
0.0001). Transcription within mhp282 (primer set 1) was higher (P< 0.0001) than in the IG 
region (primer sets 2 and 3).  
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For region ig-682 (Fig. 3.1e) where flanking ORFs transcribe into the IG region, 
transcript levels between mhp682 (primer set 1) and the bridge region (primer set 2) were the 
same followed by a decrease (P< 0.01) in the IG region (primer set 3). No signal was 
detected with the ig-682/mhp683 bridging region (primer set 5) even though the DNA 
template control was positive (data not shown). Transcription in mhp683 (primer set 6) was 
higher than that of all other areas within this region (P< 0.01).   
The primer sets for region ig-684 (Fig. 3.1f) did not perform well, as indicated by the 
higher level of variation. This region is of the same type as ig-106, with both flanking ORFs 
being transcribed away from the IG region, but the region has a higher A + T content (83.3 
mol%) significantly contributing to difficulty in primer design. The trend in transcript levels 
of ig-684 is similar to ig-106, where the IG region had detectable but lower levels of 
transcription relative to either of the ORFs.  
qRT-PCR analysis of the dnaK up- and downstream regions following heat shock. 
The region surrounding dnaK was studied as a positive control because both dnaK and dnaJ 
have been  shown to be highly upregulated during heat shock (5, 19). For this study, IG 
regions upstream (ig-070/071) and downstream (ig-072) of dnaK were assayed separately. 
The results can be seen in Fig. 3.2.  
The top graph in Fig. 3.2 shows the log2 fold change in transcription levels between 
control and heat-shock conditions. All target sequences in both regions indicate increased 
levels of mRNA under heat shock conditions. This increase was statistically significant (P< 
0.05) for all primer sets except for primer set 3 in ig-070/071 (P= 0.11). In region ig-070/071, 
the dnaK target sequence was the most upregulated at 13.38-fold higher amount of transcript 
than under normal growth conditions. All other target sequences in this region were 
upregulated about 2-fold. In region ig-072, the mhp072 bridge target sequence had the 
highest level of upregulation (20.95-fold higher transcript levels), with dnaK as the next 
highest level of transcript increase (7.26-fold). The rest of region ig-072 was upregulated at 
3-4-fold, except for the other bridge area with dnaJ, which was upregulated about 5-fold. 
The lower graph depicts the relative index (Cq'/m) averaged across the three biological 
replicates within each treatment for both regions. Primer sets 1, 2 and 5 in region ig-070/071 
have lower levels than primer sets 3, 4 and 6 (P< 0.01) for both treatment groups. The results 
for region ig-072 are very similar to the results from the qRT-PCR region assay described 
above. For both treatment groups, the bridge areas have an appreciably lower level of 
transcription, and the IG region has levels of transcription closer to the dnaJ levels. 
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Fig. 3.2. Transcriptional analysis of IG regions flanking dnaK following heat shock. The map 
shows the corresponding region in the genome of M. hyopneumoniae given in base pairs. The 
ORF designation and gene name is given for each gene, and the arrows indicate the direction 
of transcription. mhp071 is a hypothetical gene. Open bars indicate the location of probes 
(PCR products or oligonucleotides) used in the microarrays. Filled bars indicate the qRT-
PCR target sequences, and the numbers indicate the qRT-PCR primer sets described in Table 
3.1 in that region. The upper panel gives the fold change (mean ± 2 SEM) of triplicate 
samples. The asterisks indicate significant differences between the control and heat-shocked 
samples (* , P< 0.05; ** , P< 0.01). The lower panel gives the relative quantity (Cq'/m) 
estimates of each qRT-PCR at the two temperatures. Control samples are represented by 
circles and heat-shocked samples are represented by squares. Data represents the mean ± 2 
SEM of triplicate samples (note: most SEM bars are not visible due to being smaller than the 
plotted point). The letters indicate significant differences. Points with the same letter are not 
significantly different (P< 0.01) for that treatment. 
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Discussion 
This study represents a global assessment of transcription within IG regions of the M. 
hyopneumoniae genome. We used both microarrays and qRT-PCR to assess transcription. 
The decision was made to limit our analysis to IG regions of 50 bp or more using a 
combination of PCR products and oligonucleotide as probes. Of the IG regions in this set, 35 
were large (>500 bp) requiring multiple PCR products or oligonucleotides for at least 50 % 
coverage. Coverage was not 100 % because of the inability to design unique primers or 
oligonucleotides in regions of high A + T content.  
We considered the possibility in our primer design that cross-hybridization between ORF 
transcripts and IG region probes could account for some of the signals we obtained, and 
without more extensive analysis could not totally discount that possibility. Our detailed 
analysis of five IG regions by qRT-PCR, however, showed no evidence of cross-
hybridization effects. All melt curves from qRT-PCR assays indicated that a single product 
was generated per target sequence. 
Our first study with the arrays was to determine the optimal conditions for generating 
cDNA for labelling reactions using two different primer sets. The hexamer subset was chosen 
based on their lack of binding to M. hyopneumoniae rRNAs and binding to annotated ORFs 
in the genome (19). It was initially thought that this primer set might not label RNAs from IG 
regions and consequently give false negative signals. The second primer set was a 
commercial random hexamer primer preparation that would label rRNAs representing about 
90 % of the total RNAs, diluting the signals on the arrays while also labelling IG region 
RNAs. Unexpectedly, both primer sets gave similar signals across both IG arrays (data not 
shown). Thus, we used both primer sets in our analysis of the IG regions transcripts. A 
posteriori, it seems that equal labelling efficiency with the two primer sets may be due to 
runoff transcription into IG regions. 
Our results indicated that a large proportion of the IG regions, 321 out 343 (93.6 %), 
were transcribed. This was unexpected and indicated that M. hyopneumoniae does not strictly 
control transcription termination as previously suggested (38). These studies are supported by 
recent studies with M. pneumoniae in which IG transcripts on a global scale were also 
identified by tiling microarrays (12) and on a limited scale with Mycoplasma genitalium and 
M. pneumoniae (2). From a physiological standpoint, the lack of transcription termination 
seems energetically wasteful, suggesting that mycoplasmas may have important roles for 
these transcripts, such as the generation of small regulatory peptides or RNAs that have yet to 
be defined in these organisms. None of these IG regions had definable promoter-like 
sequences using current algorithms (data not shown), although promoters in mycoplasmas 
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have not been fully defined by mutational analysis and could vary between species and not 
be recognized by current software. Stem-loop structures that may define rho-independent 
transcriptional termination sites are thought not to be important in mycoplasmas (38). Our 
analysis of the five IG regions and adjacent ORFs examined showed evidence of weak stem-
loop structures in two regions, ig-072 and ig-682 (data not shown). 
The five regions for qRT-PCR analysis were chosen based on size (>500 bp), direction of 
flanking ORF transcription (similar and divergent transcription) (Fig. 3.1) and in the case of 
dnaK its known transcriptional control mechanism (5). The chosen IG regions also 
represented both DNA replication forks to rule out any replication effects on transcription. In 
most bacteria, the direction of transcription and DNA replication coincide in most genes. 
Even though this is not true for M. hyopneumoniae (23), we wanted to eliminate this 
possibility by choosing IG regions from both sides of the chromosome. Regions ig-072, ig-
106 and ig-282 were associated with the right clockwise replication fork, and regions ig-682 
and ig-684 with the left counter-clockwise replication fork. Also, mhp107 and mhp684 are 
P97 paralogues (1, 23) and mhp683 is a P102 paralogue. These proteins, along with other 
members of these families, are thought to play roles in adherence to swine epithelium, 
enhance colonization and thereby contribute to virulence (1, 3, 42, 43), thus increasing our 
interest in them for defined analysis.  
Before analyzing the data, we considered two possibilities: an abrupt termination of 
transcription at the end of the flanking genes with the loss of bridging qRT-PCR products 
(mechanism 1) and a general decline in transcript levels indicating that RNA polymerase was 
slowly falling off the template in the IG region (mechanism 2). For regions with outward 
divergent transcription, we thought transcription would not occur. Our data indicate that both 
mechanisms occur along with a third mechanism: reinitiation of transcription within the IG 
region (mechanism 3).  
Analysis of five IG regions showed a general trend of lower transcription in the IG region 
relative to the flanking ORFs (Fig. 3.1). It is important to note that none of these regions 
were potentially involved in an operon producing a polycistronic message. This implies that 
there is no obvious reason for continued transcription across the region. However, it is clear 
from these studies that transcription initiated (mechanism 3) within IG regions ig-072, ig-106 
and ig-282 since downstream of the flanking ORF the level of transcripts increased 
significantly (Fig. 3.1b-d). This is independent of the direction of DNA replication; the genes 
flanking ig-072 and ig-282 are transcribed in the same direction but on opposite strands. 
There is a considerable reduction in transcript levels at the end of the first gene, a general rise 
in transcript levels in the IG region and increased transcription in the downstream gene. This 
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implies a third mechanism, one in which transcription never truly ceases between genes and 
reinitiation of transcription occurs within the IG region before encountering the promoter of 
the second flanking ORF.  
Region ig-682 differed, however. This is a region where flanking ORFs are inwardly 
divergently transcribed (Fig. 3.1e). From mhp682, transcription continued into the IG region, 
and it appeared that the RNA polymerase gradually fell off the template as it proceeded into 
the IG region (mechanism 2). This is the only region studied that showed the same transcript 
levels both within the gene (primer set 1) and the bridging region (primer set 2). For mhp683, 
however, there was an abrupt termination of transcription at the end of the gene (mechanism 
1). This was the only gene in which transcription was completely terminated; most of the 
other genes showed decreased transcription levels in bridging regions but significantly higher 
levels of transcription within the IG region (Figs. 3.1 and 3.2) or IG region transcripts 
continuing into the flanking ORF. Further analysis of the IG region adjacent to mhp683, 
however, failed to reveal a sequence suitable for rho-independent transcription termination as 
defined in other genetic systems; although a stem-loop structure could be identified just 
downstream of the left primer binding site for primer set 5 in ig-682 (Fig. 3.1e), the region 
was A + T-rich, lacking the characteristic G + C content of a transcription terminator. If this 
structure serves the purpose of a termination signal in M. hyopneumoniae, it is unusual. 
Analysis of IG regions ig-072 at the end of mhp072 and ig-282 at the end of mhp283 
revealed smaller stem-loop structures also lacking G + C content, suggesting that 
transcription termination is ineffective in the typical rho-independent fashion.  
In further analysis of the heat-shock gene dnaK and its flanking regions by qRT-PCR, we 
observed a general increase in transcription across the entire region during heat-shock (Fig. 
3.2). This region was included because of previous studies demonstrating increased 
transcription of dnaK during heat shock (5, 19), and positive control of transcription changes 
was thought to be informative. Interestingly, there was a significant difference between 
control and heat-shock samples with every primer set tested except for one. Because 
transcript profiles between control and heat-shocked samples were identical in the IG regions 
ig-070/071 and ig-072, this suggests that increased temperatures have an overall positive 
effect on transcription, at least in this genomic region. As expected, there was a much larger 
increase in mhp072 (dnaK) transcripts (5, 19), and previous studies showed that this gene is 
controlled by the heat-shock regulator HrcA (5). Also as expected, there was a sharp decrease 
in transcription at the end of dnaK, but some transcript remained, suggesting that termination 
was not complete. We were also able to show that transcript levels vary between genes: 
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mhp070 (uvrC) had significantly (P< 0.01) lower transcript levels than mhp071 and mhp072 
(dnaK) under both growth conditions.  
In summary, these results indicate that IG regions within the M. hyopneumoniae genome 
are transcriptionally active. For many regions, transcription continues from flanking genes 
with a gradual reduction until the next promoter is encountered. For some regions, there is an 
internal initiation of transcription from ill-defined sequences. Most surprising were the 
observations that almost every IG region could be detected on the arrays, suggesting that IG 
regions in mycoplasmas may hold surprises with functions yet to be determined.  
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Figure 3.S1: Histogram of IG region size. A histogram of the frequencyand size of all 573 IG 
regions. 
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Table 3.S1: The 343 IG regions of 50 bp or more.* 
 
Name Size Type Positive Signal  Name Size Type 
Positive 
Signal 
ig-001 147 1_1 Yes  ig-085 133 0_0 Yes ig-002 104 1_1 Yes  ig-088 334 0_1 Yes ig-006 105 1_1 Yes  ig-092 162 1_1 Yes ig-007 92 1_1 Yes  ig-093 232 1_1 Yes ig-008 171 1_1 Yes  ig-095 55 1_1 Yes ig-013 72 1_1 Yes  ig-100 509 0_1 No ig-016 142 0_1 Yes  ig-106 503 0_1 Yes ig-019 314 0_0 Yes  ig-107 53 1_1 Yes ig-020 157 0_0 Yes  ig-108 136 1_0 Yes ig-021 195 0_0 Yes  ig-109 290 0_0 Yes ig-022 76 0_0 Yes  ig-110 89 0_1 Yes ig-024 172 0_0 Yes  ig-112 72 0_0 Yes ig-025 113 0_0 Yes  ig-122 73 0_0 Yes ig-027 374 0_1 Yes  ig-123 106 0_1 No ig-028 392 1_1 Yes  ig-127 115 0_0 Yes ig-030 238 1_1 Yes  ig-129 278 0_1 Yes ig-031 122 1_0 Yes  ig-134 169 1_0 Yes ig-035 209 0_1 Yes  ig-135 93 0_0 Yes ig-036 101 1_1 Yes  ig-138 91 0_0 Yes ig-037 106 1_0 Yes  ig-139 527 0_1 Yes ig-039 56 0_0 Yes  ig-141 197 1_1 Yes ig-041 152 0_1 Yes  ig-143 116 1_0 Yes ig-043 87 1_1 Yes  ig-153 504 0_1 Yes ig-045 97 1_1 Yes  ig-154 418 1_1 No ig-057 218 1_1 Yes  ig-155 85 1_1 Yes ig-059 87 1_1 Yes  ig-157 57 1_1 Yes ig-066 75 1_1 Yes  ig-158 208 1_0 Yes ig-067 50 1_1 Yes  ig-159 170 0_1 Yes ig-068 118 1_1 Yes  ig-160 104 1_1 Yes ig-069 63 1_0 Yes  ig-163 97 1_0 Yes ig-070 102 0_1 Yes  ig-169 461 0_0 Yes ig-071 110 1_1 Yes  ig-16S 542 0_1 Yes ig-072 742 1_1 Yes  ig-170 169 0_1 Yes ig-073 61 1_1 Yes  ig-180 74 0_1 Yes ig-080 221 1_1 Yes  ig-181 322 1_0 Yes ig-082 279 0_0 Yes  ig-183 414 0_0 Yes ig-084 55 0_0 Yes  ig-185 409 1_1 Yes 
 
* The name, size in bp, the type of IG region based on adjacent ORFs, and microarray  
detection status is given. The type of IG region is coded by the read direction of the adjacent  
ORF. A 1 indicates the adjacent ORF is on the forward strand and a 0 indicates the adjacent  
ORF is on the reverse strand. The adjacent ORFs are represented in clockwise direction  
around the genome for the type. For example, 1_0 indicates the first ORF (read in clockwise  
direction) is on the forward strand and the next ORF (in clockwise direction) is on the reverse  
strand. 
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Table 3.S1. (continued) 
 
Name Size Type Positive Signal  Name Size Type 
Positive 
Signal 
ig-189 123 1_1 Yes  ig-296 91 1_1 Yes ig-205 114 1_1 Yes  ig-298 189 1_0 Yes ig-210 306 1_1 Yes  ig-299 217 0_0 Yes ig-214 216 1_0 Yes  ig-300 1151 0_0 Yes ig-220 224 0_0 Yes  ig-303 1246 0_0 Yes ig-226 482 1_1 Yes  ig-307 461 0_1 Yes ig-231 89 1_0 Yes  ig-308 56 1_0 Yes ig-232 77 0_0 Yes  ig-309 190 0_0 Yes ig-233 198 0_0 Yes  ig-311 76 0_1 Yes ig-237 58 0_1 Yes  ig-312 865 1_1 Yes ig-23S 466 0_0 Yes  ig-314 231 1_1 No ig-241 63 0_0 Yes  ig-315 137 1_1 Yes ig-245 59 0_0 Yes  ig-317 579 1_0 Yes ig-246 220 0_0 No  ig-318 79 0_0 Yes ig-247 251 0_1 Yes  ig-320 510 0_1 Yes ig-248 263 1_0 Yes  ig-321 324 1_0 Yes ig-250 145 0_1 Yes  ig-325 357 0_1 Yes ig-251 55 1_1 Yes  ig-327 92 1_1 Yes ig-253 74 0_1 Yes  ig-328 153 1_1 Yes ig-254 98 1_1 Yes  ig-329 214 1_1 Yes ig-255 232 1_1 Yes  ig-331 654 1_1 Yes ig-258 58 1_1 Yes  ig-335 777 1_0 Yes ig-259 170 1_0 Yes  ig-337 523 0_1 Yes ig-261 787 0_0 Yes  ig-338 137 1_0 Yes ig-263 637 0_1 Yes  ig-339 101 0_0 Yes ig-265 192 0_0 Yes  ig-340 171 0_0 Yes ig-267 68 0_0 Yes  ig-341 103 0_0 Yes ig-268 220 0_1 Yes  ig-343 195 0_0 Yes ig-269 473 1_1 Yes  ig-344 206 0_0 Yes ig-270 280 1_1 Yes  ig-345 393 0_1 Yes ig-272 229 1_1 Yes  ig-346 72 1_1 No ig-273 235 1_1 Yes  ig-347 542 1_0 Yes ig-274 177 1_1 Yes  ig-348 600 0_1 Yes ig-275 107 1_0 Yes  ig-349 619 1_0 Yes ig-276 121 0_0 Yes  ig-351 901 0_0 Yes ig-277 182 0_1 Yes  ig-352 181 0_0 No ig-281 139 0_0 Yes  ig-354 1468 0_0 Yes ig-282 546 0_0 No  ig-355 989 0_1 Yes ig-283 140 0_0 Yes  ig-358 912 1_0 Yes ig-285 135 0_1 Yes  ig-359 172 0_0 Yes ig-286 198 1_1 Yes  ig-360 201 0_0 Yes ig-288 388 1_0 Yes  ig-362 159 0_1 Yes ig-289 270 0_0 Yes  ig-365 60 1_0 Yes ig-291 100 0_1 No  ig-366 116 0_0 Yes ig-293 291 1_0 Yes  ig-367 113 0_1 Yes ig-294 50 0_1 Yes  ig-368 400 1_0 Yes ig-295 171 1_1 Yes  ig-370 320 0_1 No 
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Table 3.S1. (continued) 
 
Name Size Type Positive Signal  Name Size Type 
Positive 
Signal 
ig-373 110 1_1 Yes  ig-461 213 1_0 Yes ig-374 71 1_1 Yes  ig-462 107 0_0 Yes ig-376 268 1_1 Yes  ig-464 154 0_0 Yes ig-383 167 1_0 Yes  ig-468 180 0_1 Yes ig-385 133 0_0 Yes  ig-469 77 1_1 Yes ig-387 425 0_0 Yes  ig-470 176 1_1 Yes ig-388 66 0_0 Yes  ig-475 561 0_0 Yes ig-389 188 0_0 Yes  ig-482 337 0_1 Yes ig-390 116 0_1 Yes  ig-483 50 1_0 Yes ig-394 112 1_1 Yes  ig-484 113 0_0 Yes ig-395 100 1_0 Yes  ig-486 236 0_0 Yes ig-396 69 0_0 Yes  ig-487 347 0_1 Yes ig-399 115 1_1 Yes  ig-488 178 1_1 Yes ig-400 134 1_1 Yes  ig-489 113 1_1 Yes ig-401 258 1_1 No  ig-492 337 1_0 Yes ig-403 117 1_0 Yes  ig-493 129 0_0 Yes ig-404 789 0_1 Yes  ig-494 292 0_0 Yes ig-407 230 1_1 Yes  ig-497 211 0_0 Yes ig-411 202 0_0 Yes  ig-502 1034 0_1 Yes ig-412 199 0_0 No  ig-504 239 1_0 Yes ig-413 452 0_1 No  ig-506 122 0_0 Yes ig-415 312 0_1 Yes  ig-508 227 0_0 Yes ig-420 152 1_1 Yes  ig-510 229 0_1 Yes ig-424 126 0_0 Yes  ig-511 128 1_1 Yes ig-426 129 0_0 Yes  ig-515 246 1_0 Yes ig-427 236 0_0 Yes  ig-518 639 0_0 Yes ig-428 332 0_0 Yes  ig-519 313 0_0 Yes ig-429 268 0_1 Yes  ig-520 274 0_1 Yes ig-431 187 1_1 Yes  ig-524 74 0_1 Yes ig-434 207 0_0 Yes  ig-527 125 1_1 Yes ig-435 216 0_0 Yes  ig-534 53 1_0 Yes ig-436 125 0_0 Yes  ig-537 100 0_1 Yes ig-442 164 1_0 Yes  ig-538 400 1_1 Yes ig-443 76 0_0 Yes  ig-539 106 1_0 Yes ig-444 199 0_0 Yes  ig-540 297 0_0 Yes ig-445 473 0_0 Yes  ig-541 173 0_0 Yes ig-446 103 0_0 Yes  ig-543 56 0_0 Yes ig-447 346 0_0 Yes  ig-544 440 0_1 Yes ig-448 144 0_0 Yes  ig-545 56 1_0 Yes ig-449 76 0_0 Yes  ig-546 78 0_0 Yes ig-450 89 0_0 Yes  ig-547 62 0_0 Yes ig-451 441 0_0 Yes  ig-548 141 0_0 Yes ig-452 191 0_1 Yes  ig-552 159 0_1 Yes ig-454 61 1_1 Yes  ig-559 438 0_1 Yes ig-457 67 1_0 Yes  ig-560 397 1_1 No ig-459 217 0_0 No  ig-561 86 1_0 Yes ig-460 538 1_1 Yes  ig-562 115 0_1 Yes 
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Table 3.S1. (continued) 
 
Name Size Type Positive Signal  Name Size Type 
Positive 
Signal 
ig-564 249 1_0 Yes  ig-645 180 1_0 Yes ig-566 240 1_0 Yes  ig-646 238 0_0 Yes ig-570 328 1_0 Yes  ig-647 333 0_1 Yes ig-577 769 0_0 Yes  ig-649 93 1_0 Yes ig-579 128 0_0 Yes  ig-650 65 0_0 Yes ig-580 160 0_0 Yes  ig-651 351 0_1 Yes ig-582 901 0_0 Yes  ig-656 83 0_1 Yes ig-585 646 0_1 Yes  ig-658 206 0_0 Yes ig-586 135 1_0 Yes  ig-667 58 0_0 Yes ig-587 80 0_1 Yes  ig-672 134 0_0 Yes ig-588 60 1_0 Yes  ig-674 96 0_1 Yes ig-591 146 0_0 Yes  ig-676 142 1_1 Yes ig-592 65 0_1 Yes  ig-677 125 1_1 Yes ig-593 116 1_1 Yes  ig-678 124 1_1 Yes ig-595 116 1_0 Yes  ig-680 57 1_1 Yes ig-599 52 0_0 Yes  ig-681 66 1_1 Yes ig-5S 506 0_0 Yes  ig-682 587 1_0 Yes ig-601 74 0_0 Yes  ig-684 509 0_1 Yes ig-604 308 0_1 Yes  ig-687 87 0_0 Yes ig-605 106 1_0 Yes  ig-691 83 1_1 Yes ig-606 64 0_0 Yes  ig-696 96 0_0 Yes ig-609 66 0_1 Yes  ig-697 272 0_1 Yes ig-615 157 1_1 Yes  ig-699 151 0_1 Yes ig-617 197 1_1 Yes  ig-Arg1 81 1_1 No ig-619 167 1_1 Yes  ig-Asn3 376 1_1 Yes ig-621 53 1_1 Yes  ig-Cys 70 0_0 Yes ig-622 255 1_1 Yes  ig-Gly 96 1_1 No ig-623 146 1_1 Yes  ig-His 122 1_0 No ig-626 61 1_1 Yes  ig-Ile 73 0_0 Yes ig-627 72 1_1 Yes  ig-Leu2 263 0_0 No ig-628 221 1_1 No  ig-Lys 61 1_1 Yes ig-629 336 1_0 Yes  ig-Met2 58 1_1 No ig-630 254 0_0 Yes  ig-Phe 238 1_1 Yes ig-631 453 0_0 Yes  ig-rnpB 176 0_0 Yes ig-633 64 0_0 Yes  ig-Ser2 258 0_1 Yes ig-635 59 0_0 Yes  ig-Ser3 364 0_1 Yes ig-636 209 0_0 Yes  ig-Thr2 97 0_0 Yes ig-638 377 0_1 Yes  ig-tmRNA 429 0_0 Yes ig-641 290 0_1 Yes  ig-Trp2 156 0_0 Yes ig-642 190 1_1 Yes  ig-Tyr 249 0_1 Yes ig-644 450 1_1 No      
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The amplification curve for the reference gene target sequence from the MxPro 4.1 
software package is in Fig. 3.S2. The sample was run in duplicate with 6 dilutions thereby 
generating 12 data points. The horizontal line at dRn = 0.0385 was determined by the 
software as the midpoint of the exponential phase of the amplification curve across all 96 
samples on the assay plate. The Cq value for a particular sample is the intersection of the 
amplification curve with this horizontal line. Table 3.S2 and Fig. 3.S3 display the results for 
this target sequence primer set where Cq is the quantification cycle and x = log2(z) where z is 
the dilution factor. 
The Cq values of duplicate samples (technical replicates) are then averaged (Table 3.S2) 
and a simple linear model (Cq = mx + b) was fit to the data. Fig. 3.S4 depicts the fitted curve 
with m = -1.02 and b = 14.23. The relative quantity index is then simply  
 
92.13
02.1
23.14
−=
−
=
m
b . 
This index is directly comparable to other indexed target sequences with different 
efficiencies. The difference between any two relative indices is the log2 difference in the 
number target sequence strands in the biological sample. For example, a difference of +1 
index unit would indicate that the biological sample has twice as many strands of a particular 
target sequence in comparison to the number of strands of the other target sequence. 
Normalizing Cq values 
A Cq value for a sample is normalized by adding a normalizing quantity specific to that 
sample. This normalizing quantity is a function of the standard curves of both the target 
sequence of interest and the reference gene Cq values from all the samples. It is calculated as 
the product of the ratio of the target sequence slope to reference gene slope and the difference 
of the specific sample's reference gene Cq from the mean of all the reference gene Cq values. 
A step-by-step example calculation is given below. 
Table 3.S3 has the reference gene Cq values for the six individual samples from the same 
assay used to demonstrate the calculation of the relative quantity index. These individual 
samples were diluted to in-well concentrations of 1:15 which corresponds to the approximate 
center of the standard curve (x = -3.91). The samples were run in duplicate and the average 
Cq for each sample is calculated. These six samples are divided into two treatments but recall 
SUPPLEMENTAL FILE: EXAMPLE CALCULATION OF A RELATIVE 
QUANTITY INDEX b/m  
 95  
that the primer set is for the reference gene, thus it is assumed that the observed variation 
between samples is due to pipetting errors. That is, all six samples are expected to result in 
the same Cq value. The overall average Cq is then calculated and shown in Table 3.S3 ( RCq  
= 18.27). 
Table 3.S4 has the target sequence ig-070/071 PS1 Cq values for the same six samples as 
shown in Table 3.S3. The standard curve for this target sequence resulted in an m = -1.12 
(data not shown). The standard curve for the reference gene has an m = -1.02 (see relative 
quantity index example above). Thus the ratio multiplier is: 
 
Ratio 09.1
02.1
12.1
=
−
−
= .    
For sample 1 the normalized Cq values (Cq') would then calculated as: 
08.22)08.188.271(*1.09  1.872 )(*ratio)  (slope    ' 111 =−+=−+= RR CqCqCqCq  
Table 3.S4 shows the normalized Cq values (Cq') for all six samples for this target sequence. 
 
 
Figure 3.S2. Reference gene amplification plot for standard curve dilution series. 
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Table 3.S2. Data from amplification plot of reference gene. 
Well Threshold (dRn) In-well 1: z x Rep Cq 
G7 0.0385 3.00 0.33 -1.58 1 15.83 
G8 0.0385 5.77 0.17 -2.53 1 16.82 
G9 0.0385 11.10 0.09 -3.47 1 17.80 
G10 0.0385 21.36 0.05 -4.42 1 18.80 
G11 0.0385 41.10 0.02 -5.36 1 19.70 
G12 0.0385 79.08 0.01 -6.31 1 20.63 
H7 0.0385 3.00 0.33 -1.58 2 15.76 
H8 0.0385 5.77 0.17 -2.53 2 16.85 
H9 0.0385 11.10 0.09 -3.47 2 17.83 
H10 0.0385 21.36 0.05 -4.42 2 18.79 
H11 0.0385 41.10 0.02 -5.36 2 19.78 
H12 0.0385 79.08 0.01 -6.31 2 20.60 
 
 
Figure 3.S3: Graph raw data. 
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Table 3.S3: Averaged duplicate Cq values from reference gene. 
x Cq  
-1.58 15.80 
-2.53 16.84 
-3.47 17.82 
-4.42 18.80 
-5.36 19.74 
-6.31 20.62 
 
 
Figure 3.S4: Standard curve for reference genes. 
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Table 3.S4: Reference gene Cq values for individual samples. 
Sample Treatment Cq Rep 1 Cq Rep2 Cq  
1 HS 17.96 18.20 18.08 
2 HS 18.67 18.56 18.62 
3 HS 18.54 18.48 18.51 
4 Control 18.56 18.77 18.67 
5 Control 17.95 17.98 17.97 
6 Control 17.83 17.76 17.80 
   RCq  18.27 
 
 
 
Table 3.S5: Cq values for target sequence ig-070/071 PS1. 
Sample Treatment Cq Cq' 
1 HS 21.87 22.08 
2 HS 22.14 21.76 
3 HS 21.87 21.61 
4 Control 23.13 22.70 
5 Control 22.85 23.19 
6 Control 22.66 23.18 
 
 
 
 99  
CHAPTER 4. STATISTICAL METHODS TO ANALYZE SMALL-
SCALE RT-qPCR EXPERIMENTS AND TO COMPARE RELATIVE 
QUANTITIES ACROSS MULTIPLE TARGET SEQUENCES 
 
A paper prepared for submission to a peered reviewed journal and presented at the 
2010 Joint Statistical Meetings in Vancouver, BC Canada 
 
Stuart W. Gardner
1,3,4
, Jack M. Gallup
2
, Max D. Morris
3
, and F. Chris Minion
1,4
 * 
1
Department of Veterinary Microbiology and Preventive Medicine, 
2
Department of 
Veterinary Pathology, 
3
Department of Statistics, 
4
Interdepartmental Microbiology Graduate 
Program, Iowa State University, Ames, Iowa 50011, USA 
 
Abstract 
Background: Relative quantitative real-time reverse transcription PCR (RT-qPCR) is the 
top validating technology for all gene expression-capable “next-generation” technologies. 
While industrial use of high-throughput genetic analysis has expanded rapidly in the private 
sector, such technologies are still largely cost-prohibitive at the academic level. Hence, 
strategic design of a limited number of RT-qPCR assay plates to generate sufficient quality 
data to be amenable to meaningful statistical inference is necessary. In this study, the 
PREXCEL-Q-based “Stock I” regimen is compared to another design that uses serial 
dilutions of each individual sample to establish the target‟s amplification efficiency across all 
the samples.  
Results: We demonstrate that by using a limited number of plates, based on satisfying 
the preconditions of PREXCEL-Q‟s Stock I-based regimen, both designs generate 
equivalent, meaningful and statistically valid results for complex RT-qPCR. Additionally, a 
novel method to compare the relative quantity estimates of several different targets is 
presented along with various methods to obtain estimates of error of the fold change and 
relative quantity by applying top-down or bottom-up statistical approaches. We also present 
arguments on the merits of using a log base 2 transformation based on the theoretical process 
of the system and the mathematical ease of interpretation. 
Conclusions: When conducting small scale RT-qPCR studies, the error in estimation of 
amplification efficiency should not be ignored in determining statistically significant 
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differences as is commonly done in most studies. An assay design which uses serial dilutions 
of each individual sample to determine the amplification efficiency of a target sequence is 
favored over an assay design which uses the Stock I methodology to evaluate target sequence 
amplification efficiencies. However prior to conducting an assay, the PREXCEL-Q-based 
“Stock I” test plate regimen is strongly recommended to establish the valid, non-inhibitory 
working range for a RT-qPCR assay. 
 
Background 
Quantitative real-time reverse transcription PCR (RT-qPCR) is accepted as the top 
validating technology for all gene expression-capable “next-generation” technologies. With 
no better technology on the horizon, it will continue to be a main-stay technique for years to 
come.  Even with the swift rise in high-throughput technologies in nucleic acid and protein 
analysis, RT-qPCR remains singular in its ability to confirm and validate findings generated 
by these high-throughput counterpart technologies (1, 2, 4, 6). While industrial use of high-
throughput genetic analysis has expanded rapidly in the private sector, such technologies are 
still largely cost-prohibitive at the academic level. Many core facilities at universities are not 
financially able to procure the latest next-generation technology available. It is therefore 
important for investigators at the university level to be able to derive the most meaning out of 
small-scale RT-qPCR experiments; sometimes amounting to as few as two plate‟s-worth of 
examinable data. Strategic design of a limited number of RT-qPCR plates in an effort to 
generate enough quality data to be amenable to meaningful statistical inference is thus an 
important topic to explore.  
The PREXCEL-Q-based “Stock I” regimen was used to establish the valid, non-
inhibitory working range for a RT-qPCR assay (1, 2, 9, 10, 17, 19). The regimen consists of 
creating Stock I, which is a mixture of equal portions of each of the RNA (or cDNA or DNA) 
samples used in a study. Initially, Stock I is assayed in a preliminary test plate format over a 
suitably wide dilution range. By conducting a test plate on a mixture of all the samples, a 
useful dilution range for all the samples is identified for each target sequence assay. Once a 
dilution range (that avoids sample inhibition, high dilution ranges conducive to primer dimer 
formation in SYBR Green-based qPCR assays, and/or problematic reaction efficiency 
ranges) has been identified, the individual samples are assayed within the best portion of this 
range and the Stock I is serially diluted for construction of standard curves (also within this 
optimal range). 
Two different experimental designs were devised for the RT-qPCR assays and conducted 
on similar RNA samples to assess the merits and limitations of each approach. The methods 
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are devised for small-scale RT-qPCR endeavors necessitated by the availability of only one-
plate-at-a-time machines where work-flows commonly include down-time between related 
plate runs. The designs differ in their approach to estimate amplification efficiency of the 
target sequences. In the first design, a pair of plates uses the Stock I methodology to evaluate 
target sequence amplification efficiencies (Design I), while the other design uses serial 
dilutions of each individual sample to determine the efficiency of target sequence 
amplification (Design II). Each approach is assessed by an easy-to-calculate variation (see 
additional file 1) of an equivalent expression for efficiency-corrected quantification based on 
the Pfaffl and Livak/ABI approaches (13, 18). We demonstrate that by using a limited 
number of plates (as few as one), based on satisfying the preconditions of PREXCEL-Q‟s 
Stock I-based regimen, both designs generate equivalent, meaningful and statistically valid 
results for complex small-scale RT-qPCR studies. At the academic/university level, we feel 
this study provides valuable insight into the proper protocol for RT-qPCR methodology 
given limited and/or simple machine platform availability. 
In addition to comparing two assay designs, a novel method to compare the relative 
quantity estimates of several targets was developed. Multiple targets can be directly 
compared with respect to their relative amounts via a normalizing methodology that uses a 
reference gene that is stable across treatments. The normalization takes into account the 
amplification efficiencies of the multiple target sequences and the reference gene target 
sequence in order to allow direct comparisons of relative quantity estimates. We also present 
arguments on the merits of using a log base 2 transformation based on the theoretical process 
of the system and the mathematical ease of interpretation. 
Various methods to obtain estimates of error of the fold change and relative quantity by 
applying top-down or bottom-up statistical approaches are also investigated. The top-down 
approach refers to the method of calculating the quantities of interest for several samples 
(replicates) from a function of the assay‟s measurements and then calculating statistics on 
these derived quantities. In the bottom-up approach, the quantities of interest are thought of 
as functions of estimated parameters from a model of the measurements from the assay. The 
error associated with the quantity of interest is then obtained by applying the Delta Method 
(5) to these functions of estimated parameters. 
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Methods 
Mycoplasma strains and culture conditions 
Pathogenic M. hyopneumoniae strain 232, a derivative of strain 11, was used in this study 
(16). Cultures were passed fewer than fifteen times in vitro in Friis media (7). For DNA 
isolation, 125 ml Friis medium cultures in 250 ml Erlenmeyer flasks were incubated with 
slow agitation at 37°C until cultures reached mid-log phase as indicated by color change and 
turbidity. Mycoplasmal cells were pelleted by centrifugation at 24,000 × g, and the cell 
pellets were stored at -70°C until the chromosomal DNA was isolated via the method 
described by Madsen (15). For the heat shock assay, eight cultures of 5.6 ml were grown to 
exponential phase as described (14). Half of the eight cultures were then shifted to 42ºC for 2 
hours.  Cells were pelleted by centrifugation at 24,000 x g, and the pellet was resuspended in 
500 μl RNAlater (Ambion, Austin, TX). These suspensions were stored at -70ºC until the 
total RNA was isolated.  
RNA isolation 
RNA was isolated from frozen cell suspensions using Ambion‟s RiboPure Kit (Ambion) 
according to the manufacturer‟s protocol. Each sample was treated with 4 U of DNase 
(Ambion) at 37°C for 30 min followed by purification using an Ultracell YM-30 Microcon 
Centrifugal Filter Unit (Millipore Corp., Bedford, MA). Quantification and purity checks of 
each sample were done using a Nanodrop ND-1000 spectrophotometer (Thermo Fisher 
Scientific, Inc., Wilmington, DE). RNA samples were confirmed DNA free via PCR and gel 
electrophoresis.  
RT-qPCR primer design and assay conditions 
The downstream intergenic (IG) region (742 bp) of dnaK served as a positive control 
since previous studies have shown that this dnaK is up-regulated during heat shock (14). The 
IG sequence and 300 bases into adjacent ORFs were targeted for designing primer pairs for 
RT-qPCR products using the IDT Primer Quest tool (IDT: Integrated DNA Technologies, 
Inc. Coralville, IA). Our goal was to design six PCR amplicons within this region with a 
target sequence size of 80-200 bp. One amplicon each was designed to reside completely in 
each flanking ORF, one each bridged each of the transition areas from ORF to IG region, and 
two were located within the IG region itself. The reference gene used in the analysis was 
mhp381 (ugpA) which has been shown to be stable in previous heat shock experiments (14). 
Table 4.1 describes the primers used in the RT-qPCR assays. All of the primers were tested 
 103  
via PCR using M. hyopneumoniae DNA template to ensure their effectiveness in producing a 
correct product as determined by size on agarose gel electrophoresis analysis. 
The Express One-Step SYBR GreenER kit (Invitrogen, Carlsbad, CA) was used for RT-
qPCR assay on the Mx3005P QPCR System with MxPro 4.1 software (Stratagene, La Jolla, 
CA). Reaction volumes for each well totaled 15 µl and contained 0.895 µl of water, 7.5 µl 
relative quantitative PCR (qPCR) Mix, 0.6 µl of each primer at 2.5 µM, 0.03 µl ROX 
reference dye, 5 µl of sample RNA and 0.375 µl SuperScript III. The thermal cycling 
conditions were: a cDNA synthesis step at 50ºC for 30 min; an RT deactivation/Taq 
activation step at 95ºC for 10 min; 40 PCR cycles of 95ºC for 30 sec, 56ºC for 30 sec, and 
68ºC for 30 sec; and a melt curve step of 95ºC for 10 min, 55ºC for 30 sec, and 95ºC for 30 
sec. These thermal cycling conditions were used for all RT-qPCR assays throughout this 
study. 
 
Table 4.1: Primer sets for RT-qPCR assays. 
Primer Set Forward Primer Sequence Reverse Primer Sequence 
Product 
size 
1 ACAGTTCGTGCCGAAGGGCTTATT TTGGGCAGCTGCTTCAATTTGGTC 183 
2 AACCGCGCAGCAAGCAAATACATC CTAGCAGAAATTTGCAAGTGTGCGT 129 
3 AAGAAATCCAGGAAGCCTACGA AAGCCACTAGACCCACCACCAAAT 112 
4 TTTGGTGGCTCACAAGAACAAA CGCCTGAACCCTTACAGTTATCACA 157 
5 GATAACTGTAAGGGTTCAGGCGCT TGAACCCGACCAAATCCGGGAATA 116 
6 TATTCCCGGATTTGGTCGGGTTCA AAACATTCCATCCTGGATTCCGGC 166 
Reference 
Gene (RG) TGACTAAATTCGGGCAATCC ACTGTCGAATCGGTGAGGC 172 
 
Plate designs for RT-qPCR 
Test plates (8) were run on the IG region for detection of inhibition and troubleshooting 
of RT-qPCR. Two test plates were used in this study due to the differing number of samples 
used in the two different designs. One test plate (Stock I) was conducted on a mixture of 
equal volumes of six (three heat shock and three control) of the M. hyopneumoniae strain 232 
RNA samples diluted to 4 ng/μl and the other test plate (Stock II) used a mixture of the same 
 104  
six RNA samples plus two additional RNA samples (four heat shock and four control). A 
common, non-inhibitory dilution series for the six target sequences in the region of interest 
and the reference gene were determined as described previously (8).  
 
Design I 
Six RNA samples (three heat shock and three control) were used in the Design I assay. 
An assay plate consisted of six target sequences and a reference gene (mhp381) run in 
duplicate with six dilutions of Stock I in order to construct the standard curves for each 
amplicon (Figure 4.1). The three heat shock RNA samples and three control samples were 
diluted 1:3 for an in-well dilution of 1:9. These dilutions corresponded near to the center of 
the Stock I dilution series as determined from the Stock I test plate. A duplicate plate assay 
was done three hours later using the same sample and Stock I dilutions that were prepared 
and stored on ice from the first plate assay. 
 
  1 2 3 4 5 6 7 8 9 10 11 12 
PS1: A C1 C2 C3 HS1 HS2 HS3 Stock I dilution series     
PS2: B C1 C2 C3 HS1 HS2 HS3 Stock I dilution series     
PS3: C C1 C2 C3 HS1 HS2 HS3 Stock I dilution series     
PS4: D C1 C2 C3 HS1 HS2 HS3 Stock I dilution series     
PS5: E C1 C2 C3 HS1 HS2 HS3 Stock I dilution series     
PS6: F C1 C2 C3 HS1 HS2 HS3 Stock I dilution series     
RG rep 1: G C1 C2 C3 HS1 HS2 HS3 Stock I dilution series     
RG rep 2: H C1 C2 C3 HS1 HS2 HS3 Stock I dilution series     
Figure 4.1: 96-well plate layout for Design I assay. Pictured is the layout of the 96-well plate 
for the Design I assays. The top row contains the column number of the plate and the left-
hand column has the row letter of the plate. To the far left of the diagram is the primer set 
(PS) used in that row of the plate. The reference gene (RG) primer set was replicated on the 
plate. The wells on the left half of the plate contain the treatment for the wells (C = control, 
HS = heat shock) and the biological replicate number (1, 2, or 3). The wells on the right half 
of the plate were used for the Stock I (mixture of all six biological units) dilution series. 
 
Design II 
Design II consisted of a total of eight RNA samples: the same six RNA samples used in 
Design I plus an additional two RNA samples (one heat shock and one control) that were 
grown and isolated at the same time as the other six samples. Each assay plate consisted of 
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four RNA samples (two heat shock and two controls) diluted three times to the minimum, 
maximum, and midpoint of the non-inhibitory range as determined from the Stock II test 
plates (Figure 4.2). In this assay, Stock II dilutions are not prepared since the standard curves 
for each amplicon are determined from the combined information of all the separate sample 
dilution series. 
 
  1 2 3 4 5 6 7 8 9 10 11 12 
PS1: A C1 dilution series C2 dilution series HS1 dilution series HS2 dilution series 
PS2: B C1 dilution series C2 dilution series HS1 dilution series HS2 dilution series 
PS3: C C1 dilution series C2 dilution series HS1 dilution series HS2 dilution series 
PS4: D C1 dilution series C2 dilution series HS1 dilution series HS2 dilution series 
PS5: E C1 dilution series C2 dilution series HS1 dilution series HS2 dilution series 
PS6: F C1 dilution series C2 dilution series HS1 dilution series HS2 dilution series 
RG rep 1: G C1 dilution series C2 dilution series HS1 dilution series HS2 dilution series 
RG rep 2: H C1 dilution series C2 dilution series HS1 dilution series HS2 dilution series 
Figure 4.2: 96-well plate layout for Design II assay. Pictured is the layout of one of the 96-
well plates for the Design II assays. The top row contains the column number of the plate and 
the left-hand column has the row letter of the plate. To the far left of the diagram is the 
primer set (PS) used in that row of the plate. The reference gene (RG) primer set was 
replicated on the plate. The wells within the plate are in groups of three with the dilution 
series for the treatment (C = control, HS = heat shock) and the biological replicate number (1 
or 2). 
 
RT-qPCR Cq values 
Quantification cycle (Cq) values for all RT-qPCR assays were obtained from the MxPro 
4.1 software‟s default amplification-based threshold method. This method specifies the 
threshold as the mid-point (generally 10 standard deviations above background/baseline 
reaction fluorescence level) of the exponential amplification phase across all amplification 
curves on the plate. For duplicate samples on an assay plate (technical replicates), the Cq 
values were averaged for subsequent analysis. Note that the term “Cq” has been recently 
proposed by the MIQE guidelines to replace former terms such as “Ct” and “CP” (3). 
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Analysis of Design I:  
Standard curves 
Simple linear models of the form Cq = mx + b, where x = log2(z) and z is the dilution 
factor, were fit to the Stock I dilution series data in order to obtain estimates of slope and 
intercept parameters of the standard curves. Two modeling approaches were applied to both 
plates separately. In the first approach, each target sequence was fit with a separate model 
thereby assuming different mean square errors for each target sequence. In the second 
approach, all the Stock I data from a single plate (seven target sequences) were fit via a 
single linear model containing different slope and intercept parameters for each target 
sequence, thereby assuming that all the target sequences have same mean square error (see 
additional file 2). Note that in both of these model formulations, the estimated parameters 
(slope and intercept) are identical. Only the associated standard errors (SE) of the parameter 
estimates differ due to the modeling assumptions. 
Normalizing observed Cq values for Design I 
A known stable reference gene (mhp381) target sequence was used to normalize the Cq 
values of the target sequences of interest. Normalization is done by adding to the observed 
Cq for sample i (Cqi) the normalizing quantity specific to that sample. Normalizing quantities 
are obtained by multiplying the ratio of the target amplicon slope (m) to reference amplicon 
slope (n) by the difference of the samples reference amplicon Cq for sample i  
i
CqR  
from 
the mean of all the reference amplicon Cq‟s  R Cq . This normalized value for sample i is 
referred to as Cq'i. 
 
i
CqCq
n
m
CqqC ii RR   (4.1) 
Relative quantity index for Design I 
The relative quantity index (θ) for each sample is defined as the normalized Cq' value 
(Cq'i) divided by the slope (m) of the fitted curve for the target sequence. 
m
qC i
i

  (4.2) 
Recall that the linear model is Cq = mx + b, thus Cq/m = (mx + b)/m = x + b/m. Thus, this 
relative quantity index is simply a linear shift of the relative quantity index (b/m) derived 
below.  
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A relative quantity index can be derived directly from the standard curve model. If the 
sample was just detectable at the cycle preceding PCR, then that sample would have Cq = 0. 
Solving the standard curve equation for x with Cq = 0 results in x = -b/m. This quantity is a 
relative measure of the initial amount of target sequence RNA in the sample, but the dilution 
factor z (and x) is inversely related to concentration of target RNA in the sample and hence    
-b/m is also inversely related to relative quantity. Therefore, a lower -b/m corresponds to 
more target RNA in the sample. An index that would be more intuitive is the negative of this 
value, namely b/m. This index is directly related to relative quantity. That is, the greater b/m 
is, the more target sequence RNA there is in the sample. This relative quantity may also be 
derived in the following manner: b/m = -x = -log2(z) = log2(z
-1
) = log2(Q), where Q is the 
relative quantity measure of the target RNA in a sample. 
Fold change calculation for Design I 
The log base 2 fold change   is simply the difference of the relative quantities 
Cq'treated/m - Cq'control/m. This formulation is derived from the fold change of a target 
sequence defined as the ratio between 2 to the treated relative quantity and 2 to the control 
relative quantity.  
m
Cq
m
Cq
'
control
'
treated
2
2
2   (4.3) 
Additional file 1 demonstrates the equivalence of this formulation of fold change to the 
indices presented in Pfaffl and Livak/ABI (9, 18). Furthermore, it is shown that all three of 
these fold change formulations may be reduced to the following simple-to-calculate formula 
of the log base 2 fold change where we define the following terms: 
Wi = Cq for HS treatment i for target sequence 
Xi = Cq for HS treatment i for reference gene target sequence 
Yj = Cq for control treatment j for target sequence 
Zj = Cq for control treatment j for reference gene target sequence 
m = standard curve slope of target sequence  
n = standard curve slope of reference gene target sequence 
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nm
YW 
 

)2(log2  where ZX   (4.4) 
Top-Down Statistical Analysis for Design I 
Additional file 2 demonstrates the calculation of error via the top-down approach, which 
is commonly done in RT-qPCR experiments (9). In this approach, the replicate quantities of 
interest are calculated from the measurements obtained in the experiment. These quantities of 
interest are then treated as the “observed” random variables and statistics are calculated on 
these derived random variables. For the relative quantity index, the mean and SE of the mean 
are calculated for the treated and control samples separately. Note that the prime (') denotes 
the normalized Cq value. 
m
W
sm
W
s
i
i 




1
HS  (4.5) 
m
Y
tm
Y
t
j
j





1
C  (4.6) 
The difference in these quantities is the log base 2 fold change  CHS    and the 
estimation of error is obtained through standard derivations of the SE of the differences in 
means.  
    2C
2
HS  )SE( )SE()SE(    (4.7) 
Note that with either modeling approach described in the standard curves section, the 
same estimates of relative quantity are obtained since the top-down estimate can be written as 
a function of the assay Cq‟s and the estimated slope parameters from the model. The errors 
of these estimates are the same also for both modeling approaches since in the top-down 
statistical approach the errors are assumed to be only replicate-to-replicate error which 
ignores the error in the parameter estimates from the models. 
Bottom-Up Statistical Analysis for Design I 
Additional file 2 also demonstrates the error calculation via the bottom-up approach. In 
this approach, the quantities of interest are expressed in terms of the parameters obtained 
 109  
from the standard curve model and the observed Cq values. The errors on the parameters and 
the sets of observed Cq values are estimated and the Delta Method is applied to the quantities 
of interest to obtain error estimates of these quantities (5). It can be shown that the average 
Cq'/m (θ) for each treatment and target sequence can be written as follows: 
nm
W HS
HS

     where  
ts
XsZt


HS
 (4.8)
 
nm
Y C
C

     where  
ts
ZsXt


C  (4.9) 
and the log base 2 fold change has the same formula as presented in equation (4.4). The Delta 
Method is applied to all of these estimates as described in additional file 2. 
Analysis of Design II: 
Standard curves 
Simple linear models similar to those used in Design I were fit to the data. The difference 
in Design II is that a Stock II dilution series is not used. Instead, a three point dilution series 
of each sample is assayed and the model is fitted such that the slope is assumed the same for 
each sample, but their intercept may be different. Details of the two modeling approaches are 
in additional file 3. 
Normalizing b values for Design II 
The intercepts (b) of the different samples were normalized via the reference gene target 
sequence. The normalization methodology is identical to Design I with the exception of 
replacing Cq values in the equation with the b estimates. 
 
i
bb
n
m
bb ii RR 
  
 (4.10) 
Relative quantity index for Design II 
The relative quantity index (θ) is defined as normalized intercept (b') divided by the slope 
(m). See the relative quantity index for Design I for the derivation of this index. 
m
bi
i

  (4.11) 
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Fold Change calculation for Design II 
The log base 2 fold change   is the difference of the relative quantities (θHS – θC). This 
equation is identical in formulation to one presented for Design I and can be shown to be 
equivalent to the Pfaffl and Livak/ABI by recalling that Cq = mx + b. That is, calculating fold 
change based on the intercept of the model is identical to calculating fold change based on 
Cq‟s as shown in additional file 1 since the b‟s are simply a linear shift of the Cq‟s. 
Furthermore with the following definitions: 
b = intercept of target sequence heat shock samples 
β = intercept of the target sequence control samples 
m = the slope of the target sequence amplicons 
c = intercept of reference target sequence heat shock samples 
χ = intercept of the reference target sequence control samples 
n = the slope of the reference target sequence amplicons 
it can be shown that the log base 2 fold change quantity may be written as: 
nm
b
k
kk
k

 

  where   c . (4.12) 
Top-Down Statistical Analysis for Design II 
Additional file 3 demonstrates the error calculation via the top-down approach for Design 
II. In this approach, the replicate quantities of interest are calculated from the parameters 
estimated in the models. These quantities of interest are then treated as the “observed” 
random variables and statistics are calculated on these derived random variables. For the 
relative quantity index, the mean and SE of the mean are calculated for the treated and 
control samples separately.  
m
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
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
1
HS  (4.13) 
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The difference in these quantities is the log base 2 fold change  CHS    and the 
estimation of error is obtained through standard derivations of the SE of the differences in 
means (See equation (4.7)). Note that with either modeling approach described in the 
standard curves section, the same estimates and errors of these estimates are obtained in the 
top-down statistical approach as noted for Design I. 
Bottom-Up Statistical Analysis for Design II 
Additional file 3 also demonstrates the error calculation via the bottom-up approach. In 
this approach, the quantities of interest are functions of the model parameters. The errors on 
the parameters are estimated from the model and the Delta Method is applied to the 
quantities of interest to obtain error estimates of these quantities (5). It can be shown that the 
average b'/m (θ) for each treatment and target sequence can be written as follows: 
nm
b HS
HS

     where 
 
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ct





 
HS  (4.15) 
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C  (4.16) 
and the log base 2 fold change has the same formula as presented in equation (4.12). The 
Delta Method is applied to all of these estimates as described in additional file 3. 
 
Results 
The quality of the RT-qPCR data (as described by its Cq value scores) impacts an 
analysis. Therefore, our first step was to assess the raw Cq values and eliminate low quality 
(outlier) values before fitting a model. The most dilute well in the Stock I dilution series for 
the Design I assays had abnormally low Cq values across all primer sets for both plates. 
These Cq values are suspected to have resulted from improper construction of the last Stock I 
dilution and were discarded from subsequent analyses. Thus, the Stock I dilution series 
consisted of five data points instead of six. One additional Stock I dilution series data point in 
the first replicate of Design I was also discarded from the analysis due to what appeared to be 
a failed reaction. This well (third Stock I dilution for primer set 2 on the first replicate plate) 
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had an abnormally high Cq value, thus the first replicate for primer set 2 had four data points 
in the Stock I dilution series. None of the Design II Cq values appeared to be outliers, thus all 
the dilution series for Design II assays had three data points as designed. 
Table 4.2 contains the parameter estimates from the fitted standard curves along with the 
calculated amplification efficiencies and model fit statistics (adjusted R
2
) for Design I. The 
amplification efficiencies differed between the two replicate assays, but the correlation 
coefficient between the replicate assay efficiencies is 0.987. The first assay had efficiency 
ranging from 0.76 to 1.24, and the second assay ranged from 0.61 to 0.88. The linear models 
fitted to the standard curve have adjusted R
2‟s greater than 0.97, and the combined modeling 
approach had the highest adjusted R
2
 values for both assays with values greater than 0.99. As 
expected (14), Design I showed this region of the genome to be up-regulated during heat 
shock (Figure 4.3, left panel). The two replicate assays have slightly different estimates of 
fold change with the second assay having lower estimates of fold change for all six target 
sequences, but this difference is not statistically significant. The relative quantity estimates 
have the same pattern, and when normalizing to the reference gene between replicates, no 
significant differences between assay replications is observed (Figure 4.4, lower panels).  
Table 4.3 contains the parameter estimates of the slopes from the fitted standard curves 
along with the calculated amplification efficiencies and model fit statistics (adjusted R
2
) for 
Design II. Each plate was analyzed separately and then a combination of both assay plates 
was analyzed. The amplification efficiencies were very similar between the two separate 
plate assays with a correlation coefficient of 0.93. The first plate had efficiency ranging from 
0.92 to 1.43 and the second plate ranged from 0.92 to 1.34. All of the linear models fitted to 
the standard curves have adjusted R
2‟s greater than 0.99. As in Design I, Design II showed 
that this region of the genome is up-regulated during heat shock (Figure 4.3, right panel). The 
two replicate assays, which contain different biological replicates, have slightly different 
estimates of fold change, with plate 1 having lower estimates of fold change for all six target 
sequences. The relative quantity estimates have the same pattern and show no significant 
differences between assay plates even without normalizing between reference genes across 
plates (Figure 4.5). The difference between the reference gene relative quantity estimates on 
the two plates is only (-13.37) – (-13.42) = 0.05 (Table 4.4). 
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Table 4.2: Parameter estimates, efficiency calculations, and model fit statistics for Design I 
assays*. 
Rep PS b m Efficiency Adj.R
2
 
1 1 9.63 -1.21 0.78 0.99989 
  2 15.30 -0.86 1.24 0.97665 
  3 13.72 -1.15 0.82 0.99800 
  4 13.77 -1.23 0.76 0.99865 
  5 16.04 -1.05 0.93 0.99521 
  6 13.97 -1.08 0.90 0.98422 
  RG 14.13 -1.18 0.80 0.99873 
  Combined Model        0.99997 
2 1 8.90 -1.40 0.64 0.99553 
  2 14.46 -1.09 0.88 0.99768 
  3 13.07 -1.40 0.64 0.99067 
  4 12.96 -1.42 0.63 0.99139 
  5 15.06 -1.31 0.70 0.99548 
  6 12.71 -1.33 0.68 0.99632 
  RG 13.16 -1.45 0.61 0.99430 
  Combined Model        0.99995 
*For each Design I replicate plate (1 and 2), a linear model of Cq = mx + b was fit to the data 
either separately by primer set (PS) or by combining all the data from a single plate assay. 
Efficiency is calculated as 2
(-1/m)
-1. 
 
 
Figure 4.3: Fold change from both assay designs. Plotted are the log base 2 fold changes 
between control and heat shock treatments. Bottom-up combined (BU_C) model standard 
error bars are plotted for each estimate of fold change. Note that in Design II, the standard 
error bars are sometimes smaller than the plotted point symbol. 
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Figure 4.4: Design I relative quantities. The upper set of graphs plot the relative quantities 
calculated within each replicate assay. The lower set of graphs depicts the relative quantities 
with replicate 2 normalized to replicate 1 by shifting the relative quantities by the difference 
between replicate reference gene (RG) relative quantities. The error bars are the standard 
errors from the bottom-up combined model.  
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Table 4.3: Parameter estimates, efficiency calculations, and model fit statistics for Design II 
assays*. 
Plate PS m Efficiency Adj.R
2
 
1 1 -1.05 0.93 0.99976 
  2 -0.78 1.43 0.99987 
  3 -1.06 0.92 0.99997 
  4 -0.98 1.03 0.99984 
  5 -0.94 1.08 0.99995 
  6 -0.95 1.07 0.99992 
  RG -1.05 0.94 0.99996 
  Combined Model      0.99991 
2 1 -1.06 0.92 0.99996 
  2 -0.82 1.34 0.99994 
  3 -1.03 0.97 0.99997 
  4 -1.04 0.95 0.99996 
  5 -0.90 1.16 0.99993 
  6 -1.01 0.99 0.99997 
  RG -1.04 0.94 0.99998 
  Combined Model      0.99996 
both 1 -1.06 0.93 0.99987 
  2 -0.80 1.38 0.99991 
  3 -1.04 0.94 0.99997 
  4 -1.01 0.99 0.99989 
  5 -0.92 1.12 0.99994 
  6 -0.98 1.03 0.99994 
  RG -1.05 0.94 0.99997 
  Combined Model      0.99993 
 
*For each Design II assay plate (1 and 2) and a combination of both plates, linear models of 
the form Cq = mx + b was fit to the data either separately by primer set (PS) or by combining 
all the data from single or combination of plates. Efficiency is calculated as 2
(-1/m)
-1. 
 
Table 4.4 is a summary of results from all the RT-qPCR assays. The estimates of fold 
change and within-treatment relative quantities are presented along with their three different 
estimates of SE. The fold change estimates are very similar across all assays and analysis 
methods (Figures 4.3 and 4.6), however the SE estimates vary by method of estimation and 
assay design. In Design I, the SE estimates from the top-down method are less than the SE 
estimates from the bottom-up methods for fold change (Table 4.4 and Figure 4.8, top panel). 
Also, the bottom-up SE estimates for fold change in Design I are very similar for all primer 
sets and replicates and range in magnitude from 0.35 to 0.64. 
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Figure 4.5: Design II relative quantities. The Design II relative quantities for control and heat 
shock treatments from the separate plates and a combined (both) plates analysis. The error 
bars are the standard errors from the bottom-up combined model. Note that the standard error 
bars are sometimes smaller than the plotted point symbol. 
 
However, in contrast to Design I replicate plates, the two plates in Design II differed in 
their pattern of fold change SE estimates. For each primer set, most of the SE estimates for 
plate 1 were approximately double of those in plate 2 (Table 4.4). The SE estimates within 
primer sets for plate 2 are nearly identical across all three methods of SE estimation (Figure 
4.8, magenta points); whereas in plate 1, the bottom-up method SE estimates are 
approximately half of those from the top-down method SE estimates (Figure 4.8, green 
points). In the combined plate‟s analysis of Design II, the bottom-up method SE estimates are 
approximately a third of the top-down method (Figure 4.8, blue points). Thus, the general 
pattern of the fold change SE estimates is opposite between Design I and Design II. In 
Design I, the smaller SE estimates are from the top-down method; whereas in Design II, the 
smaller SE estimates are associated with the bottom-up methods (Figure 4.8). 
The relative quantity estimates for both treatments and assay designs have very similar 
patterns and are nearly identical when normalizing across assay reference genes (Figures 4.4, 
4.5, and 4.7). The relative quantity SE estimates in Design I follow a similar pattern to the 
fold change SE estimates in that the top-down method has lower estimates than the bottom-
up methods. However, the bottom-up method estimates vary across all primer sets (Figure 
4.9). In Figure 4.9, the circle and square of the same color can be used to compare the 
bottom-up method SE for a given primer set since the SE ratio has the same top-down SE 
estimate in the denominator for these points. Thus, when the bottom-up method SE estimates 
are similar, the symbols of the same color are adjacent while dissimilar estimates are more 
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distant. For example, primer set 1 for the control samples have somewhat similar bottom-up 
SE estimates for both replicates; whereas for primer set 2, the bottom-up SE estimates differ, 
and they also differ by which one is larger depending on the replicate plate. Design II has a 
similar pattern to Design I in that the top-down method SE estimate is generally less than that 
of the bottom-up method (Figure 4.10). For Design II, however, the bottom-up method SE 
estimates are more similar to each other than in Design I. 
 
Table 4.4: Summary table of the RT-qPCR assay results and model fitting*. 
   Fold Change   Relative Quantity - Control Relative Quantity - Heat Shock 
Design Rep PS Estimate TD BU_AS BU_C Estimate TD BU_AS BU_C Estimate TD BU_AS BU_C 
I 1 1 2.88 0.14 0.42 0.43 -12.98 0.12 0.12 0.45 -10.10 0.07 0.20 0.40 
  2 4.41 0.27 0.64 0.57 -24.13 0.10 2.13 1.17 -19.73 0.25 1.81 1.02 
 
 3 1.82 0.09 0.51 0.51 -16.04 0.03 0.38 0.59 -14.22 0.08 0.38 0.56 
 
 4 1.62 0.13 0.50 0.50 -15.27 0.07 0.31 0.53 -13.65 0.11 0.33 0.51 
 
 5 2.29 0.13 0.43 0.43 -19.65 0.11 0.68 0.77 -17.36 0.08 0.64 0.72 
 
 6 1.59 0.17 0.55 0.55 -16.95 0.05 1.07 0.66 -15.35 0.16 1.01 0.64 
 
 RG NA NA NA NA -15.04 0.16 0.31 0.55 -15.04 0.16 0.31 0.55 
 2 1 2.61 0.17 0.52 0.52 -11.12 0.07 0.41 0.44 -8.50 0.15 0.37 0.39 
 
 2 3.37 0.21 0.46 0.47 -18.58 0.04 0.46 0.87 -15.21 0.21 0.45 0.77 
 
 3 1.50 0.07 0.45 0.45 -13.22 0.02 0.65 0.50 -11.72 0.06 0.60 0.46 
 
 4 1.48 0.10 0.48 0.48 -12.96 0.04 0.62 0.49 -11.48 0.09 0.57 0.45 
 
 5 1.66 0.11 0.35 0.35 -15.32 0.10 0.52 0.60 -13.66 0.05 0.49 0.56 
 
 6 1.47 0.16 0.55 0.55 -13.44 0.12 0.46 0.56 -11.97 0.11 0.41 0.50 
 
 RG NA NA NA NA -12.03 0.13 0.47 0.45 -12.03 0.13 0.47 0.45 
II both 1 3.17 0.36 0.09 0.09 -10.61 0.36 0.27 0.26 -7.44 0.05 0.22 0.21 
 
 2 4.55 0.42 0.15 0.13 -21.16 0.40 0.69 0.59 -16.61 0.14 0.58 0.49 
 
 3 1.72 0.33 0.06 0.08 -14.33 0.10 0.22 0.33 -12.62 0.32 0.20 0.31 
 
 4 1.75 0.34 0.09 0.08 -15.23 0.08 0.46 0.36 -13.48 0.34 0.43 0.33 
 
 5 2.14 0.33 0.08 0.09 -18.41 0.24 0.46 0.45 -16.27 0.22 0.42 0.42 
 
 6 1.75 0.31 0.07 0.09 -15.33 0.11 0.36 0.37 -13.58 0.29 0.33 0.34 
 
 RG NA NA NA NA -13.39 0.17 0.23 0.33 -13.39 0.17 0.23 0.33 
 p1 1 2.67 0.47 0.24 0.21 -10.20 0.46 0.51 0.42 -7.53 0.03 0.42 0.35 
 
 2 4.03 0.64 0.34 0.30 -21.20 0.57 1.19 1.01 -17.16 0.29 1.01 0.86 
 
 3 1.32 0.33 0.12 0.20 -14.21 0.14 0.29 0.53 -12.89 0.30 0.27 0.50 
 
 4 1.35 0.33 0.27 0.21 -15.92 0.10 0.87 0.63 -14.57 0.31 0.83 0.60 
 
 5 1.44 0.40 0.17 0.22 -17.66 0.30 0.56 0.72 -16.22 0.27 0.53 0.68 
 
 6 1.37 0.41 0.20 0.22 -16.00 0.27 0.62 0.66 -14.63 0.31 0.58 0.62 
 
 RG NA NA NA NA -13.42 0.27 0.36 0.52 -13.42 0.27 0.36 0.52 
 p2 1 3.67 0.12 0.11 0.14 -11.03 0.002 0.21 0.29 -7.36 0.12 0.17 0.23 
 
 2 5.05 0.25 0.23 0.20 -21.13 0.11 0.77 0.63 -16.08 0.22 0.63 0.52 
 
 3 2.12 0.14 0.11 0.14 -14.46 0.09 0.30 0.37 -12.34 0.11 0.28 0.34 
 
 4 2.13 0.18 0.13 0.14 -14.58 0.09 0.37 0.37 -12.45 0.15 0.34 0.34 
 
 5 2.86 0.18 0.21 0.16 -19.18 0.10 0.73 0.53 -16.33 0.15 0.67 0.48 
 
 6 2.12 0.21 0.12 0.14 -14.70 0.03 0.33 0.38 -12.59 0.21 0.31 0.35 
 
 RG NA NA NA NA -13.37 0.23 0.27 0.35 -13.37 0.23 0.27 0.35 
* Abbreviations: PS = Primer Set, p1 = plate 1, p2 = plate 2, TD = top-down standard errors, 
BU_AS = bottom-up standard errors from the all separate model, BU_C = bottom-up 
standard errors from the combined model.  
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Figure 4.11 compares the SE estimates between designs by plotting the ratio of the 
Design II estimate divided by Design I estimate for the three methods of SE estimation 
separately. Since the estimation of SE from Design I is only from a single plate of data, only 
ratios to Design II single plate analyses are presented. For fold change, the top-down SE 
estimates for Design II are generally greater; whereas for both bottom-up methods, Design I 
estimates are greater. The comparisons are more variable for the relative quantity SE 
estimates, but in general, they follow the same pattern as that observed for the fold change 
SE estimates. There are several exceptions though; for example, the top-down SE estimate 
for primer set 1 was sometimes smaller for Design II. The bottom-up combined method SE 
estimates (Figure 4.11, blue points) appear to be fairly consistent in that the Design I SE 
estimates are greater than Design II. 
 
 
 
 
 
 
Figure 4.6: Fold change of Design I versus Design II. Fold change of Design I replicate 1 is 
plotted with the fold change of Design II combined analysis. The error bars are the standard 
errors from the bottom-up combined model. Note that the standard error bars are sometimes 
smaller than the plotted point symbol. 
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Figure 4.7: Within treatment relative quantity of Design I versus Design II. The upper set of 
graphs plot the relative quantities for the control and heat shock treatments of Design I 
replicate 1 with the relative quantities of the Design II combined analysis. The lower set of 
graphs depicts the relative quantities with the Design II combined analysis normalized to 
Design I replicate 1 by shifting the relative quantities by the difference between assays‟ 
reference gene (RG) relative quantities. The error bars are the standard errors from the 
bottom-up combined model. Note that the standard error bars are sometimes smaller than the 
plotted point symbol. 
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Figure 4.8: Standard error ratios for fold change estimates. Plotted are the ratios of the 
standard errors from the bottom-up methods divide by the top-down methods for the fold 
change estimates. Circles denote the bottom-up all separate method and squares denote the 
bottom-up combined method. The horizontal line at the ratio value of 1 denotes the equality 
of the standard errors. The colors denote different assays and analyses: black = Design I rep 
1, red = Design I rep 2, blue = Design II both plates, green = Design II plate 1, magenta = 
Design II plate 2. 
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Figure 4.9: Design I relative quantity standard errors. Plotted are the ratios of the standard 
errors from the bottom-up methods divided by the top-down methods for the relative quantity 
estimates. Circles denote the bottom-up all separate method and squares denote the bottom-
up combined method. The horizontal line at the ratio value of 1 denotes the equality of the 
standard errors. The colors denote different assays and analyses: black = Design I rep 1, red 
= Design I rep 2. 
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Figure 4.10: Design II relative quantity standard errors. Plotted are the ratios of the standard 
errors from the bottom-up methods divided by the top-down methods for the relative quantity 
estimates. Circles denote the bottom-up all separate method and squares denote the bottom-
up combined method. The horizontal line at the ratio value of 1 denotes the equality of the 
standard errors. The colors denote different assays and analyses:  blue = Design II both 
plates, green = Design II plate 1, magenta = Design II plate 2. Note that the ratios for PS 1 
plate 2 (magenta) control treatment are not plotted since the ratios are extremely large: 
BU_AS/TD = 122 and BU_C/TD = 166. 
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Figure 4.11: Within SE calculation method comparison of designs. Plotted are the SE ratios 
(Design II/Design I) of single plate assays. The upside-down triangle denotes ratios of 
Design II plate 1 to Design I plate 1 and the diamond denotes ratios of Design II plate 2 to 
Design I plate 1. The colors of the plotted points denote the method of SE calculation. RQ = 
relative quantity 
 
 124  
Discussion 
The choice of using a log base 2 transformation for modeling is intuitive based on the 
theory of the PCR system, a 2
n
 process of the target amplicon at each cycle. Thus 
mathematically, one would most logically use the log base 2 transformation to linearize a 
doubling process. Therefore, standard curves in log base 2 have slopes of -1 when the 
amplification efficiency is 100% as opposed to a slope of -1/log10(2) ≈ -3.3219 on the log 
base 10 scale. The choice of base for the log transformation does not change the resultant 
statistical calculations and hypothesis tests, however. Using either base for the log 
transformation will result in the same conclusions about the experiment. Thus, we propose 
the use of the log base 2 transformation for these four reasons: 1) it models the biological 
system better, 2) it is easier to interpret the slopes of standard curves, 3) the statistical results 
are identical to those arrived at by log base 10 transformation, and 4) the log base 2 
transformation lends itself to simple formulas for calculating the log base 2 fold change. For 
example in Design I, the equation for the log base 2 fold change only requires the average of 
the observed Cq values and a division by the slope from the standard curve (equation (4.4)), 
and in Design II, the equation only requires the average of the standard curve intercepts and 
division by the slope of the standard curve (equation (4.12)). These formulations bypass the 
need to transform to log base 2 scale from log base 10 scale that many qPCR publications 
(including the MIQE Guidelines) and machine platforms currently implement. 
A novel method to compare the relative quantity estimates (Design I: equation (4.2) and 
Design II: equation (4.11)) of several different target sequences was developed. By 
normalizing all target sequence relative quantities to those of a common, stable reference 
gene, an estimate of comparable relative quantities and their SE can be made. Furthermore, 
these relative quantities can then be used directly to determine the fold change between 
control and treated samples by subtracting one from the other for a given target sequence 
since they have been normalized. The relative quantities from different target sequences can 
be compared directly by statistical tests such as all pair-wise comparisons. An example of 
this application was employed in a previous study in which the reliability of qPCR was 
demonstrated via an assay with Mycoplasma hyopneumoniae chromosomal DNA template 
used as a negative control (11). In an assay with DNA template, no significant differences 
between the six target sequences in the IG region would be expected since the relative 
concentration of target template should be the same across all areas of the IG and flanking 
regions. This assay demonstrated the reliability and suitability of these targets to assess qPCR 
assay designs by showing high amplification efficiencies (0.92 to 0.97) and single product 
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melt curves on DNA template and no significant differences (p < 0.01) between targets 
relative quantities. 
The importance of efficiency calculation and the use of a reference gene (or genes) are 
clearly demonstrated from the replicate plates of the Design I assay. The efficiencies are 
drastically different between these two assays possibly due to a procedural implementation 
(diluted RNA samples were stored on ice for three hours for replicate 2), but the results are 
nearly the same after adjusting for efficiency and normalizing to the reference gene (Figures 
4.3, 4.4, 4.6, and 4.7). Fortuitously, this procedural implementation of the assay resulted in 
the unexpected observation that the RT-qPCR has some robustness when a reference gene is 
present on the assay plate and the amplification efficiency of each particular (target and 
reference gene) amplicon is determined for the assay plate. Assuming that the same target 
maintains constant amplification efficiency across multiple RT-qPCR plates is not, in our 
estimation, a good practice, and that each assay needs to be assessed within its particular 
context (plate, day, operator, reagents, etc.). The more labile nature of RNA (the nucleic acid 
template type used directly in the RT-qPCR reactions described in this study) as opposed to 
the known higher stability of gDNA and cDNA when prepared and used as a qPCR template 
may be a strong contributing factor to our need to emphasize this particular observation for 
all RT-qPCR assays. 
The benefits of Design I (in comparison to Design II) are that more biological samples 
may be assessed on a single plate and more dilutions are used in the construction of the 
standard curve. However, since the standard curve is generated from a Stock I serial dilution, 
amplification characteristics of individual samples are not measured. Only the Cq for a single 
sample dilution is measured. Another caveat for Design I is that the SE estimates from the 
top-down method were substantially smaller than the SE estimates from the bottom-up 
estimates. The bottom-up methods of SE estimation account for the error in estimating the 
slope, and the results from this study show that the top-down method appears to be 
underestimating the variation in these assays, which may lead to erroneous conclusions on 
statistical differences. Another complicating factor of Design I is that the data from a single 
plate is divided into two separate analyses, half the plate is used for estimating the 
amplification efficiency (Stock I dilution series) and the other half is used for estimating the 
relative quantities within the two treatments. This division of data complicates the 
implementation of bottom-up statistics since the parameters that compose the function of 
interest are from data that are essentially two separate assays.  
The benefits of Design II (in comparison to Design I) are that the entire plate is used to 
generate estimates of the parameters of interest, individual samples may be assessed by their 
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amplification characteristics, and even though fewer dilutions are used in the standard curve 
estimation, more data is generated for this estimation. In Design I, the standard curve could 
be estimated from six data points which results in 4 degrees of freedom (df) after estimating 
the slope intercept of the curve. In Design II, the standard curve could be estimated from 
twelve data points which results in 7 df after estimating the four intercepts and the common 
slope. Caveats of Design II are that there are fewer biological samples per plate and that the 
standard curve relies on three serial dilutions. However, this study demonstrated how to 
combine data from multiple plates appropriately and that if an optimal dilution range is 
identified, than a three point standard curve is adequate for amplification efficiency 
estimation. 
The comparison of these two designs for RT-qPCR is based on having conducted 
preliminary assays using the PREXCEL-Q-based “Stock I” test plate regimen to determine 
the valid, non-inhibitory working range of the samples and target sequences of interest. The 
importance of the pre-assay step to determine optimal dilution ranges of the samples cannot 
be over emphasized, and the use of the “Stock I” regime is an efficient way to accomplish 
this preparatory step. Once the optimal RT-qPCR range is established, our recommendation 
is to use Design II, an assay design which uses serial dilutions of each individual sample to 
determine the amplification efficiency of a target sequence, over Design I, an assay which 
uses the Stock I methodology, to evaluate target sequence amplification efficiencies.  
Reasons to favor Design II include the following: 1) there are more df available for 
estimating the random error variance, 2) methods for modeling multiple assay plates 
simultaneously are straightforward, 3) the implementation of the Delta Method is more 
obvious since the function of parameters to estimate the quantity of interest is from a single 
model of all the data, and 4) the data from this study suggests that the error estimation via the 
top-down method is more conservative than the bottom-up method for Design II. For 
instances, when conducting RT-qPCR studies, the error in estimation of amplification 
efficiency should not be ignored in determining statistically significant differences as is 
commonly done in many studies using the top-down statistical approach. Thus, if Design I is 
employed, the top-down method of SE estimation likely underestimates the SE, and the type 
I error rate would be larger than the p-value would indicate. Therefore, it is strongly 
recommended that for assays which use the Stock I methodology that the bottom-up 
statistical approach be used solely in order to account for the error in estimating the 
amplification efficiency. Another recommendation concerning the bottom-up methods is that 
the bottom-up combined method for estimating SE is recommended over the bottom-up all 
separate method for two reasons: 1) both methods resulted in very similar SE estimates, and 
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2) the combined method is probably more robust to outliers since it uses the entire data from 
the plate instead of subsets of the data.  
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SUPPLEMENTAL DATA 
Additional file 1: Demonstration of equivalence of Fold Change calculations    
The Cq values from the MxPro 4.1 software (Stratagene, La Jolla, CA) are denoted as 
follows for the analysis.         
Ud = Cq for Stock I dilution d for target sequence  
Vd = Cq for Stock I dilution d for reference gene target sequence  
where d is 1 to d*.  
Wi = Cq for HS sample i for target sequence  
Xi = Cq for HS sample i for reference gene target sequence  
Yj = Cq for control sample j for target sequence  
Zj = Cq for control sample j for reference gene target sequence 
where i is 1 to s and j is 1 to t. 
Simple linear models of the form Cq = mx + b, where x = log2(z) and z is the dilution factor, 
were fit to the data. Explicitly, the target sequence was fit as U = mx + b + εT and the 
reference gene target sequence was fit as V = nx + c + εC. 
The three methods of calculating fold change are shown to be equivalent by 
demonstrating that each formulation is equal to the following easy to calculate log base 2 
fold change   .  
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3) Relative quantity 
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Thus, 
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Thus, the log base 2 fold change is: 
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Additional file 2: Details on the analysis of the Design I assays 
Models: 
The Cq values from the MxPro 4.1 software (Stratagene, La Jolla, CA) were denoted as 
follows for the analysis of the standard curve. 
Udk = Cq for Stock I dilution d for target sequence k  
where d is 1 to d* and k is 1 to k* 
Vd = Cq for Stock I dilution d for reference gene target sequence  
Simple linear models of the form Cq = mx + b, where Cq is the quantification cycle and x = 
log2(z) and z is the dilution factor, were fit to the data.  
Two approaches were applied to each of the two plates. In the first approach, each target 
sequence was fitted separately as Uk = mkx + b + εk for the k target sequences or as V = nx + c 
+ εR for the reference gene target sequence. The second approach was to fit the linear model 
to the combined data  
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 I(k*1)(k*1)  Dd*1  
m
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
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
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 I(k*1)(k*1)  Jd*1  
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

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

  
where  DT  x1,..., xd*  ,   m
T  m1,...,mk*  ,   b
T  b1,...,bk*  ,  
 
and  is the Kronecker product (12). 
In both of these formulations, the estimated slope and intercept of target sequence k are 
mk and bk, and of the reference gene target sequence are n and c, are identical. Only the 
estimate of the associated standard error differs due to the assumptions associated with the 
models. In the first model, the standard errors are assumed to be different for each amplicon 
(εk or εR); whereas in the second approach, the standard error is assumed to be the same for 
all amplicons (ε). 
Relative Quantity: 
The Cq values from the samples were denoted as follows for the analysis: 
Wik = Cq for HS sample i for target sequence k 
Xi = Cq for HS sample i for reference gene target sequence  
Yjk = Cq for control sample j for target sequence k 
Zj = Cq for control sample j for reference gene target sequence 
where i is 1 to s and j is 1 to t.      
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The log base 2 relative quantity (θ) for each treatment was calculated as the average 
Cq'/m where Cq' is the normalized Cq. Cq' is calculated as follows: 
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It can be shown via a little algebra that the average Cq'/m (θ) for the target sequences can be 
written as follows: 
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For the reference gene, the log base 2 relative quantity (θ) is simply  
n
Cq R
R 
 
where 
ts
ZtXs
ts
ZX
Cq
s
i
t
j
ji






 
 1 1
R
 
 137  
Fold Change: 
Fold change  2  for target sequence k is calculated as the ratio treated relative quantity 
to the control relative quantity.       
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Thus the log base 2 fold change    is θHS - θC. It can be shown that this quantity may be 
written as  
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Furthermore, it can be shown that log base 2 of the Pfaffl and Livak/ABI approach to fold 
change, when formulated in the log base 2 system, can be written in the above form (See 
Additional file 1). 
Top-Down Statistics 
The top-down approach refers to the method of calculating the quantities of interest for 
several samples and then calculating statistics on these derived quantities. The log base 2 
relative quantity (θ) for each treatment was calculated as the average Cq'/m where Cq' is the 
normalized Cq. Explicitly, this can be written as 
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The standard error of the mean is then calculated by the standard method for mean 
quantities. Note that quantities associated with the reference gene are not separated by 
treatment since it is assumed that treatment has no effect on the observe response. That is 
why it is used as a reference gene. 
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The log base 2 fold change   is θHS - θC. The estimation of error is obtained through 
standard formulation of the standard error of the differences in means. Explicitly: 

SE(k)  SE(HS,k )  
2  SE(C,k )  
2    
This formulation of error estimation obtains identical results to those formed by Livak/ABI 
equation with the log base 2 fold change formulation. 
 
Bottom-Up Statistics 
In this approach, the quantities of interest are thought of as functions of estimated 
parameters. The error associated with the quantity of interest is then obtained by applying the 
Delta Method to this function of parameters. The Delta Method requires an estimation of the 
covariance matrix of the estimated parameters. Since two approaches were used to estimate 
the parameters (an all separate model and a combined model), two different estimates of the 
covariance matrix of interest are available. 
Relative Quantity: 
It was shown previously that the average Cq'/m (θ) for the target sequences can be written 
as follows:        
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The error estimates of θHS,k and θC,k is obtained in similar applications of the Delta 
Method. The partial derivatives with respective to each parameter are evaluated with the 
current estimates. For example, the partial derivatives for θHS,k are as follows:  
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The upper triangle of the covariance matrix from the two fitted models is likewise similar for 
both the error estimates of θHS,k and θC,k. For example, the upper triangle of the covariance 
matrix for θHS,k is as follows:  
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  , Cov HS , Var(mk) and Var(n) are values from 
the fitted model, and Cov(mk,n) = 0 for the all separate model or from 
the estimated value in the combined model. 
Note that the covariance between slope estimates from the Stock I Cq values and 
treatment Cq values are considered independent and therefore 0. The Stock I experimental 
unit is created by a mixing equal portions of independent experimental units and is serial 
diluted to different dilutions than the treatment experimental units that are assayed 
separately.  
For the reference gene, the log base 2 relative quantity (θ) is simply  
n
Cq R
R        
The partial derivative for R  are:        
nCq
1
R
R 


 
2
RR
n
Cq
n




   
 
The upper triangle of the covariance matrix is   
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Fold Change: 
Fold change for target sequence k is calculated as the ratio 
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change    is θHS – θC. It can be shown that this quantity may be written as  
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The Delta Method is applied to  k  as follows. The partial derivatives  k  are:  
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The upper triangle of the covariance matrix is:  
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Additional file 3: Details on the analysis of the Design II assays 
 
Models: 
The Cq values from the MxPro 4.1 software (Stratagene, La Jolla, CA) were denoted as 
follows for the analysis:  
Wdik = Cq for dilution d of HS sample i for target sequence k  
Xdi = Cq for dilution d of HS sample i for reference gene target sequence 
Ydjk = Cq for dilution d of control sample j for target sequence k  
Zdj = Cq for dilution d of control sample j for reference gene target sequence 
where i is 1 to s and j is 1 to t.  
Simple linear models of the form Cq = mx + b, where Cq is the quantification cycle and x = 
log2(z) and z is the dilution factor, were fit to the data.  
Two approaches were applied to each of the two plates. In the first approach, each target 
sequence was fitted separately as
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 is the Kronecker product (12). 
In both of these formulations, the estimated slopes and intercepts of target sequence k 
(mk, bk, βk) and of the reference gene target sequence (n, c, χ) are identical. Only the estimate 
of the associated standard error differs due to the assumptions associated with the models. In 
the first model, the standard errors are assumed to be different for each amplicon; whereas in 
the second approach, the standard error is assumed to be the same for all amplicons. 
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Relative Quantity: 
The log base 2 relative quantity (θ) for each treatment was calculated as the average 
intercept divided by the amplicons slope. For the heat shock treatment this is b'/m where b' is 
the normalized b which is calculated as follows:  
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For the control treatment this is β'/m where β' is the normalized β. β' is calculated as follows: 
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For the reference gene, the normalized intercept is the average intercept across both 
treatments. It is calculated as follows: 
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It can be shown via some algebra that the average b'/m (θHS) for the heat shock treated target 
sequences can be written as follows:  
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And it can be shown that the average β'/m (θC) for the heat shock treated target sequences can 
be written as follows:   
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For the reference gene, the log base 2 relative quantity (θR) is simply 
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Fold Change: 
Fold change  2  for target sequence k is calculated as the ratio treated relative quantity 
to the control relative quantity. 
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Thus the log base 2 fold change    is (θHS – θC). It can be shown that this quantity may be 
written as 
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This formulation of fold change can be shown to be equivalent to the Pfaffl and Livak/ABI 
equations by recalling that Cq = mx + b. That is, calculating fold change based on the 
intercept of the model is identical to calculating fold change based on Cq‟s as shown in 
additional file 1 since the b‟s are just a linear shift of the Cq‟s. 
Top-Down Statistics 
The top-down approach refers to the method of calculating the quantities of interest for 
several samples and then calculating statistics on these derived quantities. The log base 2 
relative quantity (θ) for each treatment was calculated as the average b'/m (or β'/m) where b' 
(or β') is the normalized b (or β). Explicitly, this can be written as 
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The standard error of the mean is then calculated by the standard method for mean quantities. 
Note that quantities associated with the reference gene are separated by treatment since it is 
assumed that treatment has no effect on the observe response. That is why it is used as a 
reference gene. 
The log base 2 fold change    is (θHS – θC). The estimation of error is obtained through 
standard formulation of the standard error of the differences in means. Explicitly: 

SE(k)  SE(HS,k )  
2  SE(C,k )  
2  
This formulation of error estimation obtains identical results to those formed by Livak/ABI 
equation with the log base 2 fold change formulation. 
Bottom-Up Statistics 
In this approach, the quantities of interest are thought of as functions of estimated 
parameters. The error associated with the quantity of interest is then obtained by applying the 
Delta Method to this function of parameters. The Delta Method requires an estimation of the 
covariance matrix of the estimated parameters. Since two approaches were used to estimate 
the parameters (an all separate model and a combined model), two different estimates of the 
covariance matrix of interest are available. 
Relative Quantity: 
It was shown previously that the average b'/m (or β'/m) (θ) for the target sequences can be 
written as follows: 
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The error estimates of θHS,k and θC,k  is obtained in similar applications of the Delta 
Method. The partial derivatives with respective to each parameter is evaluated with the 
current estimates. For example, the partial derivatives for θHS,k are as follows:  
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The upper triangle of the covariance matrix from the two fitted models is likewise similar 
for both the error estimates of θHS,k and θC,k. For example, the upper triangle of the 
covariance matrix for θHS,k is as follows: 
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For the reference gene, the log base 2 relative quantity (θ) is simply the mean of all the 
reference gene sample intercepts.  
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The partial derivatives for θR are: 
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Fold Change: 
Fold change for target sequence k is calculated as the ratio 
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The upper triangle of the covariance matrix is:   
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Var(mk) and Var(n) are values from the fitted models, Cov(mk,n) = 0 for 
the all separate model or from the estimated value in the combined 
model, 

Cov  bk,mk    Cov bk,mk    Cov   k,mk    Cov k,mk , 

Cov ,mk 0, 

Cov ,n 0 ,     0  , Cov, Cov  nnb kk   in the all 
separate model, and in the combined model 

Cov  bk,n    Cov bik,n  0  and 

Cov   k,n    Cov  jk,n    0 . 
Note that several of the covariance‟s are 0 since the data that are used to estimate the 
parameters are independent of each other. 
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CHAPTER 5. DISCUSSION 
 
General Discussion 
 
Two types of microarrays were constructed (one consisting of PCR products and the 
other of synthesized oligonucleotides) to interrogate the intergenic (IG) regions of M. 
hyopneumoniae. The 343 IG regions identified for investigation were defined as the non-
coding DNA sequences (≥ 50 bp) between annotated genes in the M. hyopneumoniae genome 
sequence (7). Two-color microarray assays identified transcripts in 321 (93.6 %) of the IG 
regions which clearly indicates that IG regions within the M. hyopneumoniae genome are 
actively transcribed and at a high frequency. These results are supported by other recent 
studies with M. pneumoniae in which IG transcripts on a global scale were identified by 
tiling microarrays (4) and on a limited scale via RT-qPCR with M. genitalium and M. 
pneumoniae (1). 
The results from the microarray assays prompted more detailed studies of five of the 
larger IG regions (> 500 bp) in M. hyopneumoniae via RT-qPCR. The aim of the RT-qPCR 
assays was to detect changes in RNA transcription levels across the IG region by designing 
primer sets whose products reside in flanking ORFs, bridge flanking ORFs and the IG region, 
or reside solely within the IG region. The overall goal of these assays was to gain insight into 
mechanisms of transcriptional control. Two possible mechanisms were considered before 
conducting the experiments: 1) an abrupt termination of transcription at the end of the 
flanking genes with the loss of bridging RT-qPCR products, and 2) a general decline in 
transcript levels indicating that RNA polymerase was slowly falling off the template in the 
IG region. An analysis of the data indicates that both of these mechanisms may occur as well 
as a third mechanism: reinitiation of transcription within the IG region.  
These RT-qPCR studies confirmed that IG regions are actively transcribed and that no 
single transcriptional start site can account for transcriptional activity within IG regions. 
Transcription can end abruptly at the end of an ORF, but this does not seem to occur at high 
frequency as previously suggested by Washio, et al. (10). Rather, transcription often 
continues past the end of the ORF, with a gradual reduction until the next promoter is 
encountered. Furthermore, transcription can also be initiated within IG regions in the absence 
of accepted promoter-like sequences and probably does so at high frequency. This suggests 
that these RNAs may play an important role in the physiology of the mycoplasma, such as 
acting as regulatory RNAs.  
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The goals of the RT-qPCR assay required the development of novel methods of data 
analysis. Most studies using RT-qPCR technology are performed to detect the changes in 
transcription levels of a specific target under different treatment conditions and report the 
fold change difference in RNA transcription. In addition to detecting changes in RNA 
transcription for a target under different treatment conditions, we were interested in 
measuring the changes in transcription levels between adjacent targets under the same 
treatment. A RT-qPCR relative quantity index was developed and tested to meet this need. 
The proposed relative quantity index (b/m) is a function of the parameters of the simple 
linear model Cq = mx + b, where Cq is the quantification cycle and x = log2(z) (where z is the 
dilution factor), fitted to the data of each primer set in an assay. Comparisons of multiple 
targets within a sample may be made directly with this relative quantity index. Variations on 
this index were developed via a normalization methodology using a stable reference gene in 
order to conduct comparisons between samples and across treatments.   
The experimental design of the RT-qPCR assay to assess changes in transcript levels 
across an IG region was investigated and two different assay designs were proposed. These 
designs were the PREXCEL-Q-based “Stock I” regimen (3) and a design that uses serial 
dilutions of each individual sample to establish the target’s amplification efficiency across all 
the samples. Both of these designs were implemented and the results compared. In addition 
to comparing the fold changes and relative quantity indices of several different targets for 
both of these designs, various methods based on top-down or bottom-up statistical 
approaches were developed to obtain error estimates of the fold change and relative quantity 
index. The results of these assays indicate that the error in estimation of amplification 
efficiency should not be ignored in determining statistically significant differences as is 
commonly done with the top-down approach that is implemented in most studies. 
Furthermore, an assay design that uses serial dilutions of each individual sample to determine 
the amplification efficiency of a target sequence is favored over an assay design which uses 
the Stock I methodology to evaluate target sequence amplification efficiencies. 
This research has demonstrated that M. hyopneumoniae has greater transcriptional 
activity than initially thought. Additionally, the methodologies of RT-qPCR assay design and 
analysis developed to assess this transcription activity showed that a design that uses serial 
dilutions for each sample outperforms a design that uses the Stock I regimen, and that the use 
of bottom-up statistical methods is preferred since it accounts for the error associated with 
the estimation of the amplification efficiency. By applying these methodologies to generate 
and analyze data, a greater understanding of the transcriptional process and insight into how 
M. hyopneumoniae is able to proliferate with such a small genome is possible. The section 
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below will present some areas of future research that may be pursued to better understand 
one of the smallest living organisms and how to further assess the proposed designs and their 
analysis. 
 
Recommendations for Future Research 
 
The prolific transcription of IG regions in M. hyopneumoniae was unexpected and leads 
to questions about what are the roles of these IG RNAs. Examples of a few questions that 
future studies may focus on are: Do IG regions participate in gene regulation? If IG regions 
are involved in gene regulation, then what are the mechanisms of regulation? Are IG RNAs 
small RNAs or simply runoff sequences from upstream ORFs?  
A first step in answering some of the questions above is to determine if the IG RNAs are 
sense or antisense transcripts. The one-step RT-qPCR assay does not distinguish which 
strand of the DNA is transcribed into RNA since both primer pairs are used in the cDNA 
reaction. A two-step RT-qPCR assay where a single primer is used during cDNA synthesis is 
a method to distinguish which strand of DNA is being transcribed. If the strand transcribed is 
antisense to a known ORF, then a hypothesis that may be investigated is that IG RNAs 
participate in gene regulation by preventing the translation of the ORF.  
Several of the IG regions studied appear to produce transcripts that do not have a well 
defined transcriptional stop site. However, one ORF (mhp683) did demonstrate a well 
defined stop. An in vitro transcription system using purified M. hyopneumoniae RNA 
polymerase (RNAP) and various synthetic DNA templates could be developed to investigate 
the properties of controlling the termination of transcription in M. hyopneumoniae. The 
template DNA would be composed of four parts: a M. hyopneumoniae transcriptional start 
sequence, a unique sequence of DNA, mhp683’s stop sequence, and finally a second unique 
DNA sequence. Transcription could then be followed across the template using the unique 
sequences to prime the reactions. By modifying mhp683’s transcriptional stop sequence, one 
could define the sequence needed to stop transcription; as the mhp683 stop sequence failed to 
halt transcription, the down-stream sequences would begin to appear in the transcripts.  
The IG regions around dnaK were investigated to determine if these regions were also 
under transcriptional control during heat shock. This region was chosen due to its known 
transcriptional control of dnaK during heat shock from previous studies (2, 5). In addition to 
heat shock, several microarray studies concerning transcriptional regulation of M. 
hyopneumoniae under different treatment conditions, such as iron depletion (6), 
norepinephrine stress (8), and hydrogen peroxide stress (9), have been done. A RT-qPCR 
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study of the IG regions adjacent to genes identified in these studies to have differential 
expression could be done to determine if these IG regions are under a similar transcriptional 
control as that of the ig-072 region downstream of dnaK. If some regions are under 
transcription control and others are not, then a detailed study of the difference in DNA 
sequence could provide insight into transcriptional regulation. 
The experimental design comparison of the RT-qPCR assay and the comparisons of error 
estimation methodologies were conducted on only a single experiment. In order to gain more 
support for the conclusions from this study, the bottom-up and top-down error estimation 
methodologies could be applied to other datasets. This would enable a better assessment of 
the importance of determining the error in estimation of the amplification efficiency of a RT-
qPCR assay. These other datasets may be preexisting data from other experiments, but to 
compare the experimental designs, a replication of this study for another region of interest 
should be conducted. Additionally, the statistical analysis applied in this study used 
frequentist methodologies. Other procedures, such as Bayesian statistical methods, could be 
explored for error estimation.  
An alternative to examining more datasets would be to conduct a simulation study of the 
proposed designs. A simulation study for comparing the experimental designs and analysis 
methods would be focused on the comparing the bias of the quantities of interest (e.g., 
relative quantity index and fold change) between the competing designs, and within a design, 
the error estimation via the top-down and bottom-up methodologies would focus on the 
frequency, relative to the nominal confidence level, with which the computed confidence 
intervals (CI) includes the quantity of interest since both these analysis methodologies 
produce the same point estimate, but different error estimates. The data simulated for the two 
designs would necessarily be different due to structural differences of each design. However, 
they would both be generated from the same linear model presented in Chapter 4: Cq = mx + 
b + ε. To generate Cq values to be analyzed by the methodologies described in Chapter 4, the 
parameters m and b are fixed as constants, x is a given constant for different dilution levels of 
the samples, and ε is simulate as ε ~N(0,σ2) where ~ denotes “is distributed as” and N denotes 
the Gaussian distribution with parameters mean (0) and variance (σ2). The simulated Cq 
values are then analyzed to estimate the m and b, and an estimate of the quantity of interest, 
such as the relative quantity index (b/m), and its associated standard error are computed. The 
true m and b are known in the simulation, thus the bias of the estimate may be computed, and 
a CI (e.g., 95% CI) based on the error estimate from the top-down or bottom-up methods 
may be computed and checked to see if the true value is included within the computed CI. 
The simulation is then repeated several thousands of times recording the bias and if the CI 
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includes the true value. Summaries of the bias and coverage rates for CIs of interest are then 
compared for various levels of σ2. 
The simulation described above may be modified in several ways to better replicate data 
from real experiments conducted in the lab and to investigate the robustness and/or stability 
of the estimate and CI performance when all the model assumptions are not correct. First, 
some additional random noise may be added to some of the simulated Cq values at a low 
probability (e.g., 0.01) by increasing the variance of ε to, for example, 1.5σ2 for this 
particular Cq. This would introduce Cq values at random that vary more than the assumed 
model, but not so much so that they would be excluded from an analysis due to being 
outliers. Another modification to the simulation is to consider that the model used to simulate 
the data is a mixed linear model instead of simple linear model. The parameters m and b 
could be generated as random variables where m~N(m*, 2mσ ) and b~N(b*,
2
bσ ) where m* and 
b* are fixed constants. This would enable the modeling of the experimental system where the 
individual reactions that produce the Cq values are from samples that have been serial 
diluted. The variation in m would reflect the variation in amplification efficiencies that may 
be due to different starting concentrations and the variation in b would reflect the variation 
that may be due to errors when constructing the diluted samples. Using the simple linear 
model to fit the simulated data, several thousand simulations are conducted and summarized 
for various combinations of σ2, 2mσ , and 
2
bσ . These simulations would enable a better 
understanding of how the different elements that affect an RT-qPCR assay and insight on 
how to design an experiment to account for these elements.  
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High vs Low Adherent Variants 
Introduction 
An analysis of microarray data aimed to detect transcriptional variation between high and 
low adherence variants of Mycoplasma hyopneumoniae was conducted. Variants of M. 
hyopneumoniae strain 232 have been previously identified based on their adherence (T. 
Young, Q. Zhang, B. Z. Erickson, and R. F. Ross, Abstr. 10th Cong., Int. Org. 
Mycoplasmol., abstr. P260, 1994). A previous microarray study compared each variant 
(isolate) against the 232 parent (data not shown). The mycoplasma strains, growth 
conditions, and RNA isolation methods used in this study are identical to those methods 
described previously (5, 6). The additional study described here compared the two adherence 
variants directly. The original study which compared the variants against the 232 parent did 
not reveal significant differences in gene transcription. Also, the arrays used were not 
optimal; they did not contain probes for all ORFs. The data reported here may be combined 
with the initial data for publication. Details of the microarray data analysis are below. 
Microarray: 
The microarray consists of PCR probes designed and generated by Madsen (5) and the 
intergenic PCR probes described Chapter 3 of this dissertation. Briefly, the array consists of 
994 PCR products (probes). Ninety-eight percent (683/698) of the total open reading frames 
(ORFs) of strain 232 (9) are represented on the array as PCR products of 70-516 base pairs in 
length. Two probes are present for 78 of the ORFs and three probes for eight of the ORFs. In 
addition to the ORF probes, five structural ribosomal RNA probes, two of which have 
multiple probes, and 159 IG probes for 112 of 215 IG regions greater than 124 bp were 
included, but no tRNA sequence probes are present. The primer design and validation have 
been described (5, 6) and in Chapter 3. The PCR product microarrays were spotted to 
Corning UltraGAPS™ glass substrates (Corning, Inc., Big Flats, N.Y.) by the University of 
Iowa DNA facility (Coralville, IA). Each slide was divided into two regions (upper and 
lower), and each region contained the full array of spots, printed in triplicate in a 
noncontiguous well-spaced format. This design allowed two independent hybridizations to be 
done simultaneously.  
Microarray data accession number: 
The microarray descriptions and the microarray data can be accessed through the Gene 
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession number TDB. 
Experimental Design: 
Thirteen independent RNA samples from variant 91-3 cells (high adherent) were paired 
with thirteen independent RNA samples from variant 60-3 cells (low adherent) for 
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hybridization on thirteen two-color microarrays on a total of six and a half slides. Variant 91-
3 was labeled with Cy3 dye and variant 60-3 was labeled with Cy5 dye for hybridization on 
six of the arrays. The other seven arrays were hybridized with a dye swap for the variants. 
The target generation and hybridization are the same as described (5, 6). 
Image acquisition and normalization: 
The seven slides (two arrays per slide) were scanned three times with each dye channel 
using a ScanArray Express laser scanner (Applied BioSystems, Inc., Foster City, Calif.) 
under varying laser power and PMT gain settings to increase the dynamic range of 
measurement (3). Images were analyzed for spots using the contour option and the signal 
intensities quantified using the softWorRx Tracker software package (Applied Precision, 
Inc.). Spot-specific mean signals were corrected for local background by subtracting spot-
specific median background intensities. All resultant negative values were converted to 0 and 
1 was added to every background-corrected signal followed by a natural logarithm 
transformation. The median of these adjusted-log-background-corrected signals across 
multiple scans was then computed for each spot to obtain one value for each combination of 
spot, array, and dye channel. These data for the two dye channels on any given array were 
normalized using LOWESS normalization to adjust for intensity-dependent dye bias (4, 17). 
Following LOWESS adjustment, the data from each channel were adjusted by an additive 
constant so that the median for all array and dye combinations would be the same. The 
difference (Cy3 minus Cy5) of the normalized-median adjusted signal for each experimental 
unit and spot combination was computed and averaged across triplicate spots to produce one 
normalized signal intensity difference value for each probe on an array. 
Data analysis: 
A linear model of the difference in signal intensity for the two dyes was fitted for each 
probe sequence using the normalized data. The model included an overall mean for the 
difference in dye effect (Cy3 minus Cy5) and a fixed effect for the difference in signal 
intensity of high minus low adherent. The model was fit using the proc glm function in SAS 
(SAS Institute, Inc., Cary, NC). As part of each linear model analysis, a two-sided t-test for 
the difference in signal intensity being different from zero was conducted for each probe. The 
p-values for all the probes were then analyzed to obtained an estimate of the false discovery 
rates (q-values) using the method proposed by Benjamini and Hochberg (1). 
Results: 
A vast majority of the probes did not detect a difference in signal intensity between the 
high and low adherent variants. Only nine probes had an estimated q-value less than 0.2. The 
table below contains statistics on these nine probes. 
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Table A.1. Most significant differentially expressed genes in high vs low adherent variants.  
ID 
Gene 
Name Estimate StdErr t-Value p-value q-value 
Fold 
Change 
log2 
(FC)* 
mhp271 CH 0.44 0.05 8.11 <0.0001 0.0048 1.56 0.64 
mhp478 CH 0.28 0.04 6.12 0.0001 0.0315 1.32 0.40 
mhp447 CH 0.46 0.08 5.60 0.0002 0.0444 1.58 0.66 
mhp477 atpA 0.20 0.04 5.29 0.0003 0.0531 1.23 0.29 
mhp021.1 CH -0.30 0.06 -4.58 0.0008 0.1312 0.74 -0.43 
mhp481 CH 0.31 0.07 4.33 0.0012 0.1667 1.36 0.44 
mhp021.2 CH -0.16 0.04 -4.07 0.0019 0.1859 0.85 -0.23 
mhp140 H -0.11 0.03 -4.07 0.0018 0.1859 0.90 -0.16 
mhp677.2 p65 -0.35 0.09 -4.02 0.0020 0.1859 0.71 -0.50 
*FC = Fold Change 
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R and SAS script 
R script for normalization and q-value calculation: 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# Load functions needed for analysis 
setwd("…") 
source("compress.R") 
source("log.0.R") 
source("msn.R") 
source("slide.comp.R") 
source("q.value.R") 
source("normalize.R") 
source("cum.mean.R") 
########################################### 
# Read in spot finding data 
setwd("…") 
a3_1dn<-read.csv("Adh3-1dn.anno.csv",head=T) 
a3_1up<-read.csv("Adh3-1up.anno.csv",head=T) 
a3_2dn<-read.csv("Adh3-2dn.anno.csv",head=T) 
a3_2up<-read.csv("Adh3-2up.anno.csv",head=T) 
a3_3dn<-read.csv("Adh3-3dn.anno.csv",head=T) 
a3_3up<-read.csv("Adh3-3up.anno.csv",head=T) 
a3_4dn<-read.csv("Adh3-4dn.anno.csv",head=T) 
a3_4up<-read.csv("Adh3-4up.anno.csv",head=T) 
a6_3dn<-read.csv("Adh6-3dn.anno.csv",head=T) 
a6_3up<-read.csv("Adh6-3up.anno.csv",head=T) 
a6_4dn<-read.csv("Adh6-4dn.anno.csv",head=T) 
a6_4up<-read.csv("Adh6-4up.anno.csv",head=T) 
a6_5dn<-read.csv("Adh6-5dn.anno.csv",head=T) 
# Slide 3 has 24 col, 3 scans (cy3->cy5), means 13-18, bkgd 19-24 
# Slide 6 has 28 col, 3 scans (cy3->cy5), means 14-19, bkgd 20-25 
########################################### 
# Background correction  
means=cbind(a3_1dn[,13:18],a3_1up[,13:18],a3_2dn[,13:18],a3_2up[,13:18],a3_3dn[,13:18], 
 a3_3up[,13:18],a3_4dn[,13:18],a3_4up[,13:18], 
 a6_3dn[,14:19],a6_3up[,14:19],a6_4dn[,14:19],a6_4up[,14:19],a6_5dn[,14:19])   
md.back=cbind(a3_1dn[,19:24],a3_1up[,19:24],a3_2dn[,19:24],a3_2up[,19:24],a3_3dn[,19:24], 
 a3_3up[,19:24],a3_4dn[,19:24],a3_4up[,19:24], 
 a6_3dn[,20:25],a6_3up[,20:25],a6_4dn[,20:25],a6_4up[,20:25],a6_5dn[,20:25]) 
log.bc.means=log.0(means-md.back) 
########################################### 
# Check raw data and compress 3 scans to one  
cols=c(3,3) 
#### Adh3-1dn 
a1=log.bc.means[,1:6] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a1),main="Adh3-1dn") 
slide.comp(cbind(a1[,1],a1[,4]),1) 
slide.comp(cbind(a1[,2],a1[,5]),1) 
slide.comp(cbind(a1[,3],a1[,6]),1) 
a1d=compress(a1,cols) 
#### Adh3-1up 
a2=log.bc.means[,7:12] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a2),main="Adh3-1up") 
slide.comp(cbind(a2[,1],a2[,4]),1) 
slide.comp(cbind(a2[,2],a2[,5]),1) 
slide.comp(cbind(a2[,3],a2[,6]),1) 
a2d=compress(a2,cols) 
#### Adh3-2dn 
a3=log.bc.means[,13:18] 
# Look at raw bc scans 
x11() 
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par(mfrow=c(2,2)) 
boxplot(as.data.frame(a3),main="Adh3-2dn") 
slide.comp(cbind(a3[,1],a3[,4]),1) 
slide.comp(cbind(a3[,2],a3[,5]),1) 
slide.comp(cbind(a3[,3],a3[,6]),1) 
a3d=compress(a3,cols) 
#### Adh3-2up 
a4=log.bc.means[,19:24] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a4),main="Adh3-2up") 
slide.comp(cbind(a4[,1],a4[,4]),1) 
slide.comp(cbind(a4[,2],a4[,5]),1) 
slide.comp(cbind(a4[,3],a4[,6]),1) 
a4d=compress(a4,cols) 
#### Adh3-3dn 
a5=log.bc.means[,25:30] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a5),main="Adh3-3dn") 
slide.comp(cbind(a5[,1],a5[,4]),1) 
slide.comp(cbind(a5[,2],a5[,5]),1) 
slide.comp(cbind(a5[,3],a5[,6]),1) 
a5d=compress(a5,cols) 
#### Adh3-3up 
a6=log.bc.means[,31:36] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a6),main="Adh3-3up") 
slide.comp(cbind(a6[,1],a6[,4]),1) 
slide.comp(cbind(a6[,2],a6[,5]),1) 
slide.comp(cbind(a6[,3],a6[,6]),1) 
a6d=compress(a6,cols) 
#### Adh3-4dn 
a7=log.bc.means[,37:42] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a7),main="Adh3-4dn") 
slide.comp(cbind(a7[,1],a7[,4]),1) 
slide.comp(cbind(a7[,2],a7[,5]),1) 
slide.comp(cbind(a7[,3],a7[,6]),1) 
a7d=compress(a7,cols) 
#### Adh3-4up 
a8=log.bc.means[,43:48] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a8),main="Adh3-4up") 
slide.comp(cbind(a8[,1],a8[,4]),1) 
slide.comp(cbind(a8[,2],a8[,5]),1) 
slide.comp(cbind(a8[,3],a8[,6]),1) 
a8d=compress(a8,cols) 
#### Adh6-3dn 
a9=log.bc.means[,49:54] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a9),main="Adh6-3dn") 
slide.comp(cbind(a9[,1],a9[,4]),1) 
slide.comp(cbind(a9[,2],a9[,5]),1) 
slide.comp(cbind(a9[,3],a9[,6]),1) 
a9d=compress(a9,cols) 
#### Adh6-3up 
a10=log.bc.means[,55:60] 
# Look at raw bc scans 
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x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a10),main="Adh6-3up") 
slide.comp(cbind(a10[,1],a10[,4]),1) 
slide.comp(cbind(a10[,2],a10[,5]),1) 
slide.comp(cbind(a10[,3],a10[,6]),1) 
a10d=compress(a10,cols) 
#### Adh6-4dn 
a11=log.bc.means[,61:66] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a11),main="Adh6-4dn") 
slide.comp(cbind(a11[,1],a11[,4]),1) 
slide.comp(cbind(a11[,2],a11[,5]),1) 
slide.comp(cbind(a11[,3],a11[,6]),1) 
a11d=compress(a11,cols) 
#### Adh6-4up 
a12=log.bc.means[,67:72] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a12),main="Adh6-4up") 
slide.comp(cbind(a12[,1],a12[,4]),1) 
slide.comp(cbind(a12[,2],a12[,5]),1) 
slide.comp(cbind(a12[,3],a12[,6]),1) 
a12d=compress(a12,cols) 
#### Adh6-5dn 
a13=log.bc.means[,73:78] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a13),main="Adh6-5dn") 
slide.comp(cbind(a13[,1],a13[,4]),1) 
slide.comp(cbind(a13[,2],a13[,5]),1) 
slide.comp(cbind(a13[,3],a13[,6]),1) 
a13d=compress(a13,cols) 
########################################### 
# Normalize data and write out for SAS analysis 
d=cbind(a1d,a2d,a3d,a4d,a5d,a6d,a7d,a8d,a9d,a10d,a11d,a12d,a13d) 
norm.d=msn(exp(d),bkgrd=NULL,sector=NULL,scale=F,center=0,frac=.4) 
x11() 
boxplot(as.data.frame(d)) 
x11() 
boxplot(as.data.frame(norm.d)) 
# Write out normalized data for checking with plot.gene 
setwd("…") 
write.csv(norm.d,"norm.d.csv",row.names=F) 
########################################### 
# Check normalized data 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a1d),main="Adh3-1dn") 
slide.comp(cbind(a1d[,1],a1d[,2]),1) 
boxplot(as.data.frame(norm.d[,1:2]),main="Adh3-1dn") 
slide.comp(cbind(norm.d[,1],norm.d[,2]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a2d),main="Adh3-1up") 
slide.comp(cbind(a2d[,1],a2d[,2]),1) 
boxplot(as.data.frame(norm.d[,3:4]),main="Adh3-1up") 
slide.comp(cbind(norm.d[,3],norm.d[,4]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a3d),main="Adh3-2dn") 
slide.comp(cbind(a3d[,1],a3d[,2]),1) 
boxplot(as.data.frame(norm.d[,5:6]),main="Adh3-2dn") 
slide.comp(cbind(norm.d[,5],norm.d[,6]),1) 
x11() 
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par(mfrow=c(2,2)) 
boxplot(as.data.frame(a4d),main="Adh3-2up") 
slide.comp(cbind(a4d[,1],a4d[,2]),1) 
boxplot(as.data.frame(norm.d[,7:8]),main="Adh3-2up") 
slide.comp(cbind(norm.d[,7],norm.d[,8]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a5d),main="Adh3-3dn") 
slide.comp(cbind(a5d[,1],a5d[,2]),1) 
boxplot(as.data.frame(norm.d[,9:10]),main="Adh3-3dn") 
slide.comp(cbind(norm.d[,9],norm.d[,10]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a6d),main="Adh3-3up") 
slide.comp(cbind(a6d[,1],a6d[,2]),1) 
boxplot(as.data.frame(norm.d[,11:12]),main="Adh3-3up") 
slide.comp(cbind(norm.d[,11],norm.d[,12]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a7d),main="Adh3-4dn") 
slide.comp(cbind(a7d[,1],a7d[,2]),1) 
boxplot(as.data.frame(norm.d[,13:14]),main="Adh3-4dn") 
slide.comp(cbind(norm.d[,13],norm.d[,14]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a8d),main="Adh3-4up") 
slide.comp(cbind(a8d[,1],a8d[,2]),1) 
boxplot(as.data.frame(norm.d[,15:16]),main="Adh3-4up") 
slide.comp(cbind(norm.d[,15],norm.d[,16]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a9d),main="Adh6-3dn") 
slide.comp(cbind(a9d[,1],a9d[,2]),1) 
boxplot(as.data.frame(norm.d[,17:18]),main="Adh6-3dn") 
slide.comp(cbind(norm.d[,17],norm.d[,18]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a10d),main="Adh6-3up") 
slide.comp(cbind(a10d[,1],a10d[,2]),1) 
boxplot(as.data.frame(norm.d[,19:20]),main="Adh6-3up") 
slide.comp(cbind(norm.d[,19],norm.d[,20]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a11d),main="Adh6-4dn") 
slide.comp(cbind(a11d[,1],a11d[,2]),1) 
boxplot(as.data.frame(norm.d[,21:22]),main="Adh6-4dn") 
slide.comp(cbind(norm.d[,21],norm.d[,22]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a12d),main="Adh6-4up") 
slide.comp(cbind(a12d[,1],a12d[,2]),1) 
boxplot(as.data.frame(norm.d[,23:24]),main="Adh6-4up") 
slide.comp(cbind(norm.d[,23],norm.d[,24]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a13d),main="Adh6-5dn") 
slide.comp(cbind(a13d[,1],a13d[,2]),1) 
boxplot(as.data.frame(norm.d[,25:26]),main="Adh6-5dn") 
slide.comp(cbind(norm.d[,25],norm.d[,26]),1) 
############################################################## 
# Calculate Cy3 - Cy5 for SAS analysis and Attach annotation 
Adh3_1dn<-as.data.frame(cbind(Flag=as.character(a3_1dn$Flag),ID=as.character(a3_1dn$ID))) 
Adh3_1dn<-cbind(Adh3_1dn,Diff=norm.d[,1]-norm.d[,2]) 
Adh3_1up<-as.data.frame(cbind(Flag=as.character(a3_1up$Flag),ID=as.character(a3_1up$ID))) 
Adh3_1up<-cbind(Adh3_1up,Diff=norm.d[,3]-norm.d[,4]) 
Adh3_2dn<-as.data.frame(cbind(Flag=as.character(a3_2dn$Flag),ID=as.character(a3_2dn$ID))) 
Adh3_2dn<-cbind(Adh3_2dn,Diff=norm.d[,5]-norm.d[,6]) 
Adh3_2up<-as.data.frame(cbind(Flag=as.character(a3_2up$Flag),ID=as.character(a3_2up$ID))) 
Adh3_2up<-cbind(Adh3_2up,Diff=norm.d[,7]-norm.d[,8]) 
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Adh3_3dn<-as.data.frame(cbind(Flag=as.character(a3_3dn$Flag),ID=as.character(a3_3dn$ID))) 
Adh3_3dn<-cbind(Adh3_3dn,Diff=norm.d[,9]-norm.d[,10]) 
Adh3_3up<-as.data.frame(cbind(Flag=as.character(a3_3up$Flag),ID=as.character(a3_3up$ID))) 
Adh3_3up<-cbind(Adh3_3up,Diff=norm.d[,11]-norm.d[,12]) 
Adh3_4dn<-as.data.frame(cbind(Flag=as.character(a3_4dn$Flag),ID=as.character(a3_4dn$ID))) 
Adh3_4dn<-cbind(Adh3_4dn,Diff=norm.d[,13]-norm.d[,14]) 
Adh3_4up<-as.data.frame(cbind(Flag=as.character(a3_4up$Flag),ID=as.character(a3_4up$ID))) 
Adh3_4up<-cbind(Adh3_4up,Diff=norm.d[,15]-norm.d[,16]) 
Adh6_3dn<-as.data.frame(cbind(Flag=as.character(a6_3dn$Flag),ID=as.character(a6_3dn$ID))) 
Adh6_3dn<-cbind(Adh6_3dn,Diff=norm.d[,17]-norm.d[,18]) 
Adh6_3up<-as.data.frame(cbind(Flag=as.character(a6_3up$Flag),ID=as.character(a6_3up$ID))) 
Adh6_3up<-cbind(Adh6_3up,Diff=norm.d[,19]-norm.d[,20]) 
Adh6_4dn<-as.data.frame(cbind(Flag=as.character(a6_4dn$Flag),ID=as.character(a6_4dn$ID))) 
Adh6_4dn<-cbind(Adh6_4dn,Diff=norm.d[,21]-norm.d[,22]) 
Adh6_4up<-as.data.frame(cbind(Flag=as.character(a6_4up$Flag),ID=as.character(a6_4up$ID))) 
Adh6_4up<-cbind(Adh6_4up,Diff=norm.d[,23]-norm.d[,24]) 
Adh6_5dn<-as.data.frame(cbind(Flag=as.character(a6_5dn$Flag),ID=as.character(a6_5dn$ID))) 
Adh6_5dn<-cbind(Adh6_5dn,Diff=norm.d[,25]-norm.d[,26]) 
# Change Abnormal points Diff to blanks==> SAS reads as NA 
#Adh3_2dn, Adh3_3dn, Adh3_4dn, Adh3_4up, Adh6_3dn, Adh6_3up, Adh6_4dn, Adh6_4up, Adh6_5dn 
Adh3_2dn$Diff[which(Adh3_2dn$Flag=="ABNORMAL")]<-"" 
Adh3_3dn$Diff[which(Adh3_3dn$Flag=="ABNORMAL")]<-"" 
Adh3_4dn$Diff[which(Adh3_4dn$Flag=="ABNORMAL")]<-"" 
Adh3_4up$Diff[which(Adh3_4up$Flag=="ABNORMAL")]<-"" 
Adh6_3dn$Diff[which(Adh6_3dn$Flag=="ABNORMAL")]<-"" 
Adh6_3up$Diff[which(Adh6_3up$Flag=="ABNORMAL")]<-"" 
Adh6_4dn$Diff[which(Adh6_4dn$Flag=="ABNORMAL")]<-"" 
Adh6_4up$Diff[which(Adh6_4up$Flag=="ABNORMAL")]<-"" 
Adh6_5dn$Diff[which(Adh6_5dn$Flag=="ABNORMAL")]<-"" 
# Need to combine (the order of genes are the same)  
out<-as.data.frame(cbind(x1=Adh3_1dn$Diff,x2=Adh3_1up$Diff,x3=Adh3_2dn$Diff,x4=Adh3_2up$Diff, 
  x5=Adh3_3dn$Diff,x6=Adh3_3up$Diff,x7=Adh3_4dn$Diff,x8=Adh3_4up$Diff, 
  x9=Adh6_3dn$Diff,x10=Adh6_3up$Diff,x11=Adh6_4dn$Diff,x12=Adh6_4up$Diff, 
  x13=Adh6_5dn$Diff)) 
out<-cbind(ID=Adh3_1dn$ID,out) 
str(out) 
# Cheat for SAS labels 
levels(out$ID)[995]<-"SpotbuffSpotbuff" 
setwd("C…") 
write.table(out,file="norm_Cy3minusCy5.txt",sep="\t",row.names=F) 
################################################################### 
# SAS code 
################################################################### 
# q-value estimation 
setwd("…") 
estimates=read.delim("estimates.txt") 
hist(estimates$p,breaks=20) 
qvals=q.value(estimates$p) 
sort(qvals)[1:100] 
write.table(data.frame(estimates,qvalue=qvals),file="results.txt",row.names=F,sep="\t") 
 
R script for plot.gene function data quality check: 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# Load functions needed for analysis 
setwd("…") 
source("plot.gene.R") 
########################################### 
# Read in spotfinding data 
setwd("…") 
a3_1dn<-read.csv("Adh3-1dn.anno.csv",head=T) 
a3_1up<-read.csv("Adh3-1up.anno.csv",head=T) 
a3_2dn<-read.csv("Adh3-2dn.anno.csv",head=T) 
a3_2up<-read.csv("Adh3-2up.anno.csv",head=T) 
a3_3dn<-read.csv("Adh3-3dn.anno.csv",head=T) 
a3_3up<-read.csv("Adh3-3up.anno.csv",head=T) 
a3_4dn<-read.csv("Adh3-4dn.anno.csv",head=T) 
a3_4up<-read.csv("Adh3-4up.anno.csv",head=T) 
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a6_3dn<-read.csv("Adh6-3dn.anno.csv",head=T) 
a6_3up<-read.csv("Adh6-3up.anno.csv",head=T) 
a6_4dn<-read.csv("Adh6-4dn.anno.csv",head=T) 
a6_4up<-read.csv("Adh6-4up.anno.csv",head=T) 
a6_5dn<-read.csv("Adh6-5dn.anno.csv",head=T) 
# Slide 3 has 24 col, 3 scans (cy3->cy5), means 13-18, bkgd 19-24 
# Slide 6 has 28 col, 3 scans (cy3->cy5), means 14-19, bkgd 20-25 
# Read in normalized data 
setwd("…") 
norm.d<-read.csv("norm.d.csv") 
########################################### 
Adh3_1dn<-as.data.frame(cbind(Flag=as.character(a3_1dn$Flag),ID=as.character(a3_1dn$ID))) 
Adh3_1dn<-cbind(Adh3_1dn,cy3=norm.d[,1],cy5=norm.d[,2]) 
Adh3_1up<-as.data.frame(cbind(Flag=as.character(a3_1up$Flag),ID=as.character(a3_1up$ID))) 
Adh3_1up<-cbind(Adh3_1up,cy3=norm.d[,3],cy5=norm.d[,4]) 
Adh3_2dn<-as.data.frame(cbind(Flag=as.character(a3_2dn$Flag),ID=as.character(a3_2dn$ID))) 
Adh3_2dn<-cbind(Adh3_2dn,cy3=norm.d[,5],cy5=norm.d[,6]) 
Adh3_2up<-as.data.frame(cbind(Flag=as.character(a3_2up$Flag),ID=as.character(a3_2up$ID))) 
Adh3_2up<-cbind(Adh3_2up,cy3=norm.d[,7],cy5=norm.d[,8]) 
Adh3_3dn<-as.data.frame(cbind(Flag=as.character(a3_3dn$Flag),ID=as.character(a3_3dn$ID))) 
Adh3_3dn<-cbind(Adh3_3dn,cy3=norm.d[,9],cy5=norm.d[,10]) 
Adh3_3up<-as.data.frame(cbind(Flag=as.character(a3_3up$Flag),ID=as.character(a3_3up$ID))) 
Adh3_3up<-cbind(Adh3_3up,cy3=norm.d[,11],cy5=norm.d[,12]) 
Adh3_4dn<-as.data.frame(cbind(Flag=as.character(a3_4dn$Flag),ID=as.character(a3_4dn$ID))) 
Adh3_4dn<-cbind(Adh3_4dn,cy3=norm.d[,13],cy5=norm.d[,14]) 
Adh3_4up<-as.data.frame(cbind(Flag=as.character(a3_4up$Flag),ID=as.character(a3_4up$ID))) 
Adh3_4up<-cbind(Adh3_4up,cy3=norm.d[,15],cy5=norm.d[,16]) 
Adh6_3dn<-as.data.frame(cbind(Flag=as.character(a6_3dn$Flag),ID=as.character(a6_3dn$ID))) 
Adh6_3dn<-cbind(Adh6_3dn,cy3=norm.d[,17],cy5=norm.d[,18]) 
Adh6_3up<-as.data.frame(cbind(Flag=as.character(a6_3up$Flag),ID=as.character(a6_3up$ID))) 
Adh6_3up<-cbind(Adh6_3up,cy3=norm.d[,19],cy5=norm.d[,20]) 
Adh6_4dn<-as.data.frame(cbind(Flag=as.character(a6_4dn$Flag),ID=as.character(a6_4dn$ID))) 
Adh6_4dn<-cbind(Adh6_4dn,cy3=norm.d[,21],cy5=norm.d[,22]) 
Adh6_4up<-as.data.frame(cbind(Flag=as.character(a6_4up$Flag),ID=as.character(a6_4up$ID))) 
Adh6_4up<-cbind(Adh6_4up,cy3=norm.d[,23],cy5=norm.d[,24]) 
Adh6_5dn<-as.data.frame(cbind(Flag=as.character(a6_5dn$Flag),ID=as.character(a6_5dn$ID))) 
Adh6_5dn<-cbind(Adh6_5dn,cy3=norm.d[,25],cy5=norm.d[,26]) 
########################################### 
# Change Abnormal points Diff to blanks==> SAS reads as NA 
#Adh3_2dn, Adh3_3dn, Adh3_4dn, Adh3_4up, Adh6_3dn, Adh6_3up, Adh6_4dn, Adh6_4up, Adh6_5dn 
Adh3_2dn$cy3[which(Adh3_2dn$Flag=="ABNORMAL")]<-"NA" 
Adh3_3dn$cy3[which(Adh3_3dn$Flag=="ABNORMAL")]<-"NA" 
Adh3_4dn$cy3[which(Adh3_4dn$Flag=="ABNORMAL")]<-"NA" 
Adh3_4up$cy3[which(Adh3_4up$Flag=="ABNORMAL")]<-"NA" 
Adh6_3dn$cy3[which(Adh6_3dn$Flag=="ABNORMAL")]<-"NA" 
Adh6_3up$cy3[which(Adh6_3up$Flag=="ABNORMAL")]<-"NA" 
Adh6_4dn$cy3[which(Adh6_4dn$Flag=="ABNORMAL")]<-"NA" 
Adh6_4up$cy3[which(Adh6_4up$Flag=="ABNORMAL")]<-"NA" 
Adh6_5dn$cy3[which(Adh6_5dn$Flag=="ABNORMAL")]<-"NA" 
Adh3_2dn$cy5[which(Adh3_2dn$Flag=="ABNORMAL")]<-"NA" 
Adh3_3dn$cy5[which(Adh3_3dn$Flag=="ABNORMAL")]<-"NA" 
Adh3_4dn$cy5[which(Adh3_4dn$Flag=="ABNORMAL")]<-"NA" 
Adh3_4up$cy5[which(Adh3_4up$Flag=="ABNORMAL")]<-"NA" 
Adh6_3dn$cy5[which(Adh6_3dn$Flag=="ABNORMAL")]<-"NA" 
Adh6_3up$cy5[which(Adh6_3up$Flag=="ABNORMAL")]<-"NA" 
Adh6_4dn$cy5[which(Adh6_4dn$Flag=="ABNORMAL")]<-"NA" 
Adh6_4up$cy5[which(Adh6_4up$Flag=="ABNORMAL")]<-"NA" 
Adh6_5dn$cy5[which(Adh6_5dn$Flag=="ABNORMAL")]<-"NA" 
########################################### 
# Need to combine (the order of genes are the same)  
out2<-as.data.frame(cbind(cy3_31d=Adh3_1dn$cy3,cy5_31d=Adh3_1dn$cy5, 
cy3_31u=Adh3_1up$cy3,cy5_31u=Adh3_1up$cy5, 
cy3_32d=Adh3_2dn$cy3,cy5_32d=Adh3_2dn$cy5,cy3_32u=Adh3_2up$cy3,cy5_32u=Adh3_2up$cy5, 
cy3_33d=Adh3_3dn$cy3,cy5_33d=Adh3_3dn$cy5,cy3_33u=Adh3_3up$cy3,cy5_33u=Adh3_3up$cy5, 
cy3_34d=Adh3_4dn$cy3,cy5_34d=Adh3_4dn$cy5,cy3_34u=Adh3_4up$cy3,cy5_34u=Adh3_4up$cy5, 
cy3_63d=Adh6_3dn$cy3,cy5_63d=Adh6_3dn$cy5,cy3_63u=Adh6_3up$cy3,cy5_63u=Adh6_3up$cy5, 
cy3_64d=Adh6_4dn$cy3,cy5_64d=Adh6_4dn$cy5,cy3_64u=Adh6_4up$cy3,cy5_64u=Adh6_4up$cy5, 
cy3_65d=Adh6_5dn$cy3,cy5_65d=Adh6_5dn$cy5)) 
out2<-cbind(ID=Adh3_1dn$ID,out2) 
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str(out2) 
chn<-as.data.frame(cbind(tapply(as.numeric(as.character(out2$cy3_31d)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy3_31u)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy3_32d)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy3_32u)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy3_33d)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy3_33u)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy3_34d)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy3_34u)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy3_63d)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy3_63u)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy3_64d)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy3_64u)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy3_65d)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy5_31d)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy5_31u)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy5_32d)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy5_32u)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy5_33d)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy5_33u)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy5_34d)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy5_34u)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy5_63d)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy5_63u)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy5_64d)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy5_64u)),out2$ID,mean,na.rm=T), 
    tapply(as.numeric(as.character(out2$cy5_65d)),out2$ID,mean,na.rm=T))) 
str(chn) 
head(chn) 
grp1<-cbind(chn[,1],chn[,14],chn[,3],chn[,16],chn[,5],chn[,18],chn[,8],chn[,21], 
chn[,10],chn[,23],chn[,12],chn[,25],chn[,3],chn[,16]) 
grp2<-cbind(chn[,2],chn[,15],chn[,4],chn[,17],chn[,6],chn[,19],chn[,7],chn[,20], 
chn[,9],chn[,22],chn[,11],chn[,24],chn[,13],chn[,26]) 
par(mfrow=c(2,2)) 
plot.gene(cbind(row.names(chn),grp1,grp2),"mhp447") 
plot.gene(cbind(row.names(chn),chn[,1],chn[,14],chn[,2],chn[,15]),"mhp447") 
plot.gene(cbind(row.names(chn),grp1,grp2),"mhp271") 
plot.gene(cbind(row.names(chn),chn[,1],chn[,14],chn[,2],chn[,15]),"mhp271") 
x11() 
par(mfrow=c(2,2)) 
plot.gene(cbind(row.names(chn),grp1,grp2),"mhp478") 
plot.gene(cbind(row.names(chn),chn[,1],chn[,14],chn[,2],chn[,15]),"mhp478") 
plot.gene(cbind(row.names(chn),grp1,grp2),"mhp477") 
plot.gene(cbind(row.names(chn),chn[,1],chn[,14],chn[,2],chn[,15]),"mhp477") 
x11() 
par(mfrow=c(2,2)) 
plot.gene(cbind(row.names(chn),grp1,grp2),"mhp021.1") 
plot.gene(cbind(row.names(chn),chn[,1],chn[,14],chn[,2],chn[,15]),"mhp021.1") 
plot.gene(cbind(row.names(chn),grp1,grp2),"mhp481") 
plot.gene(cbind(row.names(chn),chn[,1],chn[,14],chn[,2],chn[,15]),"mhp481") 
x11() 
par(mfrow=c(2,2)) 
plot.gene(cbind(row.names(chn),grp1,grp2),"mhp097") 
plot.gene(cbind(row.names(chn),chn[,1],chn[,14],chn[,2],chn[,15]),"mhp097") 
plot.gene(cbind(row.names(chn),grp1,grp2),"mhp080") 
plot.gene(cbind(row.names(chn),chn[,1],chn[,14],chn[,2],chn[,15]),"mhp080") 
x11() 
par(mfrow=c(2,2)) 
plot.gene(cbind(row.names(chn),grp1,grp2),"mhp418") 
plot.gene(cbind(row.names(chn),chn[,1],chn[,14],chn[,2],chn[,15]),"mhp418") 
plot.gene(cbind(row.names(chn),grp1,grp2),"mhp494") 
plot.gene(cbind(row.names(chn),chn[,1],chn[,14],chn[,2],chn[,15]),"mhp494") 
x11() 
par(mfrow=c(2,2)) 
plot.gene(cbind(row.names(chn),grp1,grp2),"ig-494.1") 
plot.gene(cbind(row.names(chn),chn[,1],chn[,14],chn[,2],chn[,15]),"ig-494.1") 
plot.gene(cbind(row.names(chn),grp1,grp2),"mhp057") 
plot.gene(cbind(row.names(chn),chn[,1],chn[,14],chn[,2],chn[,15]),"mhp057") 
x11() 
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par(mfrow=c(2,2)) 
plot.gene(cbind(row.names(chn),grp1,grp2),"mhp266.s1") 
plot.gene(cbind(row.names(chn),chn[,1],chn[,14],chn[,2],chn[,15]),"mhp266.s1") 
plot.gene(cbind(row.names(chn),grp1,grp2),"mhp312") 
plot.gene(cbind(row.names(chn),chn[,1],chn[,14],chn[,2],chn[,15]),"mhp312") 
SAS script for fitting proc glm: 
DM 'LOG;CLEAR;OUTPUT;CLEAR;'; 
OPTIONS NODATE NONUMBER FORMDLIM= '_' LS=85 ; TITLE ; ; 
/* Import normalized differences. Note this is all 13 arrays */ 
proc import datafile='…\norm_Cy3minusCy5.txt' 
 out=adh dbms=tab replace; run; 
proc print data=adh (obs=8); run; 
proc sort data=adh; 
 by ID; run; 
proc freq data=adh; 
 table ID; run; 
proc means data=adh noprint; 
 var x1-x13; 
 by ID; 
 output out=two n=n mean=x1-x13;  run; 
proc freq data=two; 
 table n;  run; 
* Arrange data for y=XB+e; 
data long; set two; 
  y=x1;  trtdir=  1;  output; 
  y=x2;  trtdir= -1;  output; 
  y=x3;  trtdir=  1;  output; 
  y=x4;  trtdir= -1;  output; 
  y=x5;  trtdir=  1;  output; 
  y=x6;  trtdir= -1;  output; 
  y=x7;  trtdir= -1;  output; 
  y=x8;  trtdir=  1;  output; 
  y=x9;  trtdir= -1;  output; 
  y=x10; trtdir=  1;  output; 
  y=x11; trtdir= -1;  output; 
  y=x12; trtdir=  1;  output; 
  y=x13; trtdir= -1;  output; 
  drop x1-x13;  run; 
* Analyze one gene to test coding; 
data onegene; set long; 
 if id='mhp447';  run; 
proc print data=onegene; run; 
proc glm data=onegene; 
  model y = trtdir; 
  ods output ParameterEstimates=est; 
  output out=check r=residual p=predicted;  run; 
* looks good. Now do all genes using proc glm; 
ods listing close; run; 
proc glm data=long; 
  model y = trtdir; 
  by id; 
  ods output ParameterEstimates=est; 
  output out=check r=residual p=predicted; run; 
ods listing;  run; 
data est; set est; 
  p=1*probt; 
  drop probt;  run; 
proc export data=est 
            outfile='…\estimates_glm.txt' 
            dbms=tab replace;  run; 
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High vs Low Passage in M. hyopneumoniae Strain 232 
Introduction 
An analysis of microarray data aimed to detect transcriptional variation between high and 
low passage number was conducted on cultures of Mycoplasma hyopneumoniae strain 232 
that differed in their number of in vitro passages. A low passage culture refers to a M. 
hyopneumoniae strain 232 culture that has been passage in vitro only four times, whereas a 
high passage culture refers to a culture that was passage in vitro for fifty-four times. The 
mycoplasma strains, growth conditions, and RNA isolation methods used in this study are 
identical to those methods described previously (5, 6). Details of the microarray data analysis 
are below. 
Microarray: 
The microarray consists of PCR probes designed and generated by Madsen (5) and 
details about the array platform can be accessed through the Gene Expression Omnibus 
(http://www.ncbi.nlm.nih.gov/geo) under accession number GPL5372. Construction and 
validation of these arrays have been previously described (5, 6). Briefly, the array consists of 
618 PCR amplified M. hyopneumoniae open reading frame (ORF) gene products 70-516 bp 
in length. The average PCR product size is 272.8 bp with a standard deviation of 70.5 bp. 
Each product is a unique sequence even within paralogous families as described by Minion et 
al. (9). Only ORFs greater than 125 base pairs are represented on the array and no tRNA or 
ribosomal RNA sequences were included. These products encompass 89% (618/698) of the 
ORFs in the genome. Each probe is spotted in triplicate using a nonadjacent, well-spaced 
format onto Corning UltraGAPS™ glass substrates (Corning, Inc., Big Flats, N.Y.). Each 
slide contains two complete arrays, one at each end, and a complete array consists of sixteen 
subarrays, with a twelve-column by twelve-row configuration. This design allowed two 
independent hybridizations simultaneously to reduce variation due to slide interactions. 
Slides were UV cross-linked at 450 mJ and pre-hybridized with sodium borohydride to 
reduce background (13). 
Microarray data accession number: 
The microarray descriptions and the microarray data can be accessed through the Gene 
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession number TBD. 
Experimental Design: 
A total of eight cultures each of the low and high passage number were grown to early 
exponential phase as described previously (5). RNA samples were collected and these 
samples were reverse transcribed to cDNA using ORF specific primers. The cDNA was 
indirectly fluorescently labeled using Cy3 and Cy5 dyes. Differentially labeled cDNA from 
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each culture was mixed in a dye swap format and hybridized to the two-color PCR-based 
microarrays described above. Details of the target generation and hybridization are the same 
as described previously (5, 6). 
Image acquisition and normalization: 
The four slides were scanned three times with each dye channel using a ScanArray 
Express laser scanner (Applied BioSystems, Inc., Foster City, Calif.) under varying laser 
power and PMT gain settings to increase the dynamic range of measurement (3). Images 
were analyzed for spots and the signal intensities quantified using the softWorRx Tracker 
software package (Applied Precision, Inc.). Spot-specific mean signals were corrected for 
local background by subtracting spot-specific median background intensities. All resultant 
negative values were converted to 0 and 1 was added to every background-corrected signal 
followed by a natural logarithm transformation. The median of these adjusted-log-
background-corrected signals across multiple scans was then computed for each spot to 
obtain one value for each combination of spot, array, and dye channel. These data for the two 
dye channels on any given array were normalized using LOWESS normalization to adjust for 
intensity-dependent dye bias (4, 17). Following LOWESS adjustment, the data from each 
channel were adjusted by an additive constant so that the median for all array and dye 
combinations would be the same. The difference (Cy3 minus Cy5) of the normalized-median 
adjusted signal for each experimental unit and spot combination was computed and averaged 
across triplicate spots to produce one normalized signal intensity difference value for each 
probe on an array.   
Data analysis: 
A linear model of the difference in signal intensity for the two dyes was fitted for each 
probe sequence using the normalized data. The model included an overall mean for the 
difference in dye effect (Cy3 minus Cy5) and a fixed effect for the difference in signal 
intensity of high minus low passage number. The model was fit using the proc glm function 
in SAS (SAS Institute, Inc., Cary, NC). As part of each linear model analysis, a two-sided t-
test for the difference in signal intensity being different from zero was conducted for each 
probe. The p-values for all the probes were then analyzed to obtained an estimate of the false 
discovery rates (q-values) using the method proposed by Benjamini and Hochberg (1). 
A second analysis of only half the data was also conducted. An analysis of the difference 
values indicated that on two of the slides (four arrays), the correlation between the average 
difference value of the lower and upper arrays on a single slide was approximately 0; 
whereas the other two slides had a positive correlation. This suggested that former two slides 
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may have had some error in data acquisition. Thus, a second linear model like the one 
described above was fit to the data of the two slides that displayed a positive correlation. 
Results: 
The analysis of all eight arrays resulted in large q-values. The minimum q-value of 0.218 
consisted of a list of 103 genes. The analysis of the four arrays resulted in a list of 357 genes 
with a q-value < 0.1 and 575 genes with a q-value < 0.2. The largest q-value in the list of 
genes is only 0.257. The smallest q-value in the list of genes (83 of them) is 0.066. 
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R and SAS script 
R script for normalization and q-value calculation: 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# Load functions needed for analysis 
setwd("…/R.fncs") 
source("compress.R") 
source("log.0.R") 
source("msn.R") 
source("slide.comp.R") 
source("q.value.R") 
source("normalize.R") 
source("cum.mean.R") 
########################################### 
# Read in spotfinding data 
setwd("…") 
p_1dn<-read.csv("HiLo 1 lower.csv",head=T) 
p_1up<-read.csv("HiLo 1 upper.csv",head=T) 
p_2dn<-read.csv("HiLo 2 lower.csv",head=T) 
p_2up<-read.csv("HiLo 2 upper.csv",head=T) 
p_3dn<-read.csv("HiLo 3 lower.csv",head=T) 
p_3up<-read.csv("HiLo 3 upper.csv",head=T) 
p_4dn<-read.csv("HiLo 4 lower.csv",head=T) 
p_4up<-read.csv("HiLo 4 upper.csv",head=T) 
# Slides have 15 col, 3 scans (cy3->cy5; Hi, Lo, Med), means 4-9, bkgd 10-15 
########################################### 
# Background correction  
means=cbind(p_1dn[,4:9],p_1up[,4:9],p_2dn[,4:9],p_2up[,4:9],p_3dn[,4:9], 
 p_3up[,4:9],p_4dn[,4:9],p_4up[,4:9])   
med.back=cbind(p_1dn[,10:15],p_1up[,10:15],p_2dn[,10:15],p_2up[,10:15],p_3dn[,10:15], 
 p_3up[,10:15],p_4dn[,10:15],p_4up[,10:15]) 
log.bc.means=log.0(means-med.back) 
########################################### 
# Check raw data and compress 3 scans to one  
cols=c(3,3) 
#### Pass-1dn 
a1=log.bc.means[,1:6] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a1),main="Pass-1dn") 
slide.comp(cbind(a1[,1],a1[,4]),1) 
slide.comp(cbind(a1[,2],a1[,5]),1) 
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slide.comp(cbind(a1[,3],a1[,6]),1) 
a1d=compress(a1,cols) 
#### Pass-1up 
a2=log.bc.means[,7:12] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a2),main="Pass-1up") 
slide.comp(cbind(a2[,1],a2[,4]),1) 
slide.comp(cbind(a2[,2],a2[,5]),1) 
slide.comp(cbind(a2[,3],a2[,6]),1) 
a2d=compress(a2,cols) 
#### Pass-2dn 
a3=log.bc.means[,13:18] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a3),main="Pass-2dn") 
slide.comp(cbind(a3[,1],a3[,4]),1) 
slide.comp(cbind(a3[,2],a3[,5]),1) 
slide.comp(cbind(a3[,3],a3[,6]),1) 
a3d=compress(a3,cols) 
#### Pass-2up 
a4=log.bc.means[,19:24] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a4),main="Pass-2up") 
slide.comp(cbind(a4[,1],a4[,4]),1) 
slide.comp(cbind(a4[,2],a4[,5]),1) 
slide.comp(cbind(a4[,3],a4[,6]),1) 
a4d=compress(a4,cols) 
#### Pass-3dn 
a5=log.bc.means[,25:30] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a5),main="Pass-3dn") 
slide.comp(cbind(a5[,1],a5[,4]),1) 
slide.comp(cbind(a5[,2],a5[,5]),1) 
slide.comp(cbind(a5[,3],a5[,6]),1) 
a5d=compress(a5,cols) 
#### Pass-3up 
a6=log.bc.means[,31:36] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a6),main="Pass-3up") 
slide.comp(cbind(a6[,1],a6[,4]),1) 
slide.comp(cbind(a6[,2],a6[,5]),1) 
slide.comp(cbind(a6[,3],a6[,6]),1) 
a6d=compress(a6,cols) 
#### Pass-4dn 
a7=log.bc.means[,37:42] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a7),main="Pass-4dn") 
slide.comp(cbind(a7[,1],a7[,4]),1) 
slide.comp(cbind(a7[,2],a7[,5]),1) 
slide.comp(cbind(a7[,3],a7[,6]),1) 
a7d=compress(a7,cols) 
#### Pass-4up 
a8=log.bc.means[,43:48] 
# Look at raw bc scans 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a8),main="Pass-4up") 
slide.comp(cbind(a8[,1],a8[,4]),1) 
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slide.comp(cbind(a8[,2],a8[,5]),1) 
slide.comp(cbind(a8[,3],a8[,6]),1) 
a8d=compress(a8,cols) 
########################################### 
# Normalize data and check boxplots 
d=cbind(a1d,a2d,a3d,a4d,a5d,a6d,a7d,a8d) 
norm.d=msn(exp(d),bkgrd=NULL,sector=NULL,scale=F,center=0,frac=.4) 
x11() 
boxplot(as.data.frame(d)) 
x11() 
boxplot(as.data.frame(norm.d)) 
# Write out normalized data for checking with plot.gene 
setwd("…") 
#write.csv(norm.d,"norm.d.csv",row.names=F) 
########################################### 
# Check normalized data 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a1d),main="Pass-1dn") 
slide.comp(cbind(a1d[,1],a1d[,2]),1) 
boxplot(as.data.frame(norm.d[,1:2]),main="Pass-1dn") 
slide.comp(cbind(norm.d[,1],norm.d[,2]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a2d),main="Pass-1up") 
slide.comp(cbind(a2d[,1],a2d[,2]),1) 
boxplot(as.data.frame(norm.d[,3:4]),main="Pass-1up") 
slide.comp(cbind(norm.d[,3],norm.d[,4]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a3d),main="Pass-2dn") 
slide.comp(cbind(a3d[,1],a3d[,2]),1) 
boxplot(as.data.frame(norm.d[,5:6]),main="Pass-2dn") 
slide.comp(cbind(norm.d[,5],norm.d[,6]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a4d),main="Pass-2up") 
slide.comp(cbind(a4d[,1],a4d[,2]),1) 
boxplot(as.data.frame(norm.d[,7:8]),main="Pass-2up") 
slide.comp(cbind(norm.d[,7],norm.d[,8]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a5d),main="Pass-3dn") 
slide.comp(cbind(a5d[,1],a5d[,2]),1) 
boxplot(as.data.frame(norm.d[,9:10]),main="Pass-3dn") 
slide.comp(cbind(norm.d[,9],norm.d[,10]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a6d),main="Pass-3up") 
slide.comp(cbind(a6d[,1],a6d[,2]),1) 
boxplot(as.data.frame(norm.d[,11:12]),main="Pass-3up") 
slide.comp(cbind(norm.d[,11],norm.d[,12]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a7d),main="Pass-4dn") 
slide.comp(cbind(a7d[,1],a7d[,2]),1) 
boxplot(as.data.frame(norm.d[,13:14]),main="Pass-4dn") 
slide.comp(cbind(norm.d[,13],norm.d[,14]),1) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(a8d),main="Pass-4up") 
slide.comp(cbind(a8d[,1],a8d[,2]),1) 
boxplot(as.data.frame(norm.d[,15:16]),main="Pass-4up") 
slide.comp(cbind(norm.d[,15],norm.d[,16]),1) 
############################################################## 
# Calculate Cy3 - Cy5 for SAS analysis and Attach annotation 
Pass_1dn<-as.data.frame(cbind(Flag=as.character(p_1dn$Flag),Gene=as.character(p_1dn$Gene))) 
Pass_1dn<-cbind(Pass_1dn,Diff=norm.d[,1]-norm.d[,2]) 
Pass_1up<-as.data.frame(cbind(Flag=as.character(p_1up$Flag),Gene=as.character(p_1up$Gene))) 
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Pass_1up<-cbind(Pass_1up,Diff=norm.d[,3]-norm.d[,4]) 
Pass_2dn<-as.data.frame(cbind(Flag=as.character(p_2dn$Flag),Gene=as.character(p_2dn$Gene))) 
Pass_2dn<-cbind(Pass_2dn,Diff=norm.d[,5]-norm.d[,6]) 
Pass_2up<-as.data.frame(cbind(Flag=as.character(p_2up$Flag),Gene=as.character(p_2up$Gene))) 
Pass_2up<-cbind(Pass_2up,Diff=norm.d[,7]-norm.d[,8]) 
Pass_3dn<-as.data.frame(cbind(Flag=as.character(p_3dn$Flag),Gene=as.character(p_3dn$Gene))) 
Pass_3dn<-cbind(Pass_3dn,Diff=norm.d[,9]-norm.d[,10]) 
Pass_3up<-as.data.frame(cbind(Flag=as.character(p_3up$Flag),Gene=as.character(p_3up$Gene))) 
Pass_3up<-cbind(Pass_3up,Diff=norm.d[,11]-norm.d[,12]) 
Pass_4dn<-as.data.frame(cbind(Flag=as.character(p_4dn$Flag),Gene=as.character(p_4dn$Gene))) 
Pass_4dn<-cbind(Pass_4dn,Diff=norm.d[,13]-norm.d[,14]) 
Pass_4up<-as.data.frame(cbind(Flag=as.character(p_4up$Flag),Gene=as.character(p_4up$Gene))) 
Pass_4up<-cbind(Pass_4up,Diff=norm.d[,15]-norm.d[,16]) 
# Change Abnormal points Diff to blanks==> SAS reads as NA 
# Pass_3dn, Pass_3up, Pass_4dn, Pass_4up 
Pass_3dn$Diff[which(Pass_3dn$Flag=="ABNORMAL")]<-"" 
Pass_3up$Diff[which(Pass_3up$Flag=="ABNORMAL")]<-"" 
Pass_4dn$Diff[which(Pass_4dn$Flag=="ABNORMAL")]<-"" 
Pass_4up$Diff[which(Pass_4up$Flag=="ABNORMAL")]<-"" 
# Need to combine (the order of genes are the same)  
out<-as.data.frame(cbind(x1=Pass_1dn$Diff,x2=Pass_1up$Diff,x3=Pass_2dn$Diff,x4=Pass_2up$Diff, 
  x5=Pass_3dn$Diff,x6=Pass_3up$Diff,x7=Pass_4dn$Diff,x8=Pass_4up$Diff)) 
out<-cbind(ID=Pass_1dn$Gene,out) 
str(out) 
# Cheat for SAS labels 
levels(out$ID)[632]<-"SpotbuffSpotbuff" 
setwd("…") 
#write.table(out,file="norm_Cy3minusCy5_Pass.txt",sep="\t",row.names=F) 
################################################################### 
# SAS code 
################################################################### 
setwd("…") 
estimates_all=read.delim("estimates_glm.txt") 
est<-subset(estimates_all,estimates_all$Parameter=="trtdir") 
str(est) 
hist(est$p,breaks=20) 
qvals=q.value(est$p) 
sort(qvals)[1:100] 
write.table(data.frame(est,qvalue=qvals),file="results_pass.txt",row.names=F,sep="\t") 
# Analysis with arrays discarded 
setwd("…") 
estimates_all2=read.delim("estimates_glm_sh2.txt") 
est2<-subset(estimates_all2,estimates_all2$Parameter=="trtdir") 
str(est2) 
hist(est2$p,breaks=20) 
qvals=q.value(est2$p) 
sort(qvals)[1:100] 
write.table(data.frame(est2,qvalue=qvals),file="results_pass2.txt",row.names=F,sep="\t") 
SAS script for fitting proc glm : 
DM 'LOG;CLEAR;OUTPUT;CLEAR;'; 
OPTIONS NODATE NONUMBER FORMDLIM= '_' LS=85 ; TITLE ; ; 
/* Import normalized differences. Note this is all 8 arrays     */ 
proc import datafile='…\norm_Cy3minusCy5_Pass.txt' 
 out=pas dbms=tab replace; run; 
proc print data=pas (obs=8); run; 
proc sort data=pas; 
 by ID; run; 
proc freq data=pas; 
 table ID; run; 
proc means data=pas noprint; 
 var x1-x8; 
 by ID; 
 output out=two n=n mean=x1-x8;  run; 
proc freq data=two; 
 table n; run; 
proc export data=two 
            outfile='E:\means.txt' 
            dbms=tab replace; run; 
 172 
* Arrange data for y=XB+e; 
data long; set two; 
  y=x1;  trtdir= -1;  output; 
  y=x2;  trtdir=  1;  output; 
  y=x3;  trtdir= -1;  output; 
  y=x4;  trtdir=  1;  output; 
  y=x5;  trtdir=  1;  output; 
  y=x6;  trtdir=  1;  output; 
  y=x7;  trtdir= -1;  output; 
  y=x8;  trtdir= -1;  output; 
  drop x1-x8;  run; 
* Analyze one gene to test coding; 
data onegene; set long; 
 if id='mhp447';  run; 
proc print data=onegene; run; 
* try proc glm; 
proc glm data=onegene; 
  model y = trtdir; 
  ods output ParameterEstimates=est; 
  output out=check r=residual p=predicted;  run; 
proc export data=check 
  outfile='E:\mhp447_check.txt' dbms=tab replace;  run; 
* looks good. Now do all genes using proc glm; 
ods listing close; run; 
proc glm data=long; 
  model y = trtdir; 
  by id; 
  ods output ParameterEstimates=est; 
  output out=check r=residual p=predicted;  run; 
ods listing;  run; 
data est; set est; 
  p=1*probt; 
  drop probt;   run; 
proc export data=est 
            outfile='E:\estimates_glm.txt' 
            dbms=tab replace;   run; 
DM 'LOG;CLEAR;OUTPUT;CLEAR;'; 
OPTIONS NODATE NONUMBER FORMDLIM= '_' LS=85 ; TITLE ; ; 
/* Import normalized differences. Note this is only 4 arrays    */ 
proc import datafile='E:\norm_Cy3minusCy5_Pass_sh.txt' 
 out=pas dbms=tab replace;  run; 
proc print data=pas (obs=8); run; 
proc sort data=pas; 
 by ID;   run; 
proc freq data=pas; 
 table ID;   run; 
proc means data=pas noprint; 
 var x5-x8; 
 by ID; 
 output out=two n=n mean=x5-x8;   run; 
proc freq data=two; 
 table n;  run; 
proc export data=two 
            outfile='E:\means_sh.txt' 
            dbms=tab replace;   run; 
* Arrange data for y=XB+e; 
data long; set two; 
  y=x5;  trtdir=  1;  output; 
  y=x6;  trtdir=  1;  output; 
  y=x7;  trtdir= -1;  output; 
  y=x8;  trtdir= -1;  output; 
  drop x5-x8; run; 
* Analyze one gene to test coding; 
data onegene; set long; 
 if id='mhp447';    run; 
proc print data=onegene; run; 
* try proc glm; 
proc glm data=onegene; 
  model y = trtdir; 
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  ods output ParameterEstimates=est; 
  output out=check r=residual p=predicted; run; 
proc export data=check 
  outfile='E:\mhp447_check_sh.txt' dbms=tab replace; run; 
* looks good. Now do all genes using proc glm; 
ods listing close; run; 
proc glm data=long; 
  model y = trtdir; 
  by id; 
  ods output ParameterEstimates=est; 
  output out=check r=residual p=predicted;  run; 
ods listing; run; 
data est; set est; 
  p=1*probt; 
  drop probt; run; 
proc export data=est 
            outfile='E:\estimates_glm_sh2.txt' 
            dbms=tab replace; run; 
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Hydrogen Peroxide Stress in M. hyopneumoniae strain 232 
Introduction 
An analysis of microarray data aimed to detect transcriptional response to oxidative stress 
was conducted on cultures of Mycoplasma hyopneumoniae strain 232. Cultures were grown 
to early exponential phase and then exposed to 0.5% hydrogen peroxide for 15 minutes to 
simulate oxidative stress. Extracted RNA samples from these cultures were then compared to 
samples from control cultures using two-color PCR-based microarrays. The experimental 
methods and results are published in (14). Statistical consultation and preparation of the 
microarray data for submission to Gene Expression Omnibus 
(http://www.ncbi.nlm.nih.gov/geo) was done by Stuart W. Gardner. Details of the resultant 
microarray data analysis are below. 
Microarray: 
The microarray consists of PCR probes designed and generated by Madsen (5). The array 
platform has been described above and can be accessed through the Gene Expression 
Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession number GPL5372. The GEO 
series number GSE8304 contains a description of the microarray study and the normalized 
microarray data for the six two-color microarrays. 
Experimental Design: 
Six independent RNA samples from hydrogen peroxide-exposed cultures were paired 
with six independent RNA samples from control cultures for hybridization to six two-color 
microarrays on three separate slides. For three arrays, the control RNA sample was labeled 
with Cy3 dye and the experimental RNA sample was labeled with Cy5 dye; the dyes were 
reversed for the other three arrays to account for any possible dye bias. Fluorescently labeled 
cDNA targets were generated and purified using a modified protocol as described by Boyce 
et al.(2) with a 129 hexamer primer set specific for M. hyopneumoniae ORFs used in 
previous studies (5). After cDNA target purification, they were hybridized to the array using 
the previously described protocol (5). Slides were washed using the Corning UltraGAPS 
slide wash protocol and dried by centrifugation at 1500 g for 2 min.  
Image acquisition and normalization: 
After hybridization and washing, the arrays were scanned using a ScanArray Express 
laser scanner (Applied Biosystems) three times with varying photomultiplier tube gain 
settings to encompass the dynamic range of the signal intensities (3). Slide images were 
analyzed using the SoftWoRx Tracker package (Applied Precision), acquiring mean spot 
intensity and median background intensity for each spot. Spot signals were corrected for 
background by subtracting the median background intensity from the mean spot intensity. 
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The natural logarithms of these background-corrected signals were adjusted by an additive 
constant to give a common median to each scan of the same array–dye combination. The data 
from both dye channels on a given array were normalized by locally weighted scatterplot 
smoother (LOWESS) normalization. These normalized datasets were then adjusted by an 
additive constant to make each median the same across all arrays. The triplicate spots were 
averaged together to produce one normalized measurement for each probe on the array. 
Data analysis: 
A separate linear mixed model analysis was conducted for each probe sequence using the 
normalized data (16). Each model included fixed effects for treatment (hydrogen peroxide vs 
control), array location on slide (upper vs lower) and dye (Cy3 vs Cy5) as well as random 
effects for slide-to-slide and region effects. Student t-tests for differential expression between 
treatments were conducted for each probe in the linear mixed model analyses. The method of 
Storey & Tibshirani (15) was used to estimate the q-values based on the Student t-test p-
values. These q-values were used to approximate the false discovery rate (FDR) as described 
by Mosig et al. (10). Fold changes of expression between treatments were also estimated for 
each probe by taking the inverse natural logarithm of the estimated mean treatment 
difference from the linear mixed model analyses. 
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hybridizations, and slide scanning. Michael J. Oneal and Erin R. Schafer performed the 
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SAS script 
SAS script for fitting proc mixed and GEO submission: 
DM 'LOG;CLEAR;OUTPUT;CLEAR;'; 
OPTIONS NODATE NONUMBER FORMDLIM= '_' LS=85 ; TITLE ; ; 
/* Import normalized data . Note this is all 6 arrays */ 
proc import datafile='...\normalizeddataH2O2.txt' 
            out=one dbms=tab replace;  run; 
proc print data=one (obs=8);  run; 
proc sort data=one; 
  by id;  run; 
proc means data=one noprint; 
  var x1-x12; 
  by id; 
  output out=two  n=n mean=x1-x12;  run; 
data two; set two; 
  drop _TYPE_ _FREQ_;  run; 
/* write out mean values for GEO submission */ 
proc export data=two 
            outfile='… \d.txt' 
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            dbms=tab replace;  run; 
/* Set up data for proc mixed */ 
data long; set two; 
  y=x1;   slide=1;  part='u';  trt='232';   dye=3;   output; 
  y=x2;   slide=1;  part='u';  trt='H2O2';  dye=5;   output; 
  y=x3;   slide=1;  part='l';  trt='H2O2';  dye=3;   output; 
  y=x4;   slide=1;  part='l';  trt='232';   dye=5;   output; 
  y=x5;   slide=2;  part='u';  trt='232';   dye=3;   output; 
  y=x6;   slide=2;  part='u';  trt='H2O2';  dye=5;   output; 
  y=x7;   slide=2;  part='l';  trt='H2O2';  dye=3;   output; 
  y=x8;   slide=2;  part='l';  trt='232';   dye=5;   output; 
  y=x9;   slide=3;  part='u';  trt='232';   dye=3;   output; 
  y=x10;  slide=3;  part='u';  trt='H2O2';  dye=5;   output; 
  y=x11;  slide=3;  part='l';  trt='H2O2';  dye=3;   output; 
  y=x12;  slide=3;  part='l';  trt='232';   dye=5;   output; 
drop x1-x12;  run; 
proc print data=long (obs=24);  run; 
/* Test proc mixed on single gene */ 
data onegene; set long; 
 if id='mh-tmp_001';  run; 
proc print data=onegene; run; 
proc mixed data=onegene; 
  class slide part trt dye; 
  model y=trt part dye / outp=check; 
  random slide slide*part; 
  estimate 'H2O2 - 232' trt -1 1 / cl;  run; 
ods listing close;  run; 
/* Do proc mixed for all probes */ 
proc mixed data=long; 
  class slide part trt dye; 
  model y=trt part dye / outp=check; 
  random slide slide*part; 
  estimate 'H2O2 - 232' trt -1 1 / cl; 
  ods output estimates=estimates; 
  by id;  run; 
ods listing;   run; 
data estimates; set estimates; 
  p=1*probt; 
  drop probt;  run; 
proc export data=estimates 
            outfile='… \estimates.txt' 
            dbms=tab replace;  run; 
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In vitro vs in vivo grown M. hyopneumoniae Strain 232 
Introduction: 
An analysis of microarray data aimed to detect transcriptional variation between in vitro 
and in vivo grown Mycoplasma hyopneumoniae was conducted. Swine were infected with M. 
hyopneumoniae strain 232 and 28 days post infection mycoplasmas were collected from 
bronchial alveolar lavage fluid (BALF) samples. Extracted RNA from these samples was 
then compared to samples from control cultures using two-color PCR-based microarrays. The 
experimental methods and results are published in (8). Statistical consultation and 
preparation of the microarray data for submission to Gene Expression Omnibus 
(http://www.ncbi.nlm.nih.gov/geo) was done by Stuart W. Gardner. Details of the resultant 
microarray data analysis are below. 
Microarray: 
The microarray consists of PCR probes designed and generated by Madsen (5). The array 
platform has been described above and can be accessed through the Gene Expression 
Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession number GPL5372. The GEO 
series number GSE9057 contains a description of the microarray study and the normalized 
microarray data for the nine two-color microarrays. 
Experimental Design: 
Nine independent BALF samples were processed for total RNA along with nine in vitro 
cultures. Each in vivo BALF sample was paired with an independent in vitro culture sample 
for hybridization on nine two-color arrays. For five of the arrays, the control in vitro sample 
was labeled with Cy3 and compared to a Cy5-labeled BALF sample. The dye assignment to 
control samples was reversed for the other four arrays. The five slides were hybridized and 
washed under identical conditions as described in (8). 
Image acquisition and normalization: 
The five slides were scanned three times with each dye channel using a ScanArray 
Express laser scanner (Applied BioSystems, Inc., Foster City, Calif.) under varying laser 
power and PMT gain settings to increase the dynamic range of measurement (3). Slide 
images were analyzed using the SoftWorx Tracker package (Applied Precision), acquiring 
mean spot intensity and median background intensity for each spot. Spot signals were 
corrected for background by subtracting the median background intensity from the mean spot 
intensity. The natural logarithms of these background-corrected signals were adjusted by an 
additive constant to give a common median to each scan of the same array–dye combination. 
The data from both dye channels on a given array were normalized by locally weighted 
scatterplot smoother (LOWESS) normalization. These normalized datasets were then 
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adjusted by an additive constant to make each median the same across all arrays. The 
triplicate spots were averaged together to produce one normalized measurement for each 
probe on the array. 
Data analysis: 
A separate linear mixed model analysis was conducted for each probe sequence using the 
normalized data (16). Each model included fixed effects for treatment (in vitro vs in vivo), 
array location on slide (upper vs lower) and dye (Cy3 vs Cy5) as well as random effects for 
slide-to-slide and region effects. Student t-tests for differential expression between treatments 
were conducted for each probe in the linear mixed model analyses. The method of Storey & 
Tibshirani (15) was used to estimate the q-values based on the Student t-test p-values. These 
q-values were used to approximate the false discovery rate (FDR) as described by Mosig et 
al. (10). Fold changes of expression between treatments were also estimated for each probe 
by taking the inverse natural logarithm of the estimated mean treatment difference from the 
linear mixed model analyses. 
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R and SAS script 
R script for normalization and q-value calculation: 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
setwd("...") 
source("compress.R") 
source("log.0.R") 
source("msn.R") 
source("slide.comp.R") 
source("normalize.R") 
# Read in data 
setwd("...") 
s1.up=read.delim("BalSlide1Upper.txt") 
s1.low=read.delim("BalSlide1Lower.txt") 
s2.up=read.delim("BalSlide2Upper.txt") 
s2.low=read.delim("BalSlide2Lower.txt") 
s3.up=read.delim("BalSlide3Upper.txt") 
s3.low=read.delim("BalSlide3Lower.txt") 
s4.up=read.delim("melissa slide 1 upper.txt") 
s5.up=read.delim("melissa slide 2 upper.txt") 
s5.low=read.delim("melissa slide 2 lower.txt") 
means=cbind(s1.up[,4:9],s1.low[,4:9],s2.up[,4:9],s2.low[,4:9],                 
            s3.up[,4:9],s3.low[,4:9],s4.up[,4:9],s5.up[,4:9], 
            s5.low[,4:9])  
med.back=cbind(s1.up[,10:15],s1.low[,10:15],s2.up[,10:15],s2.low[,10:15], 
               s3.up[,10:15],s3.low[,10:15],s4.up[,10:15],s5.up[,10:15], 
  s5.low[,10:15]) 
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log.bc.means=log.0(means-med.back) 
cols<-c(3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3) 
d=compress(log.bc.means,cols) 
x11() 
boxplot(as.data.frame(d)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d,1) 
slide.comp(d,2) 
slide.comp(d,3) 
slide.comp(d,4) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d,5) 
slide.comp(d,6) 
slide.comp(d,7) 
slide.comp(d,8) 
x11() 
slide.comp(d,9) 
# Normalize the data. 
norm.d=msn(exp(d)) 
x11() 
boxplot(as.data.frame(norm.d)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(norm.d,1) 
slide.comp(norm.d,2) 
slide.comp(norm.d,3) 
slide.comp(norm.d,4) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(norm.d,5) 
slide.comp(norm.d,6) 
slide.comp(norm.d,7) 
slide.comp(norm.d,8) 
x11() 
slide.comp(norm.d,9) 
write.table(data.frame(ID=s1.up$ID,norm.d),file=".../normalizeddata.txt",sep="\t",
 row.names=F) 
# 
#After SAS analysis... 
# 
estimates=read.delim(".../estimates.txt") 
hist(estimates$p) 
length(estimates$p)-mosig(estimates$p) #Estimate No. Diff. Exp. Genes 
qvals=q.value(estimates$p) 
sort(qvals)[1:100] 
write.table(data.frame(estimates,qvalue=qvals),file="results.txt",row.names=F,sep="\t") 
 
SAS script for fitting proc mixed: 
DM 'LOG;CLEAR;OUTPUT;CLEAR;'; 
OPTIONS NODATE NONUMBER FORMDLIM= '_' LS=85 ; TITLE ; ; 
* Import normalized Bal data; 
proc import datafile='…\normalizeddata.txt' 
            out=one dbms=tab replace;  run; 
proc print data=one (obs=10);  run; 
proc sort data=one; 
  by id;  run; 
proc means data=one noprint; 
  var x1-x18; 
  by id; 
  output out=two n=n mean=x1-x18;  run; 
data two; set two; 
  drop _TYPE_ _FREQ_;  run; 
proc print data=two (obs=20);  run; 
proc freq data=two; 
  table n;  run; 
data temp; set two; 
 180 
  if n>3;  run; 
proc print data=temp;  run; 
data long; set two; 
  y=x1;  slide=1;  part='u';  trt='control';  dye=555;  output; 
  y=x2;  slide=1;  part='u';  trt='Bal';      dye=647;  output; 
  y=x3;  slide=1;  part='l';  trt='Bal';    dye=555;  output; 
  y=x4;  slide=1;  part='l';  trt='control';  dye=647;  output; 
  y=x5;  slide=2;  part='u';  trt='control';  dye=555;  output; 
  y=x6;  slide=2;  part='u';  trt='Bal';    dye=647;  output; 
  y=x7;  slide=2;  part='l';  trt='Bal';    dye=555;  output; 
  y=x8;  slide=2;  part='l';  trt='control';  dye=647;  output; 
  y=x9;  slide=3;  part='u';  trt='control';  dye=555;  output; 
  y=x10; slide=3;  part='u';  trt='Bal';    dye=647;  output; 
  y=x11; slide=3;  part='l';  trt='Bal';    dye=555;  output; 
  y=x12; slide=3;  part='l';  trt='control';  dye=647;  output; 
  y=x13; slide=4;  part='u';  trt='Bal';    dye=555;  output; 
  y=x14; slide=4;  part='u';  trt='control';  dye=647;  output; 
  y=x15; slide=5;  part='u';  trt='control';  dye=555;  output; 
  y=x16; slide=5;  part='u';  trt='Bal';    dye=647;  output; 
  y=x17; slide=5;  part='l';  trt='Bal';    dye=555;  output; 
  y=x18; slide=5;  part='l';  trt='control';  dye=647;  output; 
  drop n x1-x18;   run; 
proc print data=long (obs=24);  run; 
ods listing close;  run;  
proc mixed data=long; 
  class slide part trt dye; 
  model y=trt part dye / outp=check; 
  random slide slide*part; 
  estimate 'Bal - control' trt 1 -1 / cl; 
  ods output estimates=estimates; 
  by id;  run; 
data estimates; set estimates; 
  p=1*probt; 
  drop probt;  run; 
proc export data=estimates 
            outfile='…\estimates.txt' 
            dbms=tab replace;   run; 
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Norepinephrine Stress in M. hyopneumoniae strain 232 
Introduction: 
An analysis of microarray data aimed to detect transcriptional response to a host hormone 
catecholamine norepinephrine was conducted on cultures of Mycoplasma hyopneumoniae 
strain 232. Cultures were grown to early exponential phase and then exposed to 100 μM 
concentration of norepinephrine for 4 hours. Extracted RNA samples from these cultures 
were then compared to samples from control cultures using two-color PCR-based 
microarrays. The experimental methods and results are published in (11, 14). Statistical 
consultation and preparation of the microarray data for submission to Gene Expression 
Omnibus (http://www.ncbi.nlm.nih.gov/geo) was done by Stuart W. Gardner. Details of the 
resultant microarray data analysis are below. 
Microarray: 
The microarray consists of PCR probes designed and generated by Madsen (5). The array 
platform has been described above and can be accessed through the Gene Expression 
Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession number GPL5372. The GEO 
series number GSE8494 contains a description of the microarray study and the normalized 
microarray data for the six two-color microarrays. 
Experimental Design: 
Six independent RNA samples from norepinephrine-exposed cultures were paired with 
six independent RNA samples from control cultures for hybridization to six two-color 
microarrays on three separate slides. For three arrays, the control RNA sample was labeled 
with Cy3 dye and the experimental RNA sample was labeled with Cy5 dye; the dyes were 
reversed for the other three arrays to account for any possible dye bias. Fluorescently labeled 
cDNA targets were generated and purified using a modified protocol as described by Boyce 
et al.(2) with a 129 hexamer primer set specific for M. hyopneumoniae ORFs used in 
previous studies (5). After cDNA target purification, they were hybridized to the array using 
the previously described protocol (5). Slides were washed using the Corning UltraGAPS 
slide wash protocol and dried by centrifugation at 1500 g for 2 min.  
Image acquisition and normalization: 
After hybridization and washing, the arrays were scanned and analyzed as described 
previously (5, 6). Spot signals were corrected for background, transformed, and adjusted to a 
common median for each scan of the same array–dye combination. Locally weighted 
scatterplot smoother (LOWESS) normalization was applied and triplicate spots were 
averaged together to produce one normalized measurement for each probe on the array.  
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Data analysis: 
A separate linear mixed model analysis was conducted for each probe sequence using the 
normalized data (16). Each model included fixed effects for treatment (norepinephrine vs 
control), array location on slide (upper vs lower) and dye (Cy3 vs Cy5) as well as random 
effects for slide-to-slide and region effects. Student t-tests for differential expression between 
treatments were conducted for each probe in the linear mixed model analyses. The method of 
Storey & Tibshirani (15) was used to estimate the q-values based on the Student t-test p-
values. These q-values were used to approximate the false discovery rate (FDR) as described 
by Benjamini & Hochberg (1). Fold changes of expression between treatments were also 
estimated for each probe by taking the inverse natural logarithm of the estimated mean 
treatment difference from the linear mixed model analyses. 
Acknowledgements:  
Nancy Upchurch, Barb Erickson, Michael J. Oneal, and Erin R. Schafer grew the 
cultures. Erin R. Schafer completed the RNA extractions, cDNA generation, slide 
hybridizations, and slide scanning. Michael J. Oneal and Erin R. Schafer performed the 
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SAS script 
SAS script for fitting proc mixed:  
proc import datafile='…\normalizeddataNorep.txt' 
            out=one dbms=tab replace;  run; 
proc print data=one (obs=8);  run; 
proc sort data=one; 
  by id; run; 
proc means data=one noprint; 
  var x1-x12; 
  by id; 
  output out=two  n=n mean=x1-x12;   run; 
data two; set two; 
  drop _TYPE_ _FREQ_;  run; 
proc export data=two 
            outfile='…\d.txt' 
            dbms=tab replace;  run; 
proc print data=two (obs=20);  run; 
proc freq data=two; 
  table n;  run; 
data temp; set two; 
  if n>3;  run; 
proc print data=temp;  run; 
data long; set two; 
  y=x1;  slide=1;  part='u';  trt='232';    dye=3;  output; 
  y=x2;  slide=1;  part='u';  trt='Norep';  dye=5;  output; 
  y=x3;  slide=1;  part='l';  trt='Norep';  dye=3;  output; 
  y=x4;  slide=1;  part='l';  trt='232';    dye=5;  output; 
  y=x5;  slide=2;  part='u';  trt='Norep';  dye=3;  output; 
  y=x6;  slide=2;  part='u';  trt='232';    dye=5;  output; 
  y=x7;  slide=2;  part='l';  trt='232';    dye=3;  output; 
  y=x8;  slide=2;  part='l';  trt='Norep';  dye=5;  output; 
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  y=x9;  slide=3;  part='u';  trt='232';    dye=3;  output; 
  y=x10; slide=3;  part='u';  trt='Norep';  dye=5;  output; 
  y=x11; slide=3;  part='l';  trt='Norep';  dye=3;  output; 
  y=x12; slide=3;  part='l';  trt='232';    dye=5;  output; 
drop x1-x12;  run; 
proc print data=long (obs=24); run; 
ods listing close;  run; 
proc mixed data=long; 
  class slide part trt dye; 
  model y=trt part dye / outp=check; 
  random slide slide*part; 
  estimate 'Norep - 232' trt -1 1 / cl; 
  ods output estimates=estimates; 
  by id;  run; 
ods listing;  run; 
proc print data=estimates;  run; 
data estimates; set estimates; 
  p=1*probt; 
  drop probt;  run; 
proc export data=estimates 
            outfile='…\estimatesNorep.txt' 
            dbms=tab replace; run; 
 
SAS Script for GEO submission: 
DM 'LOG;CLEAR;OUTPUT;CLEAR;'; 
OPTIONS NODATE NONUMBER FORMDLIM= '_' LS=85 ; TITLE ; ; 
/* This code is for deleting the data from analyzed fix files for data submission  
and changing labels accordingly. first it deals with the raw data files and then it 
works with the normalized data files  */ 
/* Import fix data, and delete points not needed. 
 Note: Make sure the column labels are corrected after exporting  
  The imported file should only have ID, spot means, and Bkgrd medians  
  easiest to copy and paste the headings from fix, since SAS truncates  
column headings  */ 
* RAW data; 
proc import datafile='…\Mhyo Norep Slide 1 Lower.fix.csv' 
            out=one dbms=csv replace;  run; 
proc print data=one (obs=10); run; 
* Drop IDs that aren't going to be analyzed; 
data two; set one; 
 if ID='NAGINA' then delete; 
 if ID='gapA' then delete; 
 if ID='pvp' then delete; 
 if ID='spotbuff' then delete; 
 if ID='spotbu' then delete; 
 if ID='blank' then delete;  run; 
* Delete genes not being submitted in the primer sequence, these are not on the 2005 slides; 
data two; set two; 
 if id='mhp045' then delete; 
 if id='mhp051' then delete; 
 if id='mhp055' then delete; 
 if id='mhp063' then delete; 
 if id='mhp068' then delete; 
 if id='mhp074' then delete; 
 if id='mhp266' then delete; 
 if id='mhp272' then delete; 
 if id='mhp426' then delete; 
 if id='mhp463' then delete; 
 if id='mhp534' then delete; 
 if id='mhp573' then delete; 
 if id='mhp587' then delete; 
 if id='mhp626' then delete;  run; 
proc freq data=two; table ID; run; 
data two; set two; 
 if id='C2-mhp097' then id='mhp214'; 
 if id='mhp645' then id='mhp646'; 
 if id='mhp023/_0' then id='mhp021'; 
 if id='mhp182/_2' then id='mhp182'; 
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 if id='mhp435/_4' then id='mhp435'; 
 if id='mhp461/42' then id='mhp461'; 
 if id='mhp583/_5' then id='mhp578';  run; 
proc freq data=two; table ID; run; 
proc sort data=two; by ID; run; 
proc export data=two 
            outfile='…\Mhyo Norep Slide 1 Lower.raw.txt' 
            dbms=tab replace;  run; 
* ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^; 
proc import datafile='…\Mhyo Norep Slide 1 Upper.fix.csv' 
            out=one dbms=csv replace;  run; 
proc print data=one (obs=10); run; 
* Drop IDs that aren't going to be analyzed; 
data two; set one; 
 if ID='NAGINA' then delete; 
 if ID='gapA' then delete; 
 if ID='pvp' then delete; 
 if ID='spotbuff' then delete; 
 if ID='spotbu' then delete; 
 if ID='blank' then delete;  run; 
* Delete genes not being submitted in the primer sequence, these are not on the 2005 slides; 
data two; set two; 
 if id='mhp045' then delete; 
 if id='mhp051' then delete; 
 if id='mhp055' then delete; 
 if id='mhp063' then delete; 
 if id='mhp068' then delete; 
 if id='mhp074' then delete; 
 if id='mhp266' then delete; 
 if id='mhp272' then delete; 
 if id='mhp426' then delete; 
 if id='mhp463' then delete; 
 if id='mhp534' then delete; 
 if id='mhp573' then delete; 
 if id='mhp587' then delete; 
 if id='mhp626' then delete;  run; 
proc freq data=two; table ID; run; 
data two; set two; 
 if id='C2-mhp097' then id='mhp214'; 
 if id='mhp645' then id='mhp646'; 
 if id='mhp023/_0' then id='mhp021'; 
 if id='mhp182/_2' then id='mhp182'; 
 if id='mhp435/_4' then id='mhp435'; 
 if id='mhp461/42' then id='mhp461'; 
 if id='mhp583/_5' then id='mhp578';   run; 
proc freq data=two; table ID; run; 
proc sort data=two; by ID; run; 
proc export data=two 
            outfile='…\Mhyo Norep Slide 1 Upper.raw.txt' 
            dbms=tab replace;  run; 
* ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^; 
proc import datafile='...\Mhyo Norep Slide 2 Lower.fix.csv' 
            out=one dbms=csv replace;  run; 
proc print data=one (obs=10); run; 
* Drop IDs that aren't going to be analyzed; 
data two; set one; 
 if ID='NAGINA' then delete; 
 if ID='gapA' then delete; 
 if ID='pvp' then delete; 
 if ID='spotbuff' then delete; 
 if ID='spotbu' then delete; 
 if ID='blank' then delete;  run; 
* Delete genes not being submitted in the primer sequence, these are not on the 2005 slides; 
data two; set two; 
 if id='mhp045' then delete; 
 if id='mhp051' then delete; 
 if id='mhp055' then delete; 
 if id='mhp063' then delete; 
 if id='mhp068' then delete; 
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 if id='mhp074' then delete; 
 if id='mhp266' then delete; 
 if id='mhp272' then delete; 
 if id='mhp426' then delete; 
 if id='mhp463' then delete; 
 if id='mhp534' then delete; 
 if id='mhp573' then delete; 
 if id='mhp587' then delete; 
 if id='mhp626' then delete;  run; 
proc freq data=two; table ID; run; 
data two; set two; 
 if id='C2-mhp097' then id='mhp214'; 
 if id='mhp645' then id='mhp646'; 
 if id='mhp023/_0' then id='mhp021'; 
 if id='mhp182/_2' then id='mhp182'; 
 if id='mhp435/_4' then id='mhp435'; 
 if id='mhp461/42' then id='mhp461'; 
 if id='mhp583/_5' then id='mhp578'; run; 
proc freq data=two; table ID; run; 
proc sort data=two; by ID; run; 
proc export data=two 
            outfile='...\Mhyo Norep Slide 2 Lower.raw.txt' 
            dbms=tab replace;   run; 
* ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^; 
proc import datafile='...\Mhyo Norep Slide 2 Upper.fix.csv' 
            out=one dbms=csv replace;  run; 
proc print data=one (obs=10); run; 
* Drop IDs that aren't going to be analyzed; 
data two; set one; 
 if ID='NAGINA' then delete; 
 if ID='gapA' then delete; 
 if ID='pvp' then delete; 
 if ID='spotbuff' then delete; 
 if ID='spotbu' then delete; 
 if ID='blank' then delete;  run; 
* Delete genes not being submitted in the primer sequence, these are not on the 2005 slides; 
data two; set two; 
 if id='mhp045' then delete; 
 if id='mhp051' then delete; 
 if id='mhp055' then delete; 
 if id='mhp063' then delete; 
 if id='mhp068' then delete; 
 if id='mhp074' then delete; 
 if id='mhp266' then delete; 
 if id='mhp272' then delete; 
 if id='mhp426' then delete; 
 if id='mhp463' then delete; 
 if id='mhp534' then delete; 
 if id='mhp573' then delete; 
 if id='mhp587' then delete; 
 if id='mhp626' then delete;   run; 
proc freq data=two; table ID; run; 
data two; set two; 
 if id='C2-mhp097' then id='mhp214'; 
 if id='mhp645' then id='mhp646'; 
 if id='mhp023/_0' then id='mhp021'; 
 if id='mhp182/_2' then id='mhp182'; 
 if id='mhp435/_4' then id='mhp435'; 
 if id='mhp461/42' then id='mhp461'; 
 if id='mhp583/_5' then id='mhp578';  run; 
proc freq data=two; table ID; run; 
proc sort data=two; by ID; run; 
proc export data=two 
            outfile='...\Mhyo Norep Slide 2 Upper.raw.txt' 
            dbms=tab replace;  run; 
* ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^; 
proc import datafile='...\Mhyo Norep Slide 3 Lower.fix.csv' 
            out=one dbms=csv replace;  run; 
proc print data=one (obs=10); run; 
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* Drop IDs that aren't going to be analyzed; 
data two; set one; 
 if ID='NAGINA' then delete; 
 if ID='gapA' then delete; 
 if ID='pvp' then delete; 
 if ID='spotbuff' then delete; 
 if ID='spotbu' then delete; 
 if ID='blank' then delete;  run; 
* Delete genes not being submitted in the primer sequence, these are not on the 2005 slides; 
data two; set two; 
 if id='mhp045' then delete; 
 if id='mhp051' then delete; 
 if id='mhp055' then delete; 
 if id='mhp063' then delete; 
 if id='mhp068' then delete; 
 if id='mhp074' then delete; 
 if id='mhp266' then delete; 
 if id='mhp272' then delete; 
 if id='mhp426' then delete; 
 if id='mhp463' then delete; 
 if id='mhp534' then delete; 
 if id='mhp573' then delete; 
 if id='mhp587' then delete; 
 if id='mhp626' then delete; run; 
proc freq data=two; table ID; run; 
data two; set two; 
 if id='C2-mhp097' then id='mhp214'; 
 if id='mhp645' then id='mhp646'; 
 if id='mhp023/_0' then id='mhp021'; 
 if id='mhp182/_2' then id='mhp182'; 
 if id='mhp435/_4' then id='mhp435'; 
 if id='mhp461/42' then id='mhp461'; 
 if id='mhp583/_5' then id='mhp578';  run; 
proc freq data=two; table ID; run; 
proc sort data=two; by ID; run; 
proc export data=two 
            outfile='Z:\...\Mhyo Norep Slide 3 Lower.raw.txt' 
            dbms=tab replace;   run; 
* ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^; 
proc import datafile='Z:\...\Mhyo Norep Slide 3 Upper.fix.csv' 
            out=one dbms=csv replace;  run; 
proc print data=one (obs=10); run; 
* Drop IDs that aren't going to be analyzed; 
data two; set one; 
 if ID='NAGINA' then delete; 
 if ID='gapA' then delete; 
 if ID='pvp' then delete; 
 if ID='spotbuff' then delete; 
 if ID='spotbu' then delete; 
 if ID='blank' then delete;  run; 
* Delete genes not being submitted in the primer sequence, these are not on the 2005 slides; 
data two; set two; 
 if id='mhp045' then delete; 
 if id='mhp051' then delete; 
 if id='mhp055' then delete; 
 if id='mhp063' then delete; 
 if id='mhp068' then delete; 
 if id='mhp074' then delete; 
 if id='mhp266' then delete; 
 if id='mhp272' then delete; 
 if id='mhp426' then delete; 
 if id='mhp463' then delete; 
 if id='mhp534' then delete; 
 if id='mhp573' then delete; 
 if id='mhp587' then delete; 
 if id='mhp626' then delete;   run; 
proc freq data=two; table ID; run; 
data two; set two; 
 if id='C2-mhp097' then id='mhp214'; 
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 if id='mhp645' then id='mhp646'; 
 if id='mhp023/_0' then id='mhp021'; 
 if id='mhp182/_2' then id='mhp182'; 
 if id='mhp435/_4' then id='mhp435'; 
 if id='mhp461/42' then id='mhp461'; 
 if id='mhp583/_5' then id='mhp578';  run; 
proc freq data=two; table ID; run; 
proc sort data=two; by ID; run; 
proc export data=two 
            outfile='Z:\...\Mhyo Norep Slide 3 Upper.raw.txt' 
            dbms=tab replace;  run; 
* ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^; 
* NORMALIZED data; 
proc import datafile='Z:\...\d.txt' 
            out=one dbms=tab replace;  run; 
proc print data=one (obs=10); run; 
* Drop IDs that aren't going to be analyzed; 
data two; set one; 
 if ID='NAGINA' then delete; 
 if ID='gapA' then delete; 
 if ID='pvp' then delete; 
 if ID='spotbuff' then delete; 
 if ID='spotbu' then delete; 
 if ID='blank' then delete;  run; 
* Delete genes not being submitted in the primer sequence, these are not on the 2005 slides; 
data two; set two; 
 if id='mhp045' then delete; 
 if id='mhp051' then delete; 
 if id='mhp055' then delete; 
 if id='mhp063' then delete; 
 if id='mhp068' then delete; 
 if id='mhp074' then delete; 
 if id='mhp266' then delete; 
 if id='mhp272' then delete; 
 if id='mhp426' then delete; 
 if id='mhp463' then delete; 
 if id='mhp534' then delete; 
 if id='mhp573' then delete; 
 if id='mhp587' then delete; 
 if id='mhp626' then delete;  run; 
proc freq data=two; table ID; run; 
data two; set two; 
 if id='C2-mhp097' then id='mhp214'; 
 if id='mhp645' then id='mhp646'; 
 if id='mhp023/_0' then id='mhp021'; 
 if id='mhp182/_2' then id='mhp182'; 
 if id='mhp435/_4' then id='mhp435'; 
 if id='mhp461/42' then id='mhp461'; 
 if id='mhp583/_5' then id='mhp578';  run; 
proc freq data=two; table ID; run; 
proc sort data=two; by ID; run; 
* Separate files and export; 
data oneup; set two; 
 keep ID n x1 x2;  run; 
proc export data=oneup 
            outfile='Z:\...\nd.Mhyo Norep Slide 1 Upper.txt' 
            dbms=tab replace;  run; 
data onelow; set two; 
 keep ID n x3 x4;  run; 
proc export data=onelow 
            outfile='Z:\...\nd.Mhyo Norep Slide 1 Lower.txt' 
            dbms=tab replace;  run; 
data twoup; set two; 
 keep ID n x5 x6;  run; 
proc export data=twoup 
            outfile='Z:\...\nd.Mhyo Norep Slide 2 Upper.txt' 
            dbms=tab replace;  run; 
data twolow; set two; 
 keep ID n x7 x8;  run; 
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proc export data=twolow 
            outfile='Z:\...\nd.Mhyo Norep Slide 2 Lower.txt' 
            dbms=tab replace;  run; 
data threeup; set two; 
 keep ID n x9 x10;  run; 
proc export data=threeup 
            outfile='Z:\...\nd.Mhyo Norep Slide 3 Upper.txt' 
            dbms=tab replace;   run; 
data threelow; set two; 
 keep ID n x11 x12;  run; 
proc export data=threelow 
            outfile='Z:\...\nd.Mhyo Norep Slide 3 Lower.txt' 
            dbms=tab replace;  run; 
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Comparative Hybridization Analysis of M. hyopneumoniae Field Isolates 
Introduction: 
An analysis of microarray data aimed to detect genomic variation between fourteen field 
strains of M. hyopneumoniae and lab strain 232 was conducted. In this study, fourteen field 
strains that were cultured from US Midwest case studies obtained by the Iowa State 
University Veterinary Diagnostic Laboratory (Ames, Iowa) were compared to samples from 
control cultures using two-color PCR-based microarrays. The experimental methods and 
results are published in (7). Statistical analysis of the microarray data, a permutation test to 
assess spatial clustering of genomic variation hot spots, and preparation of the microarray 
data for submission to Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) was 
done by Stuart W. Gardner. Details of the resultant microarray data analysis are below. 
Microarray: 
The microarray consists of PCR probes designed and generated by Madsen (5). The array 
platform has been described above and can be accessed through the Gene Expression 
Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession number GPL5372. The GEO 
series number GSE8306 contains a description of the microarray study and the normalized 
microarray data for the six two-color microarrays. 
Experimental Design: 
TempliPhi™ amplified DNA samples from field isolates were compared to control strain 
232 using a two-color PCR-based microarray design. Independent samples from one isolate 
labeled with one dye were paired with control samples labeled with the alternate dye; the 
samples were mixed and hybridized to the microarray. For nine of the fourteen isolates, four 
independent field isolate DNA samples were paired with four independent DNA samples 
from control 232. In two of the four arrays, the control sample was labeled with Alexa 555 
dye and compared to the field isolate sample labeled with Alexa 647 dye (Molecular Probes, 
Inc., Eugene, Ore.). The dye assignment to control and treated samples was reversed for the 
other two arrays (dye swap). The arrays were hybridized under identical conditions as 
described below. This procedure was repeated for another independent isolate for a total of 
four arrays, where the control sample was labeled with Alexa 647 dye in three of the arrays 
and Alexa 555 dye for the fourth array. For four other independent isolates, a total of five 
arrays each, including two dye swaps, were done; and for the last independent isolate, a total 
of six arrays were done with the control labeled with Alexa 555 dye for four of the arrays and 
Alexa 647 for the other two arrays. 
Field isolate samples yielded low amounts of genomic DNA compared to strain 232 due 
to their fastidious growth and lack of adaptation to growth media. To overcome the issue of 
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limited quantities of DNA, genomic samples were amplified using the TempliPhi™ 100 
Reaction Kit (Amersham, Biosciences, Piscataway, N.J.) according to the manufacturer’s 
protocol. A total of five reactions were combined for each field isolate and strain 232, 
yielding approximately 5-8 µg total DNA in each preparation which was subjected to 
mechanical shearing.  
The DNA was mechanically sheared prior to labeling to ensure an optimized fragment 
size for efficient labeling and hybridization. Each amplified sample was added to the 
modified nebulizer (product # 4100, MEDEX, Carlsbad, Calif.) containing 2 ml of sterile 
50% glycerol. The nebulizer was modified by removing the plastic cuff, trimming the edge 
and inverting it during reassembly. The samples were sheared using a 10 psi nitrogen stream 
for 15 min. The fragment size of less than 1,000 base pairs was optimal for efficient labeling 
and signal strength. This was confirmed by gel electrophoresis on 1.5% agarose gel.  
Targets were generated and purified from mechanically sheared DNA samples using the 
BioPrime® Plus Array CGH Indirect Genomic Labeling System (Invitrogen Corp., Carlsbad, 
Calif.). A set of 129 open reading frame-specific hexamer oligonucleotide primers (5) was 
used to generate amino-allyl modified DNA targets. These targets were then labeled with 
either Alexa Fluor™ 555 Reactive Dye or Alexa Fluor™ 647 Reactive Dye (Molecular 
Probes, Inc.) according to the experimental design. Following purification of the 
fluorescently labeled cDNA per manufacturer’s instructions, samples were dried in a vacuum 
centrifuge and then resuspended in 10 µl Pronto! cDNA/long oligo hybridization solution 
(Corning). Targets were denatured at 95°C for 5 min and centrifuged at 13,000 x g for 2 min 
at room temperature. Labeled targets from one 232 control and one field isolate were then 
combined, pipetted to an array, and covered with a 22 x 22 mm HybriSlip™ (Schleicher & 
Schuell, Keene, N. H.). Slides were placed in a Corning hybridization chamber and incubated 
in a 42°C water bath for 12-16 h. Slides were washed according to Corning’s UltraGAPS™ 
protocol and dried by centrifugation. 
Image acquisition and normalization: 
Eight of the fourteen isolate arrays were scanned with each dye channel using a 
ScanArray Express laser scanner (Applied BioSystems, Inc., Foster City, Calif.) under 
varying laser power and PMT gain settings to increase the dynamic range of measurement 
(3). The other six arrays were scanned with an Applied Precision’s ArrayWoRx® Biochip 
Reader (Applied Precision, Inc., Issaquah, Wash.). 
Images were analyzed for spots and signal intensities quantified using the softWorRx 
Tracker software package (Applied Precision, Inc.). Spot-specific mean signals were 
corrected for local background by subtracting spot-specific median background intensities. 
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The natural logarithms of the background-corrected signals from a single scan were adjusted 
by an additive constant so that all scans of the same array-by-dye combination would have a 
common median. The median of these adjusted-log-background-corrected signals across 
multiple scans was then computed for each spot to obtain one value for each combination of 
spot, array, and dye channel. These data for the two dye channels on any given array were 
normalized using LOWESS normalization to adjust for intensity-dependent dye bias  (4, 17). 
Following LOWESS adjustment, the data from each channel were adjusted by an additive 
constant so that the median for any combination of array and dye would be the same for all 
array-by-dye combinations. The difference in normalized values for each spot was calculated 
as the signal intensity of Alexa 555 dye minus Alexa 647 dye. The differences for the 
triplicate spots were then averaged within each array to produce one normalized difference 
value for each of the 627 probe sequences.   
Data analysis: 
A linear model of the difference in signal intensity for the two dyes was fitted for each 
probe sequence using the normalized data. The model included an overall mean for the 
difference in dye effect (Alexa 555 minus 647) and, for each field isolate, a fixed effect for 
the difference in signal intensity of control minus field isolate. As part of each linear model 
analysis, a one-sided t-test for the difference in signal intensity being greater than zero was 
conducted for each probe. This test was chosen because in our experimental design, signal 
intensities can only show a decrease unlike RNA analyses where values can show variation 
in both directions concomitant with up- or down-regulation. The p-values for all the probes 
and field isolates were then analyzed to obtained false discovery rates (q-values) using the 
method proposed by Benjamini and Hochberg (1). 
The analysis of the field isolate data suggests that certain locations of the genome may 
experience more variation across strains than would be expected by chance. A permutation 
test was employed to assess spatial clustering of the variation between field strains observed 
in regions of M. hyopneumoniae genome (12). The test consisted of summing the number of 
field strains with significant variation from strain 232 in consecutively tested genes within a 
sliding window around the genome. A sliding window size of ten consecutive tested genes 
was used.   
Results: 
Data from each of the field isolate replicates were used in the statistical analysis. 
Statistical analysis indicated that 123 genes for the combined field isolates had significant 
differences from the control strain 232 at p-value < 0.004 and q-value < 0.20. The results are 
presented in Figure A.1. The field strains differed in the number of genes that had significant 
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variation from the control strain 232. The strain with the most variation was strain 
95MP1509 with 40 loci differences; strain 95MP1506 had 28 loci differences. One strain, 
95MP1507, showed one locus difference at mhp606 while strains 95MP1505 and 97MP0001 
showed only two differences. Twenty-two loci showed differences in more than one strain. 
Of these twenty-two loci, fifteen loci showed differences in two strains, two loci showed 
differences in three strains, one locus showed differences in four strains, and two loci each 
showed differences in five and six strains. Fifty-nine percent of the genes showing 
differences (72/123) were hypothetical with no known function. Twelve of the fifty-one 
lipoprotein genes showed variation. 
 
Figure A.1. Scatter plot of genetic variation of field isolates. Positions at which there is 
genetic variation are shown for each M. hyopneumoniae field strain. 
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The identification of variation hot spots among M. hyopneumoniae field strains was 
derived from a permutation test with a sliding window design. Figure 3 of the paper (7) 
shows gene location and number of field strains that have significant variation from 232. The 
graph in Figure A.2 plots the path of a sliding window across the genome with a window size 
of 10 genes. This path is determined by starting at “gene 1” and adding the number of 
significantly differing field strains from strain 232 for each gene through “gene 10”. This 
resulted in a total of three significant variations. Shift the window one gene, and from “gene 
2” to “gene 11” there were also three significant variations. This sliding window continues 
around the genome and since it is circular, the last genes are included in a window with the 
first genes. If the locations of significant variations were totally random, the sum in the 
window should vary up and down fairly regularly across the genome. To determine if there 
were hotspots of variation in the genome, 10,000 random permutations of the observed 
variation locations were done using the statistical computing program R 2.4.1 (12). The 
window with the maximum sum was retained and the 95 percentile of these 10,000 
permutations was determined to be 15. Thus, an observed sum of 15 or greater would only be 
expected to occur 5% of the time by chance. The solid horizontal line in Figure A.2 denotes 
this significance level at the 95% confidence level where only one region of variation is 
declared significant. The genes in this region of variation are listed in Table 1 of the paper 
(7).  
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Figure A.2. Permutation test of hot spots showing variation around the M. hyopneumoniae 
genome. This graph represents variation around the genome within individual genes in a 
sliding window of 10 genes. The permutation test indicates significance at p = 0.05 (solid 
horizontal line).  
 
R and SAS script 
R script for normalization and q-value calculation: 
# load data sets & do normalization for each field isolate 
# Note: Size of data sets may vary due to deletion of abnormal spots. 
# The ID order may vary between array also. 
# Start with Melissa's slides 
#^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# 00MP1301 - P 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
source("…\\log.0.R") 
source("...\\compress.R") 
source("...\\slide.comp.R") 
source("...\\msn.R") 
source("...\\normalize.R") 
# load data sets & do analysis 
# Note: Size of data sets may vary do to deletion of abnormal spots. 
# The ID order may vary between array also. 
setwd("...") 
FI.00MP1301.s1<-read.delim("00MP1301-s1.Cy3-P.Cy5-232.fix.txt") 
FI.00MP1301.s2<-read.delim("00MP1301-s2.Cy3-232.Cy5-P.fix.txt") 
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FI.00MP1301.s3<-read.delim("00MP1301-s3.Cy3-P.Cy5-232.fix.txt") 
FI.00MP1301.s4<-read.delim("00MP1301-s4.Cy3-232.Cy5-P.fix.txt") 
# Do each array separately unless they have the same number of rows. 
d.00MP1301<-compress(log.0(cbind(FI.00MP1301.s1[,2:5]-FI.00MP1301.s1[,6:9], 
     FI.00MP1301.s2[,2:7]-FI.00MP1301.s2[,8:13], 
     FI.00MP1301.s3[,2:7]-FI.00MP1301.s3[,8:13], 
     FI.00MP1301.s4[,2:7]-FI.00MP1301.s4[,8:13])), 
     c(2,2,3,3,4,2,3,3)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d.00MP1301,1) 
slide.comp(d.00MP1301,2) 
slide.comp(d.00MP1301,3) 
slide.comp(d.00MP1301,4) 
norm.d.00MP1301=msn(exp(d.00MP1301)) 
x11() 
par(mfrow=c(1,2)) 
boxplot(as.data.frame(d.00MP1301)) 
boxplot(as.data.frame(norm.d.00MP1301)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(norm.d.00MP1301,1) 
slide.comp(norm.d.00MP1301,2) 
slide.comp(norm.d.00MP1301,3) 
slide.comp(norm.d.00MP1301,4) 
# Export normalized data separately for each array 
setwd("...\\Normalized Data") 
write.table(data.frame(ID=FI.00MP1301.s1$ID,X1=norm.d.00MP1301[,1],X2=norm.d.00MP1301[,2]),fi
le="nd.00MP1301.s1.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.00MP1301.s2$ID,X3=norm.d.00MP1301[,3],X4=norm.d.00MP1301[,4]),fi
le="nd.00MP1301.s2.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.00MP1301.s3$ID,X5=norm.d.00MP1301[,5],X6=norm.d.00MP1301[,6]),fi
le="nd.00MP1301.s3.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.00MP1301.s4$ID,X7=norm.d.00MP1301[,7],X8=norm.d.00MP1301[,8]),fi
le="nd.00MP1301.s4.txt",sep="\t",row.names=F) 
save.image("00MP1301-P.RData") 
# ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# 00MP1502 - F 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
source("...\\log.0.R") 
source("...\\compress.R") 
source("...\\slide.comp.R") 
source("...\\msn.R") 
source("...\\normalize.R") 
# load data sets & do normalization 
setwd("...") 
FI.00MP1502.s1<-read.delim("00MP1502-s1.Cy3-232.Cy5-F.fix.txt") 
FI.00MP1502.s2<-read.delim("00MP1502-s2.Cy3-232.Cy5-F.fix.txt") 
FI.00MP1502.s3<-read.delim("00MP1502-s3.Cy3-232.Cy5-F.fix.txt") 
FI.00MP1502.s4<-read.delim("00MP1502-s4.Cy3-F.Cy5-232.fix.txt") 
FI.00MP1502.s5<-read.delim("00MP1502-s5.Cy3-F.Cy5-232.fix.txt") 
FI.00MP1502.s6<-read.delim("00MP1502-s6.Cy3-232.Cy5-F.fix.txt") 
# Do each array separately unless they have the same number of rows. 
d.00MP1502<-compress(log.0(cbind( FI.00MP1502.s1[,2:5]-FI.00MP1502.s1[,6:9], 
     FI.00MP1502.s2[,2:7]-FI.00MP1502.s2[,8:13], 
     FI.00MP1502.s3[,2:3]-FI.00MP1502.s3[,4:5], 
     FI.00MP1502.s4[,2:3]-FI.00MP1502.s4[,4:5], 
     FI.00MP1502.s5[,2:5]-FI.00MP1502.s5[,6:9], 
     FI.00MP1502.s6[,2:5]-FI.00MP1502.s6[,6:9])), 
     c(2,2,3,3,1,1,1,1,2,2,2,2)) 
x11() 
par(mfrow=c(3,2)) 
slide.comp(d.00MP1502,1) 
slide.comp(d.00MP1502,2) 
slide.comp(d.00MP1502,3) 
slide.comp(d.00MP1502,4) 
slide.comp(d.00MP1502,5) 
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slide.comp(d.00MP1502,6) 
norm.d.00MP1502=msn(exp(d.00MP1502)) 
x11() 
par(mfrow=c(1,2)) 
boxplot(as.data.frame(d.00MP1502)) 
boxplot(as.data.frame(norm.d.00MP1502)) 
x11() 
par(mfrow=c(3,2)) 
slide.comp(norm.d.00MP1502,1) 
slide.comp(norm.d.00MP1502,2) 
slide.comp(norm.d.00MP1502,3) 
slide.comp(norm.d.00MP1502,4) 
slide.comp(norm.d.00MP1502,5) 
slide.comp(norm.d.00MP1502,6) 
# Export normalized data separately for each array 
setwd("...\\Normalized Data") 
write.table(data.frame(ID=FI.00MP1502.s1$ID,X1=norm.d.00MP1502[,1],X2=norm.d.00MP1502[,2]),fi
le="nd.00MP1502.s1.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.00MP1502.s2$ID,X3=norm.d.00MP1502[,3],X4=norm.d.00MP1502[,4]),fi
le="nd.00MP1502.s2.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.00MP1502.s3$ID,X5=norm.d.00MP1502[,5],X6=norm.d.00MP1502[,6]),fi
le="nd.00MP1502.s3.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.00MP1502.s4$ID,X7=norm.d.00MP1502[,7],X8=norm.d.00MP1502[,8]),fi
le="nd.00MP1502.s4.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.00MP1502.s5$ID,X9=norm.d.00MP1502[,9],X10=norm.d.00MP1502[,10]),
file="nd.00MP1502.s5.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.00MP1502.s6$ID,X11=norm.d.00MP1502[,11],X12=norm.d.00MP1502[,12]
),file="nd.00MP1502.s6.txt",sep="\t",row.names=F) 
save.image("00MP1502-F.RData") 
# ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# 95MP1504 - 27008 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
source("...\\log.0.R") 
source("...\\compress.R") 
source("...\\slide.comp.R") 
source("...\\msn.R") 
source("...\\normalize.R") 
# load data sets & do analysis 
# Note: Size of data sets may vary do to deletion of abnormal spots. 
# The ID order may vary between array also. 
setwd("...") 
FI.95MP1504.s1<-read.delim("95MP1504-s1.Cy3-232.Cy5-27008.fix.txt") 
FI.95MP1504.s2<-read.delim("95MP1504-s2.Cy3-232.Cy5-27008.fix.txt") 
FI.95MP1504.s3<-read.delim("95MP1504-s3.Cy3-27008.Cy5-232.fix.txt") 
FI.95MP1504.s4<-read.delim("95MP1504-s4.Cy3-27008.Cy5-232.fix.txt") 
# Do each array separately unless they have the same number of rows. 
d.95MP1504.s1<-compress(log.0(FI.95MP1504.s1[,2:9]-FI.95MP1504.s1[,10:17]),c(4,4)) 
d.95MP1504.s2<-compress(log.0(FI.95MP1504.s2[,2:6]-FI.95MP1504.s2[,7:11]),c(2,3)) 
d.95MP1504.s3<-compress(log.0(FI.95MP1504.s3[,2:7]-FI.95MP1504.s3[,8:13]),c(3,3)) 
d.95MP1504.s4<-compress(log.0(FI.95MP1504.s4[,2:9]-FI.95MP1504.s4[,10:17]),c(4,4)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d.95MP1504.s1,1) 
slide.comp(d.95MP1504.s2,1) 
slide.comp(d.95MP1504.s3,1) 
slide.comp(d.95MP1504.s4,1) 
norm.d.95MP1504.s1=msn(exp(d.95MP1504.s1)) 
norm.d.95MP1504.s2=msn(exp(d.95MP1504.s2)) 
norm.d.95MP1504.s3=msn(exp(d.95MP1504.s3)) 
norm.d.95MP1504.s4=msn(exp(d.95MP1504.s4)) 
x11() 
par(mfrow=c(2,4)) 
boxplot(as.data.frame(d.95MP1504.s1)) 
boxplot(as.data.frame(norm.d.95MP1504.s1)) 
boxplot(as.data.frame(d.95MP1504.s2)) 
boxplot(as.data.frame(norm.d.95MP1504.s2)) 
boxplot(as.data.frame(d.95MP1504.s3)) 
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boxplot(as.data.frame(norm.d.95MP1504.s3)) 
boxplot(as.data.frame(d.95MP1504.s4)) 
boxplot(as.data.frame(norm.d.95MP1504.s4)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(norm.d.95MP1504.s1,1) 
slide.comp(norm.d.95MP1504.s2,1) 
slide.comp(norm.d.95MP1504.s3,1) 
slide.comp(norm.d.95MP1504.s4,1) 
# Export normalized data separately for each array 
setwd("...\\Normalized Data") 
write.table(data.frame(ID=FI.95MP1504.s1$ID,X1=norm.d.95MP1504.s1[,1],X2=norm.d.95MP1504.s1[,
2]),file="nd.95MP1504.s1.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1504.s2$ID,X3=norm.d.95MP1504.s2[,1],X4=norm.d.95MP1504.s2[,
2]),file="nd.95MP1504.s2.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1504.s3$ID,X5=norm.d.95MP1504.s3[,1],X6=norm.d.95MP1504.s3[,
2]),file="nd.95MP1504.s3.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1504.s4$ID,X7=norm.d.95MP1504.s4[,1],X8=norm.d.95MP1504.s4[,
2]),file="nd.95MP1504.s4.txt",sep="\t",row.names=F) 
save.image("95MP1504-27008.RData") 
# ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# 95MP1505 - 27533 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
source("...\\log.0.R") 
source("...\\compress.R") 
source("...\\slide.comp.R") 
source("...\\msn.R") 
source("...\\normalize.R") 
# load data sets & do analysis 
# Note: Size of data sets may vary do to deletion of abnormal spots. 
# The ID order may vary between array also. 
setwd("...") 
FI.95MP1505.s1<-read.delim("95MP1505-s1.Cy3-27533.Cy5-232.fix.txt") 
FI.95MP1505.s2<-read.delim("95MP1505-s2.Cy3-27533.Cy5-232.fix.txt") 
FI.95MP1505.s3<-read.delim("95MP1505-s3.Cy3-232.Cy5-27533.fix.txt") 
FI.95MP1505.s4<-read.delim("95MP1505-s4.Cy3-27533.Cy5-232.fix.txt") 
FI.95MP1505.s5<-read.delim("95MP1505-s5.Cy3-232.Cy5-27533.fix.txt") 
# The bottom of the above array had a lot of back ground.  
# So it is deleted in the data set below. 
FI.95MP1505.s5A<-read.delim("95MP1505-s5A.Cy3-232.Cy5-27533.fix.txt") 
# Decide to use one or the other before sending it to SAS. 
# Do each array separately unless they have the same number of rows. 
d.95MP1505<-compress(log.0(cbind( FI.95MP1505.s1[,2:6]-FI.95MP1505.s1[,7:11], 
     FI.95MP1505.s2[,2:7]-FI.95MP1505.s2[,8:13], 
     FI.95MP1505.s3[,2:3]-FI.95MP1505.s3[,4:5], 
     FI.95MP1505.s4[,2:3]-FI.95MP1505.s4[,4:5])), 
     c(3,2,3,3,1,1,1,1)) 
d.95MP1505.s5<-compress( log.0(FI.95MP1505.s5[,2:7]-FI.95MP1505.s5[,8:13]),c(3,3)) 
d.95MP1505.s5A<-compress( log.0(FI.95MP1505.s5A[,2:7]-FI.95MP1505.s5A[,8:13]),c(3,3)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d.95MP1505,1) 
slide.comp(d.95MP1505,2) 
slide.comp(d.95MP1505,3) 
slide.comp(d.95MP1505,4) 
norm.d.95MP1505=msn(exp(d.95MP1505)) 
norm.d.95MP1505.s5=msn(exp(d.95MP1505.s5)) 
norm.d.95MP1505.s5A=msn(exp(d.95MP1505.s5A)) 
x11() 
par(mfrow=c(1,2)) 
boxplot(as.data.frame(d.95MP1505)) 
boxplot(as.data.frame(norm.d.95MP1505)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(norm.d.95MP1505,1) 
slide.comp(norm.d.95MP1505,2) 
slide.comp(norm.d.95MP1505,3) 
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slide.comp(norm.d.95MP1505,4) 
x11() 
par(mfrow=c(1,4)) 
boxplot(as.data.frame(d.95MP1505.s5)) 
boxplot(as.data.frame(norm.d.95MP1505.s5)) 
boxplot(as.data.frame(d.95MP1505.s5A)) 
boxplot(as.data.frame(norm.d.95MP1505.s5A)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d.95MP1505.s5,1) 
slide.comp(d.95MP1505.s5A,1) 
slide.comp(norm.d.95MP1505.s5,1) 
slide.comp(norm.d.95MP1505.s5A,1) 
# There isn't much difference visually here, so just use the 95MP1505.s5 
# Export normalized data separately for each array 
setwd("...\\Normalized Data") 
write.table(data.frame(ID=FI.95MP1505.s1$ID,X1=norm.d.95MP1505[,1],X2=norm.d.95MP1505[,2]),fi
le="nd.95MP1505.s1.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1505.s2$ID,X3=norm.d.95MP1505[,3],X4=norm.d.95MP1505[,4]),fi
le="nd.95MP1505.s2.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1505.s3$ID,X5=norm.d.95MP1505[,5],X6=norm.d.95MP1505[,6]),fi
le="nd.95MP1505.s3.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1505.s4$ID,X7=norm.d.95MP1505[,7],X8=norm.d.95MP1505[,8]),fi
le="nd.95MP1505.s4.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1505.s5$ID,X9=norm.d.95MP1505.s5[,1],X10=norm.d.95MP1505.s5[
,2]),file="nd.95MP1505.s5.txt",sep="\t",row.names=F) 
save.image("95MP1505-27533.RData") 
# ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# 95MP1506 - 27604 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
source("...\\log.0.R") 
source("...\\compress.R") 
source("...\\slide.comp.R") 
source("...\\msn.R") 
source("...\\normalize.R") 
# load data sets & do analysis 
# Note: Size of data sets may vary do to deletion of abnormal spots. 
# The ID order may vary between array also. 
setwd("...") 
FI.95MP1506.s1<-read.delim("95MP1506-s1.Cy3-27604.Cy5-232.fix.txt") 
FI.95MP1506.s2<-read.delim("95MP1506-s2.Cy3-232.Cy5-27604.fix.txt") 
FI.95MP1506.s3<-read.delim("95MP1506-s3.Cy3-27604.Cy5-232.fix.txt") 
FI.95MP1506.s4<-read.delim("95MP1506-s4.Cy3-27604.Cy5-232.fix.txt") 
FI.95MP1506.s5<-read.delim("95MP1506-s5.Cy3-232.Cy5-27604.fix.txt") 
# Do each array separately unless they have the same number of rows. 
d.95MP1506<-compress(log.0(cbind( FI.95MP1506.s1[,2:3]-FI.95MP1506.s1[,4:5], 
     FI.95MP1506.s2[,2:3]-FI.95MP1506.s2[,4:5], 
     FI.95MP1506.s3[,2:9]-FI.95MP1506.s3[,10:17], 
     FI.95MP1506.s4[,2:9]-FI.95MP1506.s4[,10:17], 
     FI.95MP1506.s5[,2:7]-FI.95MP1506.s5[,8:13])), 
     c(1,1,1,1,4,4,4,4,3,3)) 
x11() 
par(mfrow=c(3,2)) 
slide.comp(d.95MP1506,1) 
slide.comp(d.95MP1506,2) 
slide.comp(d.95MP1506,3) 
slide.comp(d.95MP1506,4) 
slide.comp(d.95MP1506,5) 
norm.d.95MP1506=msn(exp(d.95MP1506)) 
x11() 
par(mfrow=c(1,2)) 
boxplot(as.data.frame(d.95MP1506)) 
boxplot(as.data.frame(norm.d.95MP1506)) 
x11() 
par(mfrow=c(3,2)) 
slide.comp(norm.d.95MP1506,1) 
slide.comp(norm.d.95MP1506,2) 
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slide.comp(norm.d.95MP1506,3) 
slide.comp(norm.d.95MP1506,4) 
slide.comp(norm.d.95MP1506,5) 
# Export normalized data separately for each array 
setwd("...\\Normalized Data") 
write.table(data.frame(ID=FI.95MP1506.s1$ID,X1=norm.d.95MP1506[,1],X2=norm.d.95MP1506[,2]),fi
le="nd.95MP1506.s1.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1506.s2$ID,X3=norm.d.95MP1506[,3],X4=norm.d.95MP1506[,4]),fi
le="nd.95MP1506.s2.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1506.s3$ID,X5=norm.d.95MP1506[,5],X6=norm.d.95MP1506[,6]),fi
le="nd.95MP1506.s3.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1506.s4$ID,X7=norm.d.95MP1506[,7],X8=norm.d.95MP1506[,8]),fi
le="nd.95MP1506.s4.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1506.s5$ID,X9=norm.d.95MP1506[,9],X10=norm.d.95MP1506[,10]),
file="nd.95MP1506.s5.txt",sep="\t",row.names=F) 
save.image("95MP1506-27604.RData") 
# ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# 95MP1507 - 27644 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
source("...\\log.0.R") 
source("...\\compress.R") 
source("...\\slide.comp.R") 
source("...\\msn.R") 
source("...\\normalize.R") 
# load data sets & do analysis 
# Note: Size of data sets may vary do to deletion of abnormal spots. 
# The ID order may vary between array also. 
setwd("...") 
FI.95MP1507.s1<-read.delim("95MP1507-s1.Cy3-27644.Cy5-232.fix.txt") 
FI.95MP1507.s2<-read.delim("95MP1507-s2.Cy3-27644.Cy5-232.fix.txt") 
FI.95MP1507.s3<-read.delim("95MP1507-s3.Cy3-232.Cy5-27644.fix.txt") 
FI.95MP1507.s4<-read.delim("95MP1507-s4.Cy3-232.Cy5-27644.fix.txt") 
FI.95MP1507.s5<-read.delim("95MP1507-s5.Cy3-232.Cy5-27644.fix.txt") 
# Do each array separately unless they have the same number of rows. 
d.95MP1507.1<-compress(log.0(cbind( FI.95MP1507.s1[,2:5]-FI.95MP1507.s1[,6:9], 
     FI.95MP1507.s2[,2:5]-FI.95MP1507.s2[,6:9], 
     FI.95MP1507.s3[,2:7]-FI.95MP1507.s3[,8:13], 
     FI.95MP1507.s4[,2:6]-FI.95MP1507.s4[,7:11])), 
     c(2,2,2,2,3,3,2,3)) 
d.95MP1507.2<-compress(log.0(cbind( FI.95MP1507.s5[,2:9]-FI.95MP1507.s5[,10:17])),c(4,4)) 
x11() 
par(mfrow=c(3,2)) 
slide.comp(d.95MP1507.1,1) 
slide.comp(d.95MP1507.1,2) 
slide.comp(d.95MP1507.1,3) 
slide.comp(d.95MP1507.1,4) 
slide.comp(d.95MP1507.2,1) 
norm.d.95MP1507.1=msn(exp(d.95MP1507.1)) 
norm.d.95MP1507.2=msn(exp(d.95MP1507.2)) 
x11() 
par(mfrow=c(1,4)) 
boxplot(as.data.frame(d.95MP1507.1)) 
boxplot(as.data.frame(norm.d.95MP1507.1)) 
boxplot(as.data.frame(d.95MP1507.2)) 
boxplot(as.data.frame(norm.d.95MP1507.2)) 
x11() 
par(mfrow=c(3,2)) 
slide.comp(norm.d.95MP1507.1,1) 
slide.comp(norm.d.95MP1507.1,2) 
slide.comp(norm.d.95MP1507.1,3) 
slide.comp(norm.d.95MP1507.1,4) 
slide.comp(norm.d.95MP1507.2,1) 
# Export normalized data separately for each array 
setwd("...\\Normalized Data") 
write.table(data.frame(ID=FI.95MP1507.s1$ID,X1=norm.d.95MP1507.1[,1],X2=norm.d.95MP1507.1[,2]
),file="nd.95MP1507.s1.txt",sep="\t",row.names=F) 
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write.table(data.frame(ID=FI.95MP1507.s2$ID,X3=norm.d.95MP1507.1[,3],X4=norm.d.95MP1507.1[,4]
),file="nd.95MP1507.s2.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1507.s3$ID,X5=norm.d.95MP1507.1[,5],X6=norm.d.95MP1507.1[,6]
),file="nd.95MP1507.s3.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1507.s4$ID,X7=norm.d.95MP1507.1[,7],X8=norm.d.95MP1507.1[,8]
),file="nd.95MP1507.s4.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1507.s5$ID,X9=norm.d.95MP1507.2[,1],X10=norm.d.95MP1507.2[,2
]),file="nd.95MP1507.s5.txt",sep="\t",row.names=F) 
save.image("95MP1507-27644.RData") 
# ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# 95MP1509 - 29024 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
source("...\\log.0.R") 
source("...\\compress.R") 
source("...\\slide.comp.R") 
source("...\\msn.R") 
source("...\\normalize.R") 
# load data sets & do analysis 
# Note: Size of data sets may vary do to deletion of abnormal spots. 
# The ID order may vary between array also. 
setwd("...") 
FI.95MP1509.s1<-read.delim("95MP1509-s1.Cy3-232.Cy5-29024.fix.txt") 
FI.95MP1509.s2<-read.delim("95MP1509-s2.Cy3-29024.Cy5-232.fix.txt") 
FI.95MP1509.s3<-read.delim("95MP1509-s3.Cy3-29024.Cy5-232.fix.txt") 
FI.95MP1509.s4<-read.delim("95MP1509-s4.Cy3-232.Cy5-29024.fix.txt") 
FI.95MP1509.s5<-read.delim("95MP1509-s5.Cy3-232.Cy5-29024.fix.txt") 
# Do each array separately unless they have the same number of rows. 
d.95MP1509<-compress(log.0(cbind( FI.95MP1509.s1[,2:5]-FI.95MP1509.s1[,6:9], 
     FI.95MP1509.s2[,2:7]-FI.95MP1509.s2[,8:13], 
     FI.95MP1509.s3[,2:7]-FI.95MP1509.s3[,8:13], 
     FI.95MP1509.s4[,2:7]-FI.95MP1509.s4[,8:13])), 
     c(2,2,3,3,3,3,3,3)) 
d.95MP1509.s5<-compress( log.0(FI.95MP1509.s5[,2:7]-FI.95MP1509.s5[,8:13]),c(3,3)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d.95MP1509,1) 
slide.comp(d.95MP1509,2) 
slide.comp(d.95MP1509,3) 
slide.comp(d.95MP1509,4) 
norm.d.95MP1509=msn(exp(d.95MP1509)) 
norm.d.95MP1509.s5=msn(exp(d.95MP1509.s5)) 
x11() 
par(mfrow=c(1,2)) 
boxplot(as.data.frame(d.95MP1509)) 
boxplot(as.data.frame(norm.d.95MP1509)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(norm.d.95MP1509,1) 
slide.comp(norm.d.95MP1509,2) 
slide.comp(norm.d.95MP1509,3) 
slide.comp(norm.d.95MP1509,4) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d.95MP1509.s5,1) 
slide.comp(norm.d.95MP1509.s5,1) 
x11() 
par(mfrow=c(1,2)) 
boxplot(as.data.frame(d.95MP1509.s5)) 
boxplot(as.data.frame(norm.d.95MP1509.s5)) 
# Slide 5 has one outlier, but it looks a lot better than slide 1. 
# Don't use slide 1. 
# Export normalized data separately for each array 
setwd("...\\Normalized Data") 
# May want to exclude the first slide from the analysis.   
# FI.95MP1509.s1. YES, don't use this one. Exclude within SAS. 
write.table(data.frame(ID=FI.95MP1509.s1$ID,X1=norm.d.95MP1509[,1],X2=norm.d.95MP1509[,2]),fi
le="nd.95MP1509.s1.txt",sep="\t",row.names=F) 
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write.table(data.frame(ID=FI.95MP1509.s2$ID,X3=norm.d.95MP1509[,3],X4=norm.d.95MP1509[,4]),fi
le="nd.95MP1509.s2.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1509.s3$ID,X5=norm.d.95MP1509[,5],X6=norm.d.95MP1509[,6]),fi
le="nd.95MP1509.s3.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1509.s4$ID,X7=norm.d.95MP1509[,7],X8=norm.d.95MP1509[,8]),fi
le="nd.95MP1509.s4.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1509.s5$ID,X9=norm.d.95MP1509.s5[,1],X10=norm.d.95MP1509[,2]
),file="nd.95MP1509.s5.txt",sep="\t",row.names=F) 
save.image("95MP1509-29024.RData") 
# ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# 95MP1510 - 27926 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
source("...\\log.0.R") 
source("...\\compress.R") 
source("...\\slide.comp.R") 
source("...\\msn.R") 
source("...\\normalize.R") 
# load data sets & do analysis 
# Note: Size of data sets may vary do to deletion of abnormal spots. 
# The ID order may vary between array also. 
setwd("...") 
FI.95MP1510.s1<-read.delim("95MP1510-s1.Cy3-232.Cy5-27926.fix.txt") 
FI.95MP1510.s2<-read.delim("95MP1510-s2.Cy3-27926.Cy5-232.fix.txt") 
FI.95MP1510.s3<-read.delim("95MP1510-s3.Cy3-27926.Cy5-232.fix.txt") 
FI.95MP1510.s4<-read.delim("95MP1510-s4.Cy3-27926.Cy5-232.fix.txt") 
FI.95MP1510.s5<-read.delim("95MP1510-s5.Cy3-232.Cy5-27926.fix.txt") 
# Do each array separately unless they have the same number of rows. 
d.95MP1510.1<-compress(log.0(cbind( FI.95MP1510.s1[,2:7]-FI.95MP1510.s1[,8:13], 
     FI.95MP1510.s2[,2:6]-FI.95MP1510.s2[,7:11], 
     FI.95MP1510.s3[,2:7]-FI.95MP1510.s3[,8:13])), 
     c(3,3,3,2,3,3)) 
d.95MP1510.2<-compress(log.0(cbind( FI.95MP1510.s4[,2:9]-FI.95MP1510.s4[,10:17])),c(4,4)) 
d.95MP1510.s5<-compress( log.0(FI.95MP1510.s5[,2:7]-FI.95MP1510.s5[,8:13]),c(3,3)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d.95MP1510.1,1) 
slide.comp(d.95MP1510.1,2) 
slide.comp(d.95MP1510.1,3) 
slide.comp(d.95MP1510.2,1) 
norm.d.95MP1510.1=msn(exp(d.95MP1510.1)) 
norm.d.95MP1510.2=msn(exp(d.95MP1510.2)) 
norm.d.95MP1510.s5=msn(exp(d.95MP1510.s5)) 
x11() 
par(mfrow=c(2,2)) 
boxplot(as.data.frame(d.95MP1510.1)) 
boxplot(as.data.frame(norm.d.95MP1510.1)) 
boxplot(as.data.frame(d.95MP1510.2)) 
boxplot(as.data.frame(norm.d.95MP1510.2)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(norm.d.95MP1510.1,1) 
slide.comp(norm.d.95MP1510.1,2) 
slide.comp(norm.d.95MP1510.1,3) 
slide.comp(norm.d.95MP1510.2,1) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d.95MP1510.s5,1) 
slide.comp(norm.d.95MP1510.s5,1) 
x11() 
par(mfrow=c(1,2)) 
boxplot(as.data.frame(d.95MP1510.s5)) 
boxplot(as.data.frame(norm.d.95MP1510.s5)) 
# One channel did not label correctly do not use slide 5. Hence don't export it. 
# Export normalized data separately for each array 
setwd("...\\Normalized Data") 
write.table(data.frame(ID=FI.95MP1510.s1$ID,X1=norm.d.95MP1510.1[,1],X2=norm.d.95MP1510.1[,2]
),file="nd.95MP1510.s1.txt",sep="\t",row.names=F) 
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write.table(data.frame(ID=FI.95MP1510.s2$ID,X3=norm.d.95MP1510.1[,3],X4=norm.d.95MP1510.1[,4]
),file="nd.95MP1510.s2.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1510.s3$ID,X5=norm.d.95MP1510.1[,5],X6=norm.d.95MP1510.1[,6]
),file="nd.95MP1510.s3.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1510.s4$ID,X7=norm.d.95MP1510.2[,1],X8=norm.d.95MP1510.2[,2]
),file="nd.95MP1510.s4.txt",sep="\t",row.names=F) 
save.image("95MP1510-27926.RData") 
# ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# now do the slides Mike Oneal did 
# ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# 05MP2301 - 19245B 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
source("...\\log.0.R") 
source("...\\compress.R") 
source("...\\slide.comp.R") 
source("...\\msn.R") 
source("...\\normalize.R") 
# load data sets & do analysis 
# Note: Size of data sets may vary do to deletion of abnormal spots. 
# The ID order may vary between array also. 
setwd("...") 
FI.05MP2301.s1<-read.delim("05MP2301-s1.Cy3-232.Cy5-19245B.fix.txt") 
FI.05MP2301.s2<-read.delim("05MP2301-s2.Cy3-19245B.Cy5-232.fix.txt") 
FI.05MP2301.s3<-read.delim("05MP2301-s3.Cy3-232.Cy5-19245B.fix.txt") 
FI.05MP2301.s4<-read.delim("05MP2301-s4.Cy3-19245B.Cy5-232.fix.txt") 
# Do each array separately unless they have the same number of rows. 
d.05MP2301<-compress(log.0(cbind( FI.05MP2301.s1[,2:5]-FI.05MP2301.s1[,6:9], 
     FI.05MP2301.s2[,2:5]-FI.05MP2301.s2[,6:9], 
     FI.05MP2301.s3[,2:5]-FI.05MP2301.s3[,6:9], 
     FI.05MP2301.s4[,2:5]-FI.05MP2301.s4[,6:9])), 
     c(2,2,2,2,2,2,2,2)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d.05MP2301,1) 
slide.comp(d.05MP2301,2) 
slide.comp(d.05MP2301,3) 
slide.comp(d.05MP2301,4) 
norm.d.05MP2301=msn(exp(d.05MP2301)) 
x11() 
par(mfrow=c(1,2)) 
boxplot(as.data.frame(d.05MP2301)) 
boxplot(as.data.frame(norm.d.05MP2301)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(norm.d.05MP2301,1) 
slide.comp(norm.d.05MP2301,2) 
slide.comp(norm.d.05MP2301,3) 
slide.comp(norm.d.05MP2301,4) 
# Export normalized data separately for each array 
setwd("...\\Normalized Data") 
write.table(data.frame(ID=FI.05MP2301.s1$ID,X1=norm.d.05MP2301[,1],X2=norm.d.05MP2301[,2]),fi
le="nd.05MP2301.s1.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.05MP2301.s2$ID,X3=norm.d.05MP2301[,3],X4=norm.d.05MP2301[,4]),fi
le="nd.05MP2301.s2.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.05MP2301.s3$ID,X5=norm.d.05MP2301[,5],X6=norm.d.05MP2301[,6]),fi
le="nd.05MP2301.s3.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.05MP2301.s4$ID,X7=norm.d.05MP2301[,7],X8=norm.d.05MP2301[,8]),fi
le="nd.05MP2301.s4.txt",sep="\t",row.names=F) 
save.image("05MP2301-19245B.RData") 
# ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# 95MP1501 - 20425B 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
source("...\\log.0.R") 
source("...\\compress.R") 
source("...\\slide.comp.R") 
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source("...\\msn.R") 
source("...\\normalize.R") 
# load data sets & do analysis 
# Note: Size of data sets may vary do to deletion of abnormal spots. 
# The ID order may vary between array also. 
setwd("...") 
FI.95MP1501.s1<-read.delim("95MP1501-s1.Cy3-232.Cy5-20425B.fix.txt") 
FI.95MP1501.s2<-read.delim("95MP1501-s2.Cy3-20425B.Cy5-232.fix.txt") 
FI.95MP1501.s3<-read.delim("95MP1501-s3.Cy3-232.Cy5-20425B.fix.txt") 
FI.95MP1501.s4<-read.delim("95MP1501-s4.Cy3-20425B.Cy5-232.fix.txt") 
# Do each array separately unless they have the same number of rows. 
d.95MP1501<-compress(log.0(cbind( FI.95MP1501.s1[,2:7]-FI.95MP1501.s1[,8:13], 
     FI.95MP1501.s2[,2:7]-FI.95MP1501.s2[,8:13], 
     FI.95MP1501.s3[,2:7]-FI.95MP1501.s3[,8:13], 
     FI.95MP1501.s4[,2:7]-FI.95MP1501.s4[,8:13])), 
     c(3,3,3,3,3,3,3,3)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d.95MP1501,1) 
slide.comp(d.95MP1501,2) 
slide.comp(d.95MP1501,3) 
slide.comp(d.95MP1501,4) 
norm.d.95MP1501=msn(exp(d.95MP1501)) 
x11() 
par(mfrow=c(1,2)) 
boxplot(as.data.frame(d.95MP1501)) 
boxplot(as.data.frame(norm.d.95MP1501)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(norm.d.95MP1501,1) 
slide.comp(norm.d.95MP1501,2) 
slide.comp(norm.d.95MP1501,3) 
slide.comp(norm.d.95MP1501,4) 
# Export normalized data separately for each array 
setwd("...\\Normalized Data") 
write.table(data.frame(ID=FI.95MP1501.s1$ID,X1=norm.d.95MP1501[,1],X2=norm.d.95MP1501[,2]),fi
le="nd.95MP1501.s1.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1501.s2$ID,X3=norm.d.95MP1501[,3],X4=norm.d.95MP1501[,4]),fi
le="nd.95MP1501.s2.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1501.s3$ID,X5=norm.d.95MP1501[,5],X6=norm.d.95MP1501[,6]),fi
le="nd.95MP1501.s3.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1501.s4$ID,X7=norm.d.95MP1501[,7],X8=norm.d.95MP1501[,8]),fi
le="nd.95MP1501.s4.txt",sep="\t",row.names=F) 
save.image("95MP1501-20425B.RData") 
# ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# 95MP1502 - 21580 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
source("...\\log.0.R") 
source("...\\compress.R") 
source("...\\slide.comp.R") 
source("...\\msn.R") 
source("...\\normalize.R") 
# load data sets & do analysis 
# Note: Size of data sets may vary do to deletion of abnormal spots. 
# The ID order may vary between array also. 
setwd("...") 
FI.95MP1502.s1<-read.delim("95MP1502-s1.Cy3-232.Cy5-21580.fix.txt") 
FI.95MP1502.s2<-read.delim("95MP1502-s2.Cy3-21580.Cy5-232.fix.txt") 
FI.95MP1502.s3<-read.delim("95MP1502-s3.Cy3-232.Cy5-21580.fix.txt") 
FI.95MP1502.s4<-read.delim("95MP1502-s4.Cy3-21580.Cy5-232.fix.txt") 
# Do each array separately unless they have the same number of rows. 
d.95MP1502<-compress(log.0(cbind( FI.95MP1502.s1[,2:7]-FI.95MP1502.s1[,8:13], 
     FI.95MP1502.s2[,2:7]-FI.95MP1502.s2[,8:13], 
     FI.95MP1502.s3[,2:7]-FI.95MP1502.s3[,8:13], 
     FI.95MP1502.s4[,2:7]-FI.95MP1502.s4[,8:13])), 
     c(3,3,3,3,3,3,3,3)) 
x11() 
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par(mfrow=c(2,2)) 
slide.comp(d.95MP1502,1) 
slide.comp(d.95MP1502,2) 
slide.comp(d.95MP1502,3) 
slide.comp(d.95MP1502,4) 
norm.d.95MP1502=msn(exp(d.95MP1502)) 
x11() 
par(mfrow=c(1,2)) 
boxplot(as.data.frame(d.95MP1502)) 
boxplot(as.data.frame(norm.d.95MP1502)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(norm.d.95MP1502,1) 
slide.comp(norm.d.95MP1502,2) 
slide.comp(norm.d.95MP1502,3) 
slide.comp(norm.d.95MP1502,4) 
# Export normalized data separately for each array 
setwd("...\\Normalized Data") 
write.table(data.frame(ID=FI.95MP1502.s1$ID,X1=norm.d.95MP1502[,1],X2=norm.d.95MP1502[,2]),fi
le="nd.95MP1502.s1.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1502.s2$ID,X3=norm.d.95MP1502[,3],X4=norm.d.95MP1502[,4]),fi
le="nd.95MP1502.s2.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1502.s3$ID,X5=norm.d.95MP1502[,5],X6=norm.d.95MP1502[,6]),fi
le="nd.95MP1502.s3.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1502.s4$ID,X7=norm.d.95MP1502[,7],X8=norm.d.95MP1502[,8]),fi
le="nd.95MP1502.s4.txt",sep="\t",row.names=F) 
save.image("95MP1502-21580.RData") 
# ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# 95MP1503 - 23829 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
source("...\\log.0.R") 
source("...\\compress.R") 
source("...\\slide.comp.R") 
source("...\\msn.R") 
source("...\\normalize.R") 
# load data sets & do analysis 
# Note: Size of data sets may vary do to deletion of abnormal spots. 
# The ID order may vary between array also. 
setwd("...") 
FI.95MP1503.s1<-read.delim("95MP1503-s1.Cy3-232.Cy5-23829.fix.txt") 
FI.95MP1503.s2<-read.delim("95MP1503-s2.Cy3-23829.Cy5-232.fix.txt") 
FI.95MP1503.s3<-read.delim("95MP1503-s3.Cy3-232.Cy5-23829.fix.txt") 
FI.95MP1503.s4<-read.delim("95MP1503-s4.Cy3-23829.Cy5-232.fix.txt") 
# Do each array separately unless they have the same number of rows. 
d.95MP1503<-compress(log.0(cbind( FI.95MP1503.s1[,2:5]-FI.95MP1503.s1[,6:9], 
     FI.95MP1503.s2[,2:5]-FI.95MP1503.s2[,6:9], 
     FI.95MP1503.s3[,2:5]-FI.95MP1503.s3[,6:9], 
     FI.95MP1503.s4[,2:5]-FI.95MP1503.s4[,6:9])), 
     c(2,2,2,2,2,2,2,2)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d.95MP1503,1) 
slide.comp(d.95MP1503,2) 
slide.comp(d.95MP1503,3) 
slide.comp(d.95MP1503,4) 
norm.d.95MP1503=msn(exp(d.95MP1503)) 
x11() 
par(mfrow=c(1,2)) 
boxplot(as.data.frame(d.95MP1503)) 
boxplot(as.data.frame(norm.d.95MP1503)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(norm.d.95MP1503,1) 
slide.comp(norm.d.95MP1503,2) 
slide.comp(norm.d.95MP1503,3) 
slide.comp(norm.d.95MP1503,4) 
# Export normalized data separately for each array 
 205 
setwd("...\\Normalized Data") 
write.table(data.frame(ID=FI.95MP1503.s1$ID,X1=norm.d.95MP1503[,1],X2=norm.d.95MP1503[,2]),fi
le="nd.95MP1503.s1.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1503.s2$ID,X3=norm.d.95MP1503[,3],X4=norm.d.95MP1503[,4]),fi
le="nd.95MP1503.s2.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1503.s3$ID,X5=norm.d.95MP1503[,5],X6=norm.d.95MP1503[,6]),fi
le="nd.95MP1503.s3.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1503.s4$ID,X7=norm.d.95MP1503[,7],X8=norm.d.95MP1503[,8]),fi
le="nd.95MP1503.s4.txt",sep="\t",row.names=F) 
save.image("95MP1503-23829.RData") 
# ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# 95MP1508 - 279784 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
source("...\\log.0.R") 
source("...\\compress.R") 
source("...\\slide.comp.R") 
source("...\\msn.R") 
source("...\\normalize.R") 
# load data sets & do analysis 
# Note: Size of data sets may vary do to deletion of abnormal spots. 
# The ID order may vary between array also. 
setwd("...") 
FI.95MP1508.s1<-read.delim("95MP1508-s1.Cy3-232.Cy5-279784.fix.txt") 
FI.95MP1508.s2<-read.delim("95MP1508-s2.Cy3-279784.Cy5-232.fix.txt") 
FI.95MP1508.s3<-read.delim("95MP1508-s3.Cy3-232.Cy5-279784.fix.txt") 
FI.95MP1508.s4<-read.delim("95MP1508-s4.Cy3-279784.Cy5-232.fix.txt") 
# Do each array separately unless they have the same number of rows. 
d.95MP1508<-compress(log.0(cbind( FI.95MP1508.s1[,2:3]-FI.95MP1508.s1[,4:5], 
     FI.95MP1508.s2[,2:3]-FI.95MP1508.s2[,4:5], 
     FI.95MP1508.s3[,2:5]-FI.95MP1508.s3[,6:9], 
     FI.95MP1508.s4[,2:5]-FI.95MP1508.s4[,6:9])), 
     c(1,1,1,1,2,2,2,2)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d.95MP1508,1) 
slide.comp(d.95MP1508,2) 
slide.comp(d.95MP1508,3) 
slide.comp(d.95MP1508,4) 
norm.d.95MP1508=msn(exp(d.95MP1508)) 
x11() 
par(mfrow=c(1,2)) 
boxplot(as.data.frame(d.95MP1508)) 
boxplot(as.data.frame(norm.d.95MP1508)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(norm.d.95MP1508,1) 
slide.comp(norm.d.95MP1508,2) 
slide.comp(norm.d.95MP1508,3) 
slide.comp(norm.d.95MP1508,4) 
# Export normalized data separately for each array 
setwd("...\\Normalized Data") 
write.table(data.frame(ID=FI.95MP1508.s1$ID,X1=norm.d.95MP1508[,1],X2=norm.d.95MP1508[,2]),fi
le="nd.95MP1508.s1.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1508.s2$ID,X3=norm.d.95MP1508[,3],X4=norm.d.95MP1508[,4]),fi
le="nd.95MP1508.s2.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1508.s3$ID,X5=norm.d.95MP1508[,5],X6=norm.d.95MP1508[,6]),fi
le="nd.95MP1508.s3.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.95MP1508.s4$ID,X7=norm.d.95MP1508[,7],X8=norm.d.95MP1508[,8]),fi
le="nd.95MP1508.s4.txt",sep="\t",row.names=F) 
save.image("95MP1508-279784.RData") 
# ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
# 97MP0001 - 23129B 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# load functions needed 
source("...\\log.0.R") 
source("...\\compress.R") 
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source("...\\slide.comp.R") 
source("...\\msn.R") 
source("...\\normalize.R") 
# load data sets & do analysis 
# Note: Size of data sets may vary do to deletion of abnormal spots. 
# The ID order may vary between array also. 
setwd("...") 
FI.97MP0001.s1<-read.delim("97MP0001-s1.Cy3-232.Cy5-23129B.fix.txt") 
FI.97MP0001.s2<-read.delim("97MP0001-s2.Cy3-23129B.Cy5-232.fix.txt") 
FI.97MP0001.s3<-read.delim("97MP0001-s3.Cy3-23129B.Cy5-232.fix.txt") 
FI.97MP0001.s4<-read.delim("97MP0001-s4.Cy3-232.Cy5-23129B.fix.txt") 
# Do each array separately unless they have the same number of rows. 
d.97MP0001<-compress(log.0(cbind( FI.97MP0001.s1[,2:7]-FI.97MP0001.s1[,8:13], 
     FI.97MP0001.s2[,2:7]-FI.97MP0001.s2[,8:13], 
     FI.97MP0001.s3[,2:7]-FI.97MP0001.s3[,8:13], 
     FI.97MP0001.s4[,2:7]-FI.97MP0001.s4[,8:13])), 
     c(3,3,3,3,3,3,3,3)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(d.97MP0001,1) 
slide.comp(d.97MP0001,2) 
slide.comp(d.97MP0001,3) 
slide.comp(d.97MP0001,4) 
norm.d.97MP0001=msn(exp(d.97MP0001)) 
x11() 
par(mfrow=c(1,2)) 
boxplot(as.data.frame(d.97MP0001)) 
boxplot(as.data.frame(norm.d.97MP0001)) 
x11() 
par(mfrow=c(2,2)) 
slide.comp(norm.d.97MP0001,1) 
slide.comp(norm.d.97MP0001,2) 
slide.comp(norm.d.97MP0001,3) 
slide.comp(norm.d.97MP0001,4) 
# Export normalized data separately for each array 
setwd("...\\Normalized Data") 
write.table(data.frame(ID=FI.97MP0001.s1$ID,X1=norm.d.97MP0001[,1],X2=norm.d.97MP0001[,2]),fi
le="nd.97MP0001.s1.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.97MP0001.s2$ID,X3=norm.d.97MP0001[,3],X4=norm.d.97MP0001[,4]),fi
le="nd.97MP0001.s2.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.97MP0001.s3$ID,X5=norm.d.97MP0001[,5],X6=norm.d.97MP0001[,6]),fi
le="nd.97MP0001.s3.txt",sep="\t",row.names=F) 
write.table(data.frame(ID=FI.97MP0001.s4$ID,X7=norm.d.97MP0001[,7],X8=norm.d.97MP0001[,8]),fi
le="nd.97MP0001.s4.txt",sep="\t",row.names=F) 
save.image("97MP0001-23129B.RData") 
# Now import these files into to SAS for calculating differences and  
# then mean of differences. 
# Be sure to keep Mike and Melissa's separate since Mike is white light scanner data and # 
Mel is laser scanner data. 
 
# 
#After SAS analysis... 
# 
# ensure empty workspace  
rm(list=ls(all=TRUE)) 
# Import the one sided p values for all genes isolates 
setwd("…") 
x11() 
estimates=read.delim("Est.onep.final.txt") 
hist(estimates$one.p ,breaks=50) 
# load functions need for BH FDR calculations 
source("…\\bh.fdr.R") 
qvals<-bh.fdr(estimates$one.p) 
x11() 
hist(qvals ,breaks=50) 
estimates.qvals<-cbind(estimates,qvals) 
write.table(data.frame(estimates,qvalue=qvals),file="all results.final.txt", 
row.names=F,sep="\t") 
save.image("all.final.RData") 
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SAS script for fitting proc glm:  
DM 'LOG;CLEAR;OUTPUT;CLEAR;'; 
OPTIONS NODATE NONUMBER FORMDLIM= '_' LS=85 ; TITLE ; ; 
/* Bring in Melissa’s laser scan normalized data and differences & mean of differences. 
 */ 
* ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^; 
* ISOLATE 00MP1301 - P; 
proc import datafile='...\nd.00MP1301.s1.txt' 
            out=FI00MP1301s1 dbms=tab replace;  run; 
proc print data=FI00MP1301s1 (obs=8); run; 
proc import datafile='...\nd.00MP1301.s2.txt' 
            out=FI00MP1301s2 dbms=tab replace;  run; 
proc print data=FI00MP1301s2 (obs=8); run; 
proc import datafile='...\nd.00MP1301.s3.txt' 
            out=FI00MP1301s3 dbms=tab replace;  run; 
proc print data=FI00MP1301s3 (obs=8); run; 
proc import datafile='...\nd.00MP1301.s4.txt' 
            out=FI00MP1301s4 dbms=tab replace;  run; 
proc print data=FI00MP1301s4 (obs=8); run; 
* Sort these data files and combine them into one data set; 
proc sort data=FI00MP1301s1; by id; run; 
proc sort data=FI00MP1301s2; by id; run; 
proc sort data=FI00MP1301s3; by id; run; 
proc sort data=FI00MP1301s4; by id; run; 
data FI00MP1301; set FI00MP1301s1 FI00MP1301s2 FI00MP1301s3 FI00MP1301s4; 
 by id; run; 
* Calculate differences and then mean of diffs; 
data temp11; set FI00MP1301; * calculates Cy3 -Cy5; 
 y1=x1-x2; y2=x3-x4; y3=x5-x6; y4=x7-x8; 
 keep ID y1 y2 y3 y4; run; 
proc print data=temp11 (obs=8); run; 
/* Average differences for each gene */ 
proc sort data=temp11; by ID; run; 
ods listing close; run; 
proc means data=temp11; 
 var y1 y2 y3 y4; by ID; 
 output out=temp11 n=n mean=y1 y2 y3 y4;  run; 
ods listing; run; 
proc print data=temp11 (obs=8); run; 
/* Need to denote if 232 is cy3 or cy5 */ 
data temp12; set temp11; * dye denotes 232 label; 
 isolate='00MP1301'; intensity=y1; dye="cy5"; output; 
 isolate='00MP1301'; intensity=y2; dye="cy3"; output; 
 isolate='00MP1301'; intensity=y3; dye="cy5"; output; 
 isolate='00MP1301'; intensity=y4; dye="cy3"; output; 
 drop _type_ _freq_ y1-y4 n;  run; 
data temp12; set temp12; scan="laser"; run; 
proc print data=temp12 (obs=20); run; 
proc freq data=temp12; table id; run; 
* ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^; 
* ISOLATE 00MP1502 - F; 
proc import datafile='...\nd.00MP1502.s1.txt' 
            out=FI00MP1502s1 dbms=tab replace;  run; 
proc print data=FI00MP1502s1 (obs=8); run; 
proc import datafile='...\nd.00MP1502.s2.txt' 
            out=FI00MP1502s2 dbms=tab replace;  run; 
proc print data=FI00MP1502s2 (obs=8); run; 
proc import datafile='...\nd.00MP1502.s3.txt' 
            out=FI00MP1502s3 dbms=tab replace;  run; 
proc print data=FI00MP1502s3 (obs=8); run; 
proc import datafile='...\nd.00MP1502.s4.txt' 
            out=FI00MP1502s4 dbms=tab replace;  run; 
proc print data=FI00MP1502s4 (obs=8); run; 
proc import datafile='...\nd.00MP1502.s5.txt' 
            out=FI00MP1502s5 dbms=tab replace;  run; 
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proc print data=FI00MP1502s5 (obs=8); run; 
proc import datafile='...\nd.00MP1502.s6.txt' 
            out=FI00MP1502s6 dbms=tab replace;  run; 
proc print data=FI00MP1502s6 (obs=8); run; 
* Sort these data files and combine them into one data set; 
proc sort data=FI00MP1502s1; by id; run; 
proc sort data=FI00MP1502s2; by id; run; 
proc sort data=FI00MP1502s3; by id; run; 
proc sort data=FI00MP1502s4; by id; run; 
proc sort data=FI00MP1502s5; by id; run; 
proc sort data=FI00MP1502s6; by id; run; 
data FI00MP1502;  
set FI00MP1502s1 FI00MP1502s2 FI00MP1502s3 FI00MP1502s4 FI00MP1502s5 FI00MP1502s6; 
 by id; run; 
* Calculate differences and then mean of diffs; 
data temp21; set FI00MP1502; * calculates Cy3 -Cy5; 
 y1=x1-x2; y2=x3-x4; y3=x5-x6; y4=x7-x8; y5=x9-x10; y6=x11-x12; 
 keep ID y1 y2 y3 y4 y5 y6; run; 
proc print data=temp21 (obs=8); run; 
/* Average differences for each gene */ 
proc sort data=temp21; by ID; run; 
ods listing close; run; 
proc means data=temp21; 
 var y1 y2 y3 y4 y5 y6; 
 by ID; 
 output out=temp21 n=n mean=y1 y2 y3 y4 y5 y6;  run; 
ods listing; run; 
proc print data=temp21 (obs=8); run; 
/* Need to denote if 232 is cy3 or cy5 */ 
data temp22; set temp21; * dye denotes 232 label; 
 isolate='00MP1502'; intensity=y1; dye="cy3"; output; 
 isolate='00MP1502'; intensity=y2; dye="cy3"; output; 
 isolate='00MP1502'; intensity=y3; dye="cy3"; output; 
 isolate='00MP1502'; intensity=y4; dye="cy5"; output; 
 isolate='00MP1502'; intensity=y5; dye="cy5"; output; 
 isolate='00MP1502'; intensity=y6; dye="cy3"; output; 
 drop _type_ _freq_ y1-y6 n;  run;  
data temp22; set temp22; scan="laser"; run; 
proc print data=temp22 (obs=20); run; 
proc freq data=temp22; table id; run; 
* ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^; 
* ISOLATE 95MP1504 - 27008; 
proc import datafile='...\nd.95MP1504.s1.txt' 
            out=FI95MP1504s1 dbms=tab replace;  run; 
proc print data=FI95MP1504s1 (obs=8); run; 
proc import datafile='...\nd.95MP1504.s2.txt' 
            out=FI95MP1504s2 dbms=tab replace;  run; 
proc print data=FI95MP1504s2 (obs=8); run; 
proc import datafile='...\nd.95MP1504.s3.txt' 
            out=FI95MP1504s3 dbms=tab replace;  run; 
proc print data=FI95MP1504s3 (obs=8); run; 
proc import datafile='...\nd.95MP1504.s4.txt' 
            out=FI95MP1504s4 dbms=tab replace;  run; 
proc print data=FI95MP1504s4 (obs=8); run; 
* Sort these data files and combine them into one data set; 
proc sort data=FI95MP1504s1; by id; run; 
proc sort data=FI95MP1504s2; by id; run; 
proc sort data=FI95MP1504s3; by id; run; 
proc sort data=FI95MP1504s4; by id; run; 
data FI95MP1504; set FI95MP1504s1 FI95MP1504s2 FI95MP1504s3 FI95MP1504s4; 
 by id; run; 
* Calculate differences and then mean of diffs; 
data temp31; set FI95MP1504; * calculates Cy3 -Cy5; 
 y1=x1-x2; y2=x3-x4; y3=x5-x6; y4=x7-x8; 
 keep ID y1 y2 y3 y4; run; 
proc print data=temp31 (obs=8); run; 
/* Average differences for each gene */ 
proc sort data=temp31; by ID; run; 
ods listing close; run; 
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proc means data=temp31; 
 var y1 y2 y3 y4; by ID; 
 output out=temp31 n=n mean=y1 y2 y3 y4;  run; 
ods listing; run; 
proc print data=temp31 (obs=8); run; 
/* Need to denote if 232 is cy3 or cy5 */ 
data temp32; set temp31; * dye denotes 232 label; 
 isolate='95MP1504'; intensity=y1; dye="cy3"; output; 
 isolate='95MP1504'; intensity=y2; dye="cy3"; output; 
 isolate='95MP1504'; intensity=y3; dye="cy5"; output; 
 isolate='95MP1504'; intensity=y4; dye="cy5"; output; 
 drop _type_ _freq_ y1-y4 n;  run; 
data temp32; set temp32; scan="laser"; run; 
proc print data=temp32 (obs=20); run; 
proc freq data=temp32; table id; run; 
* ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^; 
* ISOLATE 95MP1505 - 27533; 
proc import datafile='...\nd.95MP1505.s1.txt' 
            out=FI95MP1505s1 dbms=tab  replace;  run; 
proc print data=FI95MP1505s1 (obs=8); run; 
proc import datafile='...\nd.95MP1505.s2.txt' 
            out=FI95MP1505s2 dbms=tab replace;  run; 
proc print data=FI95MP1505s2 (obs=8); run; 
proc import datafile='...\nd.95MP1505.s3.txt' 
            out=FI95MP1505s3 dbms=tab replace;  run; 
proc print data=FI95MP1505s3 (obs=8); run; 
proc import datafile='...\nd.95MP1505.s4.txt' 
            out=FI95MP1505s4 dbms=tab replace;  run; 
proc print data=FI95MP1505s4 (obs=8); run; 
proc import datafile='...\nd.95MP1505.s5.txt' 
            out=FI95MP1505s5 dbms=tab replace;  run; 
proc print data=FI95MP1505s5 (obs=8); run; 
* Sort these data files and combine them into one data set; 
proc sort data=FI95MP1505s1; by id; run; 
proc sort data=FI95MP1505s2; by id; run; 
proc sort data=FI95MP1505s3; by id; run; 
proc sort data=FI95MP1505s4; by id; run; 
proc sort data=FI95MP1505s5; by id; run; 
data FI95MP1505; set FI95MP1505s1 FI95MP1505s2 FI95MP1505s3 FI95MP1505s4 FI95MP1505s5; 
 by id; run; 
* Calculate differences and then mean of diffs; 
data temp41; set FI95MP1505; * calculates Cy3 -Cy5; 
 y1=x1-x2; y2=x3-x4; y3=x5-x6; y4=x7-x8; y5=x9-x10; 
 keep ID y1 y2 y3 y4 y5; run; 
proc print data=temp41 (obs=8); run; 
/* Average differences for each gene */ 
proc sort data=temp41; by ID; run; 
ods listing close; run; 
proc means data=temp41; 
 var y1 y2 y3 y4 y5; by ID; 
 output out=temp41 n=n mean=y1 y2 y3 y4 y5;  run; 
ods listing; run; 
proc print data=temp41 (obs=8); run; 
/* Need to denote if 232 is cy3 or cy5 */ 
data temp42; set temp41; * dye denotes 232 label; 
 isolate='95MP1505'; intensity=y1; dye="cy5"; output; 
 isolate='95MP1505'; intensity=y2; dye="cy5"; output; 
 isolate='95MP1505'; intensity=y3; dye="cy3"; output; 
 isolate='95MP1505'; intensity=y4; dye="cy5"; output; 
 isolate='95MP1505'; intensity=y5; dye="cy3"; output; 
 drop _type_ _freq_ y1-y5 n;  run; 
data temp42; set temp42; scan="laser"; run; 
proc print data=temp42 (obs=20); run; 
proc freq data=temp42; table id; run; 
* ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^; 
* ISOLATE 95MP1506 - 27604; 
proc import datafile='...\nd.95MP1506.s1.txt' 
            out=FI95MP1506s1 dbms=tab replace;  run; 
proc print data=FI95MP1506s1 (obs=8); run; 
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proc import datafile='...\nd.95MP1506.s2.txt' 
            out=FI95MP1506s2 dbms=tab replace;  run; 
proc print data=FI95MP1506s2 (obs=8); run; 
proc import datafile='...\nd.95MP1506.s3.txt' 
            out=FI95MP1506s3 dbms=tab replace;  run; 
proc print data=FI95MP1506s3 (obs=8); run; 
proc import datafile='...\nd.95MP1506.s4.txt' 
            out=FI95MP1506s4 dbms=tab replace;  run; 
proc print data=FI95MP1506s4 (obs=8); run; 
proc import datafile='...\nd.95MP1506.s5.txt' 
            out=FI95MP1506s5 dbms=tab replace;  run; 
proc print data=FI95MP1506s5 (obs=8); run; 
* Sort these data files and combine them into one data set; 
proc sort data=FI95MP1506s1; by id; run; 
proc sort data=FI95MP1506s2; by id; run; 
proc sort data=FI95MP1506s3; by id; run; 
proc sort data=FI95MP1506s4; by id; run; 
proc sort data=FI95MP1506s5; by id; run; 
data FI95MP1506; set FI95MP1506s1 FI95MP1506s2 FI95MP1506s3 FI95MP1506s4 FI95MP1506s5; 
 by id; run; 
* Calculate differences and then mean of diffs; 
data temp51; set FI95MP1506; * calculates Cy3 -Cy5; 
 y1=x1-x2; y2=x3-x4; y3=x5-x6; y4=x7-x8; y5=x9-x10; 
 keep ID y1 y2 y3 y4 y5; run; 
proc print data=temp51 (obs=8); run; 
/* Average differences for each gene */ 
proc sort data=temp51; by ID; run; 
ods listing close; run; 
proc means data=temp51; 
 var y1 y2 y3 y4 y5; by ID; 
 output out=temp51 n=n mean=y1 y2 y3 y4 y5;  run; 
ods listing; run; 
proc print data=temp51 (obs=8); run; 
/* Need to denote if 232 is cy3 or cy5 */ 
data temp52; set temp51; * dye denotes 232 label; 
 isolate='95MP1506'; intensity=y1; dye="cy5"; output; 
 isolate='95MP1506'; intensity=y2; dye="cy3"; output; 
 isolate='95MP1506'; intensity=y3; dye="cy5"; output; 
 isolate='95MP1506'; intensity=y4; dye="cy5"; output; 
 isolate='95MP1506'; intensity=y5; dye="cy3"; output; 
 drop _type_ _freq_ y1-y5 n;  run; 
data temp52; set temp52; scan="laser"; run; 
proc print data=temp52 (obs=20); run; 
proc freq data=temp52; table id; run; 
* ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^; 
* ISOLATE 95MP1507 - 27644; 
proc import datafile='...\nd.95MP1507.s1.txt' 
            out=FI95MP1507s1 dbms=tab replace;  run; 
proc print data=FI95MP1507s1 (obs=8); run; 
proc import datafile='...\nd.95MP1507.s2.txt' 
            out=FI95MP1507s2 dbms=tab replace;  run; 
proc print data=FI95MP1507s2 (obs=8); run; 
proc import datafile='...\nd.95MP1507.s3.txt' 
            out=FI95MP1507s3 dbms=tab replace;  run; 
proc print data=FI95MP1507s3 (obs=8); run; 
proc import datafile='...\nd.95MP1507.s4.txt' 
            out=FI95MP1507s4 dbms=tab replace;  run; 
proc print data=FI95MP1507s4 (obs=8); run; 
proc import datafile='...\nd.95MP1507.s5.txt' 
            out=FI95MP1507s5 dbms=tab replace;  run; 
proc print data=FI95MP1507s5 (obs=8); run; 
* Sort these data files and combine them into one data set; 
proc sort data=FI95MP1507s1; by id; run; 
proc sort data=FI95MP1507s2; by id; run; 
proc sort data=FI95MP1507s3; by id; run; 
proc sort data=FI95MP1507s4; by id; run; 
proc sort data=FI95MP1507s5; by id; run; 
data FI95MP1507; set FI95MP1507s1 FI95MP1507s2 FI95MP1507s3 FI95MP1507s4 FI95MP1507s5; 
 by id; run; 
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* Calculate differences and then mean of diffs; 
data temp61; set FI95MP1507; * calculates Cy3 -Cy5; 
 y1=x1-x2; y2=x3-x4; y3=x5-x6; y4=x7-x8;  y5=x9-x10; 
 keep ID y1 y2 y3 y4 y5; run; 
proc print data=temp61 (obs=8); run; 
/* Average differences for each gene */ 
proc sort data=temp61; by ID; run; 
ods listing close; run; 
proc means data=temp61; 
 var y1 y2 y3 y4 y5; by ID; 
 output out=temp61 n=n mean=y1 y2 y3 y4 y5;  run; 
ods listing; run; 
proc print data=temp61 (obs=8); run; 
/* Need to denote if 232 is cy3 or cy5 */ 
data temp62; set temp61; * dye denotes 232 label; 
 isolate='95MP1507'; intensity=y1; dye="cy5"; output; 
 isolate='95MP1507'; intensity=y2; dye="cy5"; output; 
 isolate='95MP1507'; intensity=y3; dye="cy3"; output; 
 isolate='95MP1507'; intensity=y4; dye="cy3"; output; 
 isolate='95MP1507'; intensity=y5; dye="cy3"; output; 
 drop _type_ _freq_ y1-y5 n;  run; 
data temp62; set temp62; scan="laser"; run; 
proc print data=temp62 (obs=20); run; 
proc freq data=temp62; table id; run; 
* ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^; 
* ISOLATE 95MP1509 - 29024; 
* Note: This first slide should be dropped from the analysis; 
/*; 
proc import datafile='...\nd.95MP1509.s1.txt' 
            out=FI95MP1509s1 dbms=tab replace;  run; 
proc print data=FI95MP1509s1 (obs=8); run; 
proc freq data=FI95MP1509s1; table id; run; 
*/ 
proc import datafile='...\nd.95MP1509.s2.txt' 
            out=FI95MP1509s2 dbms=tab replace;  run; 
proc print data=FI95MP1509s2 (obs=8); run; 
proc import datafile='...\nd.95MP1509.s3.txt' 
            out=FI95MP1509s3 dbms=tab replace;  run; 
proc print data=FI95MP1509s3 (obs=8); run; 
proc import datafile='...\nd.95MP1509.s4.txt' 
            out=FI95MP1509s4 dbms=tab replace;  run; 
proc print data=FI95MP1509s4 (obs=8); run; 
proc import datafile='...\nd.95MP1509.s5.txt' 
            out=FI95MP1509s5 dbms=tab replace;  run; 
proc print data=FI95MP1509s5 (obs=8); run; 
* Sort these data files and combine them into one data set; 
/* proc sort data=FI95MP1509s1; by id; run; */ 
proc sort data=FI95MP1509s2; by id; run; 
proc sort data=FI95MP1509s3; by id; run; 
proc sort data=FI95MP1509s4; by id; run; 
proc sort data=FI95MP1509s5; by id; run; 
data FI95MP1509;  
set /*FI95MP1509s1*/ FI95MP1509s2 FI95MP1509s3 FI95MP1509s4 FI95MP1509s5; 
 by id; run; 
* Calculate differences and then mean of diffs; 
data temp71; set FI95MP1509; * calculates Cy3 -Cy5; 
 *y1=x1-x2; y2=x3-x4; y3=x5-x6; y4=x7-x8; y5=x9-x10; 
 keep ID /*y1*/ y2 y3 y4 y5; run; 
proc print data=temp71 (obs=8); run; 
/* Average differences for each gene */ 
proc sort data=temp71; by ID; run; 
ods listing close; run; 
proc means data=temp71; 
 var /*y1*/ y2 y3 y4 y5; by ID; 
 output out=temp71 n=n mean=/*y1*/ y2 y3 y4 y5;  run; 
ods listing; run; 
proc print data=temp71 (obs=8); run; 
/* Need to denote if 232 is cy3 or cy5 */ 
data temp72; set temp71; * dye denotes 232 label; 
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 /* isolate='95MP1509'; intensity=y1; dye="cy3"; output; */ 
 isolate='95MP1509'; intensity=y2; dye="cy5"; output; 
 isolate='95MP1509'; intensity=y3; dye="cy5"; output; 
 isolate='95MP1509'; intensity=y4; dye="cy3"; output; 
 isolate='95MP1509'; intensity=y5; dye="cy3"; output; 
 drop _type_ _freq_ y2-y5 n;  run; 
data temp72; set temp72; scan="laser"; run; 
proc print data=temp72 (obs=20); run; 
proc freq data=temp72; table id; run; 
* ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^; 
* ISOLATE 95MP1510 - 27926; 
proc import datafile='...\nd.95MP1510.s1.txt' 
            out=FI95MP1510s1 dbms=tab replace;  run; 
proc print data=FI95MP1510s1 (obs=8); run; 
proc import datafile='...\nd.95MP1510.s2.txt' 
            out=FI95MP1510s2 dbms=tab replace;  run; 
proc print data=FI95MP1510s2 (obs=8); run; 
proc import datafile='...\nd.95MP1510.s3.txt' 
            out=FI95MP1510s3 dbms=tab replace;  run; 
proc print data=FI95MP1510s3 (obs=8); run; 
proc import datafile='...\nd.95MP1510.s4.txt' 
            out=FI95MP1510s4 dbms=tab replace;  run; 
proc print data=FI95MP1510s4 (obs=8); run; 
* Sort these data files and combine them into one data set; 
proc sort data=FI95MP1510s1; by id; run; 
proc sort data=FI95MP1510s2; by id; run; 
proc sort data=FI95MP1510s3; by id; run; 
proc sort data=FI95MP1510s4; by id; run; 
data FI95MP1510; set FI95MP1510s1 FI95MP1510s2 FI95MP1510s3 FI95MP1510s4; 
 by id; run; 
* Calculate differences and then mean of diffs; 
data temp81; set FI95MP1510; * calculates Cy3 -Cy5; 
 y1=x1-x2; y2=x3-x4; y3=x5-x6; y4=x7-x8; 
 keep ID y1 y2 y3 y4; run; 
proc print data=temp81 (obs=8); run; 
/* Average differences for each gene */ 
proc sort data=temp81; by ID; run; 
ods listing close; run; 
proc means data=temp81; 
 var y1 y2 y3 y4; by ID; 
 output out=temp81 n=n mean=y1 y2 y3 y4;  run; 
ods listing; run; 
proc print data=temp81 (obs=8); run; 
/* Need to denote if 232 is cy3 or cy5 */ 
data temp82; set temp81; * dye denotes 232 label; 
 isolate='95MP1510'; intensity=y1; dye="cy3"; output; 
 isolate='95MP1510'; intensity=y2; dye="cy5"; output; 
 isolate='95MP1510'; intensity=y3; dye="cy5"; output; 
 isolate='95MP1510'; intensity=y4; dye="cy5"; output; 
 drop _type_ _freq_ y1-y4 n;  run; 
data temp82; set temp82; scan="laser"; run; 
proc print data=temp82 (obs=20); run; 
proc freq data=temp82; table id; run; 
* ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~; 
* Now bring in Mike's White light scanner data; 
* ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~; 
* ISOLATE 05MP2301 - 19245B; 
proc import datafile='...\nd.05MP2301.s1.txt' 
            out=FI05MP2301s1 dbms=tab replace;  run; 
proc print data=FI05MP2301s1 (obs=8); run; 
proc import datafile='...\nd.05MP2301.s2.txt' 
            out=FI05MP2301s2 dbms=tab replace;  run; 
proc print data=FI05MP2301s2 (obs=8); run; 
proc import datafile='...\nd.05MP2301.s3.txt' 
            out=FI05MP2301s3 dbms=tab replace;  run; 
proc print data=FI05MP2301s3 (obs=8); run; 
proc import datafile='...\nd.05MP2301.s4.txt' 
            out=FI05MP2301s4 dbms=tab replace;  run; 
proc print data=FI05MP2301s4 (obs=8); run; 
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* Sort these data files and combine them into one data set; 
proc sort data=FI05MP2301s1; by id; run; 
proc sort data=FI05MP2301s2; by id; run; 
proc sort data=FI05MP2301s3; by id; run; 
proc sort data=FI05MP2301s4; by id; run; 
data FI05MP2301; set FI05MP2301s1 FI05MP2301s2 FI05MP2301s3 FI05MP2301s4; 
 by id; run; 
* Calculate differences and then mean of diffs; 
data temp91; set FI05MP2301; * calculates Cy3 -Cy5; 
 y1=x1-x2; y2=x3-x4; y3=x5-x6; y4=x7-x8; 
 keep ID y1 y2 y3 y4; run; 
proc print data=temp91 (obs=8); run; 
/* Average differences for each gene */ 
proc sort data=temp91; by ID; run; 
ods listing close; run; 
proc means data=temp91; 
 var y1 y2 y3 y4; by ID; 
 output out=temp91 n=n mean=y1 y2 y3 y4;  run; 
ods listing; run; 
proc print data=temp91 (obs=8); run; 
/* Need to denote if 232 is cy3 or cy5 */ 
data temp92; set temp91; * dye denotes 232 label; 
 isolate='05MP2301'; intensity=y1; dye="cy3"; output; 
 isolate='05MP2301'; intensity=y2; dye="cy5"; output; 
 isolate='05MP2301'; intensity=y3; dye="cy3"; output; 
 isolate='05MP2301'; intensity=y4; dye="cy5"; output; 
 drop _type_ _freq_ y1-y4 n;  run; 
data temp92; set temp92; scan="white"; run; 
proc print data=temp92 (obs=20); run; 
proc freq data=temp92; table id; run; 
* ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~; 
* ISOLATE 95MP1501 - 20425B; 
proc import datafile='...\nd.95MP1501.s1.txt' 
            out=FI95MP1501s1 dbms=tab replace;  run; 
proc print data=FI95MP1501s1 (obs=8); run; 
proc import datafile='...\nd.95MP1501.s2.txt' 
            out=FI95MP1501s2 dbms=tab replace;  run; 
proc print data=FI95MP1501s2 (obs=8); run; 
proc import datafile='...\nd.95MP1501.s3.txt' 
            out=FI95MP1501s3 dbms=tab replace;  run; 
proc print data=FI95MP1501s3 (obs=8); run; 
proc import datafile='...\nd.95MP1501.s4.txt' 
            out=FI95MP1501s4 dbms=tab replace;  run; 
proc print data=FI95MP1501s4 (obs=8); run; 
* Sort these data files and combine them into one data set; 
proc sort data=FI95MP1501s1; by id; run; 
proc sort data=FI95MP1501s2; by id; run; 
proc sort data=FI95MP1501s3; by id; run; 
proc sort data=FI95MP1501s4; by id; run; 
data FI95MP1501; set FI95MP1501s1 FI95MP1501s2 FI95MP1501s3 FI95MP1501s4; 
 by id; run; 
* Calculate differences and then mean of diffs; 
data temp101; set FI95MP1501; * calculates Cy3 -Cy5; 
 y1=x1-x2; y2=x3-x4; y3=x5-x6; y4=x7-x8; 
 keep ID y1 y2 y3 y4; run; 
proc print data=temp101 (obs=8); run; 
/* Average differences for each gene */ 
proc sort data=temp101; by ID; run; 
ods listing close; run; 
proc means data=temp101; 
 var y1 y2 y3 y4; by ID; 
 output out=temp101 n=n mean=y1 y2 y3 y4;  run; 
ods listing; run; 
proc print data=temp101 (obs=8); run; 
/* Need to denote if 232 is cy3 or cy5 */ 
data temp102; set temp101; * dye denotes 232 label; 
 isolate='95MP1501'; intensity=y1; dye="cy3"; output; 
 isolate='95MP1501'; intensity=y2; dye="cy5"; output; 
 isolate='95MP1501'; intensity=y3; dye="cy3"; output; 
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 isolate='95MP1501'; intensity=y4; dye="cy5"; output; 
 drop _type_ _freq_ y1-y4 n;  run; 
data temp102; set temp102; scan="white"; run; 
proc print data=temp102 (obs=20); run; 
proc freq data=temp102; table id; run; 
* ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~; 
* ISOLATE 95MP1502 - 21580; 
proc import datafile='...\nd.95MP1502.s1.txt' 
            out=FI95MP1502s1 dbms=tab replace;  run; 
proc print data=FI95MP1502s1 (obs=8); run; 
proc import datafile='...\nd.95MP1502.s2.txt' 
            out=FI95MP1502s2 dbms=tab replace;  run; 
proc print data=FI95MP1502s2 (obs=8); run; 
proc import datafile='...\nd.95MP1502.s3.txt' 
            out=FI95MP1502s3 dbms=tab replace;  run; 
proc print data=FI95MP1502s3 (obs=8); run; 
proc import datafile='...\nd.95MP1502.s4.txt' 
            out=FI95MP1502s4 dbms=tab replace;  run; 
proc print data=FI95MP1502s4 (obs=8); run; 
* Sort these data files and combine them into one data set; 
proc sort data=FI95MP1502s1; by id; run; 
proc sort data=FI95MP1502s2; by id; run; 
proc sort data=FI95MP1502s3; by id; run; 
proc sort data=FI95MP1502s4; by id; run; 
data FI95MP1502; set FI95MP1502s1 FI95MP1502s2 FI95MP1502s3 FI95MP1502s4; 
 by id; run; 
* Calculate differences and then mean of diffs; 
data temp111; set FI95MP1502; * calculates Cy3 -Cy5; 
 y1=x1-x2; y2=x3-x4; y3=x5-x6; y4=x7-x8; 
 keep ID y1 y2 y3 y4; run; 
proc print data=temp111 (obs=8); run; 
/* Average differences for each gene */ 
proc sort data=temp111; by ID; run; 
ods listing close; run; 
proc means data=temp111; 
 var y1 y2 y3 y4; by ID; 
 output out=temp111 n=n mean=y1 y2 y3 y4;  run; 
ods listing; run; 
proc print data=temp111 (obs=8); run; 
/* Need to denote if 232 is cy3 or cy5 */ 
data temp112; set temp111; * dye denotes 232 label; 
 isolate='95MP1502'; intensity=y1; dye="cy3"; output; 
 isolate='95MP1502'; intensity=y2; dye="cy5"; output; 
 isolate='95MP1502'; intensity=y3; dye="cy3"; output; 
 isolate='95MP1502'; intensity=y4; dye="cy5"; output; 
 drop _type_ _freq_ y1-y4 n;  run; 
data temp112; set temp112; scan="white"; run; 
proc print data=temp112 (obs=20); run; 
proc freq data=temp112; table id; run; 
* ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~; 
* ISOLATE 95MP1503 - 23829; 
proc import datafile='...\nd.95MP1503.s1.txt' 
            out=FI95MP1503s1 dbms=tab replace;  run; 
proc print data=FI95MP1503s1 (obs=8); run; 
proc import datafile='...\nd.95MP1503.s2.txt' 
            out=FI95MP1503s2 dbms=tab replace;  run; 
proc print data=FI95MP1503s2 (obs=8); run; 
proc import datafile='...\nd.95MP1503.s3.txt' 
            out=FI95MP1503s3 dbms=tab replace;  run; 
proc print data=FI95MP1503s3 (obs=8); run; 
proc import datafile='...\nd.95MP1503.s4.txt' 
            out=FI95MP1503s4 dbms=tab replace;  run; 
proc print data=FI95MP1503s4 (obs=8); run; 
* Sort these data files and combine them into one data set; 
proc sort data=FI95MP1503s1; by id; run; 
proc sort data=FI95MP1503s2; by id; run; 
proc sort data=FI95MP1503s3; by id; run; 
proc sort data=FI95MP1503s4; by id; run; 
data FI95MP1503; set FI95MP1503s1 FI95MP1503s2 FI95MP1503s3 FI95MP1503s4; 
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 by id; run; 
* Calculate differences and then mean of diffs; 
data temp121; set FI95MP1503; * calculates Cy3 -Cy5; 
 y1=x1-x2; y2=x3-x4; y3=x5-x6; y4=x7-x8; 
 keep ID y1 y2 y3 y4; run; 
proc print data=temp121 (obs=8); run; 
/* Average differences for each gene */ 
proc sort data=temp121; by ID; run; 
ods listing close; run; 
proc means data=temp121; 
 var y1 y2 y3 y4; by ID; 
 output out=temp121 n=n mean=y1 y2 y3 y4;  run; 
ods listing; run; 
proc print data=temp121 (obs=8); run; 
/* Need to denote if 232 is cy3 or cy5 */ 
data temp122; set temp121; * dye denotes 232 label; 
 isolate='95MP1503'; intensity=y1; dye="cy3"; output; 
 isolate='95MP1503'; intensity=y2; dye="cy5"; output; 
 isolate='95MP1503'; intensity=y3; dye="cy3"; output; 
 isolate='95MP1503'; intensity=y4; dye="cy5"; output; 
 drop _type_ _freq_ y1-y4 n;  run; 
data temp122; set temp122; scan="white"; run; 
proc print data=temp122 (obs=20); run; 
proc freq data=temp122; table id; run; 
* ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~; 
* ISOLATE 95MP1508 - 279784; 
proc import datafile='...\nd.95MP1508.s1.txt' 
            out=FI95MP1508s1 dbms=tab replace;  run; 
proc print data=FI95MP1508s1 (obs=8); run; 
proc import datafile='...\nd.95MP1508.s2.txt' 
            out=FI95MP1508s2 dbms=tab replace;  run; 
proc print data=FI95MP1508s2 (obs=8); run; 
proc import datafile='...\nd.95MP1508.s3.txt' 
            out=FI95MP1508s3 dbms=tab replace;  run; 
proc print data=FI95MP1508s3 (obs=8); run; 
proc import datafile='...\nd.95MP1508.s4.txt' 
            out=FI95MP1508s4 dbms=tab replace;  run; 
proc print data=FI95MP1508s4 (obs=8); run; 
* Sort these data files and combine them into one data set; 
proc sort data=FI95MP1508s1; by id; run; 
proc sort data=FI95MP1508s2; by id; run; 
proc sort data=FI95MP1508s3; by id; run; 
proc sort data=FI95MP1508s4; by id; run; 
data FI95MP1508; set FI95MP1508s1 FI95MP1508s2 FI95MP1508s3 FI95MP1508s4; 
 by id; run; 
* Calculate differences and then mean of diffs; 
data temp131; set FI95MP1508; * calculates Cy3 -Cy5; 
 y1=x1-x2; y2=x3-x4; y3=x5-x6; y4=x7-x8; 
 keep ID y1 y2 y3 y4; run; 
proc print data=temp131 (obs=8); run; 
/* Average differences for each gene */ 
proc sort data=temp131; by ID; run; 
ods listing close; run; 
proc means data=temp131; 
 var y1 y2 y3 y4; by ID; 
 output out=temp131 n=n mean=y1 y2 y3 y4;  run; 
ods listing; run; 
proc print data=temp131 (obs=8); run; 
/* Need to denote if 232 is cy3 or cy5 */ 
data temp132; set temp131; * dye denotes 232 label; 
 isolate='95MP1508'; intensity=y1; dye="cy3"; output; 
 isolate='95MP1508'; intensity=y2; dye="cy5"; output; 
 isolate='95MP1508'; intensity=y3; dye="cy3"; output; 
 isolate='95MP1508'; intensity=y4; dye="cy5"; output; 
 drop _type_ _freq_ y1-y4 n;  run; 
data temp132; set temp132; scan="white"; run; 
proc print data=temp132 (obs=20); run; 
proc freq data=temp132; table id; run; 
* ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~; 
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* ISOLATE 97MP0001 - 23129B; 
proc import datafile='...\nd.97MP0001.s1.txt' 
            out=FI97MP0001s1 dbms=tab replace;  run; 
proc print data=FI97MP0001s1 (obs=8); run; 
proc import datafile='...\nd.97MP0001.s2.txt' 
            out=FI97MP0001s2 dbms=tab replace;  run; 
proc print data=FI97MP0001s2 (obs=8); run; 
proc import datafile='...\nd.97MP0001.s3.txt' 
            out=FI97MP0001s3 dbms=tab replace;  run; 
proc print data=FI97MP0001s3 (obs=8); run; 
proc import datafile='...\nd.97MP0001.s4.txt' 
            out=FI97MP0001s4 dbms=tab replace;  run; 
proc print data=FI97MP0001s4 (obs=8); run; 
* Sort these data files and combine them into one data set; 
proc sort data=FI97MP0001s1; by id; run; 
proc sort data=FI97MP0001s2; by id; run; 
proc sort data=FI97MP0001s3; by id; run; 
proc sort data=FI97MP0001s4; by id; run; 
data FI97MP0001; set FI97MP0001s1 FI97MP0001s2 FI97MP0001s3 FI97MP0001s4; 
 by id; run; 
* Calculate differences and then mean of diffs; 
data temp141; set FI97MP0001; * calculates Cy3 -Cy5; 
 y1=x1-x2; y2=x3-x4; y3=x5-x6; y4=x7-x8; 
 keep ID y1 y2 y3 y4; run; 
proc print data=temp141 (obs=8); run; 
/* Average differences for each gene */ 
proc sort data=temp141; by ID; run; 
ods listing close; run; 
proc means data=temp141; 
 var y1 y2 y3 y4; by ID; 
 output out=temp141 n=n mean=y1 y2 y3 y4;  run; 
ods listing; run; 
proc print data=temp141 (obs=8); run; 
/* Need to denote if 232 is cy3 or cy5 */ 
data temp142; set temp141; * dye denotes 232 label; 
 isolate='97MP0001'; intensity=y1; dye="cy3"; output; 
 isolate='97MP0001'; intensity=y2; dye="cy5"; output; 
 isolate='97MP0001'; intensity=y3; dye="cy5"; output; 
 isolate='97MP0001'; intensity=y4; dye="cy3"; output; 
 drop _type_ _freq_ y1-y4 n;  run; 
data temp142; set temp142; scan="white"; run; 
proc print data=temp142 (obs=20); run; 
proc freq data=temp142; table id; run; 
* %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%; 
/* combine all the data sets */ 
data all; set temp12 temp22 temp32 temp42 temp52 temp62 temp72 temp82 temp92 temp102 temp112 
temp122 temp132 temp142; 
  by isolate;  run; 
* Drop IDs that aren't going to be analyzed; 
data all; set all; 
 if ID='NAGINA' then delete; 
 if ID='gapA' then delete; 
 if ID='pvp' then delete; 
 if ID='spotbuff' then delete; 
 if ID='spotbu' then delete; 
 if ID='blank' then delete;  run; 
* Delete genes not being submitted in the primer sequence, these are not on the 2005 slides; 
data all; set all; 
 if id='mhp045' then delete; 
 if id='mhp051' then delete; 
 if id='mhp055' then delete; 
 if id='mhp063' then delete; 
 if id='mhp068' then delete; 
 if id='mhp074' then delete; 
 if id='mhp266' then delete; 
 if id='mhp272' then delete; 
 if id='mhp426' then delete; 
 if id='mhp463' then delete; 
 if id='mhp534' then delete; 
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 if id='mhp573' then delete; 
 if id='mhp587' then delete; 
 if id='mhp626' then delete;  run; 
proc freq data=all; 
 table isolate isolate*id;  run; 
proc export data=all 
  outfile='…\FImeans.txt' 
     dbms=tab replace;  run; 
DM 'LOG;CLEAR;OUTPUT;CLEAR;'; 
OPTIONS NODATE NONUMBER FORMDLIM= '_' LS=85 ; TITLE ; ; 
/* Import the normalized difference means and analyze by scanner type */ 
proc import datafile='…\FImeans.txt' 
            out=means dbms=tab replace; run; 
/* need to code X matrix */ 
data means; set means; 
  x1=0; 
 if isolate='00MP1301' and dye='cy3' then x1=1; 
 if isolate='00MP1301' and dye='cy5' then x1=-1; 
  x2=0; 
 if isolate='00MP1502' and dye='cy3' then x2=1; 
 if isolate='00MP1502' and dye='cy5' then x2=-1; 
  x3=0; 
 if isolate='95MP1504' and dye='cy3' then x3=1; 
 if isolate='95MP1504' and dye='cy5' then x3=-1; 
  x4=0; 
 if isolate='95MP1505' and dye='cy3' then x4=1; 
 if isolate='95MP1505' and dye='cy5' then x4=-1; 
  x5=0; 
 if isolate='95MP1506' and dye='cy3' then x5=1; 
 if isolate='95MP1506' and dye='cy5' then x5=-1; 
  x6=0; 
 if isolate='95MP1507' and dye='cy3' then x6=1; 
 if isolate='95MP1507' and dye='cy5' then x6=-1; 
  x7=0; 
 if isolate='95MP1509' and dye='cy3' then x7=1; 
 if isolate='95MP1509' and dye='cy5' then x7=-1; 
  x8=0; 
 if isolate='95MP1510' and dye='cy3' then x8=1; 
 if isolate='95MP1510' and dye='cy5' then x8=-1; 
  x9=0; 
 if isolate='05MP2301' and dye='cy3' then x9=1; 
 if isolate='05MP2301' and dye='cy5' then x9=-1; 
  x10=0; 
 if isolate='95MP1501' and dye='cy3' then x10=1; 
 if isolate='95MP1501' and dye='cy5' then x10=-1; 
  x11=0; 
 if isolate='95MP1502' and dye='cy3' then x11=1; 
 if isolate='95MP1502' and dye='cy5' then x11=-1; 
  x12=0; 
 if isolate='95MP1503' and dye='cy3' then x12=1; 
 if isolate='95MP1503' and dye='cy5' then x12=-1; 
  x13=0; 
 if isolate='95MP1508' and dye='cy3' then x13=1; 
 if isolate='95MP1508' and dye='cy5' then x13=-1; 
  x14=0; 
 if isolate='97MP0001' and dye='cy3' then x14=1; 
 if isolate='97MP0001' and dye='cy5' then x14=-1;  run; 
proc sort data=means;  by scan; run; 
proc print data=means (obs=10); run; 
/*the data for a single gene*/ 
data onegene; set means; if ID='mhp001';  run; 
proc print data=onegene; run; 
* Analyze one gene; 
proc glm data=onegene; 
 model intensity = x1 x2 x3 x4 x5 x6 x7 x8 x9 x10 x11 x12 x13 x14; 
 ods output ParameterEstimates=estonegene; 
 output out=check r=residual p=predicted;  
 by scan;  run; 
proc print data=check; run; 
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data estone; set estonegene; 
 FI='temporar'; * makes the column FI big enough; 
 if parameter='Intercept' then FI='dye'; 
 if parameter='x1' then FI='00MP1301'; 
 if parameter='x2' then FI='00MP1502'; 
 if parameter='x3' then FI='95MP1504'; 
 if parameter='x4' then FI='95MP1505'; 
 if parameter='x5' then FI='95MP1506'; 
 if parameter='x6' then FI='95MP1507'; 
 if parameter='x7' then FI='95MP1509'; 
 if parameter='x8' then FI='95MP1510'; 
 if parameter='x9' then FI='05MP2301'; 
 if parameter='x10' then FI='95MP1501'; 
 if parameter='x11' then FI='95MP1502'; 
 if parameter='x12' then FI='95MP1503'; 
 if parameter='x13' then FI='95MP1508'; 
 if parameter='x14' then FI='97MP0001';  run; 
proc print data=estone;  run; 
/* Looks ok, do all genes */ 
proc sort data=means; by scan id;  run; 
ods listing close; run; 
proc glm data=means; 
 model intensity = x1 x2 x3 x4 x5 x6 x7 x8 x9 x10 x11 x12 x13 x14; 
 ods output ParameterEstimates=est; 
 output out=check r=residual p=predicted;  
 by scan id;  run; 
ods listing; run; 
data est; set est; 
  p=1*probt; 
  drop probt;   run; 
data est; set est; 
 FI='temporar'; * makes the column FI big enough; 
 if parameter='Intercept' then FI='dye'; 
 if parameter='x1' then FI='00MP1301'; 
 if parameter='x2' then FI='00MP1502'; 
 if parameter='x3' then FI='95MP1504'; 
 if parameter='x4' then FI='95MP1505'; 
 if parameter='x5' then FI='95MP1506'; 
 if parameter='x6' then FI='95MP1507'; 
 if parameter='x7' then FI='95MP1509'; 
 if parameter='x8' then FI='95MP1510'; 
 if parameter='x9' then FI='05MP2301'; 
 if parameter='x10' then FI='95MP1501'; 
 if parameter='x11' then FI='95MP1502'; 
 if parameter='x12' then FI='95MP1503'; 
 if parameter='x13' then FI='95MP1508'; 
 if parameter='x14' then FI='97MP0001';  run; 
data est2; set est; 
 if FI='dye' then delete;  run; 
proc export data=est2 
            outfile='…\est2side.final.txt' 
            dbms=tab replace; run; 
proc export data=check 
            outfile='…\residuals.final.txt' 
            dbms=tab replace; run; 
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APPENDIX B. CUSTOM R FUNCTIONS 
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bh.fdr.R 
`bh.fdr` <- 
function(p) 
{ 
# 
#This function computes q-values using Benjamini and Hochberg's (1995) 
#approach for controlling FDR. 
# 
#Author: Dan Nettleton 
# 
  m = length(p) 
  k = 1:m 
  ord = order(p) 
  p[ord] = (p[ord] * m)/(1:m) 
  qval = p 
  for(i in (m-1):1) { 
    qval[ord[i]] = min(c(qval[ord[i]],qval[ord[i+1]])) 
  } 
  return(qval) 
} 
 
compress.R 
`compress` <- 
function (d,cols)  
{ 
# 
#d is a matrix containing log-scale background-corrected expression. 
#One column per scans.  Scans from the same channel appear consecutively. 
#Channels from the same slide appear together. 
#cols is a vector that tells how many scans correspond to each channel. 
#For example cols=c(3,4,3,3) would indicated a total of 4 channels on 
#2 slides. The first channel has 3 scans, the next 4, and last two channels 
#on the second slide have 3 scans each. 
# 
  m=length(cols) 
  x=matrix(0,nrow=nrow(d),ncol=m) 
  end=cumsum(cols) 
  start=c(1,end[-m]+1) 
  for(i in 1:m){ 
    if(cols[i]>1){ 
      z=d[,start[i]:end[i]] 
      medians=apply(z,2,median) 
      center=median(medians) 
      z=sweep(z,2,medians)+center 
      x[,i]=apply(z,1,median) 
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    } 
    else{ 
      x[,i]=d[,end[i]] 
    } 
  } 
  return(x) 
} 
 
 
cum.mean.R 
`cum.mean` <- 
function(x) 
{ 
# 
#x is a vector. 
#The function returns the vector whose ith component is the mean of 
#x[1],...,x[i] 
# 
  n <- length(x) 
  return(cumsum(x)/(1:n)) 
} 
 
 
log.0.R 
`log.0` <- 
function(x) 
{ 
# 
#Replaces all negative values with 0. 
#Adds 1 to all values. 
#Takes natural log of the result. 
#Any value that was originally less than or equal to 0 
#will end up as 0.  Any value that was positive will 
#remain positive.  The rank order of values will remain 
#the same except that all values originally less than 
#or equal to 0 will become tied at 0. 
# 
  x[x<0]=0   
  y=log(1+x) 
  return(y) 
} 
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msn.R 
`msn` <- 
function (signal,bkgrd=NULL,sector=NULL,scale=F,center=0,frac=.4)  
{ 
# 
#Performs Lowess normalization for each of several slides. 
#All channels will be aligned to a common median equal to 
#the value of center. 
#Lowess normalization will be done separately for each sector if 
#a vector indicating sectors is passed as the sector argument. 
#signal is a matrix of signals with one column for each channel. 
#The columns should be sorted by slide and then by dye so that 
#consecutive columns correspond to a single slide.  If background 
#subtraction is desired a matrix of backgrounds with columns that 
#correspond to the columns of signal should be passed as the bkgrd 
#argument.  Scale normalization will be carried out if scale is set 
#to true.  The data fraction associated with lowess normalization 
#is controlled by frac.  frac=0.4 was recommended by Yang et al. 
#(2002).  The higher the frac value the smoother the lowess curve. 
# 
#Author: Dan Nettleton 
# 
  nslides=ncol(signal)/2 
  if(!is.null(bkgrd)){ 
    signal=signal-bkgrd 
  } 
  if(min(signal)>0){ 
    d=log(signal) 
  } 
  else{ 
    d=log.0(signal) 
  } 
  if(is.null(sector)){ 
    for(i in 1:nslides){ 
      out<-normalize(d[,2*i-1],d[,2*i],frac=frac) 
      d[,2*i-1]<-out$norm.green 
      d[,2*i]<-out$norm.red   
    } 
  }  
  else{ 
    for(i in 1:nslides){ 
      out<-norm.by.sector(cbind(d[,2*i-1],d[,2*i],sector,frac=frac)) 
      d[,2*i-1]<-out$norm.green 
      d[,2*i]<-out$norm.red 
    }   
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  } 
  slide.medians<-apply(d,2,median) 
  d=sweep(d,2,slide.medians) 
  d=d+center 
  if(scale){ 
    d=scale.norm(d) 
  } 
  return(d)   
} 
 
 
normalize.R 
`normalize` <- 
function(loggreen, logred, frac = 0.4) 
{ 
# 
#Performs Lowess normalization of data from a 
#single slide.  This function is called by msn. 
# 
#Author: Dan Nettleton 
# 
  M <- logred - loggreen 
  A <- 0.5 * (logred + loggreen) 
  ord<-order(A) 
  adj<-rep(0,length(loggreen)) 
  adj[ord] <- lowess(A, M, f = frac)$y 
  norm.red <- logred - adj/2 
  norm.green <- loggreen + adj/2 
  return(list(norm.green=norm.green,norm.red=norm.red)) 
} 
 
 
plot.gene.R 
`plot.gene` <- 
function (d,gene) 
{ 
# 
#Plots the data for a single gene. 
#Each point is color coded according to dye. 
#The two data points from a single spot are connected by a line. 
# 
#d is a matrix of data.  The first column of d contains the gene IDs. 
#The subsequent columns contain the data for each channel in the dataset. 
#The columns are sorted by slide and then dye 
#(slide1cy3,slide1cy5,slide2cy3,slide2cy5,...). 
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#The function assumes two treatments. 
#The first half of the slides are assumed to be cy3trt1,cy5trt2. 
#The last half of the slides are assumed to be cy3trt2,cy5trt1. 
# 
#Author:  Dan Nettleton 
# 
  nslides=ncol(d[,-1])/2 
  slide=rep(1:nslides,rep(2,nslides)) 
  dye=rep(c(3,5),nslides) 
  trt=c(rep(c(1,2),nslides/2),rep(c(2,1),nslides/2))   
  y=d[d[,1]==gene,-1] 
  col=(9-dye)/2 
  plot(trt,y,pch=16,col=col,xlab="Treatment", 
       ylab="Normalized Log Signal",axes=F,xlim=range(trt)+c(-.25,.25)) 
  title(paste("Normalized Data for Gene",gene)) 
  axis(1,labels=trt,at=trt) 
  axis(2) 
  box() 
  for(j in 1:nslides){ 
    lines(trt[slide==j],y[slide==j]) 
  } 
} 
 
q.value.R 
`q.value` <- 
function(p, lambda=seq(0,0.95,0.05)) { 
# 
#This is Storey and Tibshirani's (PNAS, 2003) default method 
#for determining the q-values. 
# 
#Code was originally obtained from John Storey's Web site. 
#It has been edited slightly. 
# 
  m<-length(p)  
  pi0 <- rep(0,length(lambda)) 
  for(i in 1:length(lambda)) { 
    pi0[i] <- mean(p >= lambda[i])/(1-lambda[i]) 
  } 
  spi0 <- smooth.spline(lambda,pi0,df=3) 
  pi0 <- max(predict(spi0,x=1)$y,0) 
  pi0 <- min(pi0,1) 
  u <- order(p) 
  v <- rank(p) 
  qvalue <- pi0*m*p/v 
  qvalue[u[m]] <- min(qvalue[u[m]],1) 
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  for(i in (m-1):1) { 
    qvalue[u[i]] <- min(qvalue[u[i]],qvalue[u[i+1]],1) 
  } 
  return(qvalue) 
} 
 
 
slide.comp.R 
`slide.comp` <- 
function(d,slide,diagonal=T) 
{ 
# 
#Makes a scatter plot of data to compare the 
#channels on a microarray slide. 
#d is a matrix of log scale expression measures. 
#Columns correspond to channels.  Columns should be sorted by slide. 
#If diagonal=F, MA plots will be produced. 
# 
#Author:  Dan Nettleton 
# 
  index<-(1:2)+2*(slide-1) 
  x<-d[,index[1]] 
  y<-d[,index[2]] 
  par(pty = "s") 
  r <- range(c(x, y)) 
  if(diagonal){ 
    plot(x, y, xlim = r, ylim = r) 
    lines(r, r,lwd=2,col=2) 
  } 
  else{ 
    par(pty = "m") 
    M <- y - x 
    A <- 0.5 * (x + y) 
    plot(A, M) 
    lines(c(-9999, 9999), c(0, 0),lwd=2,col=2) 
  } 
} 
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